BP 2014 Index

page numbers in bold type relate to monograph titles Index V-A767
Index
Page numbers in bold type relate to monograph titles.
Pages – Vol I: i – xxxiv, (Preliminaries and Introduction)

1 – 1250, (General Notices and Monographs)
Pages – Vol II: i – viii, (Preliminaries)
Pages – Vol III: i – viii, (Preliminaries)
Pages – Vol IV: i – viii, (Preliminaries)
Pages – Vol V: i – viii, (Preliminaries)
1 – 34, (General Notices)
S1 – S144, (Spectra)
A1 – A766, (Appendices; Supplementary Chapters)
Acetate Buffer Solution pH 4.6, see N-Acetyl-L-cysteine, V-A20

A Acetate Buffer pH 4.6 N-Acetylneuraminic Acid, V-A21
Abacavir, V-S4 Acetate Buffer Solution pH 6.0, see Acetylsalicylic Acid Tablets, see Aspirin
Abacavir Oral Solution, III-83 Acetate Buffer pH 6.0 Tablets
Abacavir Sulfate, I-39 Acetate Buffer Solution pH 4.4, V-A150 Acetylsalicylic Acid, see Aspirin
Abacavir Tablets, III-84 Acetate Buffer Solution pH 4.5, V-A150 Acetyltryptophan, I-64, V-A21
Abbreviated, V-A579 Acetate Buffer Solution pH 4.7, V-A150 N-Acetyltryptophan, see Acetyltryptophan
Adjectives, V-A579 Acetate Buffer Solution pH 5.0, V-A150 Acetyltyrosine, I-66
Anions, V-A579 Acetate Buffer Solution pH 6.0, V-A150 Acetyltyrosine Ethyl Ester, V-A21
Cations, V-A579 Acetate–edetate Buffer Solution pH 5.5, Acetyltyrosine Ethyl Ester, 0.2M, V-A21
Preparations, V-A579 V-A150 N-Acetyltyrosine, see Acetyltyrosine
Titles of Monographs, V-A579 Acetates, Reactions of, V-A255 Aciclovir, I-67
Abbreviated Titles, Status of, I-7, II-7, Acetazolamide, I-54, V-S5 Aciclovir Cream, III-91
III-7, IV-7, V-7 Acetazolamide Oral Suspension, III-87 Aciclovir Eye Ointment, III-92
Abnormal Toxicity, Test for, V-A395 Acetazolamide Tablets, III-88 Aciclovir Infusion, III-93
About, definition of, I-5, II-5, III-5, Acetic Acid, V-A19 Aciclovir Intravenous Infusion, see
IV-5, V-5 Acetic Acid (6 per cent), I-56 Aciclovir Infusion,
Absolute Alcohol, see Ethanol Acetic Acid (33 per cent), I-57 Aciclovir Oral Suspension, III-94
Absolute Ethanol, V-A61 Acetic Acid, Anhydrous, V-A20 Aciclovir Sodium for Infusion, III-93
Absolute Ethanol R1, V-A61 Acetic Acid, Deuterated, V-A49 Aciclovir Sodium for Intravenous
Absolute viscometers, V-A245, V-A246 Acetic Acid, Dilute, V-A20 Infusion, see Aciclovir Sodium for
Absorbable Braided Sutures, Sterile Acetic Acid, Dilute, see Acetic Acid Infusion,
Synthetic, IV-723 (6 per cent) Aciclovir Tablets, III-96
Absorbable Monofilament Sutures, Acetic Acid, Glacial, V-A20 Aciclovir Tablets, Dispersible, III-97
Sterile Synthetic, IV-724 Acetic Acid in Synthetic Peptides, Acicular, V-A504
Absorbent Cotton, IV-719 Determination of, V-A286 Acid Blue 92, V-A21
Absorbent Viscose Wadding, IV-720 Acetic Acid VS, V-A139 Acid Blue 92 Solution, V-A21
Absorption spectrophotometry, infrared, Acetic Acid, see Acetic Acid (33 per cent) Acid Blue 83, V-A21
V-A159 Acetic Anhydride, V-A20 Acid Blue 93 Solution, V-A21
Absorption Spectrophotometry, Acetic Anhydride Solution R1, V-A20 Acid Blue 90, V-A21
Ultraviolet and Visible, V-A165 Acetic Anhydride–Dioxan Solution, Acid Gentian Mixture, IV-191
Acacia, I-41, V-A19 V-A20 Acid Gentian Oral Solution, IV-191
Acacia Solution, V-A19 Acetic Anhydride–Sulfuric Acid Solution, Acid Potassium Iodobismuthate
Acacia, Spray-dried, I-42 V-A20 Solution, V-A106
Acamprosate Calcium, I-43 Acetic Anhydride–Sulphuric Acid Acid Value, V-A304
Acanthopanax Bark, IV-49 Solution, see Acetic Anhydride–Sulfuric Acid/base Indicators, V-A760
Acarbose, I-44 Acid Solution Acid-base titrations, V-A759
Accuracy, V-A654 Acetic Bromine Solution, V-A34 Acidified Chloroform, V-A41
Acebutolol Capsules, III-85 Acetone, I-57, V-A20 Acidified Dichloromethane, V-A52
Acebutolol Hydrochloride, I-46, V-S5, Acetone, Deuterated, V-A49 Acidified Methanol, V-A84
V-A19 Acetone Solution, Buffered, V-A150 Acidified Methylene Chloride, see
Acebutolol Tablets, III-86 Acetone-dried Ox Brain, V-A97 Acidified Dichloromethane
Aceclofenac, I-48 Acetonitrile, V-A20 Acid-insoluble Ash, Determination of,
Acemetacin, I-50 Acetonitrile for Chromatography, V-A20 V-A322
Acenocoumarol, I-52, V-S5 Acetonitrile R1, V-A20 Acid-washed Diatomaceous Support,
Acenocoumarol Tablets, III-86 Acetoxyvalerenic Acid, V-A20 V-A50
Acesulfame Potassium, I-53 Acetyl Chloride, V-A20 Acitretin, I-69
Acetal, V-A19 Acetyl groups (O) in Polysaccharide Acitretin Capsules, III-98
Acetaldehyde, V-A19 Vaccines, V-A450 Acknowledgements, I-xxvii
Acetaldehyde Ammonia Trimer Acetyl Groups, Reactions of, V-A255 Acrylamide, V-A21
Trihydrate, V-A19 Acetyl Value, Determination of, V-A304, Acrylamide/bisacrylamide (29:1)
Acetaldehyde Standard Solution V-A305, V-A306, V-A307, V-A308, Solution, 30 per cent, V-A21
(100 ppm C2H4O), V-A145 V-A309, V-A310, V-A311, V-A312, Acrylamide/bisacrylamide (36.5:1)
Acetaldehyde Standard Solution V-A313, V-A314, V-A315, V-A316, Solution, 30 per cent, V-A21
(100 ppm C2H4O) R1, V-A145 V-A317, V-A318 Acrylic Acid, V-A21
Acetamide, V-A19 Acetylacetamide, V-A20 Actein, V-A21
Acetaminophen, see Paracetamol Acetylacetone, V-A20 Acteoside, V-A21
Acetate Buffer pH 2.8, V-A150 Acetylacetone Reagent R1, V-A20 Action and Use Statement, Status of,
Acetate Buffer pH 2.45, V-A150 Acetylacetone Reagent R2, V-A20 I-17, II-17, III-17, IV-17, V-17
Acetate Buffer pH 3.4, V-A150 4-Acetylbiphenyl, V-A20 Activated Acid Aluminium Oxide, V-A23
Acetate Buffer pH 3.5, V-A150 N-Acetyl-e-caprolactam, V-A20 Activated Attapulgite, I-215
Acetate Buffer pH 3.7, V-A150 Acetylcholine Chloride, I-58, V-A20 Activated Charcoal, I-489, V-A40
Acetate Buffer pH 4.4, V-A150 Acetylcysteine, I-59, V-S6 Activated coagulation factors, V-A406
Acetate Buffer pH 4.6, V-A150 Acetylcysteine Eye Drops, III-88 Activated protein C chromogenic
Acetate Buffer pH 5.0, V-A150 Acetylcysteine Injection, III-89 substrate, V-A410
Acetate Buffer pH 6.0, V-A150 Acetyldigoxin, I-61 Activated Zinc, V-A138
Acetate Buffer Solution pH 4.7 R1, b-Acetyldigoxin, see Acetyldigoxin Active Moiety, V-A631
V-A150 Acetyleugenol, V-A20 Active Substances, I-37, II-37, III-37,
Acetate Buffer Solution pH 4.4, see N-Acetylglucosamine, V-A20 IV-37, see also Substances for
Acetate Buffer pH 4.4 Acetyl-11-keto-b-boswellic Acid, V-A20 Pharmaceutical Use
V-A770 Index
Adamantane, V-A21 Diphtheria, Tetanus, Pertussis (Acellular Alcoholic Dimethylaminobenzaldehyde

Adapalene, I-71 Component) and Inactivated Poliomyelitis Solution, V-A55
Adapalene Cream, III-99 Vaccine, (Adsorbed) Alcoholic Hydroxylamine Solution,
Adapalene Gel, III-100 Adsorbed Diphtheria Vaccine for Adults V-A73
Additions, List of, I-xxviii and Adolescents, see Diphtheria Vaccine Alcoholic Iodine Solution, III-675,
Additions, List of Monographs, I-xxii (Adsorbed, Reduced Antigen Content) V-A74
Additives, Plastic, V-A573 Adsorbed Diphtheria Vaccine, see Alcoholic Potassium Hydroxide, 2M,
Adenine, I-72, V-A21 Diphtheria Vaccine, Adsorbed V-A106
Adeno-associated-virus Vectors for Adsorbed Pertussis Vaccine (Acellular Alcoholic Potassium Hydroxide, see
Human Use, V-A742 Component), IV-581 Potassium Hydroxide VS, Ethanolic
Adenosine, I-74, V-A21 Adsorbed Pertussis Vaccine (Acellular, Alcoholic Potassium Hydroxide Solution,
Adenovirus Vectors for Human Use, Co-purified), IV-582 V-A106
V-A736 Adsorbed Tetanus Vaccine, IV-609 Alcoholic Potassium Hydroxide Solution
Adipic Acid, I-75, V-A21 Adsorbed Vaccines, Aluminium in, R1, V-A106
Adrenaline, I-76, V-A21 V-A446 Alcoholic Solution of Sulfuric Acid,
Adrenaline Acid Tartrate, I-78, V-A21 Adsorbed Vaccines, Calcium in, V-A447 V-A126
Adrenaline and Cocaine Intranasal Aerodynamic Assessment of Fine Alcoholic Sulfuric Acid, 0.25M, V-A126
Solution, III-105 Particles, V-A361 Alcoholimetric Tables, V-A667
Adrenaline (Epinephrine), V-S6 Aescin, V-A21 Alcohol, see Ethanol (96%)
Adrenaline Eye Drops, Epinephrine Eye Aflatoxin B1 in Herbal Drugs, Alcuronium Chloride, I-85
Drops, Neutral, III-102 Determination of, V-A327 Aldehyde Dehydrogenase, V-A22
Adrenaline Eye Drops/Epinephrine Eye Aflatoxin B1, V-A22 Aldehyde Dehydrogenase Solution,
Drops, III-102 Agar, I-79, V-A22 V-A22
Adrenaline Injection, Bupivacaine and, Agarose for Chromatography, V-A22 Aldehyde-free alcohol, see Ethanol (96%),
III-218 Agarose for Chromatography, Cross- Aldehyde-free
Adrenaline Injection, Dilute (1 in linked, V-A22 Aldehyde-free Ethanol (96%), V-A61
10,000), III-103 Agarose for Chromatography R1, Cross- Aldehyde-free Methanol, V-A84
Adrenaline Injection, Lidocaine and, linked, V-A22 Aldehydes, Determination of, V-A308
III-729 Agarose for Electrophoresis, V-A22 Aldrin, V-A22
Adrenaline Injection/Epinephrine Agarose/Cross-linked Polyacrylamide, Alendronate Sodium Tablets, see
Injection, III-103 V-A22 Alendronic Acid Tablets
Adrenaline Solution/Epinephrine Agarose-DEAE for Ion Exchange Alendronic Acid Tablets, III-107
Solution, III-104 Chromatography, V-A22 Aleuritic Acid, V-A22
Adrenaline Tartrate Agglomerate, V-A504 Alexandrian Senna Fruit, IV-349
Injection/Epinephrine Tartrate Aggregate, V-A504 Alexandrian Senna Pods, see Alexandrian
Injection, III-103 Agnus Castus Fruit, IV-50 Senna Fruit
Adrenaline Tartrate Agrimony, IV-52 Alfacalcidol, I-87
Solution/Epinephrine Tartrate Air, Medical, I-80 Alfadex, I-88
Solution, III-104 Air Permeability, Specific Surface Area Alfentanil Hydrochloride, I-90
Adrenaline Tartrate, see Adrenaline Acid by, V-A487 Alfuzosin, V-S7
Tartrate Air, Synthetic, I-82 Alfuzosin Hydrochloride, I-91
Adrenalone Hydrochloride, V-A21 Air, Synthetic Medicinal, see Synthetic Air Alfuzosin Tablets, III-109
Adsorbed Diphtheria and Tetanus Airtight Container, V-A530 Alfuzosin Tablets, Prolonged-release,
Vaccine for Adults and Adolescents, Airtight container, Definition of, I-28, III-110
see Diphtheria and Tetanus Vaccine II-28, III-28, IV-28, V-28 Alginate Antacid Oral Suspension,
(Adsorbed, Reduced Antigen(s) Content) Alanine, I-83, V-A22 Compound, III-111
Adsorbed Diphtheria and Tetanus ß-Alanine, see 3-Aminopropionic Acid Alginate Oral Suspension, Raft-forming,
Vaccine, see Diptheria and Tetanus Albendazole, I-84 III-112
Vaccine, (Adsorbed) Albumin, Bovine, V-A22 Alginate Raft-forming Oral Suspension,
Adsorbed Diphtheria, Tetanus and Albumin, Bovine R1, V-A22 III-112
Pertussis (Acellular Component) Albumin, Human, V-A22 Alginic Acid, I-92
Vaccine, see Diphtheria, Tetanus and Albumin Injection, Iodinated (125I), Alimemazine, V-S7
Pertussis (Acellular Component) Vaccine, IV-648 Alimemazine Oral Solution, Paediatric,
(Adsorbed) Albumin Solution, IV-455 III-113
Adsorbed Diphtheria, Tetanus, Pertussis Albumin Solution, Human, V-A22 Alimemazine Tablets, III-114
(Acellular Component) and Albumin Solution R1, Human, V-A22 Alimemazine Tartrate, I-93
Haemophilus Type b Conjugate Albumin, see Albumin Solution Alizarin S, V-A22
Vaccine, see Diphtheria, Tetanus, Alchemilla, IV-53 Alizarin S Solution, V-A22
Pertussis (Acellular Component) and Alcohol (20 per cent), I-884 Alkaline Corallin Solution, V-A46
Haemophilus Type b Conjugate Vaccine, Alcohol (25 per cent), I-884 Alkaline Eye Drops, see Hypromellose Eye
(Adsorbed) Alcohol (45 per cent), I-884 Drops
Adsorbed Diphtheria, Tetanus, Pertussis Alcohol (50 per cent), I-884 Alkaline Gentian Mixture, IV-192
(Acellular Component) and Hepatitis Alcohol (60 per cent), I-884 Alkaline Gentian Oral Solution, IV-192
B (rDNA) Vaccine, see Diphtheria, Alcohol (70 per cent), I-884 Alkaline Hydroxylamine Solution, V-A73
Tetanus, Pertussis (Acellular Component) Alcohol (80 per cent), I-884 Alkaline Hydroxylamine Solution R1,
and Hepatitis B (rDNA) Vaccine, Alcohol (90 per cent), I-884 V-A73
(Adsorbed) Alcohol, Aldehyde-free, see Ethanol Alkaline Potassium Mercuri-iodide
Adsorbed Diphtheria, Tetanus, Pertussis (96%), Aldehyde-free Solution, V-A107
(Acellular Component) and Alcoholic Calcium Standard Solution Alkaline Potassium Tetraiodomercurate
Inactivated Poliomyelitis Vaccine, see (100 ppm Ca), V-A146 Solution, V-A107
Alkaline Pyrogallol Solution, V-A109 Aluminium Hydroxide Tablets, see Amiloride Hydrochloride, I-137
Alkaline Sodium Picrate Solution, Chewable Aluminium Hydroxide Tablets Amiloride Tablets, III-123
V-A122 Aluminium in Adsorbed Vaccines, Amines, Primary Aromatic, Reactions of,
Alkaline Tetrazolium Blue Solution, V-A446 V-A255
V-A129 Aluminium, Limit Test for, V-A259 Amino Acid Analysis, Apparatus,
Alkali-washed Diatomaceous Support, Aluminium Magnesium Silicate, I-117 V-A218
V-A50 Aluminium Nitrate, V-A23 Amino Acid Analysis, Calibration of
Alkaloids, Complete Extraction of, Aluminium Oxide, Activated Acid, Instrumentation, V-A218
V-A321 V-A23 Amino Acid Analysis, Data Calculation
Alkaloids, Reactions of, V-A255 Aluminium Oxide, Anhydrous, V-A23 and Analysis, V-A224
Allantoin, I-94, V-A23 Aluminium Oxide, Basic, V-A23 Amino Acid Analysis, General
Allergen Products, I-95 Aluminium Oxide, Deactivated, V-A23 Precautions, V-A218
Allopurinol, I-97 Aluminium Oxide G, V-A23 Amino Acid Analysis, Internal Standards,
Allopurinol Oral Suspension, III-114 Aluminium Oxide, Hydrated, see Dried V-A219
Allopurinol Tablets, III-115 Aluminium Hydroxide Amino Acid Analysis, Protein Hydrolysis,
all-rac-Alpha-Tocopherol, II-1049 Aluminium Oxide, Neutral, V-A23 V-A219
all-rac-Alpha-Tocopherol, see Tocopherol, Aluminium Paste, Compound, III-117 Amino Acid Analysis, Reference
all-rac-Alpha Aluminium Phosphate, Dried, I-119 Material, V-A218
all-rac-Alpha-Tocopheryl Acetate, Aluminium Phosphate Gel, I-119 Amino Acid Analysis, Repeatability,
II-1051 Aluminium Phosphate, Hydrated, see V-A218
Almagate, I-99 Dried Aluminium Phosphate Amino Acid Analysis, Sample
Almond Oil Ear Drops, III-116 Aluminium Potassium Sulfate, V-A23 Preparation, V-A219
Almond Oil, Refined, I-101 Aluminium Potassium Sulphate, see Alum Amino Acids, Use of Codes for, I-8,
Almond Oil, Virgin, I-101 Aluminium Potassium Sulphate, see II-8, III-8, IV-8, V-8
Almond Oil, see Virgin Almond Oil Aluminium Potassium Sulfate Aminoazobenzene, V-A23
Aloes, Barbados, IV-53 Aluminium Powder, I-120 Aminobenzoic Acid, I-139, V-A23
Aloes, Cape, IV-54 Aluminium Salts, Reactions of, V-A255 4-Aminobenzoic Acid Solution, V-A23
Aloes, Curaçao, see Barbados Aloes Aluminium Sodium Silicate, I-121 4-Aminobenzoic Acid, see Aminobenzoic
Aloes Dry Extract, Standardised, IV-55 Aluminium Standard Solution (2 ppm Acid
Aloxiprin, I-102 Al), V-A146 (4-Aminobenzoyl)-L-glutamic Acid,
Aloxiprin Tablets, III-117 Aluminium Standard Solution (10 ppm V-A24
Alpha Tocopheryl Acetate Concentrate Al), V-A146 4-Aminobutanoic acid, see 4-Amino-n-
(Powder Form), II-1054 Aluminium Standard Solution (100 ppm butyric Acid
Alpha Tocopheryl Hydrogen Succinate, Al), V-A146 2-Aminobutan-1-ol, V-A24
II-1055, II-1057 Aluminium Standard Solution (200 ppm Aminocaproic Acid, I-140
Alpha Tocopheryl Succinate Tablets, Al), V-A146 2-Amino-5-chlorobenzophenone, V-A24
III-1121 Aluminium Stearate, I-122 Aminochlorobenzophenone, see 2-Amino-
Alphacyclodextrin, see Alfadex Aluminium Sulfate, I-125, V-A23 5-chlorbenzophenone
RRR-Alpha-Tocopherol, II-1050 Aluminium Sulphate, see Aluminium 4-Aminofolic Acid, V-A24
RRR-Alpha-Tocopheryl Acetate, II-1053 Sulfate Aminoglutethimide, I-141, V-S8
Alprazolam, I-103 Alverine Capsules, III-120 Aminoglutethimide Tablets, III-124
Alprenolol Hydrochloride, I-105 Alverine Citrate, I-125, V-S7 Aminohexadecylsilyl Silica Gel for
Alprostadil, I-106 Amantadine Capsules, III-121 Chromatography, V-A113
Alteplase for Injection, I-109 Amantadine Hydrochloride, I-126 6-Aminohexanoic Acid, V-A24
Alternative Methods for Control of Amantadine Oral Solution, III-121 p-Aminohippuric Acid, V-A24
Microbiological Quality, V-A716 Amantidine, V-S8 Aminohippuric Acid Reagent, V-A24
Altizide, I-112 Amaranth S, V-A23 4-Amino-3-hydroxynaphthalene-1-
Alum, I-113 Amaranth Solution, V-A23 sulfonic Acid, V-A24
Aluminium, V-A22 Ambroxol Hydrochloride, I-128 Aminohydroxynaphthalenesulfonic Acid
Aluminium Acetate Ear Drops, III-118 Americium-243 Spiking Solution, V-A23 Solution, V-A24
Aluminium Chloride, V-A22 Amethocaine Eye Drops, see Tetracaine Aminohydroxynaphthalenesulfonic Acid
Aluminium Chloride Hexahydrate, I-114 Eye Drops Solution, Strong, V-A24
Aluminium Chloride Reagent, V-A23 Amethocaine Hydrochloride, see Aminohydroxynaphthalenesulphonic
Aluminium Chloride Solution, III-118, Tetracaine Hydrochloride Acid Solution, Strong, see
V-A23 Amfetamine Sulfate, I-129 Aminohydroxynaphthalenesulfonic Acid
Aluminium Glycinate, I-115 Amfetamine Sulphate, see Amfetamine Solution, Strong
Aluminium Hydroxide and Magnesium Sulfate Aminohydroxynaphthalenesulphonic
Trisilicate Tablets, Chewable, III-753 Amido Black 10B Solution, V-A23 Acid Solution, see
Aluminium Hydroxide, Dried, I-116 Amidohexadecylsilyl Silica Gel for Aminohydroxynaphthalenesulfonic Acid
Aluminium Hydroxide Gel, V-A23 chromatography, V-A113 Solution
Aluminium Hydroxide, Hydrated, for Amidotrizoic Acid Dihydrate, I-130 4-Amino-3-hydroxynaphthalene-1-
Adsorption, I-115 Amikacin, I-132 sulphonic Acid, see 4-Amino-3-
Aluminium Hydroxide Oral Suspension, Amikacin Injection, III-122 hydroxynaphthalene-1-sulfonic Acid
III-119 Amikacin Sulfate, I-134 Aminohydroxynaphthalenesulphonic,
Aluminium Hydroxide Oral Suspension, Amiloride and Furosemide Tablets, see Acid, see Aminonaphthalenesulfonic Acid
Magnesium Hydroxide and, III-382 Co-amilofruse Tablets Solution
Aluminium Hydroxide Tablets, Amiloride and Hydrochlorothiazide Oral 5-Aminoimidazole-4-carboxamide
Chewable, III-119 Solution, see Co-amilozide Oral Solution Hydrochloride, V-A24
Aluminium Hydroxide Tablets, Amiloride and Hydrochlorothiazide cis-Aminoindanol, V-A24
Magnesium Hydroxide and, III-383 Tablets, see Co-amilozide Tablets
V-A772 Index
Aminomethylalizarindiacetic Acid Ammonia, Concentrated, V-A25 Ammonium Citrate, V-A26

Reagent, V-A24 Ammonia, Lead-free, V-A25 Ammonium Citrate Solution, V-A26
Aminomethylalizarindiacetic Acid Ammonia, Methanolic, V-A25 Ammonium Cobaltothiocyanate
Solution, V-A24 Ammonia R1, Concentrated, V-A25 Solution, V-A26
3-Aminomethylalizarin-N,N-diacetic Ammonia R1, Dilute, V-A25 Ammonium Dihydrogen
Acid, V-A24 Ammonia R2, Dilute, V-A25 Orthophosphate, V-A26
4-Aminomethylbenzoic acid, V-A24 Ammonia R3, Dilute, V-A25 Ammonium Formate, V-A26
3-(Aminomethyl)pyridine, V-A24 Ammonia Solution, Aromatic, III-133 Ammonium Glycyrrhizate, see Ammonium
8-Aminonaphthalene-2-sulfonic Acid, Ammonia Solution, Concentrated, see Glycyrrhizinate
V-A25 Strong Ammonia Solution Ammonium Glycyrrhizinate, I-159
Aminonaphthalenesulfonic Acid Ammonia Solution, Dilute, III-134 Ammonium Hexafluorogermanate,
Solution, V-A25 Ammonia Solution, Strong, I-154 V-A26
Aminonaphthalenesulphonic Acid Ammonia Spirit, Aromatic, III-134 Ammonium Hydrogen Carbonate,
Solution, see Aminonaphthalenesulfonic Ammoniacal Copper Oxide Solution, V-A26
Acid Solution V-A46 Ammonium Hydrogen Carbonate, see
8-Aminonaphthalene-2-sulphonic Acid, Ammoniacal Silver Nitrate Solution, Ammonium Bicarbonate
see 8-Aminonaphthalene-2-sulfonic Acid V-A118 Ammonium Ichthosulphonate, see
4-Amino-n-butyric Acid, V-A24 Ammoniacal Solution of Copper Ichthammol
2-Amino-5-nitrobenzophenone, V-A25 Tetrammine, V-A46 Ammonium Iron(II) Sulfate, V-A26
Aminonitrobenzophenone, see 2-Amino-5- Ammonia-free Water, V-A137 Ammonium Iron(II) Sulfate VS, V-A140
nitrobenzophenone Ammonio Methacrylate Copolymer Ammonium Iron(II) Sulphate VS, see
4-Aminophenazone, V-A25 (Type A), I-155 Ammonium Iron(II) Sulfate VS
Aminophenazone Solution, V-A25 Ammonio Methacrylate Copolymer Ammonium Iron(II) Sulphate, see
4-Aminophenol, V-A25 (Type B), I-156 Ammonium Iron(II) Sulfate
4-Aminophenol-free Paracetamol, V-A97 Ammonium Acetate, V-A26 Ammonium Iron(III) Citrate, V-A26
Aminophylline, I-143 Ammonium Acetate Solution, V-A26 Ammonium Iron(III) Sulfate, V-A26
Aminophylline Hydrate, I-145 Ammonium Acetate Solution, Strong, Ammonium Iron(III) Sulfate Solution R1,
Aminophylline Injection, III-125 III-135 V-A26
Aminophylline Tablets, III-126 Ammonium and Cerium Nitrate, see Ammonium Iron(III) Sulfate Solution R2,
Aminophylline Tablets, Prolonged- Ammonium Cerium(IV) Nitrate V-A26
release, III-127 Ammonium and Cerium Sulfate, see Ammonium Iron(III) Sulfate Solution R5,
Aminopolyether, V-A25 Ammonium Cerium(IV) Sulfate V-A26
3-Aminopropanol, V-A25 Ammonium and Cerium Sulphate, see Ammonium Iron(III) Sulfate Solution R6,
3-Aminopropionic Acid, V-A25 Ammonium and Cerium Sulfate V-A26
Aminopropylmethylsilyl Silica Gel for Ammonium Bicarbonate, I-157 Ammonium Iron(III) Sulfate VS, V-A140
Chromatography, V-A113 Ammonium Bromide, I-158 Ammonium Iron(III) Sulphate Solution
Aminopropylsilyl Silica Gel for Ammonium Carbamate, V-A26 R1, see Ammonium Iron(III) Sulfate
Chromatography, V-A113 Ammonium Carbonate, V-A26 Solution R1
Aminopropylsilyl Silica Gel for Ammonium Carbonate Buffer Solution Ammonium Iron(III) Sulphate Solution
Chromatography R1, V-A113 pH 10.3, 0.1M, V-A150 R2, see Ammonium Iron(III) Sulfate
Aminopyrazolone, see 4-Aminophenazone Ammonium Carbonate Solution, V-A26 Solution R2
Aminopyrazolone Solution, see Ammonium Carbonate Solution, Dilute, Ammonium Iron(III) Sulphate Solution
Aminophenazone Solution V-A26 R6, see Ammonium Iron(III) Sulfate
3-Aminosalicylic Acid, V-A25 Ammonium carbonate solution R1, Solution R5
Amiodarone, V-S8 V-A26 Ammonium Iron(III) Sulphate VS, see
Amiodarone Concentrate, Sterile, Ammonium Cerium(IV) Nitrate, V-A26 Ammonium Iron(III) Sulfate VS
III-127 Ammonium Cerium(IV) Nitrate VS, Ammonium Iron(III) Sulphate, see
Amiodarone Hydrochloride, I-146 V-A139 Ammonium Iron(III) Sulfate
Amiodarone Infusion, III-127 Ammonium Cerium(IV) Sulfate, V-A26 Ammonium, Limit Test for, V-A259
Amiodarone Intravenous Infusion, see Ammonium Cerium(IV) Sulfate VS, Ammonium Mercaptoacetate Solution,
Amiodarone Infusion, V-A139 V-A26
Amiodarone Oral Suspension, III-128 Ammonium Cerium(IV) Sulphate VS, see Ammonium Mercurithiocyanate Reagent,
Amiodarone Sterile Concentrate, III-127 Ammonium Cerium(IV) Sulfate VS V-A26
Amiodarone Tablets, III-129 Ammonium Cerium(IV) Sulphate, see Ammonium Metavanadate, V-A26
Amisulpride, I-148, V-S9 Ammonium Cerium(iv) Sulfate Ammonium Metavanadate Solution,
Amisulpride Oral Solution, III-130 Ammonium Chloride, I-159, V-A26 V-A27
Amisulpride Tablets, III-131 Ammonium Chloride Buffer Solution Ammonium Molybdate, V-A27
Amitriptyline Embonate, I-150 pH 10.0, see Ammonia Buffer pH 10.0 Ammonium Molybdate Reagent, V-A27
Amitriptyline Hydrochloride, I-151 Ammonium Chloride Buffer Solution Ammonium Molybdate Reagent R1,
Amitriptyline Tablets, III-133 pH 10.4, V-A150 V-A27
Amlodipine Besilate, I-152 Ammonium Chloride Buffer Solution Ammonium Molybdate Reagent R2,
Ammonia, V-A25 pH 10.7, V-A150 V-A27
Ammonia (13N) Injection, IV-649 Ammonium Chloride Buffer Solution Ammonium Molybdate Solution, V-A27
Ammonia Buffer pH 9.5, see Ammonium pH 9.5, V-A150 Ammonium Molybdate Solution R2,
Chloride Buffer Solution pH 9.5 Ammonium Chloride Buffer Solution V-A27
Ammonia Buffer pH 10.9, V-A150 pH 10.0, V-A150 Ammonium Molybdate Solution R3,
Ammonia Buffer pH 10.9, Dilute, Ammonium Chloride Mixture, III-135 V-A27
V-A150 Ammonium Chloride Oral Solution, Ammonium Molybdate Solution R4,
Ammonia Buffer pH 10.0, V-A150 III-135 V-A27
Ammonia, Chloride-free, V-A25 Ammonium Chloride Solution, V-A26
Ammonium Molybdate Solution R5, Amoxicillin Injection, III-136 Anhydrous Calcium Lactate, I-373
V-A27 Amoxicillin Oral Suspension, III-138 Anhydrous Chlorobutanol, I-509
Ammonium Molybdate Solution R6, Amoxicillin Sodium, I-162, V-S9 Anhydrous Citric Acid, I-560, V-A44
V-A27 Amoxicillin Sodium for Injection, Anhydrous Copper Sulfate, I-638
Ammonium Molybdate-Sulfuric Acid III-137 Anhydrous Copper Sulphate, see
Solution, V-A27 Amoxicillin Trihydrate, I-165, V-S9, Anhydrous Copper Sulfate
Ammonium Molybdate-Sulphuric Acid V-A28 Anhydrous Disodium Hydrogen
Solution, see Ammonium Molybdate- Ampere, Definition of, I-32, II-32, Orthophosphate, V-A59
Sulfuric Acid Solution III-32, IV-32, V-32 Anhydrous Disodium Hydrogen
Ammonium Muriaticum, V-A590 Amperometric, Potentiometric and Phosphate, I-775
Ammonium Nitrate, V-A27 Voltametric Titrations, V-A267 Anhydrous Disodium Phosphate, see
Ammonium Nitrate R1, V-A27 Amperometric Titration, V-A267 Anhydrous Disodium Hydrogen
Ammonium Oxalate, V-A27 Amphotericin, I-167 Phosphate
Ammonium Oxalate Solution, V-A27 Amphotericin B, see Amphotericin Anhydrous Docetaxel, I-783
Ammonium Persulfate, V-A27 Amphotericin for Infusion, III-139 Anhydrous Ephedrine, I-834
Ammonium Persulphate, see Ammonium Amphotericin Lozenges, III-141 Anhydrous Ethanol, see Ethanol
Persulfate Amphotericin Oral Suspension, III-141 Anhydrous Formic Acid, V-A66
Ammonium Phosphate, see Diammonium Ampicillin, I-169 Anhydrous Glucose, I-1055
Hydrogen Orthophosphate Ampicillin Capsules, III-142 Anhydrous Iron(III) Chloride, V-A75
Ammonium Polysulfide Solution, V-A27 Ampicillin Capsules, Flucloxacillin and, Anhydrous Lactose, II-66
Ammonium Polysulphide Solution, see see Co-fluampicil Capsules Anhydrous Lanolin, see Wool Fat
Ammonium Polysulfide Solution Ampicillin Injection, III-143 Anhydrous Lithium Metaborate, V-A80
Ammonium Pyrrolidinedithiocarbamate, Ampicillin Oral Suspension, III-145 Anhydrous Magnesium Citrate, II-166
V-A27 Ampicillin Oral Suspension, Anhydrous Methanol, V-A84
Ammonium Pyrrolidinedithiocarbamate Flucloxacillin and, see Co-fluampicil Anhydrous Morphine, V-A89
Solution, V-A27 Oral Suspension Anhydrous Nevirapine, II-357
Ammonium Reineckate, V-A27 Ampicillin Sodium, I-172, V-S10 Anhydrous Niclosamide, II-362
Ammonium Reineckate Solution, V-A27 Ampicillin Sodium for Injection, III-143 Anhydrous Paroxetine Hydrochloride,
Ammonium Salts and Salts of Volatile Ampicillin Trihydrate, I-175, V-S10 II-506
Bases, Reactions of, V-A255 Amyl Acetate, V-A28 Anhydrous Pyridine, V-A108
Ammonium Salts Reactions of, V-A255 Amyl Alcohol, see Isoamyl Alcohol Anhydrous Silica, Colloidal, II-804
Ammonium Standard Solution (1 ppm a-Amylase, V-A28 Anhydrous Silica Gel, V-A112
NH4), V-A146 a-Amylase Solution, V-A28 Anhydrous Silica, Hydrophobic
Ammonium Standard Solution (2.5 ppm Amylmetacresol, I-177, V-S10 Colloidal, II-805
NH4), V-A146 Amylose-derivative Silica Gel for Anhydrous Sodium Acetate, V-A118
Ammonium Standard Solution (3 ppm Chromatography, V-A113 Anhydrous Sodium Carbonate, II-828,
NH4), V-A146 b-Amyrin, V-A28 V-A119, V-A139
Ammonium Standard Solution (100 ppm Anaesthetic Ether, I-886 Anhydrous Sodium Dihydrogen
NH4), V-A146 Analytical Procedures, Validation of, Orthophosphate, V-A119
Ammonium Sulfamate, V-A27 V-A653 Anhydrous Sodium Dihydrogen
Ammonium Sulfate, V-A27 Analytical sieving, V-A485 Phosphate, II-838, V-A119
Ammonium Sulfide Solution, V-A27 Anastrozole, I-179 Anhydrous Sodium Sulfate, II-871,
Ammonium Sulphamate, see Ammonium Andersen cascade impactor, V-A366 V-A122
Sulfamate Andersen sizing sampler, see Andersen Anhydrous Sodium Sulfite, II-872,
Ammonium Sulphate, see Ammonium cascade impactor V-A122
Sulfate Anethole, V-A28 Anhydrous Sodium Sulphate, see
Ammonium Sulphide Solution, see Anethum Graveolens L. Sowa Group, see Anhydrous Sodium Sulfate
Ammonium Sulfide Solution Anethum Graveolens Sowa Fruit, Anhydrous Sodium Sulphite, see
Ammonium Thiocyanate, V-A27 Anethum Graveolens Sowa Fruit, IV-56 Anhydrous Sodium Sulfite
Ammonium Thiocyanate Solution, Angelica Archangelica Root, IV-57 Anhydrous Theophylline-
V-A27 Angelica Dahurica Root, IV-59 ethylenediamine, see Aminophylline
Ammonium Thiocyanate VS, V-A140 Angelica Pubescens Root, IV-60 Anhydrous Torasemide, II-1064
Ammonium Vanadate Solution, V-A28 Angelica Sinensis Root, IV-62 Anhydrous Valaciclovir Hydrochloride,
Ammonium Vanadate, see Ammonium Angelica Sinensis Root for use in THM, II-1131
Metavanadate see Angelica Sinensis Root Aniline, V-A28
Amobarbital, I-160 Angle of Repose, V-A500 Aniline Hydrochloride, V-A28
Amobarbital Sodium, I-161 Anhydrous Acetic Acid, V-A20 Aniline Hydrochloride Solution, V-A28
Amorphous Organosilica Polymer, Anhydrous Aluminium Oxide, V-A23 Animal Spongiform Encephalopathy
Octadecylsilyl, V-A96 Anhydrous Ampicillin, see Ampicillin Agents Via Human and Veterinary
Amoxicillin and Potassium Clavulanate Anhydrous Azapropazone, V-S11 Medicinal Products, Minimising the
Injection, see Co-amoxiclav Injection Anhydrous Beclometasone Dipropionate, Risk of Transmitting, V-A592
Amoxicillin and Potassium Clavulanate I-234 Animals, Use of, I-15, II-15, III-15,
Oral Suspension, see Co-amoxiclav Oral Anhydrous Caffeine, see Caffeine IV-15, V-15
Suspension Anhydrous Calcipotriol, I-348 Anion Exchange Resin, V-A28
Amoxicillin and Potassium Clavulanate Anhydrous Calcium Acetate, see Calcium Anion Exchange Resin for
Tablets, Dispersible, see Dispersible Co- Acetate Chromatography, Strongly Basic,
amoxiclav Tablets Anhydrous Calcium Chloride, V-A36 V-A28
Amoxicillin and Potassium Clavulanate Anhydrous Calcium Gluconate, I-367 Anion Exchange Resin R1, V-A28
Tablets, see Co-amoxiclav Tablets Anhydrous Calcium Hydrogen Anion Exchange Resin R2, V-A28
Amoxicillin Capsules, III-135 Phosphate, I-372 Anion exchange resin R3, V-A28
V-A774 Index
Anion Exchange Resin, Strongly Basic, Antisera, see Immunosera Aristolochic Acids I and II in Herbal
V-A28 Anti-T Lymphocyte Immunoglobulin for Drugs, Test for, V-A325, V-A327
Anion Exchange Resin, Weak, V-A28 Human Use, Animal, IV-492 Aristolochic Acids in Herbal Drugs, Test
Anionic Emulsifying Wax, see Emulsifying Antithrombin III, V-A29 for, V-A325
Wax Antithrombin III Concentrate, IV-457 Arjuna Stem Bark, see Terminalia Arjuna
Anisaldehyde, V-A28 Antithrombin III, Human, Assay of, Stem Bark
Anisaldehyde Solution, V-A28 V-A410 Arnica Flower, IV-71
Anisaldehyde Solution R1, V-A28 Antithrombin III Solution R1, V-A29 Arnica Tincture, IV-73
Anise Ketone, V-A28 Antithrombin III Solution R2, V-A29 Aromadendrene, V-A30
Anise Oil, IV-69 Antithrombin III Solution R3, V-A29 Aromatic Ammonia Solution, III-133
Anise Oil, Star, IV-67 Antithrombin III Solution R4, V-A29 Aromatic Ammonia Spirit, III-134
Anise, Star, IV-66 APCI (Atmospheric-Pressure Chemical Aromatic Cardamom Tincture, IV-125
Anise Water, Concentrated, IV-71 Ionisation), V-A177 Aromatic Magnesium Carbonate
Aniseed, IV-65 Apigenin, V-A29 Mixture, III-748
Aniseed Oil, see Anise Oil Apigenin-7-glucoside, V-A29 Aromatic Magnesium Carbonate Oral
Anise, see Aniseed Apiole, V-A29 Suspension, III-748
p-Anisidine, V-A28 Apomorphine Hydrochloride for Aromatic Waters, III-80
Anisidine Value, V-A313 Homoeopathic Preparations, IV-417 Aromatic-free Petroleum Spirit, (boiling
Anolyte for Isoelectric Focusing pH 3 to Apomorphine Hydrochloride range, 408 to 608), V-A99
5, V-A29 Hemihydrate, I-181 Arsenic Compounds, Reactions of,
Antazoline Hydrochloride, I-180 Apomorphinum Muriaticum for V-A255
Anthracene, V-A29 Homoeopathic Preparations, see Arsenic, Limit Test for, V-A259
Anthranilic Acid, see 2-Aminobenzoic Acid Apomorphine Hydrochloride for Arsenic Standard Solution (0.1 ppm As),
Anthrax Vaccine, IV-505 Homoeopathic Preparations V-A146
Anthrax Vaccine for Human Use Apparatus and procedures, I-23, II-23, Arsenic Standard Solution (1 ppm As),
(Adsorbed, Prepared from Culture III-23, IV-23, V-23 V-A146
Filtrates), IV-505 Apparent Density, Determination of, Arsenic Standard Solution (10 ppm As),
Anthrone, V-A29 V-A243 V-A146
Anthrone Reagent, V-A29 Apparent dissolution, V-A356 Arsenic Trioxide, V-A139
Anti-A and anti-B haemagglutinins Appendices, I-xxiv Arsenious Trioxide, V-A30, V-A139
(indirect method), V-A418 Appendices, Contents of the, V-A3 Arsenious Trioxide for Homoeopathic
Antibiotics, Microbiological Assay of, Application of dissolution limits, V-A629 Preparations, IV-417
V-A382, V-A634 Application of the F0 concept to steam Arsenite Solution, V-A30
Antibiotics, Potency of, I-14, II-14, sterilisation of aqueous preparations, Artemisia Cina for Homoeopathic
III-14, IV-14, V-14 V-A529 Preparations, IV-418
Anticoagulant and Preservative Solutions Approved Synonyms, V-A579 Articaine Hydrochloride, I-193
for Blood, IV-449 Approved Synonyms for Homoeopathic Artichoke Leaf, IV-75
Anticoagulant and Preservative Solutions Use, V-A590 Artichoke Leaf Dry Extract, IV-77
for Human Blood, see Anticoagulant Aprotinin, I-183, V-A29 Artificial Gastric Juice, V-A67
and Preservative Solutions for Blood Aprotinin Concentrated Solution, I-185 Artificial Tears, see Hypromellose Eye
Anticomplementary activity of aP, see Adsorbed Pertussis Vaccine Drops
immunoglobulin, Test for, V-A413 (Acellular Component) Ascending Paper Chromatography,
Anti-D antibodies in human aP, see Adsorbed Pertussis Vaccine V-A200
immunoglobulin for intravenous (Acellular, Co-purified) Ascorbic Acid, I-195, V-A30
administration, test for, V-A417 Aqueous Calamine Cream, III-225 Ascorbic Acid Injection, III-148
Anti-D Immunoglobulin for Intravenous Aqueous Cream, III-146 Ascorbic Acid, see L-Ascorbic Acid
Use, IV-474 Aqueous Cream, Menthol in, see Ascorbic Acid Solution, V-A30
Anti-D immunoglobulin, human, Assay Levomenthol Cream Ascorbic Acid Tablets, III-149
of, V-A415 Aqueous Iodine Oral Solution, III-675 Ascorbic Acid Tablets, Chewable,
Anti-D (Rh0) Immunoglobulin, IV-474 Aqueous Nile Blue A Solution, V-A92 III-149
Antimicrobial Preservation, Efficacy of, Aqueous Phenol Injection, III-947 Ascorbyl Palmitate, I-197
V-A476, V-A633 L-Arabinose, V-A30 Aseptic preparation, V-A527
Antimicrobial preservation, Test for Arabinose, see L-Arabinose Ash, Determination of, V-A322
efficacy of, V-A477 Arachidic Alcohol, V-A30 Ash, Determination of Acid-insoluble,
Antimicrobial Preservatives, Definition of Arachis Oil, I-188 V-A322
Suitable, I-11, II-11, III-11, IV-11, Arachis Oil Enema, III-146 Ash, Determination of Sulfated, V-A293,
V-11 Arachis Oil, Hydrogenated, I-188 V-A294, V-A295, V-A296, V-A297,
Antimony Compounds, Reactions of, Arbutin, V-A30 V-A298, V-A299, V-A300, V-A301,
V-A255 Argentum Nitricum, V-A590 V-A302, V-A303
Antimony Potassium Tartrate, V-A29 Arginine, I-189, V-A30 Ash Insoluble in Hydrochloric Acid,
Antimony Standard Solution (1 ppm Arginine Aspartate, I-190 V-A322
Sb), V-A146 Arginine Hydrochloride, I-191 Ash Leaf, IV-78
Antimony Standard Solution (100 ppm Arginine Hydrochloride Infusion, III-146 Asiaticoside, V-A30
Sb), V-A146 Arginine Hydrochloride Intravenous Asparagine Monohydrate, I-197
Antimony Trichloride, V-A29 Infusion, III-146 Aspartame, I-198
Antimony Trichloride in Dichloroethane Arginine Hydrochloride Oral Solution, Aspartic Acid, I-200, V-A30
Solution, V-A29 III-147 L-Aspartyl-L-phenylalanine, V-A30
Antimony Trichloride Solution, V-A29 Argon, I-192, V-A30 Aspirin, I-201
Antimony Trichloride Solution R1, Argon for Chromatography, V-A30 Aspirin and Caffeine Tablets, III-152
V-A29 Argon R1, V-A30
Aspirin and Codeine Tablets, Azadirachta indica Leaf for use in Barbitone Sodium, V-A31
Dispersible, see Co-codaprin Tablets, THMP, see Azadiracta Indica Leaf Barbiturates, Non-nitrogen Substituted,
Dispersible Azadirachtin, V-A30 Reactions of, V-A255
Aspirin and Codeine Tablets, see Co- Azadirachtin A CRS, V-A157 Barbituric Acid, V-A31
codaprin Tablets Azapropazone, I-216, V-S11 Barium Acetate, V-A31
Aspirin Tablets, III-150 Azapropazone, Anhydrous, V-S11 Barium Carbonate, V-A31
Aspirin Tablets, Dispersible, III-150 Azapropazone Capsules, III-158 Barium Chloride, V-A31
Aspirin Tablets, Effervescent, III-151 Azapropazone Tablets, III-159 Barium Chloride Dihydrate for
Aspirin Tablets, Gastro-resistant, III-151 Azathioprine, I-217 Homoeopathic Preparations, IV-419
Assay of 1,8-cineole in essential oils, see Azathioprine Oral Suspension, III-159 Barium Chloride Solution, V-A31
Determination of Cineole Azathioprine Tablets, III-161 Barium Chloride Solution R1, V-A31
Assay of human plasmin inhibitor, Azelastine Hydrochloride, I-219, V-S12 Barium Chloride Solution R2, V-A31
V-A408 Azidothymidine (AZT), see Zidovudine Barium Chloride VS, V-A140
Assay of human protein C, V-A410 Azithromycin, I-220 Barium Hydroxide, V-A31
Assay of human protein S, V-A411 Azobenzene, V-A30 Barium Hydroxide Solution, V-A31
Assay of human a-1-proteinase inhibitor, Azomethine H, V-A30 Barium Nitrate, V-A31
V-A419 Azomethine H Solution, V-A30 Barium Perchlorate VS, V-A140
Assay of Interferons, V-A439 Barium Standard Solution (2 ppm Ba),
Assay, Release and Check, V-A636 V-A146
Assays and Tests, I-12, II-12, III-12,
IV-12, V-12
B Barium Standard Solution (50 ppm Ba),
V-A146
Bacampicillin Hydrochloride, I-223
Astragaloside I CRS, V-A157 Barium Sulfate, I-233, V-A31
Bacillus Calmette-Guérin Vaccine,
Astragaloside II CRS, V-A157 Barium Sulfate for Suspension, I-234
IV-507
Astragaloside IV, V-A30 Barium Sulfate Oral Suspension, III-164
Bacitracin, I-225
Astragaloside IV CRS, V-A157 Barium Sulphate for Suspension, see
Bacitracin Eye Ointment, Polymyxin
Astragalus Mongholicus Root, IV-79 Barium Sulfate for Suspension
and, III-966
ATCC, V-A608 Barium Sulphate Oral Suspension, see
Bacitracin Ointment, Polymyxin and,
ATCC - American Type Culture Barium Sulfate Oral Suspension
III-968
Collection, address of, I-31, II-31, Barium Sulphate, see Barium Sulfate
Bacitracin Zinc, I-227
III-31, IV-31, V-31 Bark, Cinchona, see Cinchona Bark
Back titrations, V-A760
Atenolol, I-203, V-S11, V-A30 Base-deactivated End-capped
Baclofen, I-230
Atenolol and Chlortalidone Tablets, Octadecylsilyl Silica Gel for
Baclofen Oral Solution, III-162
III-386 Chromatography, V-A114
Baclofen Tablets, III-163
Atenolol Injection, III-153 Base-deactivated End-capped
Bacopa Monnieri, IV-84
Atenolol Oral Solution, III-154 Octadecylsilyl Silica Gel for
Bacopa Monnieri for use in THMP,
Atenolol Tablets, III-155 Chromatography R1, V-A116
IV-84
Atmospheric-Pressure Chemical Base-deactivated End-capped Octylsilyl
Bacopaside I CRS, V-A157
Ionisation (APCI), V-A177 Silica Gel for Chromatography,
Bacopaside II CRS, V-A157
Atomic absorption spectrometry, V-A173 V-A115
Bacoside A CRS, V-A157
Atomic emission spectrometry, V-A170 Base-deactivated Octadecylsilyl Silica Gel
Bacterial Cells Used for the Manufacture
Atomic Emission Spectrometry, for Chromatography, V-A114
of Plasmid Vectors for Human Use,
Inductively Coupled Plasma-, V-A171 Base-deactivated Octylsilyl Silica Gel for
V-A735
Atomic Spectrometry, Elementary Chromatography, V-A115
Bacterial Endotoxin Testing, V-A620
Standard Solutions for, V-A147 Basic Aluminium Oxide, V-A23
Bacterial Endotoxin Testing,
Atomic Spectrophotometry, Emission Basic Butylated Methacrylate
Supplementary Information, V-A620
and Absorption, V-A170 Copolymer, II-231
Bacterial Endotoxins, Test for, V-A390
Atomic Weights, I-6, II-6, III-6, IV-6, Basic Fuchsin, V-A66
Baical Skullcap Root, see Scutellariae
V-6 Basic Fuchsin Solution, V-A67
Baicalensis Root
Atomic Weights of Elements, Names, Batch Release, I-9, II-9, III-9, IV-9, V-9
Baicalin, V-A30
Symbols and, V-A609 BCG for Immunotherapy, IV-508
Balsam, Peru, IV-315
Atorvastatin Calcium Trihydrate, I-204 BCG Vaccine, Freeze-dried, see Bacillus
B.A.L., see Dimercaprol
Atovaquone, I-207 Calmette-Guérin Vaccine
Baltimore Paste, III-117
Atractylodes Lancea Rhizome, IV-81 BCG, see Bacillus Calmette-Guérin Vaccine
Bambuterol Hydrochloride, I-231
Atractylodes Rhizome, Largehead, IV-81 Bearberry Leaf, IV-85
BAN, V-A639
Atracurium Besilate, I-208 Beclometasone Aqueous Nasal Spray,
Barbados Aloes, IV-53
Atropine, I-211 III-168
Barbaloin, V-A31
Atropine Eye Drops, III-155 Beclometasone Cream, III-164
Barbital, I-232, V-A31
Atropine Eye Ointment, III-156 Beclometasone Dipropionate (1), V-S12
Barbital Buffer Solution pH 8.6 R1, see
Atropine Injection, III-156 Beclometasone Dipropionate (2), V-S12
Barbitone Buffer pH 8.6 R1
Atropine Injection, Morphine and, Beclometasone Dipropionate,
Barbital Buffer Solution pH 7.4, see
III-835 Anhydrous, I-234
Barbitone Buffer pH 7.4
Atropine Sulfate, I-213, V-A30 Beclometasone Dipropionate
Barbital Buffer Solution pH 8.4, V-A150
Atropine Sulphate, see Atropine Sulfate Monohydrate, I-237, V-S13
Barbital Buffer Solution pH 8.6 R1,
Atropine Tablets, III-157 Beclometasone Dipropionate, see
V-A151
Atropinum Sulfuricum, V-A590 Anhydrous Beclometasone Dipropionate
Barbital Sodium, V-A31
Attapulgite, I-214 Beclometasone Inhalation Powder,
Barbital Sodium, see Barbitone Sodium
Attapulgite, Activated, I-215 III-165
Barbitone, V-A31
Aucubin, V-A30 Beclometasone Inhalation Powder, pre-
Barbitone Buffer pH 8.6 R1, V-A151
Azadirachta Indica Leaf, IV-82 dispensed, III-166
Barbitone Buffer pH 7.4, V-A151
Beclometasone Nasal Spray, III-168
V-A776 Index
Beclometasone Ointment, III-169 Benzoin Inhalation, Menthol and, Betamethasone Eye Drops, III-182
Beclometasone Powder for Inhalation, IV-270 Betamethasone Injection, III-183
Metered dose Powder Inhaler, see Benzoin Inhalation Vapour, IV-95 Betamethasone Sodium Phosphate, I-279
Beclometasone Inhalation Powder Benzoin Inhalation Vapour, Menthol Betamethasone Sodium Phosphate
Beclometasone Powder for Inhalation, and, IV-270 Tablets, III-187
pre-metered units, see Beclometasone Benzoin, Siam, IV-92 Betamethasone Tablets, III-184
Inhalation Powder, pre-dispensed Benzoin, Sumatra, IV-93 Betamethasone Valerate, I-281
Beclometasone Pressurised Inhalation, Benzoin Tincture, Compound, IV-95 Betamethasone Valerate Cream, III-188
III-167 Benzoin Tincture, Siam, IV-92 Betamethasone Valerate Cutaneous
Beeswax, White, I-239 Benzoin Tincture, Sumatra, IV-94 Solution, III-189
Beeswax, Yellow, I-239 Benzophenone, V-A31 Betamethasone Valerate Lotion, III-189
Belerica Fruit, see Terminalia Belerica 1,4-Benzoquinone, V-A31 Betamethasone Valerate Ointment,
Belladonna Herb, Prepared, see Prepared Benzoyl Chloride, V-A32 III-190
Belladonna Benzoyl Peroxide, V-A32 Betamethasone Valerate Scalp
Belladonna Herb, see Belladonna Leaf Benzoyl Peroxide Cream, III-174 Application, III-188
Belladonna Leaf, IV-86 Benzoyl Peroxide Cream, Potassium Betaxolol Eye Drops, Solution, III-191
Belladonna Leaf Dry Extract, Hydroxyquinoline and, III-976 Betaxolol Eye Drops, Suspension,
Standardised, IV-89 Benzoyl Peroxide Cutaneous Suspension, III-192
Belladonna Leaf Tincture, Standardised, III-176 Betaxolol Hydrochloride, I-283
see Belladonna Tincture Benzoyl Peroxide Gel, III-175 Betulin, V-A32
Belladonna, Prepared, IV-88 Benzoyl Peroxide, Hydrous, I-259 Bezafibrate, I-284, V-S15
Belladonna Tincture, IV-90 Benzoyl Peroxide Lotion, III-176 Bezafibrate Tablets, III-193
Benazepril Hydrochloride, I-240 Benzoylarginine Ethyl Ester Bezafibrate Tablets, Prolonged-release,
Bendrofluazide Tablets, see Hydrochloride, V-A31 III-194
Bendroflumethiazide Tablets Benzoylecgonine Hydrate, V-A32 Bibenzyl, V-A32
Bendrofluazide, see Bendroflumethiazide N-Benzoyl-L-prolyl-L-phenylalanyl-L- Bicalutamide, I-286, V-S15
Bendroflumethiazide, I-242 arginine 4-Nitroanilide Acetate, V-A32 Bicalutamide Tablets, III-195
Bendroflumethiazide Tablets, III-170 3-Benzoylpropionic Acid, V-A32 Bicarbonates, Reactions of, V-A255
Benorilate, I-243, V-S13 2-Benzoylpyridine, V-A32 Bifonazole, I-288
Benorilate Oral Suspension, III-171 Benzydamine Cream, III-176 Bilberry, Dried, IV-97
Benorilate Tablets, III-171 Benzydamine Hydrochloride, I-260, Bilberry, Fresh, IV-98
Benperidol, I-244 V-S14 Bioavailability, V-A629
Benserazide Hydrochloride, I-245 Benzydamine Mouthwash, III-177 Bioequivalence, V-A629
Benserazide Hydrochloride and Benzydamine Oromucosal Spray, III-178 Bioequivalence of Oral Liquids, V-A755
Levodopa Capsules, see Co-beneldopa Benzyl Alcohol, I-261, V-A32 Biological Assays, V-A382
Capsules Benzyl Benzoate, I-263, V-A32 Biological Assays and Tests, V-A631
Benserazide Hydrochloride and Benzyl Benzoate Application, III-179 Biological Assays and Tests,
Levodopa Tablets, Dispersible, see Benzyl Cinnamate, V-A32 Supplementary Information, V-A631
Dispersible Co-beneldopa Tablets Benzyl Cyanide, V-A32 Biological indicators of sterilisation,
Bentonite, I-247 Benzyl Ether, V-A32 V-A528
Benzalacetone, V-A31 Benzyl Hydroxybenzoate, I-264, V-S14 Biological Medicinal Products, Similar,
Benzaldehyde, I-248, V-A31 Benzylparaben, see Benzyl V-A765
Benzalkonium Chloride, I-248, V-A31 Hydroxybenzoate Biological Products, Terminology used in
Benzalkonium Chloride Solution, I-250, Benzylpenicillin for Injection, III-179 Monographs on, V-A446
V-A31 Benzylpenicillin Injection, III-179 Biological Reference Materials, see
Benzathine Benzylpenicillin, I-252 Benzylpenicillin Potassium, I-264 Reference Materials
Benzatropine Injection, III-172 Benzylpenicillin Sodium, I-266, V-A32 Biological Reference Preparations, I-15,
Benzatropine Mesilate, I-254, V-S13 2-Benzylpyridine, V-A32 II-15, III-15, IV-15, V-15
Benzatropine Tablets, III-173 Benzyltrimethylammonium Chloride, Biological Tests, V-A382
Benzbromarone, I-255 V-A32 Bioluminescence for Enumeration of
Benzene, V-A31 Berberine Chloride, V-A32 Micro-Organisms, V-A725
Benzene-1,2,4-triol, V-A31 Berberis Aristata, IV-96 Biosimilar, see Similar Biological Medicinal
Benzethonium Chloride, I-256, V-A31 Bergapten, V-A32 Products
Benzethonium Chloride VS, 0.004M, BET (Brunauer, Emmett and Teller) Biotin, I-289
V-A140 theory and specific surface area Biperiden Hydrochloride, I-290
Benzhexol Hydrochloride, see determination, V-A497 Biphasic Insulin Injection, III-669
Trihexyphenidyl Hydrochloride Betacarotene, I-268 Biphasic Insulin, see Biphasic Insulin
Benzhexol Tablets, see Trihexyphenidyl Betacyclodextrin, see Betadex Injection
Tablets Betadex, I-269 Biphasic Isophane Insulin Injection,
Benzidine, V-A31 Betahistine Dihydrochloride, I-271 III-669
Benzil, V-A31 Betahistine Dihydrochloride Tablets, Biphasic Isophane Insulin, see Biphasic
Benzoates, Reactions of, V-A255 III-180 Isophane Insulin Injection
Benzocaine, I-257, V-A31 Betahistine Mesilate, I-272 Biphenyl, V-A32
Benzoic Acid, I-258, V-S14, V-A31, Betamethasone, I-273, V-S15, V-A32 Biphenyl-4-ol, V-A32
V-A139 Betamethasone Acetate, I-275 Birch Leaf, IV-100
Benzoic Acid Ointment, Compound, Betamethasone and Clioquinol Cream, (–)-a-Bisabolol, V-A32
III-173 III-185 Bisacodyl, I-292
Benzoic Acid Solution, III-174 Betamethasone and Clioquinol Bisacodyl Suppositories, III-196
Benzoin, V-A31 Ointment, III-186 Bisacodyl Tablets, Gastro-resistant, see
Benzoin Inhalation, IV-95 Betamethasone Dipropionate, I-277 Gastro-resistant Bisacodyl Tablets
Bisbenzimide, V-A33 Blood and Blood Components, Materials Bromazepam, I-309

Bisbenzimide Stock Solution, V-A33 Based on Plasticised Poly(Vinyl Bromelains, V-A34
Bisbenzimide Working Solution, V-A33 Chloride) for Tubing Used in Sets for Bromelains Solution, V-A34
Bismuth and Bismuth Compounds, the Transfusion of, V-A548 Bromhexine Hydrochloride, I-310
Reactions of, V-A256 Blood and Related Products, V-A402 Bromides, Reactions of, V-A256
Bismuth Carbonate, see Bismuth Blue Dextran 2000, V-A33 Brominated Hydrochloric Acid, V-A71
Subcarbonate Blue Litmus Paper, V-A80 Bromine, V-A34
0.01M Bismuth Nitrate, V-A140 Blue primary solution, V-A233 Bromine Solution, V-A34
Bismuth Nitrate Pentahydrate, V-A33 Bogbean Leaf, IV-109 Bromine Solution, Acetic, V-A34
Bismuth Oxycarbonate, V-A33 Boiling Point, Determination of, V-A240 Bromine VS, V-A140
Bismuth Oxynitrate, V-A33 Boldine, V-A33 Bromine Water, V-A34
Bismuth Oxynitrate R1, V-A33 Boldo Leaf, IV-110 Bromine Water R1, V-A34
Bismuth Oxynitrate Solution, V-A33 Boldo Leaf Dry Extract, IV-111 Bromobenzene, V-A34
Bismuth Standard Solution (100 ppm Borage Oil, Refined, I-301 Bromocresol Green, V-A34
Bi), V-A146 Borate Buffer pH 7.5, V-A151 Bromocresol Green Solution, V-A34
Bismuth Subcarbonate, I-293, V-A33 Borate Buffer pH 9.6, V-A151 Bromocresol Green-Methyl Red
Bismuth Subcarbonate, see Bismuth Borate Buffer pH 8.0, V-A151 Solution, V-A34
Oxycarbonate Borate Buffer pH 9.0, V-A151 Bromocresol Purple, V-A34
Bismuth Subgallate, I-294 Borate Buffer Solution pH 8.4, 0.2M, Bromocresol Purple Solution, V-A34
Bismuth Subnitrate, V-A33 V-A151 Bromocriptine Capsules, III-202
Bismuth Subnitrate, Heavy, I-295 Borate Buffer Solution pH 7.5, see Borate Bromocriptine Mesilate, I-311
Bismuth Subnitrate R1, V-A33 Buffer pH 7.5 Bromocriptine Tablets, III-203
Bismuth Subnitrate Solution, V-A33 Borate Buffer Solution pH 10.4, V-A151 5-Bromo-2-deoxyuridine, V-A34
Bismuth Subsalicylate, I-296 Borate Buffer Solution pH 7.5, V-A151 Bromomethoxynaphthalene, V-A34
Bisoprolol Fumarate, I-297 Borate Solution, V-A33 Bromophenol Blue, V-A34
Bisoprolol Tablets, III-198 Borax, I-301 Bromophenol Blue Solution, V-A35
Bistort Rhizome, IV-102 Boric Acid, I-302, V-A33 Bromophenol Blue Solution R1, V-A35
Bis(trimethylsilyl)trifluoroacetamide, Boric Acid Solution, V-A33 Bromophenol Blue Solution R2, V-A35
V-A33 Boric Acid Solution, Cold Saturated, Bromophos, V-A35
Bitter Fennel, IV-176 V-A33 Bromophos-ethyl, V-A35
Bitter Orange Flower Oil, see Neroli Oil Boric Buffer pH 9.0, V-A151 Bromothymol Blue, V-A35
Bitter-Fennel Fruit Oil, IV-177 D-Borneol, V-A33 Bromothymol Blue Solution R1, V-A35
Bitter-Fennel Herb Oil, IV-179 Bornyl Acetate, V-A33, V-A34 Bromothymol Blue Solution R2, V-A35
Bitterness Value, Determination of, Boron Trichloride, V-A34 Bromothymol Blue Solution R3, V-A35
V-A324 Boron Trichloride-Methanol Solution, Bromothymol Blue Solution R4, V-A35
Bitterness Value, Determination of the V-A34 Bromperidol, I-314
Correction Factor, V-A324 Boron Trifluoride, V-A34 Bromperidol Decanoate, I-315
Bitter-Orange Epicarp and Mesocarp, see Boron Trifluoride Solution, V-A34 Brompheniramine Maleate, I-317
Dried Bitter-Orange Peel Boron Trifluoride-Methanol Solution, Brompheniramine Tablets, III-204
Bitter-Orange Flower, IV-294 V-A34 Bronopol, I-319, V-S16
Bitter-Orange-Epicarp and Mesocarp Bot/Ser, see Botulinum Antitoxin Broom, Butcher’s, IV-115
Tincture, see Orange Tincture Botulinum Antitoxin, IV-495 Brotizolam, I-320
Biuret, V-A33 Botulinum Toxin Type A for Injection, BRP, I-15, II-15, III-15, IV-15, V-15,
Biuret Reagent, V-A33 I-302 V-A608
Black Cohosh, IV-103 Botulinum Toxin Type B for Injection, BRP Indicator Solution, V-A35
Black Currant, IV-106 I-304 Brucine, V-A35
Black Currant Syrup, IV-106 Bovine Albumin, V-A22 Brunauer, Emmett and Teller (BET)
Black Horehound, IV-108 Bovine Coagulation Factor Xa, V-A34 theory and specific surface area
Blackcurrant Leaf, IV-106 Bovine Euglobulins, V-A64 determination, V-A497
Bladderwrack, see Kelp Bovine Factor Xa Solution, V-A34 BS, V-A608
Bleomycin Injection, III-200 Bovine Factor Xa Solution R1, V-A34 Buckwheat Herb, IV-112
Bleomycin Sulfate, I-299, V-S16 Bovine Insulin, I-1182 Buclizine Hydrochloride, I-321, V-S17
Bleomycin Sulfate for Injection, III-200 Bovine Serum, I-306 Budesonide, I-322
Bleomycin Sulphate for Injection, see Bovine Thrombin, V-A130 Budesonide Aqueous Nasal Spray,
Bleomycin Sulfate for Injection BP, I-3, II-3, III-3, IV-3, V-3 III-205
Bleomycin Sulphate, see Bleomycin Sulfate BPCRS, I-15, II-15, III-15, IV-15, Budesonide Inhalation Powder, III-207
Blocking Solution, V-A33 V-15, V-A608 Budesonide Inhalation Powder, pre-
Blood, V-A537 BPCRS, see British Pharmacopoeia dispensed, III-208
Components, Containers for, V-A537 Chemical Reference Substances Budesonide Nebuliser Suspension,
Containers for, V-A537 Braided Sutures, Sterile Synthetic III-206
Blood and Blood Components, Human, Absorbable, IV-723 Budesonide Powder for Inhalation,
Materials Based on Plasticised Bretylium Injection, III-201 metered dose powder inhaler, see
Poly(Vinyl Chloride) for Tubing Used Bretylium Tosilate, I-307, V-S16 Budesonide Inhalation Powder
in Sets for the Transfusion of, V-A548 Brilliant Blue, see Acid Blue 83 Budesonide Powder for Inhalation, pre-
Blood and Blood Components, Human, Brilliant Green, V-A34 metered units, see Budesonide Inhalation
Materials for Containers for, V-A545 British Anti-Lewisite, see Dimercaprol Powder, pre-dispensed
Blood and Blood Components, Materials British Approved Names, V-A639 Budesonide Pressurised Inhalation,
Based on Plasticised Poly(Vinyl British Pharmacopoeia Chemical III-210
Chloride) for Containers for, V-A545 Reference Substances, V-A653 Bufexamac, I-324
British Pharmacopoeia Commission, I-xi
V-A778 Index
Buffer (Acetate) Solution pH 5.0, Bupivacaine and Diamorphine Injection, Cadmium Sulfate Hydrate for
V-A151 III-218 Homoeopathic Preparations, IV-420
Buffer (HEPES) Solution pH 7.5, Bupivacaine and Epinephrine Injection, Cadmium Sulphate Hydrate for
V-A151 see Bupivacaine and Adrenaline Injection Homoeopathic Preparations, see
Buffer (Phosphate) Solution pH 9.0, Bupivacaine and Fentanyl Injection, Cadmium Sulfate Hydrate for
V-A151 III-219 Homoeopathic Preparations
Buffer Solution pH 9.0 R1, see Boric Bupivacaine and Glucose Injection, Caesium Chloride, V-A36
Buffer pH 9.0 III-216 Caffeic Acid, V-A36
Buffer Solution pH 2.5 R1, V-A151, Bupivacaine Heavy Injection, III-216 Caffeine, I-343, V-A36
V-A152 Bupivacaine Hydrochloride, I-328 Caffeine Citrate Injection, III-224
Buffer Solution pH 10.9, see Ammonia Bupivacaine Injection, III-215 Caffeine Citrate Oral Solution, III-224
Buffer pH 10.9 Buprenorphine, I-330 Caffeine Hydrate, I-344
Buffer solution pH 9.0, see Borate Buffer Buprenorphine Hydrochloride, I-332 Caffeine Monohydrate, see Caffeine
pH 9.0 Buprenorphine Injection, III-220 Hydrate
Buffer Solution pH 2.0, see Chloride Buprenorphine Sublingual Tablets, Caffeine Tablets, Aspirin and, III-152
Buffer pH 2.0, 0.1M III-222 Caffeine Tablets, Paracetamol and, see
Buffer Solution pH 3.6, see Phthalate Buprenorphine Transdermal Patches, Paracetamol and Caffeine Tablets
Buffer pH 3.6 III-221 Calamine, I-346
Buffer Solution pH 10.9, V-A152 Burnet Root, Greater, IV-114 Calamine and Coal Tar Ointment,
Buffer Solution pH 5.2, V-A151, Buserelin, I-334 III-226
V-A152 Buspirone Hydrochloride, I-336 Calamine Cream, Aqueous, III-225
Buffer Solution pH 2.0, V-A151 Busulfan, I-338, V-S18 Calamine Lotion, III-225
Buffer Solution pH 2.2, V-A151 Busulfan Tablets, III-223 Calamine Ointment, III-226
Buffer Solution pH 2.5, V-A151 Butanal, V-A35 Calamine Ointment, Compound, III-226
Buffer Solution pH 3.0, V-A151 Butane-1,3-diol, V-A35 Calamine, Prepared, I-346
Buffer Solution pH 3.5, V-A151 Butanol, V-A35 Calcifediol, I-347
Buffer Solution pH 3.6, V-A151 2-Butanol R1, V-A35 Calciferol, V-A36
Buffer Solution pH 3.7, V-A151 Butan-2-one, V-A35 Calciferol Tablets, see Colecalciferol
Buffer Solution pH 7.4, V-A152 Butcher’s Broom, IV-115 Tablets or Ergocalciferol Tablets
Buffer Solution pH 6.5, V-A151 Butyl Acetate, V-A35 Calcipotriol, Anhydrous, I-348
Buffer Solution pH 5.5, V-A151 Butyl Acetate R1, V-A35 Calcipotriol Monohydrate, I-351
Buffer Solution pH 6.6, V-A152 Butyl Chloride, see 1-Chlorobutane Calcitonin (Salmon), I-353
Buffer Solution pH 7.0, V-A152 Butyl Hydroxybenzoate, I-339, V-S18, Calcitonin (Salmon) Injection, III-226
Buffer Solution pH 8.0, V-A152 V-A36 Calcitriol, I-356
Buffer Solution pH 9.0, V-A152 Butyl Methacrylate, V-A36 Calcitriol Capsules, III-227
Buffer Solution pH 11, V-A152 Butyl Parahydroxybenzoate, V-A36 Calcium Acetate, I-357
Buffer Solution pH 9.0 R1, V-A152 Butyl Parahydroxybenzoate, see Butyl Calcium Acetate, Anhydrous, see Calcium
Buffer Solution pH 3.5, see Acetate Buffer Hydroxybenzoate Acetate
pH 3.5 Butylamine, V-A35 Calcium Acetate, Dried, V-A36
Buffer Solutions, V-A150 Butylated Hydroxyanisole, I-340, V-A36 Calcium and Calcium Salts, Reactions
Buffered Acetone Solution, V-A150 Butylated Hydroxytoluene, I-341, V-A36 of, V-A256
Buffered Copper Sulfate Solution Butylboronic Acid, V-A36 Calcium and Colecalciferol Tablets,
pH 5.2, V-A152 Butylhydroxyanisole, see Butylated III-228
Buffered Copper Sulfate Solution Hydroxyanisole Calcium and Colecalciferol Tablets,
pH 4.0, V-A152 Butylhydroxytoluene, see Butylated Chewable, III-229
Buffered Copper Sulphate Solution Hydroxytoluene Calcium and Ergocalciferol Tablets,
pH 5.2, see Buffered Copper Sulfate Butylparaben, see Butyl Hydroxybenzoate III-230
Solution pH 5.2 Butylsilyl Silica Gel for Chromatography, Calcium and Ergocalciferol Tablets,
Buffered Copper Sulphate Solution V-A113 Chewable, III-231
pH 4.0, see Buffered Copper Sulfate Butyric Acid, V-A36 Calcium Ascorbate, I-358
Solution pH 4.0 Butyrolactone, V-A36 Calcium Carbonate, I-359, V-A36
Buffered Cream, III-211 Calcium Carbonate and Heavy
Buffered Salt Solution pH 7.2, V-A152 Magnesium Carbonate Tablets,
Buffered Sodium Acetate Solution
pH 6.0, V-A155
C Chewable, III-232
Calcium Carbonate R1, V-A36
Cabergoline, I-342
Buflomedil Hydrochloride, I-325 Calcium Carbonate Tablets, Chewable,
Cadmium, V-A36
Bulk and tapped density, V-A254 III-232
Cadmium Acetate, V-A36
Bulk Density and Tapped Density of Calcium Chloride, V-A36
Cadmium- and Lead-free Nitric Acid,
Powders, V-A516 Calcium Chloride, Anhydrous, V-A36
V-A93
Bumetanide, I-327, V-S17 Calcium Chloride Dihydrate, I-360
Cadmium and Ninhydrin Solution,
Bumetanide and Prolonged-release Calcium Chloride Hexahydrate, I-361
V-A36
Potassium Tablets, III-214 Calcium Chloride Injection, III-233
Cadmium Iodide, V-A36
Bumetanide Injection, III-211 Calcium Chloride Intravenous Infusion,
Cadmium Iodide Solution, V-A36
Bumetanide Oral Solution, III-212 see Calcium Chloride Injection
Cadmium Nitrate Tetrahydrate, V-A36
Bumetanide Tablets, III-213 Calcium Chloride R1, V-A36
Cadmium Standard Solution (0.1% Cd),
Bupivacaine, V-S17 Calcium Chloride Solution, V-A36
V-A146
Bupivacaine and Adrenaline Injection, Calcium chloride solution, 0.025M,
Cadmium Standard Solution (10 ppm
III-218 V-A36
Cd), V-A146
Bupivacaine and Dextrose Injection, Calcium Dobesilate Monohydrate, I-362
III-216 Calcium Folinate, I-363, V-S18
Calcium Folinate for Injection, III-234 Calcium Sulphate Dihydrate, see Calcium Carbaryl Lotion, III-241
Calcium Folinate Injection, III-233 Sulfate Dihydrate Carbasalate Calcium, I-397
Calcium Folinate Tablets, III-235 Calcium Sulphate Solution, see Calcium Carbazole, V-A37
Calcium Glucoheptonate, I-365 Sulfate Solution Carbenoxolone, V-S20
Calcium Gluconate, I-366 Calcium Sulphate, see Calcium Sulfate Carbenoxolone Sodium, I-399
Calcium Gluconate, Anhydrous, I-367 Calconcarboxylic Acid, V-A37 Carbidopa, I-400
Calcium Gluconate for Injection, I-368 Calconcarboxylic Acid Triturate, V-A37 Carbidopa Tablets, Levodopa and,
Calcium Gluconate Injection, III-236 Calculations, Pharmacopoeial, V-A757 III-357
Calcium Gluconate Tablets, III-236 Calendula Flower, IV-116 Carbimazole, I-401, V-S20
Calcium Gluconate Tablets, Chewable, Calibration of the Chromatographic Carbimazole Tablets, III-242
III-236 System, V-A197 Carbocisteine, I-402
Calcium Gluconate Tablets, Camphene, V-A37 Carbomer, V-A37
Effervescent, III-237 Camphor, V-A37 Carbomer Eye Drops, III-242
Calcium Glycerophosphate, I-370 Camphor, Natural, I-385 Carbomers, I-403
Calcium Hydrogen Phosphate, I-370 Camphor, Racemic, I-387 Carbon, Determination of Total Organic,
Calcium Hydrogen Phosphate, Camphor Water, Concentrated, III-238 V-A253
Anhydrous, I-372 Camphorated Opium Tincture, IV-293 Carbon Dioxide, I-405, V-A37
Calcium Hydrogen Phosphate Dihydrate, Camphorated Opium Tincture, Carbon Dioxide in Medicinal Gases,
see Calcium Hydrogen Phosphate Concentrated, IV-293 Determination of, V-A297
Calcium Hydroxide, I-373, V-A36 D-Camphor, see Natural Camphor Carbon Dioxide R1, V-A37
Calcium Hydroxide, Saturated at 25 8C, Candela, Definition of, I-32, II-32, Carbon Dioxide R2, V-A37
V-A249 III-32, IV-32, V-32 Carbon Dioxide-free Water, V-A137
Calcium Hydroxide Solution, III-237, Candesartan Cilexetil, I-388 Carbon Disulfide, V-A38
V-A36 Cape Aloes, IV-54 Carbon Disulphide, see Carbon Disulfide
Calcium in Adsorbed Vaccines, V-A447 Capillary Electrophoresis, V-A206 Carbon for Chromatography,
Calcium Iodide Tetrahydrate for Capillary Electrophoresis, Isoelectric Graphitised, V-A38
Homoeopathic Preparations, IV-420 Focusing, V-A209 Carbon Monoxide, I-406, V-A38
Calcium Lactate, V-A36 Capillary Electrophoresis, Micellar Carbon Monoxide (15O), IV-650
Calcium Lactate, Anhydrous, I-373 Electrokinetic Chromatography, Carbon Monoxide in Medicinal Gases,
Calcium Lactate Monohydrate, I-374 V-A209 Limit Test for, V-A296
Calcium Lactate Pentahydrate, I-375 Capillary electrophoresis/mass Carbon Monoxide, R1, V-A38
Calcium Lactate Tablets, III-237 spectrometry, V-A176 Carbon Tetrachloride, V-A38
Calcium Lactate Trihydrate, I-376 Capillary Gel Electrophoresis, V-A208 Carbonate Buffer pH 9.7, V-A152
Calcium Lactate, see Calcium Lactate Capillary Isoelectric Focusing, V-A209 Carbonate-free Sodium Hydroxide
Pentahydrate Capillary viscometer method, V-A244 Solution, V-A120
Calcium Levofolinate Pentahydrate, Capital Initial Letters, Significance of, Carbonates and Bicarbonates, Reactions
I-376 I-8, II-8, III-8, IV-8, V-8 of, V-A256
Calcium Levulinate Dihydrate, I-379 Capric Acid, V-A37 Carbonates, Reactions of, V-A256
Calcium, Limit Test for, V-A260 Capric Alcohol, see Decan-1-ol Carbophenothion, V-A38
Calcium Pantothenate, I-380 Caproic Acid, V-A37 Carboplatin, I-407
Calcium Phosphate, I-381 e-Caprolactam, V-A37 Carboplatin Injection, III-243
Calcium Phosphate for Homoeopathic Caprylic Acid, V-A37 Carboprost Trometamol, I-409
Preparations, IV-421 Caprylic Acid, see Octanoic Acid Cardamom Fruit, IV-124
Calcium Phosphate Monobasic Caprylocaproyl Macrogolglycerides, Cardamom Oil, IV-125
Monohydrate, V-A37 I-390 Cardamom Tincture, Aromatic, IV-125
Calcium Phosphoricum for Capsaicin, V-A37 Cardamom Tincture, Compound,
Homoeopathic Preparations, see Capsicum, IV-118 IV-125
Calcium Phosphate for Homoeopathic Capsicum Soft Extract, Standardised, Car-3-ene, V-A38
Preparations IV-120 Carisoprodol, I-410
Calcium Polystyrene Sulfonate, I-382, Capsicum Tincture, Standardised, see Carmellose, I-411
V-S19 Standardised Capsicum Tincture, Carmellose Calcium, I-412
Calcium Polystyrene Sulphonate, see Capsules, III-40 Carmellose Sodium, I-412
Calcium Polystyrene Sulfonate Capsules, Disintegration Test for, Carmellose Sodium Eye Drops, III-244
Calcium Standard Solution V-A333–V-A378 Carmellose Sodium, Low-substituted,
(10 ppm Ca), V-A146 Capsules, Dissolution Test for, V-A336 I-413
Calcium Standard Solution Capsules of the BP, III-41 Carmellose Sodium, Microcrystalline
(100 ppm Ca), V-A146 Captopril, I-391, V-S19 Cellulose, and, I-472
Calcium Standard Solution Captopril Oral Solution, III-238 Carminic Acid, V-A38
(100 ppm Ca), Alcoholic, V-A146 Captopril Powder for Oral Solution, Carmustine, I-415
Calcium Standard Solution III-239 Carnauba Wax, I-415
(100 ppm Ca) R1, V-A146 Captopril Tablets, III-239 Carob Bean Gum, V-A38
Calcium Standard Solution Caraway, IV-122 Carrageenan, IV-125
(400 ppm Ca), V-A146 Caraway Fruit, see Caraway Carteolol Eye Drops, III-244
Calcium Standard Solution Caraway Oil, IV-123 Carteolol Hydrochloride, I-416
(1000 ppm Ca), V-A146 Carbachol, I-394 Cartridges, Extractable Volume test,
Calcium Stearate, I-383 Carbamazepine, I-395, V-S19 V-A361
Calcium Sulfate, V-A37 Carbamazepine Tablets, III-240 Carum Carvi, V-A590
Calcium Sulfate Dihydrate, I-385 Carbamide, see Urea Carvacrol, V-A38
Calcium Sulfate, Dried, I-384 Carbaryl, I-397, V-S20 Carvedilol, I-418
Calcium Sulfate Solution, V-A37 Carbaryl Cutaneous Solution, III-241 Carveol, V-A38
V-A780 Index
(–)-Carvone, V-A38 Cefazolin Sodium for Injection, III-255 Cellulose, Microcrystalline, see Cellulose
Carvone R1, V-A38 Cefepime Dihydrochloride Monohydrate, for Chromatography R1
b-Caryophyllene, V-A38 see Cefepime Hydrochloride Monohydrate Cellulose Nitrate, see Pyroxylin
Caryophyllene Oxide, V-A39 Cefepime Hydrochloride Monohydrate, Cellulose, Powdered, I-473
Cascade impactor, Andersen, V-A366 I-438 Cellulose, see Cellulose for Chromatography
Cascara, IV-126 Cefixime, I-440
Cascara Dry Extract, Standardised, see Cefoperazone Sodium, I-441 Celsius, Definition of, I-32, II-32,
Standardised Cascara Dry Extract, Cefotaxime Injection, III-256 III-32, IV-32, V-32
Cascara Sagrada, V-A590 Cefotaxime Sodium, I-443, V-S21 Centaury, IV-133
Cascara Tablets, IV-129 Cefotaxime Sodium for Injection, III-256 Centella, IV-134
Casein, V-A39 Cefoxitin Injection, III-257 Centigrade, Definition of, I-32, II-32,
Casein Substrate, Concentrated, V-A39 Cefoxitin Sodium, I-445, V-S21 III-32, IV-32, V-32
Cashew, Oriental, for Homoeopathic Cefoxitin Sodium for Injection, III-258 Centrifugation, Definition of, I-32, II-32,
Preparations, IV-421 Cefpodoxime Proxetil, I-447 III-32, IV-32, V-32
Cassava Starch, II-914 Cefprozil Monohydrate, I-450 Cephalin Regent, V-A39
Cassia Oil, IV-131 Cefradine, I-452, V-S22 Cephaëline Dihydrochloride, V-A39
Casticin, V-A39 Cefradine Capsules, III-259 Cerium (IV) Sulfate, see Cerium Sulfate
Castor Oil Cream, Zinc and, III-1179 Cefradine for Injection, III-261 Cerium Sulfate, see Cerium Sulfate
Castor Oil, Hydrogenated, I-419 Cefradine Injection, III-261 Cerium Sulphate, see Cerium Sulfate
Castor Oil, Hydrogenated Polyoxyl, Cefradine Oral Suspension, III-263 Cerium(III) Nitrate, V-A40
I-421 Ceftazidime for Injection, III-265 Cerium(III) Nitrate Solution, V-A40
Castor Oil Ointment, Zinc and, III-1179 Ceftazidime Injection, III-265 Cerium(IV) Sulfate, V-A40
Castor Oil, Polyoxyethylated, V-A104 Ceftazidime Pentahydrate, I-455 Cerium(IV) Sulfate VS, V-A140
Castor Oil, Polyoxyl, I-420 Ceftazidime Pentahydrate with Sodium Cerium(IV) Sulphate VS, see Cerium(IV)
Castor Oil, Refined, I-422 Carbonate for Injection, I-457 Sulfate VS
Castor Oil, Virgin, I-423 Ceftazidime, see Ceftazidime Pentahydrate Cerium(IV) Sulphate, see Cerium Sulfate
Castor Oil, see Virgin Castor Oil Ceftriaxone Injection, III-267 Cerous Nitrate, see Cerium(III) Nitrate
Catalpol, V-A39 Ceftriaxone Sodium, I-459, V-S22 Certification Scheme, European
Catechin, V-A39 Ceftriaxone Sodium for Injection, Pharmacopoeia, V-A657
Catechol, V-A39 III-267 Cetirizine Dihydrochloride, see Cetirizine
Catgut, Sterile, IV-721 Cefuroxime Axetil, I-461, V-S22 Hydrochloride
Catholyte for Isoelectric Focusing Cefuroxime Axetil Oral Suspension, Cetirizine Hydrochloride, I-479, V-S23
pH 3 to 5, V-A39 III-271 Cetirizine Oral Solution, III-275
Cation Exchange Resin, V-A39 Cefuroxime Axetil Tablets, III-273 Cetirizine Tablets, III-276
Cation Exchange Resin (Calcium Form), Cefuroxime Eye Drops, III-268 Cetomacrogol Emulsifying Ointment,
Strong, V-A39 Cefuroxime Injection, III-268 III-277
Cation Exchange Resin R1, V-A39 Cefuroxime Injection, Intracameral, Cetomacrogol Emulsifying Wax, III-277
Cation-exchange resin (sodium form), III-270 Cetostearyl Alcohol, I-480, V-A40
strong, V-A39 Cefuroxime Intracameral Injection, Cetostearyl Alcohol (Type A),
Cation-Exchange Resin, Strong, V-A39 III-270 Emulsifying, I-481
Cationic Resin, Weak, V-A39 Cefuroxime Sodium, I-462, V-S23 Cetostearyl Alcohol (Type B),
Caustic Potash, see Potassium Hydroxide Cefuroxime Sodium for Injection, Emulsifying, I-482
Caustic Soda, see Sodium Hydroxide III-268 Cetostearyl Isononanoate, I-484
Caution Statements, I-7, II-7, III-7, Celandine, Greater, IV-132 Cetrimide, I-484, V-A40
IV-7, V-7 Celecoxib, I-464 Cetrimide Cream, III-278
CCID50, Definition of, I-30, II-30, Celiprolol Hydrochloride, I-465, V-S23 Cetrimide Cutaneous Solution, III-278
III-30, IV-30, V-30 Celiprolol Tablets, III-274 Cetrimide Cutaneous Solution, Sterile,
CCID50, V-A608 Cell component analysis methods for the III-279
CD34/CD45þ Cells in Haematopoietic detection of micro-organisms, V-A720 Cetrimide Emulsifying Ointment, III-278
Products, Numeration of, V-A441 Cell cultures, Test methods for, V-A455 Cetrimide Solution, III-278
Cedarwood Oil, V-A39 Cell method, Dissolution Test for Cetrimide Solution, Sterile, III-279
Cefaclor, I-424 Transdermal Patches, V-A347 Cetrimide Solution, Strong, I-485
Cefaclor Capsules, III-245 Cell Substrates for the Production of Cetyl Alcohol, I-486, V-A40
Cefaclor Oral Suspension, III-246 Vaccines for Human Use, V-A454 Cetyl Esters Wax, see Cetyl Palmitate
Cefaclor Tablets, Prolonged-release, Cellacefate, I-466 Cetyl Palmitate, I-487
III-248 Cellular Products, Microbiological Cetylpyridinium Chloride, I-488, V-A40
Cefadroxil Capsules, III-249 Control of, V-A479 Cetylpyridinium Chloride Monohydrate,
Cefadroxil Monohydrate, I-426 Cellulose Acetate, I-477 V-A40
Cefadroxil Oral Suspension, III-250 Cellulose Acetate Butyrate, I-478 Cetylpyridinium Chloride VS, V-A140
Cefalexin, V-S21 Cellulose Acetate Phthalate, see Cetyltrimethylammonium Bromide,
Cefalexin Capsules, III-251 Cellacefate V-A40
Cefalexin Monohydrate, I-428 Cellulose, Dispersible, I-467 Ceylon Cinnamon Bark Oil, IV-140
Cefalexin Oral Suspension, III-252 Cellulose for Chromatography, V-A39 Ceylon Cinnamon Leaf Oil, IV-141
Cefalexin Tablets, III-253 Cellulose for Chromatography F254, Ceylon Cinnamon, see Cinnamon
Cefalotin Sodium, I-429 V-A39 Chalk, I-489
Cefamandole Nafate, I-431 Cellulose for Chromatography R1, Chalk, Prepared, I-489
Cefapirin Sodium, I-433 V-A39 Chamazulene, V-A40
Cefatrizine Propylene Glycol, I-434 Cellulose F254, see Cellulose for Chamomile Flowers, IV-135
Cefazolin Injection, III-255 Chromatography F254 Changes in Monograph Titles, V-A639
Cefazolin Sodium, I-435 Cellulose, Microcrystalline, I-468 Changes in Title of Monographs, I-xxxiii
Characterisation of Crystalline and Chewing Gums, Medicated, III-49 Chlorides, Limit Test for, V-A260
Partially Crystalline Solids by X-ray Chicken Flocks Free from Specified Chlorides, Reactions of, V-A256
Powder Diffraction (XRPD), V-A508 Pathogens for the Production and Chlorinated Lime, I-508
Characterisation of Crystalline Solids by Quality Control of Vaccines, V-A452 Chlormethine Hydrochloride, I-508
Microcalorimetry and Solution Child-proof Container, V-A530 Chlormethine Hydrochloride for
Calorimetry, V-A523 China, V-A590 Injection, III-291
Characteristics of Discontinuous Buffer Chininum Sulfuricum, V-A590 Chlormethine Injection, III-291
System Gel Electrophoresis, V-A203 Chitosan Hydrochloride, I-492 4-Chloroacetanilide, V-A40
Characteristics, Status of, I-11, II-11, Chloral Hydrate, I-493, V-A40 Chloroacetanilide, see 4-Chloroacetanilide
III-11, IV-11, V-11 Chloral Hydrate Oral Solution, III-279 Chloroacetic Acid, V-A40
Characters, I-26, II-26, III-26, IV-26, Chloral Hydrate Solution, V-A40 4-Chloroaniline, V-A40
V-26 Chlorambucil, I-493 Chloroaniline, see 4-Chloroaniline
Characters Section in Monographs, Chlorambucil Tablets, III-279 Chloroauric Acid, V-A40
V-A716 Chloramine Solution, V-A40 Chloroauric Acid Solution, V-A40
Charcoal, Activated, I-489, V-A40 Chloramine Solution R1, V-A40 Chlorobenzene, V-A40
Chebula Fruit, see Terminalia Chebula Chloramine Solution R2, V-A40 4-Chlorobenzenesulfonamide, V-A41
Fruit Chloramine T, V-A40 4-Chlorobenzenesulphonamide, see
Check Assay, V-A636 Chloramine, see Chloramine T 4-Chlorobenzenesulfonamide
Chemical Abstracts Service Registry Chloramine, see Tosylchloramide Sodium 2-Chlorobenzoic Acid, V-A41
Number, Status, I-4, II-4, III-4, IV-4, Chloramphenicol, I-495 3-(4-Chlorobenzoyl)propionic Acid,
V-4 Chloramphenicol Capsules, III-280 V-A41
Chemical and Biological Reference Chloramphenicol Ear Drops, III-281 1-(2-Chlorobenzoyl)-3-
Materials, see Reference Materials Chloramphenicol Eye Drops, III-282 (4-triflumoromethoxyphenyl)ureaSee
Chemical Formulae, I-8, II-8, III-8, Chloramphenicol Eye Ointment, III-283 Triflumuron, V-A134
IV-8, V-8 Chloramphenicol Palmitate, I-496 1-Chlorobutane, V-A41
Chemical Ionisation Mass Spectrometry, Chloramphenicol Sodium Succinate, Chlorobutanol, I-508, V-A41
V-A177 I-497 Chlorobutanol, Anhydrous, I-509
Chemical Reference Materials, see Chloramphenicol Sodium Succinate for Chlorobutanol Hemihydrate, see
Reference Materials Injection, III-284 Chlorobutanol
Chemical Reference Substances, I-15, Chloramphenicol Sodium Succinate Chlorocresol, I-510
II-15, III-15, IV-15, V-15 Injection, III-284 2-Chloro-2-deoxy-d-glucose, V-A41
Chenodeoxycholic Acid, I-490 Chlorcyclizine Hydrochloride, I-499 1-Chloro-2,4-dinitrobenzene, V-A41
Chewable Aluminium Hydroxide and Chlordane, V-A40 Chlorodyne, III-291
Magnesium Trisilicate Tablets, III-753 Chlordiazepoxide, I-500, V-A40 2-Chloroethanol, V-A41
Chewable Aluminium Hydroxide Chlordiazepoxide Capsules, III-285 2-Chloroethanol Solution, V-A41
Tablets, III-119 Chlordiazepoxide Hydrochloride, I-501 Chloroethylamine Hydrochloride, V-A41
Chewable Ascorbic Acid Tablets, III-149 Chlordiazepoxide Hydrochloride Tablets, (2-Chloroethyl)diethylamine
Chewable Calcium and Colecalciferol III-286 Hydrochloride, V-A41
Tablets, III-229 Chlorfenvinphos, V-A40 Chloroform, I-510, V-S24, V-A41
Chewable Calcium and Ergocalciferol Chlorhexidine V-S24 Chloroform, Acidified, V-A41
Tablets, III-231 Chlorhexidine Acetate, I-502, V-A40 Chloroform and Morphine Tincture,
Chewable Calcium and Ergocalciferol Chlorhexidine Diacetate, see III-291
Tablets, Chewable Calcium and, Chlorhexidine Acetate Chloroform, Ethanol-free, V-A41
III-231 Chlorhexidine Digluconate Eye Drops, Chloroform IR, V-A41
Chewable Calcium Carbonate and Heavy see Chlorhexidine Gluconate Eye Drops Chloroform Spirit, III-291
Magnesium Carbonate Tablets, Chlorhexidine Digluconate Solution, see Chloroform Stabilised with Amylene,
III-232 Chlorhexidine Gluconate Solution V-A41
Chewable Calcium Carbonate Tablets, Chlorhexidine Dihydrochloride, see Chloroform Water, V-A41
III-232 Chlorhexidine Hydrochloride Chloroform Water, Double-strength,
Chewable Calcium Gluconate Tablets, Chlorhexidine Gel, Lidocaine and, III-292
III-236 III-730 Chloroformic Iodine Solution, V-A75
Chewable Compound Magnesium Chlorhexidine Gel, Lignocaine and, see Chlorogenic Acid, V-A41
Trisilicate Tablets, III-753 Lidocaine and Chlorhexidine Gel 5-Chloro-8-hydroxyquinoline, V-A41
Chewable Heavy Magnesium Carbonate Chlorhexidine Gluconate Eye Drops, 3-Chloro-2-methylaniline, V-A41
and Calcium Carbonate Tablets, III-287 2-Chloro-N-(2,6-
III-232 Chlorhexidine Gluconate Gel, III-288 dimethylphenyl)acetamide, V-A42
Chewable Magnesium Glycerophosphate Chlorhexidine Gluconate Solution, I-503 2-Chloronicotinic Acid, V-A42
Tablets, III-750 Chlorhexidine Hydrochloride, I-506, 2-Chloro-4-nitroaniline, V-A41, V-A42
Chewable Magnesium Trisilicate V-A40 2-Chloro-5-Nitrobenzoioc Acid, V-A42
Tablets, Aluminium Hydroxide and, Chlorhexidine Irrigation Solution, 4-Chloro-o-cresol, V-A41
III-753 III-289 4-Chlorophenol, V-A42
Chewable Magnesium Trisilicate Chlorhexidine Mouthwash, III-290 Chlorophenol, see 4-Chlorophenol
Tablets, Compound, III-753 Chloride Buffer pH 2.0, 0.1M, V-A152 Chloroplatinic Acid Solution, V-A42
Chewable Piperazine Phosphate Tablets, Chloride Standard Solution (5 ppm Cl), Chloroplatinic Acid, see Chloroplatinic(IV)
III-963 V-A146 Acid
Chewable Vitamin C Tablets see Chloride Standard Solution (8 ppm Cl), Chloroplatinic(IV) Acid, V-A42
Chewable Ascorbic Acid Tablets, V-A146 3-Chloropropane-1,3-diol, V-A42
III-149 Chloride Standard Solution (50 ppm 1-Chloropropyl(dimethyl)amine
Chewing Gum, Drug Release from Cl), V-A146 Hyrochloride, V-A42
Medicated, V-A350 Chloride-free Ammonia, V-A25 Chloroquine, V-S24
V-A782 Index
Chloroquine Phosphate, I-512 Cholera(oral), see Cholera Vaccine Chromophore Substrate R2, V-A43
Chloroquine Phosphate Tablets, III-292 (Inactivated, Oral) Chromophore Substrate R3, V-A43
Chloroquine Sulfate, I-513 Cholera, see Cholera Vaccine Chromotrope IIB, V-A43
Chloroquine Sulfate Injection, III-293 (5a)-Cholestane, V-A42 Chromotrope IIB Solution, V-A43
Chloroquine Sulfate Tablets, III-293 Cholesterinum, V-A590 Chromotropic Acid, V-A43
Chloroquine Sulphate Injection, see Cholesterol, I-525, V-A42 Chromotropic Acid Sodium Salt, V-A43
Chloroquine Sulfate Injection Cholesterol for Parenteral Use, I-526 Chromotropic Acid Sodium Salt
Chloroquine Sulphate Tablets, see Cholesteryl Benzoate, V-A42 Solution, V-A43
Chloroquine Sulfate Tablets Choline Chloride, V-A42 Chromotropic Acid Solution, V-A43
5-Chloroquinolin-8-ol, V-A42 Choline Salicylate, V-S26 Chromotropic Acid-Sulfuric Acid
4-Chlororesorcinol, V-A42 Choline Salicylate Ear Drops, III-302 Solution, V-A43
5-Chlorosalicylic Acid, V-A42 Choline Salicylate Oromucosal Gel, Chromotropic Acid-Sulphuric Acid
4-Chlorosulfamoylbenzoic Acid, V-A42 III-302 Solution, see Chromotropic Acid-Sulfuric
Chlorothiazide, V-A42 Choline Salicylate Solution, I-528 Acid Solution
Chlorotrimethylsilane, see Choline Theophyllinate, I-528, V-S26 Chrysanthemin, V-A43
Trimethylchlorosilane Choline Theophyllinate Tablets, III-302 Chymotrypsin, I-532
Chlorotriphenylmethane, V-A42 Chondroitin Sulfate Sodium, I-529 a-Chymotrypsin for Peptide Mapping,
Chloroxylenol, I-513, V-S25 Chondroitin Sulphate Sodium, see V-A43
Chloroxylenol Solution, III-294 Chondroitin Sulfate Sodium Ciclesonide, I-534
Chlorphenamine Injection, III-294 Chondroitinase ABC, V-A42 Ciclopirox, I-535
Chlorphenamine Maleate, I-514 Chondroitinase AC, V-A42 Ciclopirox Olamine, I-536
Chlorphenamine Oral Solution, III-295 Chorionic Gonadotrophin, I-532, V-A69 Ciclosporin, I-538, V-S27
Chlorphenamine Tablets, III-296 Chorionic Gonadotrophin for Injection, Ciclosporin Eye Drops, III-304
Chlorpheniramine Injection, see III-303 Cilastatin Sodium, I-539
Chlorphenamine Injection Chorionic Gonadotrophin Injection, Cilazapril, I-541
Chlorpheniramine Maleate, see III-303 Cimetidine, I-543, V-S27
Chlorphenamine Maleate Chromatogram, Definition, V-A184 Cimetidine Hydrochloride, I-545
Chlorpheniramine Oral Solution, see Chromatographic Separation, V-A216 Cimetidine Injection, III-304
Chlorphenamine Oral Solution Chromatographic Separation Cimetidine Oral Solution, III-305
Chlorpheniramine Tablets, see Techniques, V-A184 Cimetidine Oral Suspension, III-306
Chlorphenamine Tablets Chromatographic Tests, I-xxiv Cimetidine Tablets, III-307
Chlorpromazine, I-515, V-S25 Chromatographic Tests, Materials Used Cimifugin, V-A43
Chlorpromazine Elixir, III-297 in, V-A712 Cinchocaine Hydrochloride, I-547
Chlorpromazine Hydrochloride, I-516 Chromatography, Liquid, V-A199 Cinchona Bark, IV-136
Chlorpromazine Injection, III-296 Chromazurol S, see Chrome Azurol S Cinchona Liquid Extract, Standardised,
Chlorpromazine Oral Solution, III-297 Chrome Azurol S, V-A42 see Standardised Cinchona Liquid
Chlorpromazine Suppositories, III-297 Chromic Acid Cleansing Mixture, see Extract,
Chlorpromazine Tablets, III-298 Chromic-Sulfuric Acid Mixture Cinchona, see Cinchona Bark
Chlorpropamide, I-518, V-S25 Chromic Potassium Sulfate, see Cinchonidine, V-A43
Chlorpropamide Tablets, III-298 Chromium(III) Potassium Sulfate Cinchonine, V-A43
Chlorprothixene Hydrochloride, I-519 Chromic Potassium Sulphate, see Cineole, I-548, V-A43, V-A44
Chlorpyriphos, V-A42 Chromic Potassium Sulfate Cineole, Determination of in Essential
Chlorpyriphos-methyl, V-A42 Chromic-Sulfuric Acid Mixture, V-A43 Oils, V-A307
Chlortalidone, I-521, V-S26 Chromic-Sulphuric Acid Mixture, see Cineole Type Niaouli Oil, IV-278
Chlortalidone Tablets, III-299 Chromic-Sulfuric Acid Mixture Cineraria Maritima for Homoeopathic
Chlortalidone Tablets, Atenolol and, Chromium (51Cr) Edetate Injection, Preparations, IV-423
III-386 IV-651 Cinnamaldehyde, V-A44
Chlortetracycline Eye Ointment, III-300 Chromium Liposoluble Standard Cinnamamide, V-A44
Chlortetracycline Hydrochloride, I-522, Solution (1000 ppm Cr), V-A146 Cinnamic Acid, I-549, V-S27, V-A44
V-A42 Chromium Standard Solution (0.1% Cinnamic Aldehyde, see Cinnamaldehyde
Chlortetracycline Ointment, III-301 Cr), V-A147 Cinnamomum, V-A590
Chocolate Basis for Tablets, III-75 Chromium Standard Solution (0.1 ppm Cinnamon, IV-139
Choice of vaccine strain, Choice of Cr), V-A147 Cinnamon Bark Oil, Ceylon, IV-140
vaccine composition, I-25, II-25, Chromium Standard Solution (100 ppm Cinnamon Bark, see Cinnamon
III-25, IV-25, V-25 Cr), V-A147 Cinnamon Leaf Oil, Ceylon, see Ceylon
Cholecalciferol Concentrate (Oily Form), Chromium Trioxide, see Chromium(VI) Cinnamon Leaf Oil
see Colecalciferol Concentrate (Oily Oxide Cinnamon Oil, see Ceylon Cinnamon Bark
Form) Chromium(III) Acetylacetonate, V-A43 Oil
Cholecalciferol Concentrate (Powder Chromium(III) Potassium Sulfate, V-A43 Cinnamon Tincture, IV-141
Form), see Colecalciferol Concentrate Chromium(III) Potassium Sulphate, see Cinnamon Water, Concentrated, IV-141
(Powder Form) Chromium(III) Potassium Sulfate Cinnamyl Acetate, V-A44
Cholecalciferol Concentrate (Water- Chromium(III) Trichloride Hexahydrate, Cinnarizine, I-549
dispersible Form), see Colecalciferol V-A43 CIP, V-A608
Concentrate (Water-dispersible Form) Chromium(VI) Oxide, V-A43 C.I.P. - Collection de Bactéries de
Cholecalciferol, see Colecalciferol Chromogenic Substrate R1, V-A43 l’Institut Pasteur, address of, I-31,
Cholera Vaccine, IV-510 Chromogenic Substrate R2, V-A43 II-31, III-31, IV-31, V-31
Cholera Vaccine, Freeze-dried, IV-510 Chromogenic Substrate R3, V-A43 Ciprofibrate, I-551
Cholera Vaccine (Inactivated, Oral), Chromogenic Substrate R4, V-A43 Ciprofloxacin, I-552
IV-511 Chromogenic Substrate R5, V-A43 Ciprofloxacin Hydrochloride, I-554
Chromophore Substrate R1, V-A43 Ciprofloxacin Infusion, III-308
Ciprofloxacin Intravenous Infusion, see Clioquinol, I-573, V-S28 Coal Tar Paste, Zinc and, III-1179
Ciprofloxacin Infusion Clioquinol Cream, Hydrocortisone and, Coal Tar Solution, III-1090
Ciprofloxacin Tablets, III-309 III-631 Coal Tar Solution, Strong, III-1091
Circular Dichroism, Determination of, Clobazam, I-575, V-S29 Co-amilofruse Tablets, III-341
V-A247 Clobazam Oral Suspension, III-321 Co-amilozide Oral Solution, III-342
Cisplatin, I-555 Clobazam Tablets, III-322 Co-amilozide Tablets, III-343
Cisplatin for Injection, III-312 Clobetasol Cream, III-324 Co-amoxiclav for Injection, III-344
Cisplatin Injection, III-311 Clobetasol Ointment, III-324 Co-amoxiclav Injection, III-344
Citalopram Hydrobromide, I-557 Clobetasol Propionate, I-576, V-S29, Co-amoxiclav Oral Suspension, III-346
Citalopram Hydrochloride, I-559 V-A45 Co-amoxiclav Tablets, III-348
Citral, V-A44 Clobetasone Butyrate, I-578 Co-amoxiclav Tablets, Dispersible,
Citrate Buffer Solution pH 5.0, V-A152 Clobetasone Cream, III-325 III-350
Citrate Buffered Saline, V-A44 Clobetasone Ointment, III-325 Coarse Powder, Definition of, V-A483
Citrated Rabbit Plasma, V-A44, V-A102 Clodronate Disodium Tetrahydrate, Cobalt Chloride, see Cobalt(II) Chloride
Citrates, Reactions of, V-A256 II-834 Cobalt Nitrate, see Cobalt(II) Nitrate
Citric Acid, V-A44 Clofazimine, I-579, V-S29 Cobalt Standard Solution (100 ppm Co),
Citric Acid, Anhydrous, I-560, V-A44 Clofazimine Capsules, III-326 V-A147
Citric Acid Monohydrate, I-561 Clofibrate, I-580 Cobalt(II) Acetate, V-A45
Citric Acid, see Anhydrous Citric Acid Clofibrate Capsules, III-327 Cobalt(II) Chloride, V-A45
Citric-Molybdic Acid Solution, V-A44 Clomethiazole, I-581, V-S30 Cobalt(II) Nitrate, V-A45
Citronella Oil, IV-142 Clomethiazole Capsules, III-327 Co-beneldopa Capsules, III-351
Citronellal, V-A44 Clomethiazole Edisilate, I-582, V-S30 Co-beneldopa Tablets, Dispersible,
Citronellol, V-A44 Clomethiazole Infusion, III-328 III-354
Citronellyl Acetate, V-A45 Clomethiazole Intravenous Infusion, see Cocaine, I-597, V-S31
Citro-phosphate Buffer pH 4.5, V-A152 Clomethiazole Infusion Cocaine Eye Drops, III-355
Citro-phosphate Buffer pH 5.0, V-A152 Clomethiazole Oral Solution, III-330 Cocaine Hydrochloride, I-598
Citro-phosphate Buffer pH 6.0, V-A152 Clomifene Citrate, I-583 Cocaine Intranasal Solution, Adrenaline
Citro-phosphate Buffer pH 6.5, V-A152 Clomifene Tablets, III-330 and, III-105
Citro-phosphate Buffer pH 6.8, V-A152 Clomipramine Capsules, III-331 Cocaine Intranasal Solution, Epinephrine
Citro-phosphate Buffer pH 7.0, V-A152 Clomipramine Hydrochloride, I-585, and, see Adrenaline and Cocaine
Citro-phosphate Buffer pH 7.2, V-A152 V-S30 Intranasal Solution
Citro-phosphate Buffer pH 7.6, V-A152 Clomipramine Tablets, Prolonged- Cocaine Paste, III-356
Citropten, V-A45 release, III-332 Co-careldopa Tablets, III-357
Citrullus Colocynthis Fruit for Clonazepam, I-587, V-S31 Cocculus Indicus for Homoeopathic
Homoeopathic Preparations, IV-424 Clonazepam Concentrate, Sterile, Preparations, IV-425
Cladribine, I-562 III-333 Cochineal, I-599
Clarithromycin, I-564, V-S28 Clonazepam Injection, III-333 Cocoa Butter, see Theobroma Oil
Clarithromycin for Infusion, III-312 Clonazepam Oral Suspension, III-334 Co-codamol Capsules, III-358
Clarithromycin Tablets, III-314 Clonazepam Tablets, III-336 Co-codamol Tablets, III-360
Clarithromycin Tablets, Prolonged- Clonidine Hydrochloride, I-588 Co-codamol Tablets, Effervescent,
release, III-315 Clonidine Injection, III-337 III-361
Clarity of Solution, V-A231 Clonidine Tablets, III-338 Co-codaprin Tablets, III-363
Clarity of Solution, Instrumental Clopamide, I-589 Co-codaprin Tablets, Dispersible,
Methods, V-A231 Clopidogrel Hydrogen Sulfate, I-590 III-364
Clarity of Solution, Visual Method, Closures and Tubing, Silicone Elastomer Coconut Oil, I-599
V-A231 for, V-A572 Coconut Oil, Fractionated, see Medium-
Clary Sage Oil, see Sage Oil Clotrimazole, I-592 chain Triglycerides
Clavulanic Acid for Infusion, Ticarcillin Clotrimazole Cream, III-338 Cocoyl Caprylocaprate, I-600
and, III-1111 Clotrimazole Pessaries, III-339 Co-danthrusate Capsules, III-365
Clavulanic Acid for Intravenous Infusion, Clove, IV-144 Code of Practice, I-xiii, I-xxvi
Ticarcillin and, see Ticarcillin and Clove Oil, IV-145 Codeine, I-601, V-S32, V-A45
Clavulanic Acid for Infusion Cloxacillin Sodium, I-594 Codeine Hydrochloride, I-603
Clavulanic Acid Infusion, Ticarcillin and, Clozapine, I-595, V-S31 Codeine Hydrochloride Dihydrate, see
III-1111 Clozapine Oral Suspension, III-340 Codeine Hydrochloride
Clavulanic Acid Intravenous Infusion, Coagulation activator, V-A411 Codeine Linctus, III-366
Ticarcillin and, see Ticarcillin and Coagulation factor II, Human, Assay of, Codeine Linctus, Paediatric, III-367
Clavulanic Acid for Infusion V-A402 Codeine Oral Solution, III-366
Clebopride Malate, I-566 Coagulation Factor V Solution, V-A45 Codeine Oral Solution, Paediatric,
Clemastine Fumarate, I-568 Coagulation factor X, Human, Assay of, III-367
Clemastine Hydrogen Fumarate, see V-A405 Codeine Phosphate, I-605, V-A45
Clemastine Fumarate Coagulation factor XI, Human, Assay of, Codeine Phosphate and Paracetamol
Clemastine Oral Solution, III-317 V-A405 Tablets, Effervescent, see Effervescent
Clemastine Tablets, III-318 Coagulation factors, Activated, V-A406 Co-codamol Tablets
Clematis Armandii Stem, IV-143 Coal Tar, II-974 Codeine Phosphate and Paracetamol
Clenbuterol Hydrochloride, I-569 Coal Tar and Salicylic Acid Ointment, Tablets, see Co-codamol Tablets
Clindamycin Capsules, III-319 III-1091 Codeine Phosphate Hemihydrate, see
Clindamycin Hydrochloride, I-571, Coal Tar and Zinc Ointment, III-1091 Codeine Phosphate
V-S28 Coal Tar Ointment, Calamine and, Codeine Phosphate Injection, III-367
Clindamycin Injection, III-320 III-226 Codeine Phosphate Oral Solution,
Clindamycin Phosphate, I-572 Coal Tar Paste, III-1090 III-368
V-A784 Index
Codeine Phosphate, Paracetamol Colour of Solution, V-A233 Compound Tolu Oral Solution,
Capsules, see Co-codamol Capsules Colour of Solution, Standard Solutions, Paediatric, IV-379
Codeine Phosphate Sesquihydrate, I-607 V-A233 Compound Zinc Paste, III-1177
Codeine Phosphate Tablets, III-369 Coloured glass, V-A530 Compressibility Index, V-A501
Codeine Tablets, Aspirin and, see Co- Colouring Agents, Permitted Compressible Sugar, II-934, V-S32
codaprin Tablets Alternatives, I-11, II-11, III-11, Concentrated Ammonia, V-A25
Codeine Tablets, Dispersible Aspirin IV-11, V-11 Concentrated Ammonia R1, V-A25
and, see Co-codaprin Tablets, Dispersible Colourless glass, V-A530 Concentrated Anise Water, IV-71
Codergocrine Mesilate, I-609 Columnar, V-A504 Concentrated Camphor Water, III-238
Codergocrine Tablets, III-369 Co-magaldrox Oral Suspension, III-382 Concentrated Camphorated Opium
Cod-liver Oil (Type A), I-615 Co-magaldrox Tablets, III-383 Tincture, IV-293
Cod-liver Oil (Type B), I-619 Common Stinging Nettle for Concentrated Casein Substrate, V-A39
Co-dydramol Tablets, III-371 Homoeopathic Preparations, IV-439 Concentrated Cinnamon Water, IV-141
Co-fluampicil Capsules, III-373 Competent authority, Definition of, I-5, Concentrated Compound Gentian
Co-fluampicil Oral Suspension, III-374 II-5, III-5, IV-5, V-5 Infusion, IV-191
Coix Seed, IV-146 Complementary Medicines, Crude Concentrated Hydrochloric Acid, see
Cola, IV-147 Drugs; Traditional Herbal and, Status Hydrochloric Acid
Colchicine, I-623 of, I-17, II-17, III-17, IV-17, V-17 Concentrated Orange Peel Infusion,
Colchicine Tablets, III-375 Complete Spectrum Mode, Signal IV-298
Cold Saturated Boric Acid Solution, acquisition, Mass Spectrometry, Concentrated Peppermint Emulsion,
V-A33 V-A178 IV-313
Colecalciferol, I-625 Complexometric indicators, V-A760 Concentrated Phosphoric Acid, see
Colecalciferol Concentrate (Oily Form), Complexometric Titrations, V-A268, Phosphoric Acid
I-626 V-A759 Concentrated Solutions for Injections,
Colecalciferol Concentrate (Powder Composition of Fatty Acids in Oils Rich III-66
Form), I-628 in Omega-3-acids, V-A313 Concentrations, Expression of, I-6, II-6,
Colecalciferol Concentrate (Water- Composition of Polysaccharide Vaccines, III-6, IV-6, V-6
dispersible Form), I-629 V-A449 Concentric Cylinder Viscometers,
Colecalciferol Injection, III-375 Compound Alginate Antacid Oral V-A245
Colecalciferol Tablets, III-376 Suspension, III-111 Conductivity, Determination of, V-A252
Colecalciferol Tablets, Calcium and, Compound Aluminium Paste, III-117 Coneflower Herb, Purple, see Echinacea
III-228 Compound Benzoic Acid Ointment, Purpurea Herb
Colecalciferol Tablets, Chewable III-173 Coneflower Root, Narrow-leaved, see
Calcium and, III-229 Compound Benzoin Tincture, IV-95 Echinacea Angustifolia Root
Colestipol Granules, III-377 Compound Calamine Ointment, III-226 Coneflower Root, Pale, see Echinacea
Colestipol Hydrochloride, I-631 Compound Cardamom Tincture, IV-125 Pallida Root
Colestyramine, I-632, V-S32 Compound Docusate Enema, III-468 Coneflower Root, Purple, see Echinacea
Colestyramine Oral Powder, III-378 Compound Gentian Infusion, IV-191 Purpurea Root
Colistimethate Injection, III-378 Compound Gentian Infusion, Cone-plate Viscometers, V-A246
Colistimethate Nebuliser Solution, see Concentrated, IV-191 Confidence Interval, V-A635
Colistimethate Sodium Powder for Compound Glucose, Sodium Chloride Conglomerate, V-A504
Nebuliser Solution and Sodium Citrate Oral Solution, Congo Red, V-A45
Colistimethate Sodium, I-634 III-598 Congo Red Fibrin, V-A45
Colistimethate Sodium for Injection, Compound Magnesium Trisilicate Congo Red Paper, V-A45
III-378 Mixture, III-752 Congo Red Solution, V-A45
Colistimethate Sodium for Nebulisation, Compound Magnesium Trisilicate Oral Conjugated Estrogens, I-871
see Colistimethate Sodium Powder for Powder, III-753 Conjugated Oestrogens, see Conjugated
Nebuliser Solution Compound Magnesium Trisilicate Estrogens
Colistimethate Sodium Powder for Tablets, Chewable, III-753 Consistency by Penetrometry,
Nebuliser Solution, III-379 Compound Orange Spirit, IV-297 Measurement of, V-A490
Colistin Sulfate, I-635 Compound Podophyllin Cutaneous Consistency of Formulated Preparations,
Colistin Sulphate, see Colistin Sulfate Solution, IV-321 V-A357
Colistin Tablets, III-380 Compound Podophyllin Paint, IV-321 Constant Weight, Definition of, I-6, II-6,
2,4,6-Collidine, V-A45 Compound Rhubarb Tincture, IV-331 III-6, IV-6, V-6
Collodion, Flexible, III-381 Compound Sodium Bicarbonate Tablets, Contact Points, V-A647
Collodion for the Preparation of Flexible III-1048 Containers, I-24, II-24, III-24, IV-24,
Collodion, III-382 Compound Sodium Chloride V-24, V-A530, V-A537
Collodions, III-43 Mouthwash, III-1050 Airtight, V-A530
Colloidal Anhydrous Silica, II-804 Compound Sodium Lactate Infusion, Child-proof, V-A530
Colloidal Anhydrous Silica, III-1059 Multidose, V-A530
Hydrophobic, II-805 Compound Sodium Lactate Injection, Sealed, V-A530
Colloidal Hydrated Silica, II-804 III-1059 Single-dose, V-A530
Colloidal Silver for External Use, II-807 Compound Sodium Lactate Intravenous Tamper-proof, V-A530
Colony-forming Cell Assay for Human Infusion, see Compound Sodium Lactate Well-closed, V-A530
Haematopoietic Progenitor Cells, Infusion for Blood and Blood Components,
V-A443 Compound Sodium Picosulfate Powder V-A537
Colophony, IV-148 for Oral Soution, III-1062 Containers and Closures for Parenteral
Colour Change Interval, V-A760 Compound Squill Linctus, IV-360 Preparations and Ophthalmic
Colour of Certain Indicators, Reaction of Compound Tolu Linctus, Paediatric, Preparations, Polypropylene for,
Solution and, V-A248 IV-379 V-A566
Containers and Tubing for Total Copper Standard Solution (0.1% Cu), Co-trimoxazole Tablets, Paediatric,
Parenteral Nutrition Preparations, V-A147 III-392
Poly(ethylene - vinyl acetate) for, Copper Standard Solution (0.1 ppm Cotton, Absorbent, IV-719
V-A569 Cu), V-A147 Cottonseed Oil, Hydrogenated, I-641
Containers for Aqueous Solutions for Copper Standard Solution (10 ppm Cu), Couch Grass Rhizome, IV-151
Intravenous Infusion, Materials Based V-A147 Couette type viscometer, V-A245
on Plasticised Poly(Vinyl Chloride) Copper Sulfate, Anhydrous, I-638 Coulometric titration, see Determination of
for, V-A554 Copper Sulfate Pentahydrate, I-639 Water, Method III
Containers for Human Blood and Blood Copper Sulfate Solution, V-A46 Coumaphos, V-A46
Components, Materials Based on Copper Sulfate Solution pH 5.2, Coumarin, V-A46
Plasticised Poly(Vinyl Chloride) for, Buffered, V-A152 Coumestrol, V-A46
V-A545 Copper Sulfate Solution pH 2.0, V-A152 Cream of Tartar, see Potassium Hydrogen
Containers for Human Blood and Blood Copper Sulfate Solution pH 4.0, Tartrate
Components, Materials for, V-A545 Buffered, V-A152 Cream, Oily, III-641
Containers for Non-injectable, Aqueous Copper Sulfate Solution, Weak, V-A46 Creams, III-72
Solutions, Materials Based on Non- Copper Sulfate VS, V-A141 Cresol, I-642, V-A46
plasticised Poly(Vinyl Chloride) for, Copper Sulfate-Pyridine Reagent, V-A46 Cresol, Crude, I-643
V-A550 Copper Sulfate, see Copper Sulfate m-Cresol Purple, V-A47
Containers for Parenteral and Opthalmic Pentahydrate m-Cresol Purple Solution, V-A47
Preparations, Polyethylene With Copper Sulfate, see Copper(II) Sulfate Cresol Red, V-A47
Additives for, V-A562 Copper Sulphate Pentahydrate, see Cresol Red Solution, V-A47
Containers for Parenteral Preparations Copper Sulfate Pentahydrate Cresol, see o-Cresol
and for Ophthalmic Preparations, Copper Sulphate Solution pH 5.2, Croscarmellose Sodium, I-643
Polyethylene Without Additives for, Buffered, see Copper Sulfate Solution Crospovidone, I-645
V-A561 pH 5.2, Buffered Cross-linked Agarose for
Containers for Pharmaceutical Use, Copper Sulphate Solution pH 4.0, Chromatography, V-A22
Glass, V-A530 Buffered, see Copper Sulfate Solution Cross-linked Agarose for
Containers for Preparations not for pH 4.0, Buffered Chromatography R1, V-A22
Parenteral Use, Polyethylene Copper Sulphate Solution pH 2.0, see Cross-linked Dextran for
Terephthalate for, V-A576 Copper Sulfate Solution pH 2.0 Chromatography R2, V-A50
Containers, Materials Used for the Copper Sulphate Solution, Weak, see Cross-linked Dextran for
Manufacture of, V-A545 Copper Sulfate Solution, Weak Chromatography R3, V-A50
Containers, Polyethylene, V-A561 Copper Sulphate Solution, see Copper Crotamiton, I-646
Content of Active Ingredient in, III-41 Sulfate Solution Crotamiton Cream, III-392
Capsules, III-41 Copper Sulphate VS, see Copper Sulfate Crotamiton Cutaneous Suspension,
Content of Active Ingredient of, III-75 VS III-394
Tablets, III-75 Copper Sulphate-Pyridine Reagent, see Crotamiton Lotion, III-394
Content, Standards for, I-5, II-5, III-5, Copper Sulfate-Pyridine Reagent CRS, I-15, II-15, III-15, IV-15, V-15,
IV-5, V-5 Copper Sulphate, see Copper Sulfate V-A608
Contents of the Appendices, V-A3 Copper Tetrammine, Ammoniacal Crude Cresol, I-643
Continuous Extraction of Drugs, V-A320 Solution of, V-A46 Crude Drugs, Macroscopical
Control of Impurities in Substances for Copper(II) Acetate, V-A46 characteristics of, I-17, II-17, III-17,
Pharmaceutical Use, V-A713 Copper(II) Chloride, V-A46 IV-17, V-17
Conventional terms, I-21, II-21, III-21, Copper(II) Nitrate, V-A46 Crude Drugs; Traditional Herbal and
IV-21, V-21 Copper(II) Sulfate, V-A46 Complementary Medicines, Status of,
Conversion tables for commonly used Copper(II) Sulphate, see Copper(II) Sulfate I-17, II-17, III-17, IV-17, V-17
units, V-A607 Co-proxamol Tablets, III-383 Crushing of Tablets, Resistance to,
Coomassie Blue, see Acid Blue 92 Corallin, V-A46 V-A495
Coomassie Blue Solution, see Acid Blue Corallin Solution, Alkaline, V-A46 Crystal Violet, V-A47
92 Solution Coriander, IV-149 Crystal Violet Solution, V-A47
Coomassie Staining Solution, V-A45 Coriander Oil, IV-150 Crystalline and Partially Crystalline
Coomassie Staining Solution R1, V-A45 Correction Factor, Definition of, V-A618 Solids by X-ray Powder Diffraction
Copovidone, I-636 Corresponds, definition of, I-5, II-5, (XRPD), Characterisation of, V-A508
Copper, V-A46 III-5, IV-5, V-5 Crystallinity, V-A521, V-A716
Copper Acetate Monohydrate for Cortisone, V-A46 Crystallinity, characterisation of, V-A503
Homoeopathic Preparations, IV-427 Cortisone Acetate, I-640, V-A46 Cupric Chloride, see Copper(II) Chloride
Copper Acetate, see Copper(II) Acetate Cortisone Tablets, III-385 Cupri-citric Solution, V-A47
Copper Carbonate, V-A46 Co-tenidone Tablets, III-386 Cupri-citric Solution R1, V-A47
Copper Chloride-Pyridine Reagent, Co-triamterzide Tablets, III-388 Cupriethylenediamine hydroxide
V-A46 Co-trimoxazole Concentrate, Sterile, solution, V-A47, V-A141
Copper Edetate Solution, V-A46 III-389 Cupri-tartaric Solution, V-A47
Copper for Homoeopathic Preparations, Co-trimoxazole Infusion, III-389 Cupri-tartaric Solution R1, V-A47
IV-427 Co-trimoxazole Intravenous Infusion, Cupri-tartaric Solution R2, V-A47
Copper for Homoeopathic Use, see III-389 Cupri-tartaric Solution R3, V-A47
Copper for Homoeopathic Preparations Co-trimoxazole Oral Suspension, III-390 Cupri-tartaric Solution R4, V-A47
Copper Liposoluble Standard Solution Co-trimoxazole Oral Suspension, Curaçao Aloes, see Barbados Aloes
(1000 ppm Cu), V-A147 Paediatric, III-390 Curcumin, V-A47
Copper Oxide Solution, Ammoniacal, Co-trimoxazole Tablets, III-391 Curcuminoids, V-A48
V-A46 Co-trimoxazole Tablets, Dispersible, Cut Valerian, IV-387
III-392 Cutaneous Application, III-42
V-A786 Index
Liquids for, III-42 Cytometry (Solid and Flow) for Denaturing polyacrylamide gel
Cutaneous Application, Powders for, Enumeration of Micro-Organisms, electrophoresis, V-A202
III-67 V-A725 Density, Determination of, V-A242
Cutaneous Application, Semi-solid Cytosine, V-A48 Density, Determination of Apparent,
Preparations for, III-70 V-A243
Cyanoacetic Acid, V-A48 Density, Determination of Relative,
Cyanocobalamin, I-648, V-A48
Cyanocobalamin (57Co) Capsules,
D V-A242
Density of Solids, Determination of,
Dacarbazine, I-661, V-S35
IV-652 V-A254
Dacarbazine for Injection, III-404
Cyanocobalamin (57Co) Solution, IV-653 Density of Solids, Pycnometric, V-A496
Dacarbazine Injection, III-403
Cyanocobalamin (58Co) Capsules, Density, Relative Density and Apparent
Daidzein, V-A48
IV-654 Density, Determination of Weight per
Daidzin, V-A49
Cyanocobalamin (58Co) Solution, IV-654 Millilitre, V-A241
Dalteparin Sodium, I-662
Cyanocobalamin Tablets, III-394 Dental-type Silica, II-806
Dalteparin Sodium Injection, III-404
Cyanogen Bromide Solution, V-A48 Deodorised Kerosene, V-A77
Danaparoid Sodium, I-664
1-Cyanoguanidine, V-A48 2-Deoxy-D-ribose, V-A49
Dandelion Herb with Root, IV-152
Cyanoguanidine, see 1-Cyanoguanidine 2-Deoxyuridine, V-A49
Dandelion Root, IV-153
Cyanosilyl Silica Gel for Depressor Substances, Test for, V-A395
Dantrolene Oral Suspension, III-406
Chromatography, V-A113 Deptropine Citrate, I-673
Dantrolene Sodium, I-666, V-S36
Cyclizine, I-649, V-S33 Dequalinium Chloride, I-674
Dantron, I-667, V-S36
Cyclizine Hydrochloride, I-650, V-S33 Derivative Spectrophotometry, V-A166
Dantron and Docusate Sodium
Cyclizine Injection, III-395 Descending Paper Chromatography,
Capsules, see Co-danthrusate Capsules
Cyclizine Tablets, III-396 V-A201
Dantron, see 1,8-Dihydroxyanthraquinone
Cyclizine Tablets, Dipipanone and, Desferrioxamine Injection, III-409
Dapsone, I-668, V-S36
III-451 Desferrioxamine Mesilate, I-677, V-S36
Dapsone Tablets, III-407
Cyclobutane-1,1-dicarboxylic Acid, Desferrioxamine Mesilate for Injection,
Date, Effective dates, I-ix, II-vii, III-vii,
V-A48 III-409
IV-vii, V-vii
a-Cyclodextrin, V-A48 Desflurane, I-680
Dates of Implementation, V-A657
b-Cyclodextrin for Chiral Design of Biological Assays, V-A632
Daunorubicin Hydrochloride, I-669
Chromatography, Modified, V-A48 Desipramine Hydrochloride, I-679,
Deactivated Aluminium Oxide, V-A23
b-Cyclodextrin for Chiral V-S37
Debrisoquine Sulfate, I-670
Chromatography, Modified R1, V-A48 Desipramine Tablets, III-410
Debrisoquine Sulphate, see Debrisoquine
Cyclohexane, V-A48 Deslanoside, I-682
Sulfate
Cyclohexane R1, V-A48 Desmopressin, I-683
Decanal, V-A49
Cyclohexylamine, V-A48 Desmopressin Injection, III-411
n-Decane, V-A49
Cyclohexylenedinitrilotetra-acetic Acid, Desmopressin Intranasal Solution,
Decane, see n-Decane
V-A48 III-412
Decan-1-ol, V-A49
Cyclohexylmethanol, V-A48 Desmopressin Tablets, III-413
Decanol, see Decan-1-ol
3-Cyclohexylpropionic Acid, V-A48 Desogestrel, I-684, V-S37
Declaration of Interests, I-xiii
Cyclopenthiazide, I-651, V-S33 Desogestrel Tablets, III-414
Decolorised Fuchsin Solution, V-A67
Cyclopenthiazide Tablets, III-396 Desoxycortone Acetate, I-686
Decolorised Fuchsin Solution R1, V-A67
Cyclopentolate, V-S34 4-Desoxypyridoxine Hydrochloride,
Decolorised Pararosaniline Solution,
Cyclopentolate Eye Drops, III-397 V-A49
V-A98
Cyclopentolate Hydrochloride, I-652 Destaining Solution, V-A49
Decolourising Charcoal, see Activated
Cyclophosphamide, I-653, V-S34 Detection Limit, V-A655
Charcoal
Cyclophosphamide for Injection, III-398 Detector Tubes, Gas, V-A299
Decyl Oleate, I-671
Cyclophosphamide Injection, III-398 Detectors, Liquid Chromatography,
Deferoxamine Mesilate, see
Cyclophosphamide Oral Solution, V-A200
Desferrioxamine Mesilate
III-399 Determination of Aflatoxin B1 in Herbal
Definition, I-25, II-25, III-25, IV-25,
Cyclophosphamide Tablets, III-400 Drugs, V-A327
V-25
Cyclosporin, see Ciclosporin Determination of Carbon Dioxide in
Definition of Terms, I-5, II-5, III-5,
Cydonia Oblonga for Homoeopathic Medicinal Gases, V-A297
IV-5, V-5
Preparations, IV-428 Determination of Cineole, V-A307
Definition, Status of, I-8, II-8, III-8,
Cyhalothrin, V-A48 Determination of Foreign Matter,
IV-8, V-8
p-Cymene, V-A48 V-A319
Dehydrated Alcohol, see Ethanol
Cynarin, V-A48 Determination of Methanol and Propan-
Deltamethrin, V-A49
Cypermethrin, V-A48 2-ol, V-A273
Demeclocycline Capsules, III-408
Cyproheptadine, V-S34 Determination of Mycotoxins in Herbal
Demeclocycline Hydrochloride, I-672,
Cyproheptadine Hydrochloride, I-654 Drugs, V-A327
V-A49
Cyproheptadine Tablets, III-400 Determination of Nitrogen, V-A274
Dementholised Mint Oil, IV-273
Cyproterone Acetate, I-655, V-S35 Determination of N,N-Dimethylaniline,
Demethylflumazenil, V-A49
Cyproterone Tablets, III-401 V-A282
Demonstration of Uniformity of Dosage
L-Cysteine, V-A48 Determination of Ochratoxin A in
Units Using Large Samples Sizes,
Cysteine Hydrochloride, I-658, V-A48 Herbal Drugs, V-A329
V-A376
Cysteine Hydrochloride Monohydrate, Determination of Oxygen in Medicinal
Denatured Alcohol, Industrial, see
see Cysteine Hydrochloride Gases, V-A298
Industrial Methylated Spirit
Cystine, I-659, V-A48 Determination of Sorption-Desorption
Denatured Alcohol (Ketone-free),
Cytarabine, I-660, V-S35 Isotherms and of Water Activity
Industrial, see Industrial Methylated
Cytarabine for Injection, III-403 Water-Solid Interactions, V-A300
Spirit (Ketone-free)
Cytarabine Injection, III-402 Determination of Sulfated Ash, V-A293
Determination of Sulfur Dioxide, Dextran 70 Intravenous Infusion, III-425 Diatomaceous Earth for GC R1,
V-A293 Dextran 2000, Blue, V-A33 Silanised, V-A50
Determination of Sulphated Ash, see Dextran for Chromatography R2, Cross- Diatomaceous Earth for GC R2, V-A50
Determination of Sulfated Ash linked, V-A50 Diatomaceous Earth, see Diatomaceous
Determination of Sulphur Dioxide, see Dextranomer, I-702 Support
Determination of Sulfur Dioxide Dextrans, Molecular Mass Distribution Diatomaceous Filter-aid, Washed, Flux-
Determination of Water by Distillation, in, V-A197 calcined, V-A50
V-A295 Dextrin, I-703 Diatomaceous Support, V-A50
Determination of Water in Medicinal Dextromethorphan Hydrobromide, I-704 Diatomaceous Support, Acid-washed,
Gases, V-A298 Dextromoramide, V-S38 V-A50
Determination of Water, Micro, V-A296 Dextromoramide Tablets, III-426 Diatomaceous Support, Alkali-washed,
Determination of Weight per Millilitre, Dextromoramide Tartrate, I-705 V-A50
Density, Relative Density and Dextropropoxyphene, V-S38 Diatomaceous Support, Silanised, V-A51
Apparent Density, V-A241 Dextropropoxyphene Capsules, III-426 Diazepam, I-709
Deuterated Acetic Acid, V-A49 Dextropropoxyphene Hydrochloride, Diazepam Injection, III-428
Deuterated Acetone, V-A49 I-706 Diazepam Oral Solution, III-428
Deuterated Acetonitrile, V-A49 Dextropropoxyphene Hydrochloride and Diazepam Rectal Solution, III-429
Deuterated Chloroform, see Paracetamol Tablets, see Co-proxamol Diazepam Tablets, III-429
Deuterochloroform Tablets Diazinon, V-A51
Deuterated Dimethyl Sulfoxide, V-A49 Dextropropoxyphene Napsilate, I-708, Diazobenzenesulfonic Acid Solution,
Deuterated Dimethyl Sulphoxide, see V-S38 V-A51
Deuterated Dimethyl Sulfoxide Dextrose Infusion, Potassium Chloride Diazobenzenesulfonic Acid Solution R1,
Deuterated Methanol, V-A49 and, see Potassium Chloride and Glucose V-A51
Deuterated Sodium Phosphate Buffer Infusion Diazobenzenesulphonic Acid Solution
Solution pH 5.0, 0.2M, V-A152 Dextrose Infusion, Potassium Chloride, R1, see Diazobenzenesulfonic Acid
Deuterated Sodium Sodium Chloride and, see Potassium Solution R1
Trimethylsilylpropionate, V-A49 Chloride, Sodium Chloride and Glucose Diazobenzenesulphonic Acid Solution,
Deuterium Chloride, V-A49 Infusion see Diazobenzenesulfonic Acid Solution
Deuterium chloride solution, V-A50 Dextrose Infusion, Sodium Chloride and, Diazotised Nitroaniline Solution, V-A93
Deuterium Oxide, V-A50 see Sodium Chloride and Glucose Infusion Diazotised Sulfanilic Acid Solution,
Deuterium Oxide, Isotopically Pure, Dextrose Injection, Bupivacaine and, V-A125
V-A50 III-216 Diazoxide, I-711, V-S39
Deuterium Oxide R1, V-A50 Dextrose Intravenous Infusion, Diazoxide Injection, III-430
Deuterochloroform, V-A50 Potassium Chloride and, see Potassium Diazoxide Tablets, III-431
Devarda’s Alloy, V-A50 Chloride and Glucose Infusion Dibasic Calcium Phosphate, see Calcium
Developer Solution, V-A50 Dextrose Intravenous Infusion, Hydrogen Phosphate
Devil’s Claw, IV-154 Potassium Chloride, Sodium Chloride Dibenzosuberone, V-A51
Devil’s Claw Dry Extract, IV-155 and, see Potassium Chloride, Sodium Dibrompropamidine Diisetionate, see
Devil’s Claw Root, see Devil’s Claw Chloride and Glucose Infusion Dibrompropamidine Isetionate
Dexamethasone, I-687, V-S37, V-A50 Dextrose Intravenous Infusion, Sodium Dibrompropamidine Isetionate, I-712,
Dexamethasone Acetate, I-689 Chloride and, see Sodium Chloride and V-S39
Dexamethasone and Neomycin Ear Glucose Infusion Dibutyl Ether, V-A51
Spray, III-418 Dextrose, see D-Glucose Dibutyl Phthalate, I-713, V-A51
Dexamethasone Eye Drops, Suspension, 8-b-D-Glucopyranosyl-7-hydroxy-3- Dibutylamine, V-A51
III-415 (4-hydroxyphenyl)-4H-1-benzopyran- Dibutylamine, see Di-n-butylamine
Dexamethasone Isonicotinate, I-691 4-one, see Puerarin Dibutylammonium Phosphate for Ion-
Dexamethasone Sodium Phosphate, Dialysis Solutions, Peritoneal, III-940 pairing, V-A51
I-692 3,3-Diaminobenzidine Dicarboxidine Hydrochloride, V-A51
Dexamethasone Sodium Phosphate Eye Tetrahydrochloride, V-A50 Dichlofenthion, V-A51
Drops, Solution, III-420 Diammonium 2,2- Dichloroacetic Acid, V-A51
Dexamethasone Sodium Phosphate azinobis(3-ethylbenzothiazoline-6- Dichloroacetic Acid Solution, V-A51
Injection, III-421 sulfonate), V-A50 3,5-Dichloroaniline, V-A51
Dexamethasone Sodium Phosphate Oral Diammonium 2,2- 1,2-Dichlorobenzene, V-A51
Solution, III-422 azinobis(3-ethylbenzothiazoline-6- Dichlorobenzene, see 1,2-Dichlorobenzene
Dexamethasone Tablets, III-417 sulphonate), see Diammonium 2,2 0 - 2,3-Dichloro-5,6-dicyanobenzoquinone,
Dexamfetamine Sulfate, I-695 azinobis(3-ethylbenzothiazoline- V-A51
Dexamfetamine Sulphate, see 6-sulfonate) 1,2-Dichloroethane, V-A51
Dexamfetamine Sulfate Diammonium Hydrogen 2,7-Dichlorofluorescein, V-A51
Dexamfetamine Tablets, III-423 Orthophosphate, V-A50 Dichlorofluorescein, see 2,7-
Dexchlorpheniramine Maleate, I-696 Diamorphine Hydrochloride, I-708, Dichlorofluorescein
Dexpanthenol, I-697 V-S39 5,7-Dichloro-8-hydroxyquinoline, V-A51
Dextran 1 for Injection, I-698 Diamorphine Hydrochloride for Dichloromethane, I-714, V-A51
Dextran 40 for Injection, I-699 Injection, III-427 Dichloromethane, Acidified, V-A52
Dextran 40 Infusion, III-424 Diamorphine Injection, III-427 Dichloromethane IR, V-A52
Dextran 40 Injection, III-424 Diamorphine Injection, Bupivacaine and, Dichloromethane Reagent, V-A52
Dextran 40 Intravenous Infusion, III-424 III-218 2,4-Dichloro-1-naphthol, V-A52
Dextran 60 for Injection, I-700 Diatomaceous Earth for Gas Dichlorophen, I-715
Dextran 70 for Injection, I-701 Chromatography, see Diatomaceous Dichlorophen Tablets, III-431
Dextran 70 Infusion, III-425 Support, Acid-Washed 2,6-Dichlorophenol, V-A52
Dextran 70 Injection, III-425 Diatomaceous Earth for GC R1, V-A50
V-A788 Index
2,6-Dichlorophenolindophenol Sodium Diethylene Glycol in Ethoxylated 5,7-Di-iodo-8-hydroxyquinoline, V-A54

Salt, V-A52 Substances, Ethylene Glycol and, 1,5-Di-iodopentane, V-A54
Dichlorophenolindophenol, Sodium Salt, V-A275 5,7-Di-iodoquinolin-8-ol, V-A54
see 2,6-Dichlorophenolindophenol Sodium Diethylene Glycol Monoethyl Ether, Di-isobutyl Ketone, V-A54
Salt I-727 Di-isobutyloctadecylsilyl Silica Gel for
2,6-Dichlorophenolindophenol Solution, Diethylene Glycol Monopalmitostearate, Chromatography, V-A113
V-A52 see Diethylene Glycol Palmitostearate Di-isopropyl Ether, V-A54
2,6-Dichlorophenolindophenol Solution, Diethylene Glycol Palmitostearate, I-728 Di-isopropyl Ether, Stabiliser-free,
Double-strength, Standard, V-A52 Di(2-ethylhexyl) Phthalate, V-A53 V-A54
Dichlorophenolindophenol Solution, Diethylphenylenediamine Sulfate Diisopropylcyanopropylsilyl silica gel for
Standard, V-A52 Solution, V-A53 chromatography, V-A113
5,7-Dichloroquinolin-8-ol, V-A52 Diethylphenylenediamine Sulfate, see Di-isopropylethylamine, V-A54
Dichloroquinonechlorimide, see 2,6- N,N-Diethyl-p-phenylenediamine Sulfate Dill Oil, IV-158
Dichloroquinone-4-chloroimide Diethylphenylenediamine Sulphate Dillapiole, V-A54
2,6-Dichloroquinone-4-chloroimide, Solution, see Diethylphenylenediamine Diloxanide Furoate, I-746, V-S42
V-A52 Sulfate Solution Diloxanide Tablets, III-446
Dichlorvos, V-A52 Diethylphenylenediamine Sulphate, see Diltiazem Hydrochloride, I-747
Diclofenac, V-S40 Diethylphenylenediamine Sulfate Diltiazem Tablets, Prolonged-release,
Diclofenac Capsules, Prolonged-release, Diethylstilbestrol, I-729 III-446
III-432 Diethylstilbestrol Pessaries, III-439 Dilute Acetic Acid, V-A20
Diclofenac Diethylamine, I-716, V-S40 Diethylstilbestrol Tablets, III-439 Dilute Acetic Acid, see Acetic Acid
Diclofenac Gel, III-433 Differential scanning calorimetry, (6 per cent)
Diclofenac Potassium, I-717 V-A250 Dilute Adrenaline Injection 1 in
Diclofenac Sodium, I-719 Diffraction, anomalous, V-A504 10,000/Dilute Epinephrine Injection 1
Diclofenac Tablets, Gastro-resistant, Diffraction, Particle Size Analysis by in 10,000, III-103
III-434 Laser Light, V-A504 Dilute Ammonia Buffer pH 10.9,
Diclofenac Tablets, Prolonged-release, Diflubenzuron, V-A53 V-A150
III-435 Diflucortolone Cream, III-440 Dilute Ammonia R1, V-A25
Diclofenac Tablets, see Gastro-resistant Diflucortolone Oily Cream, III-440 Dilute Ammonia R2, V-A25
Diclofenac Tablets Diflucortolone Ointment, III-441 Dilute Ammonia R3, V-A25
Dicloxacillin Sodium, I-720 Diflucortolone Valerate, I-730, V-S41 Dilute Ammonia Solution, III-134
Di-2-cyanoethyl Ether, V-A52 Diflunisal, I-731, I-xxx Dilute Ammonium Carbonate Solution,
Dicyclohexyl, V-A52 Diflunisal (Form B), V-S42 V-A26
Dicyclohexylamine, V-A52 Diflunisal Tablets, III-441 Dilute Ethanols, I-884
1,3-Dicyclohexylurea, V-A52 Digitalis Leaf, IV-156 Dilute Hydrobromic Acid, V-A71
Dicyclohexylurea, see 1,3-Dicyclohexylurea Digitonin, V-A53 Dilute Hydrobromic Acid R1, V-A71
Dicyclomine Hydrochloride, see Digitoxin, I-733, V-A53 Dilute Hydrochloric Acid, I-1123, V-A71
Dicycloverine Hydrochloride Digitoxin Standard Solution, V-A147 Dilute Hydrochloric Acid R1, V-A72
Dicyclomine Oral Solution, see Digitoxin Tablets, III-442 Dilute Hydrochloric Acid R2, V-A72
Dicycloverine Oral Solution Digoxin, I-734 Dilute Hydrogen Peroxide Solution, see
Dicyclomine Tablets, see Dicycloverine Digoxin Injection, III-442 Hydrogen Peroxide Solution (3 per cent)
Tablets Digoxin Injection, Paediatric, III-443 Dilute Nitric Acid, V-A93
Dicycloverine Hydrochloride, I-722, Digoxin Oral Solution, Paediatric, Dilute Phosphomolybdotungstic Reagent,
V-S40 III-443 V-A101
Dicycloverine Oral Solution, III-436 Digoxin Reagent, V-A53 Dilute Phosphoric Acid, II-573, V-A101
Dicycloverine Tablets, III-437 Digoxin Tablets, III-444 Dilute Potassium Dichromate Solution,
Didanosine, I-722 Dihydralazine Sulfate, Hydrated, I-736 V-A105
Didocosahexaenoin, V-A52 Dihydrocapsaicin, V-A53 Dilute Potassium Hexacyanoferrate(III)
Didodecyl 3,3-thiodipropionate, V-A52 10,11-Dihydrocarbamazepine, V-A53 Solution, V-A106
Dieldrin, V-A52 Dihydrocarvone, V-A53 Dilute Potassium Iodide Solution,
Diethanolamine, V-A52 Dihydrocodeine, V-S42 V-A106
Diethanolamine Buffer Solution Dihydrocodeine Hydrogen Tartrate, see Dilute Potassium Iodobismuthate
pH 10.0, V-A152 Dihydrocodeine Tartrate Solution, V-A106
2,5-Diethoxytetrahydrofuran, V-A53 Dihydrocodeine Injection, III-444 Dilute Potassium Permanganate
Diethoxytetrahydrofuran, see 2,5- Dihydrocodeine Oral Solution, III-445 Solution, V-A107
Diethoxytetrahydrofuran Dihydrocodeine Tablets, III-446 Dilute Sodium Carbonate Solution,
Diethyl Phthalate, I-724, V-A53 Dihydrocodeine Tartrate, I-737 V-A119
Diethylamine, V-A53 Dihydroergocristine Mesilate, I-739 Dilute Sodium Hydroxide Solution,
Diethylamine R1, V-A53 Dihydroergotamine Mesilate, I-741 V-A120
Diethylamine Salicylate, I-725, V-S41 Dihydroergotamine Tartrate, I-743 Dilute Sodium Hypochlorite Solution,
Diethylamine Salicylate Cream, III-437 Dihydrotachysterol, I-745 III-1058, V-A121
Diethylaminoethyldextran, V-A53 1,8-Dihydroxyanthraquinone, V-A54 Dilute Sulfuric Acid, II-952, V-A126
Diethylammonium Phosphate Buffer 2,5-Dihydroxybenzoic Acid, V-A54 Dilute Sulphuric Acid, see Dilute Sulfuric
Solution pH 6.0, V-A152 7,4-Dihydroxy-8-C-glucosyliso- Acid
Diethylcarbamazine, V-S41 haloprone, see Puerarin Dilute Tetramethylammonium
Diethylcarbamazine Citrate, I-726 5,7-Dihydroxy-4-methylcoumarin, V-A54 Hydroxide Solution, V-A129
Diethylcarbamazine Tablets, III-438 2,7-Dihydroxynaphthalene Solution, see Diluted Isosorbide Dinitrate, I-1236
Diethylene Glycol, V-A53 Naphthalenediol Solution Diluted Isosorbide Mononitrate, I-1238
1,3-Dihydroxynaphthalene, see Diluted Pentaerythrityl Tetranitrate,
Naphthalene-1,3-diol II-518
Diluted Potassium Clavulanate, II-626 2,6-Dimethylaniline Hydrochloride, Dioctyl Sodium Sulphosuccinate, see
Dilution buffer pH 8.4, V-A410, V-A411 V-A55 Docusate Sodium
Dilution buffer pH 7.5, V-A408 Dimethylaniline, see N,N-Dimethylaniline Diol Silica Gel for Chromatography,
Dilution of Creams, III-72 Dimethyl-b-cyclodextrin, V-A55 V-A113
Dilution of Ointments, III-72 Dimethyldecylamine, V-A55 Diosmin, I-759
Dimenhydrinate, I-749, V-S43 1,1-Dimethylethyl Methyl Ether, V-A56 1,4-Dioxan, V-A57
Dimenhydrinate Tablets, III-448 1,1-Dimethylethyl Methyl Ether R1, Dioxan and Ethylene Oxide, Residual,
Dimercaprol, I-751 V-A56 V-A281
Dimercaprol Injection, III-448 1,1-Dimethylethylamine, V-A55 Dioxan Solution, V-A57
2,5-Dimethoxybenzaldehyde, V-A54 Dimethylformamide, V-A56 Dioxan Solution R1, V-A58
4,4-Dimethoxybenzophenone, V-A54 Dimethylformamide Diethylacetal, Dioxan Stock Solution, V-A58
3,4-Dimethoxyphenethylamine, V-A54 V-A56 Dioxan, see 1,4-Dioxan
2,2-Dimethoxypropane, V-A54 Dimethylglyoxime, V-A56 Diphenhydramine Hydrochloride, I-761,
Dimethoxypropane, see 2,2- 1,3-Dimethyl-2-imidazolidinone, V-A56 V-S44
Dimethoxypropane Dimethyloctadecylsilyl Silica Gel for Diphenhydramine Oral Solution, III-450
Dimethyl Carbonate, V-A55 Chromatography, V-A113 Diphenhydramine Tablets, III-450
Dimethyl Phthalate, I-752, V-S43, 2,5-Dimethylphenol, V-A56 Diphenoxylate Hydrochloride, I-762
V-A56 Dimethylpiperazine, see N,N- Diphenylamine, V-A58
Dimethyl Sulfone, V-A56 Dimethylpiperazine Diphenylamine Solution, V-A58
Dimethyl Sulfoxide, I-753, V-A56 Dimethylstearamide, see Diphenylamine Solution R1, V-A58
Dimethyl Sulfoxide, Deuterated, V-A49 Dimethylstearylamide Diphenylamine Solution R2, V-A58
Dimethyl Sulfoxide R1, V-A56 Dimethylstearylamide, V-A56 9,10-Diphenylanthracene, V-A58
Dimethyl Sulphone, see Dimethyl Sulfone 2,4-Dimethyl-6-tert-butylphenol, V-A55 Diphenylanthracene, see 9,10-
Dimethyl Sulphoxide R1, see Dimethyl Dimeticone, I-754, V-S43, V-A57 Diphenylanthracene
Sulfoxide R1 Dimetindene Maleate, I-755 Diphenylboric Acid Aminoethyl Ester,
Dimethyl Sulphoxide, see Dimethyl Dimidium Bromide, V-A56, V-A57 V-A58
Sulfoxide Dimidium Bromide-Sulfan Blue Mixed 1,5-Diphenylcarbazide, V-A58
Dimethyl Yellow, V-A56 Solution, V-A57 Diphenylcarbazide Solution, V-A58
Dimethyl Yellow and Oracet Blue 2R Dimidium Bromide-Sulphan Blue Mixed Diphenylcarbazide, see 1,5-
Solution, V-A57 Solution, see Dimidium Bromide-Sulfan Diphenylcarbazide
Dimethyl Yellow and Oracet Blue Blue Mixed Solution 1,5-Diphenylcarbazone, V-A58
Solution, V-A56 Di-n-butylamine, V-A51 Diphenylcarbazone Mercuric Reagent,
Dimethyl Yellow Solution, V-A57 1,3-Dinitrobenzene, V-A57 V-A58
Dimethylacetamide, I-751, V-A54 Dinitrobenzene Solution, V-A57 Diphenylcarbazone, see 1,5-
Dimethylamine, V-A54 Dinitrobenzene, see 1,3-Dinitrobenzene Diphenylcarbazone
Dimethylamine Hydrochloride, V-A54 3,5-Dinitrobenzoic Acid, V-A57 2,2-Diphenylglycine, V-A58
Dimethylamine solution, V-A54 Dinitrobenzoic Acid Solution, V-A57 1,2-Diphenylhydrazine, V-A58
4-Dimethylaminobenzaldehyde, V-A55 Dinitrobenzoic Acid, see 3,5- Diphenylmethanol, V-A58
Dimethylaminobenzaldehyde Reagent, Dinitrobenzoic Acid Diphenyloxazole, V-A58
V-A55 Dinitrobenzoyl Chloride, V-A57 Diphenylphenylene Oxide Polymer,
Dimethylaminobenzaldehyde Solution, 2,4-Dinitrophenylhydrazine, V-A57 V-A58
Alcoholic, V-A55 Dinitrophenylhydrazine-aceto- Diphenylpyraline Hydrochloride, I-763,
Dimethylaminobenzaldehyde Solution hydrochloric Solution, V-A57 V-S44
R1, V-A55 Dinitrophenylhydrazine-hydrochloric Diphtheria and Tetanus Vaccine,
Dimethylaminobenzaldehyde Solution Solution, V-A57 (Adsorbed), IV-515
R2, V-A55 Dinitrophenylhydrazine, see 2,4- Diphtheria and Tetanus Vaccine
Dimethylaminobenzaldehyde Solution Dinitrophenylhydrazine (Adsorbed, Reduced Antigen(s)
R6, V-A55 Dinitrophenylhydrazine-sulfuric Acid Content), IV-516
Dimethylaminobenzaldehyde Solution Solution, V-A57 Diphtheria Antitoxin, IV-496
R7, V-A55 Dinitrophenylhydrazine-sulphuric Acid Diphtheria, Tetanus and Hepatitis B
Dimethylaminobenzaldehyde Solution Solution, see Dinitrophenylhydrazine- (rDNA) Vaccine (Adsorbed), IV-517
R8, V-A55 sulfuric Acid Solution Diphtheria, Tetanus and Pertussis
Dimethylaminobenzaldehyde, see Dinonyl Phthalate, V-A57 (Acellular Component) Vaccine,
4-Dimethylaminobenzaldehyde Dinoprost Trometamol, I-756 (Adsorbed), IV-519
4-Dimethylaminocinnamaldehyde, Dinoprostone, I-757, V-S44 Diphtheria, Tetanus and Pertussis
V-A55 Dinoprostone Oral Solution, III-449 (Whole Cell) Vaccine, (Adsorbed),
4-Dimethylaminocinnamaldehyde Dioctadecyl Disulfide, V-A57 IV-518
Solution, V-A55 Dioctadecyl Disulphide, see Dioctadecyl Diphtheria, Tetanus and Poliomyelitis
2-(Dimethylamino)ethyl Methacrylate, Disulfide (Inactivated) Vaccine (Adsorbed,
V-A55 Dioctadecyl 3,3-Thiodipropionate, Reduced Antigen(s) Content), IV-527
Dimethylaminonaphthalenesulfonyl V-A57 Diphtheria, Tetanus, Pertussis (Acellular
Chloride, V-A55 2,2-Di(octadecyloxy)-5,5-spirobi(1,3,2- Component) and Haemophilus Type b
Dimethylaminonaphthalenesulphonyl dioxaphosphorinane, V-A57 Conjugate Vaccine, (Adsorbed),
Chloride, see Dioctyl Sodium Sulfosuccinate, V-A57 IV-521
Dimethylaminonaphthalenesulfonyl Dioctyl Sodium Sulfosuccinate VS, Diphtheria, Tetanus, Pertussis (Acellular
Chloride V-A141 Component) and Hepatitis B (rDNA)
3-Dimethylaminophenol, V-A55 Dioctyl Sodium Sulphosuccinate VS, see Vaccine, (Adsorbed), IV-523
2-(Dimethylamino)thioacetamide Dioctyl Sodium Sulfosuccinate VS Diphtheria, Tetanus, Pertussis (Acellular,
hydrochloride, V-A55 Dioctyl Sodium Sulphosuccinate, see Component) and Poliomyelitis
2,3-Dimethylaniline, V-A55 Dioctyl Sodium Sulfosuccinate
V-A790 Index
(Inactivated) Vaccine (Adsorbed, Dipyridamole Oral Suspension, III-456 Disodium Tetraborate, see Sodium
Reduced Antigen(s) Content), IV-529 Dipyridamole Tablets, III-457 Tetraborate
Diphtheria, Tetanus, Pertussis (Acellular 2,2-Dipyridyl, V-A58 Disodium thiosulfateSee Sodium
Component) and Poliomyelitis 2,2-Dipyridylamine, V-A58 Thiosulfate, Anhydrous, V-A123
(Inactivated)Vaccine, (Adsorbed), Dipyrimadole, V-S45 Disopyramide, I-777, V-S46
IV-525 Dipyrone, I-771 Disopyramide Capsules, III-458
Diphtheria, Tetanus, Pertussis (Acellular, Direct Measurement methods for the Disopyramide Phosphate, I-778
Component), Hepatitis B (rDNA), detection of micro-organisms, V-A719 Disopyramide Phosphate Capsules,
Poliomyelitis (Inactivated) and Direct titrations, V-A759 III-459
Haemophilus Type b Conjugate Dirithromycin, I-772 Dispersible Aciclovir Tablets, III-97
Vaccine (Adsorbed), IV-533 Disintegration, V-A333 Dispersible Amoxicillin and Potassium
Diphtheria, Tetanus, Pertussis (Acellular, Disintegration Test for Suppositories and Clavulanate Tablets, see Dispersible Co-
Component), Poliomyelitis Pessaries, V-A335 amoxiclav Tablets
(Inactivated) and Haemophilus Type b Disintegration Test for Tablets and Dispersible Aspirin and Codeine Tablets,
Conjugate Vaccine (Adsorbed), IV-531 Capsules, V-A333–V-A378 see Co-codaprin Tablets, Dispersible
Diphtheria, Tetanus, Pertussis (Whole Disk assembly method, Dissolution Test Dispersible Aspirin Tablets, III-150
Cell) and Poliomyelitis (Inactivated) for Transdermal Patches, V-A346 Dispersible Benserazide Hydrochloride
Vaccine (Adsorbed), see Diptheria, Disodium Arsenate, V-A59 and Levodopa Tablets, see Dispersible
Tetanus, Pertussis (Whole Cell) and Disodium Bicinchoninate, V-A59 Co-beneldopa Tablets
Poliomyelitis (Inactivated) Vaccine Disodium Catechol-3,5-disulfonate, Dispersible Cellulose, I-467
(Adsorbed) V-A59 Dispersible Co-amoxiclav Tablets,
Diphtheria, Tetanus, Pertussis (Whole Disodium Catechol-3,5-disulphonate, see III-350
Cell), Poliomyelitis (Inactivated) and Disodium Catechol-3,5-disulfonate Dispersible Co-beneldopa Tablets,
Haemophilus Type b Conjugate Disodium Edetate, I-774, V-A59 III-354
Vaccine (Adsorbed), see Diptheria, Disodium Edetate Eye Drops, III-458 Dispersible Co-codaprin Tablets, III-364
Tetanus, Pertussis (Whole Cell), Disodium Edetate VS, V-A141 Dispersible Co-trimoxazole Tablets,
Poliomyelitis (Inactivated) and Disodium Ethanedisulfonate, V-A59 III-392
Haemophilus Type b Conjugate Vaccine Disodium Ethanedisulphonate, see Dispersible Doxycycline Tablets, III-483
(Adsorbed) Vaccine Disodium Ethanedisulfonate Dispersible Lamotrigine Tablets, III-712
Diphtheria Vaccine, (Adsorbed), IV-512 Disodium Etidronate, I-901 Dispersible Paracetamol Tablets, III-920
Diphtheria Vaccine (Adsorbed), Assay Disodium Hydrogen Citrate, II-814, Dispersible Trimethoprim and
of, V-A420 V-A59 Sulfamethoxazole Tablets, III-392
Diphtheria Vaccine (Adsorbed, Reduced Disodium Hydrogen Orthophosphate, Dissolution, V-A336
Antigen Content), IV-514 V-A59 Dissolution, Intrinsic, V-A354, V-A356
Dipipanone, V-S45 Disodium Hydrogen Orthophosphate, Dissolution limits, V-A629
Dipipanone and Cyclizine Tablets, Anhydrous, V-A59 Dissolution test for lipophilic solid
III-451 Disodium Hydrogen Orthophosphate dosage forms, V-A349
Dipipanone Hydrochloride, I-764 Dihydrate, V-A59 Dissolution Test for Solid Dosage
Dipivefrine Eye Drops, III-452 Disodium Hydrogen Phosphate, Forms, V-A336
Dipivefrine Hydrochloride, I-764, V-S45 Anhydrous, I-775 Dissolution Test for Tablets and
Dipotassium Clorazepate, I-766 Disodium Hydrogen Phosphate, Capsules, V-A336
Dipotassium Edetate, V-A58 Anhydrous, see Disodium Hydrogen Dissolution Test for Tablets and
Dipotassium Hydrogen Orthophosphate, Orthophosphate, Anhydrous Capsules, Additional points for the
V-A58 Disodium Hydrogen Phosphate British Pharmacopoeia, V-A344
Dipotassium Hydrogen Phosphate, I-767 Dihydrate, I-776 Dissolution Test for Transdermal
Dipotassium Hydrogen Phosphate Disodium Hydrogen Phosphate Patches, V-A346
Injection, III-453 Dihydrate, see Disodium Hydrogen Dissolution Testing of Solid Oral Dosage
Dipotassium Hydrogen Phosphate Orthophosphate Dihydrate Forms, V-A624
Trihydrate, V-A58 Disodium Hydrogen Phosphate Dissymmetry factor, V-A247
Dipotassium Phosphate Injection, Dodecahydrate, I-776 Distillation Range, Determination of,
III-453 Disodium Hydrogen Phosphate Solution, V-A239
Dipotassium Phosphate, see Dipotassium V-A59 Distilled Water, V-A137
Hydrogen Phosphate Disodium Hydrogen Phosphate, see Distribution constant, V-A185
Dipotassium Sulfate, see Potassium Sulfate Disodium Hydrogen Orthophosphate Disulfiram, I-779, V-S46
Dipotassium Sulphate, see Dipotassium Disodium Hydrogen Phosphate, see Disulfiram Tablets, III-459
Sulfate Disodium Hydrogen Phosphate Ditalimphos, V-A59
Dipotassium (þ)-Tartrate, V-A58 Dodecahydrate 5,5-Dithiobis(2-nitrobenzoic) Acid,
Diprophylline, I-768 Disodium Pamidronate, V-S46 V-A59
Dip/Ser, see Diphtheria Antitoxin Disodium Pamidronate Intravenous Dithiol, V-A59
Diptheria, Tetanus, Pertussis (Whole Infusion, see Pamidronate Disodium Dithiol Reagent, V-A59
Cell), Poliomyelitis (Inactivated) and Intravenous Infusion Dithiothreitol, V-A59
Haemophilus Type b Conjugate Disodium Pamidronate, see Pamidronate Dithizone, V-A59
Vaccine (Adsorbed) Vaccine, IV-536 Disodium Pentahydrate Dithizone R1, V-A59
Diptheria, Tetanus, Pertussis (Whole Disodium Phosphate Dihydrate, see Dithizone Solution, V-A59
Cell) and Poliomyelitis (Inactivated) Disodium Hydrogen Phosphate Dihydrate Dithizone Solution R2, V-A59
Vaccine (Adsorbed), IV-539 Disodium Phosphate Dodecahydrate, see Dithranol, I-780
Dipyridamole, I-769 Disodium Hydrogen Phosphate Dithranol and Salicylic Acid Ointment,
Dipyridamole Capsules, Prolonged- Dodecahydrate III-463
release, III-453 Disodium Tetraborate 0.01 M, V-A249 Dithranol Cream, III-460
Dipyridamole Infusion, III-454 Dithranol Ointment, III-461
Dithranol Paste, III-462, V-A756 Doxapram Hydrochloride, I-799, V-S48 Haemophilus Type b Conjugate Vaccine
Divanadium Pentoxide, V-A59 Doxapram Injection, III-478 (Adsorbed)
Divanadium Pentoxide Solution in Doxazosin Mesilate, I-801 DTaP/HepB, see Diphtheria, Tetanus,
Sulfuric Acid, V-A60 Doxepin Capsules, III-479 Pertussis (Acellular Component) and
Divanadium Pentoxide Solution in Doxepin Hydrochloride, I-802, V-S48 Hepatitis B(rDNA) Vaccine, Adsorbed
Sulphuric Acid, see Divanadium Doxorubicin Hydrochloride, I-804 DTaP/Hib, see Diphtheria, Tetanus,
Pentoxide Solution in Sulfuric Acid Doxorubicin Hydrochloride for Injection, Pertussis (Acellular Component) and
Divinylbenzene and Vinylpyrrolidone III-481 Haemophilus Type b Conjugate Vaccine,
Copolymer for Chromatography, Doxorubicin Injection, III-480 Adsorbed
V-A60 Doxycycline, V-A60 DTaP/IPV/Hib, see Diphtheria, Tetanus,
DNA, V-A608 Doxycycline Capsules, III-482 Pertussis (Acellular, Component),
Dobutamine Concentrate, Sterile, Doxycycline Hyclate, I-805 Poliomyelitis (Inactivated) and
III-465 Doxycycline Monohydrate, I-808 Haemophilus Type b Conjugate Vaccine
Dobutamine Hydrochloride, I-782 Doxycycline Tablets, Dispersible, III-483 (Adsorbed)
Dobutamine Hydrochloride for Injection, Doxylamine Hydrogen Succinate, see DTaP/IPV, see Diphtheria, Tetanus,
III-466 Doxylamine Succinate Pertussis (Acellular Component) and
Dobutamine Infusion, III-464 Doxylamine Succinate, I-809 Inactivated Poliomyelitis Vaccine,
Dobutamine Intravenous Infusion, Dried Aluminium Hydroxide, I-116 Adsorbed
III-464 Dried Aluminium Phosphate, I-119 dTaP/IPV, see Diphtheria, Tetanus,
Docetaxel, Anhydrous, I-783 Dried Bilberry, IV-97 Pertussis (Acellular, Component) and
Docetaxel Trihydrate, I-785 Dried Bilberry Fruit, see Dried Bilberry Poliomyelitis (Inactivated) Vaccine
Docosahexaenoic Acid Methyl Ester, Dried Bitter-Orange Peel, IV-297 (Adsorbed, Reduced Antigen(s) Content)
V-A60 Dried Calcium Acetate, V-A36 DTaP, see Diphtheria, Tetanus,and
Docusate Capsules, III-467 Dried Calcium Sulfate, I-384 Pertussis (Acellular Component) Vaccine,
Docusate Enema, Compound, III-468 Dried Calcium Sulphate, see Dried (Adsorbed)
Docusate Oral Solution, III-468 Calcium Sulfate D-Tetrahydropalmatine Hydrochloride,
Docusate Oral Solution, Paediatric, Dried Epsom Salts, II-178 V-A129
III-469 Dried Factor IX Fraction, IV-462 DT/HepB, see Diphtheria, Tetanus and
Docusate Sodium, I-787, V-S47, V-A60 Dried Factor VII Fraction, IV-458 Hepatitis B (rDNA) Vaccine
Docusate Sodium Capsules, Dantron Dried Factor VIII Fraction, IV-461 DT, see Diphtheria and Tetanus Vaccine,
and, see Co-danthrusate Capsules Dried Factor VIII (rDNA), IV-460 Adsorbed
Dodecan-1-ol, V-A60 Dried Factor XI Fraction, IV-463 dT, see Diphtheria and Tetanus Vaccine
Dodecyl Gallate, I-788 Dried Ferrous Sulfate, I-935 (Adsorbed, Reduced Antigen(s) Content)
4-Dodecylresorcinol, V-A60 Dried Ferrous Sulphate, see Dried Ferrous DTwP/IPV/Hib, see Diphtheria, Tetanus,
Dodecyltrimethylammonium Bromide, Sulfate Pertussis, Poliomyelitis (Inactivated) and
V-A60 Dried Fibrinogen, IV-466 Haemophilus Type b Conjugate Vaccine
Dog Rose, IV-158 Dried Lemon Peel, IV-238 (Adsorbed)
Domiphen Bromide, I-789, V-S47, Dried Magnesium Sulfate, II-178 DTwP/IPV, see Diphtheria, Tetanus,
V-A60 Dried Magnesium Sulphate, see Dried Pertussis and Poliomyelitis (Inactivated)
Domperidone, I-790 Magnesium Sulfate Vaccine (Adsorbed)
Domperidone Maleate, I-791 Dried Prothrombin Complex, IV-465 DTwP, see Adsorbed Diphtheria, Tetanus
Domperidone Tablets, III-469 Dried/Cholera, see Freeze-dried Cholera and Pertussis Vaccine
D-Dopa, V-A60 Vaccine Duloxetine Hydrochloride, I-814
Dopamine Concentrate, Sterile, III-471 Drop Point, V-A236 Dusting Powders, III-67
Dopamine Hydrochloride, I-793, V-S47 Droperidol, I-810, V-S49 Dwarf Pine Oil, IV-317
Dopamine Hydrochloride for Injection, Droperidol Injection, III-484 D-Xylose, see Xylose
III-472 Droperidol Tablets, III-485 Dydrogesterone, I-816, V-S49
Dopamine Infusion, III-470 Droppers, V-A19 Dydrogesterone Tablets, III-486
Dopamine Intravenous Infusion, III-470 Drops, III-47, III-60
Dopexamine Dihydrochloride, see Eye, III-47
Dopexamine Hydrochloride
Dopexamine Hydrochloride, I-795
Nasal, III-60
Drospirenone, I-812
E
Ear Preparations, III-43
Dorzolamide and Timolol Eye Drops, Drug Release from Medicated Chewing
Ebastine, I-817
III-474 Gum, V-A350
Echinacea Angustifolia Root, IV-160
Dorzolamide Eye Drops, III-473 Drusy, V-A504
Echinacea Pallida Root, IV-162
Dorzolamide Hydrochloride, I-796 Dry Dosage Forms for Oral
Echinacea Purpurea Herb, IV-163
Dosage Units, Uniformity of, V-A358 Administration, Materials Based on
Echinacea Purpurea Root, IV-165
Dosulepin Capsules, III-476 Non-plasticised Poly(Vinyl Chloride)
Echinacoside, V-A60
Dosulepin Hydrochloride, I-798, V-S48 for, V-A552
Eclipta Prostrata Whole Plant, IV-167
Dosulepin Oral Solution, III-476 Dry heat sterilisation, V-A527, V-A528
Econazole, I-818
Dosulepin Tablets, III-478 Dry Residue of Extracts, V-A325
Econazole Cream, III-486
Dothiepin Hydrochloride, see Dosulepin Drying and ignition to constant mass,
Econazole Nitrate, I-820
Hydrochloride I-23, II-23, III-23, IV-23, V-23
Econazole Pessaries, III-487
Dothiepin Tablets, see Dosulepin Tablets Drying, Determination of Loss on,
ED50, Definition of, I-30, II-30, III-30,
Dotriacontane, V-A60 V-A296
IV-30, V-30
Double-strength Chloroform Water, Drynaria Rhizome, IV-159
Edetic Acid, I-821
III-292 DTaP/HepB/IPV/Hib, see Diphtheria,
Edotreotide, V-A60
Double-strength Standard 2,6- Tetanus, Pertussis (Acellular,
Edrophonium Chloride, I-822, V-S49
Dichlorophenolindophenol Solution, Component), Hepatitis B (rDNA),
Edrophonium Injection, III-487
V-A52 Poliomyelitis (Inactivated) and
V-A792 Index
(E,E)-Farnesol, V-A64 Empty Sterile Containers of Plasticised Enteric-coated Aspirin Tablets, see
Effective date, I-ix, I-xxi, II-vii, III-vii, Poly(Vinyl Chloride) for Human Gastro-resistant Aspirin Tablets
IV-vii, V-vii Blood and Blood Components, Enteric-coated Diclofenac Tablets, see
Effervescent Aspirin Tablets, III-151 V-A539 Gastro-resistant Diclofenac Tablets
Effervescent Calcium Gluconate Tablets, Emulsifying Cetostearyl Alcohol (Type Enteric-coated Naproxen Tablets, see
III-237 A), I-481 Gastro-resistant Naproxen Tablets
Effervescent Co-codamol Tablets, Emulsifying Cetostearyl Alcohol (Type Enteric-coated Sodium Valproate
III-361 B), I-482 Tablets, see Gastro-resistant Sodium
Effervescent Paracetamol Tablets, Emulsifying Ointment, III-488 Valproate Tablets
III-920 Emulsifying Wax, III-488 Enteric-coated Sulfasalazine Tablets, see
Effervescent Potassium Chloride Tablets, Emulsions, III-58 Gastro-resistant Sulfasalazine Tablets
III-972 Oral, III-58 Eosin, V-A60
Effervescent Soluble Aspirin Tablets, Enalapril Maleate, I-825 EPBRP, I-15, II-15, III-15, IV-15,
III-151 Enalapril Tablets, III-489 V-15, V-A608
Efficacy of Antimicrobial Preservation, Enalaprilat Dihydrate, I-827 EPCRS, I-15, II-15, III-15, IV-15,
V-A476, V-A633 Encephalitis Vaccine, Inactivated, Tick- V-15, V-A608
Efficacy of Antimicrobial Preservation, borne, IV-610 Ephedra Herb, IV-173
Supplementary Information, V-A633 End-capped, Amorphous, Octadecylsilyl Ephedrine, I-833, V-S50
n-Eicosane, V-A60 Organosilica Polymer for Mass Ephedrine, Anhydrous, I-834
EID50, Definition of, I-30, II-30, III-30, Spectrometry, V-A96 Ephedrine Concentrate, Sterile, III-493
IV-30, V-30 End-capped Butylsilyl Silica Gel for Ephedrine Elixir, III-492
EID50, V-A608 Chromatography, V-A113 Ephedrine Hemihydrate, see Ephedrine
Elder Flower, IV-169 End-capped Dodecylsilyl Silica Gel for Ephedrine Hydrochloride, I-834, V-S50
Electrolyte Reagent for the Chromatography, V-A113 Ephedrine Hydrochloride, Racemic, see
Determination of Water, V-A60 End-capped Hexadecylamidylsilyl Silica Racephedrine Hydrochloride
Electron impact, Ionisation, Mass Gel for Chromatography, V-A113 Ephedrine Hydrochloride Tablets,
Spectrometry, V-A176 End-capped Nitrile Silica Gel for III-494
Electrophoresis, V-A201 Chromatography, V-A114 Ephedrine Injection, III-492
Electrophoresis, Capillary Gel, V-A208 End-capped Octadecylsilyl Silica Gel for Ephedrine Nasal Drops, III-493
Electrophoresis, Characteristics of Chromatography, V-A114 Ephedrine Oral Solution, see Ephedrine
Discontinuous Buffer System Gel, End-capped Octadecylsilyl Silica Gel for Elixir
V-A203 Chromatography R1, V-A116 (E)-4-Phenylbut-3-en-2-one, V-A100
Electrophoresis, Characteristics of End-capped Octylsilyl Silica Gel for Epinastine Hydrochloride, I-836
polyacrylamide gels, V-A202 Chromatography, V-A115 Epinephrine, I-76
Electrophoresis, Denaturing End-capped Organosilica Polymer for Epinephrine Acid Tartrate, I-78
polyacrylamide gel, V-A202 Mass Spectrometry, Amorphous, Epinephrine (Adrenaline), V-S50
Electrophoresis, Detection of proteins in Octadecylsilyl, V-A96 Epinephrine and Cocaine Intranasal
gels, V-A205 End-capped Palmitamidopropylsilyl Solution, see Adrenaline and Cocaine
Electrophoresis, Drying of stained SDS Silica Gel for Chromatography, Intranasal Solution
polyacrylamide gels, V-A205 V-A115 Epinephrine Eye Drops, see Adrenaline
Electrophoresis, Free or Moving End-capped Phenylethyl Silica Gel for Eye Drops,
Boundary, V-A201 Chromatography, V-A115 Epinephrine Injection, Bupivacaine and,
Electrophoresis, Molecular-mass End-capped Phenylhexylsilyl Silica Gel see Bupivacaine and Adrenaline Injection
determination, V-A206 for Chromatography, V-A115 Epinephrine Injection, Dilute (1 in
Electrophoresis, Polyacrylamide Rod Gel, End-capped Phenylsilyl Silica Gel for 10,000), III-103
V-A202 Chromatography, V-A115 Epinephrine Injection, Lidocaine and, see
Electrophoresis, Preparing vertical End-capped Polar-embedded Lidocaine and Adrenaline Injection
discontinuous buffer SDS Octadecylsilyl Amorphous Organosilica Epinephrine Solution/Adrenaline
polyacrylamide gels, V-A203 Polymer, V-A96 Solution, III-104
Electrophoresis, Sodium Dodecyl Sulfate End-capped Propoxybenzene Silica Gel Epirubicin Hydrochloride, I-837
Polyacrylamide Gel, V-A202 for Chromatography, V-A115 Epirubicin Injection, III-495
Electrophoresis Using a Supporting End-capped with Embedded Polar Epsom Salts, Dried, II-178
Medium, Zone, V-A201 Groups Octadecylsilyl Silica Gel for Epsom Salts, see Magnesium Sulfate
Electrospray, Ionisation, Mass Chromatography, V-A114 Heptahydrate
Spectrometry, V-A177 End-capped with Polar Incorporated Equant, V-A504
Elementary Standard Solutions for Groups Octadecylsilyl Silica Gel for Equisetum Stem, see Horsetail
Atomic Spectometry, 1.000 g/L, Chromatography, V-A114 Equivalence point, V-A760
V-A147 End-capped with Polar Incorporated Equivalent Texts, European
Elements, Names, Symbols and Atomic Groups Octylsilyl Silica Gel for Pharmacopoeia, V-A13
Weights of, V-A609 Chromatography, V-A115 Ergocalciferol, I-839
Eleutherococcus, IV-170 Endoprotease LysC, V-A60 Ergocalciferol Injection, III-496
Elixirs, III-58 a-Endosulfan, V-A60 Ergocalciferol Tablets, III-496
Embonic Acid, V-A60 a-Endosulphan, see a-Endosulfan Ergocalciferol Tablets, Calcium and,
Emedastine Difumarate, see Emedastine Endotoxins, Test for Bacterial, V-A390 III-230
Fumarate Endrin, V-A60 Ergocalciferol Tablets, Chewable
Emedastine Fumarate, I-823 Enoxaparin Sodium, I-829 Calcium and, III-231
Emetine Dihydrochloride, V-A60 Enoxaparin Sodium Injection, III-490 Ergometrine and Oxytocin Injection,
Emetine Hydrochloride Pentahydrate, Enoxolone, I-830 III-498
I-824 Entacapone, I-831 Ergometrine Injection, III-497
Emodin, V-A60 Ergometrine Maleate, I-841
Ergometrine Tablets, III-499 Estradiol and Norethisterone Tablets, Ethinylestradiol Tablets, Levonorgestrel
Ergotamine Sublingual Tablets, III-500 III-514 and, III-723
Ergotamine Tartrate, I-842 Estradiol Benzoate, I-864 Ethion, V-A62
Error, Fiducial Limits of, I-14, II-14, Estradiol Hemihydrate, I-866 Ethionamide, I-889
III-14, IV-14, V-14, V-A635 Estradiol Injection, III-512 Ethosuximide, I-889
Erucamide, V-A61 Estradiol Transdermal Patches, III-513 Ethosuximide Capsules, III-521
Erythritol, I-843, V-A61 Estradiol Valerate, I-867 Ethosuximide Oral Solution, III-521
Erythromycin, I-844, V-S51 Estragole, V-A61 Ethoxychrysoidine Hydrochloride, V-A62
Erythromycin and Zinc Acetate Estramustine Phosphate Capsules, Ethoxychrysoidine Solution, V-A62
Cutaneous Solution, see Erythromycin III-517 2-Ethoxyethanol, V-A62
and Zinc Acetate Lotion Estramustine Sodium Phosphate, I-868, Ethoxylated Substances, Ethylene Glycol
Erythromycin and Zinc Acetate Lotion, V-S52 and Diethylene Glycol in, V-A275
III-507 Estriol, I-869 Ethyl Acetate, I-891, V-A62
Erythromycin Capsules, Gastro-resistant, Estriol Cream, III-518 Ethyl Acetate, Treated, V-A62
III-501 Estrogens, Conjugated, I-871 Ethyl Acrylate, V-A62
Erythromycin Estolate, I-847, V-S51 Estropipate, I-874, V-S53 Ethyl Benzoate, V-A62
Erythromycin Estolate Capsules, III-503 Estropipate Tablets, III-519 Ethyl 5-Bromovalerate, V-A62
Erythromycin Ethyl Succinate, I-849 Etacrynic Acid, I-874, V-S53 Ethyl Cinnamate, I-892, V-S54, V-A62
Erythromycin Ethyl Succinate Oral Etamiphylline, V-S53 Ethyl Cyanoacetate, V-A62
Suspension, III-504 Etamiphylline Camsilate, V-S54 Ethyl Formate, V-A62
Erythromycin Ethyl Succinate Tablets, Etamsylate, I-876 Ethyl Gallate, I-892
III-504 Etching test, V-A533 Ethyl Hydroxybenzoate, I-893, V-A62
Erythromycin Ethylsuccinate, V-S51 Ethacridine Lactate Monohydrate, I-877 Ethyl Hydroxybenzoate Sodium, I-895
Erythromycin Ethylsuccinate, see Ethambutol Hydrochloride, I-878, V-S54 Ethyl Methanesulfonate, V-A62
Erythromycin Ethyl Succinate Ethambutol Tablets, III-520 Ethyl Methanesulfonate in
Erythromycin Lactobionate, I-852, Ethane-1,2-diol, V-A61 Methanesulfonic Acid, see Methyl,
V-S52 Ethanol, I-879 Ethyl and Isopropyl Methanesulfonate in
Erythromycin Lactobionate for Infusion, Ethanol (20 per cent), I-884 Methanesulfonic Acid
III-505 Ethanol (25 per cent), I-884 Ethyl Methyl Ketone, see Butan-2-one
Erythromycin Lactobionate for Ethanol (45 per cent), I-884 Ethyl Oleate, I-896
Intravenous Infusion, see Erythromycin Ethanol (50 per cent), I-884 Ethyl Paraben Sodium, see Ethyl
Lactobionate for Infusion Ethanol (60 per cent), I-884 Hydroxybenzoate Sodium
Erythromycin Lactobionate Infusion, Ethanol (70 per cent), I-884 Ethyl Parahydroxybenzoate, V-A62
III-505 Ethanol (80 per cent), I-884 Ethyl Parahydroxybenzoate, see Ethyl
Erythromycin Lactobionate Intravenous Ethanol (90 per cent), I-884 Parahydroxybenzoate
Infusion, see Erythromycin Lactobionate Ethanol (96%), V-A61 4-[(Ethylamino)methyl]pyridine, V-A62
Infusion Ethanol (96%), Aldehyde-free, V-A61 Ethylbenzene, V-A62
Erythromycin Stearate, I-854, V-S52 Ethanol (96 per cent), I-882 4-Ethylcatechol, V-A62
Erythromycin Stearate Tablets, III-507 Ethanol, Absolute, V-A61 Ethylcellulose, I-897
Erythromycin Tablets, Gastro-resistant, Ethanol, Determination of, V-A270 Ethylene Bis[3,3-di(3-(1,1-
III-502 Ethanol R1, Absolute, V-A61 dimethyl)ethyl-4-
Erythromycin Tablets, see Gastro-resistant Ethanol R1, see Ethanol R1, Absolute hydroxyphenyl)butyrate], V-A62
Erythromycin Tablets Ethanolamine, I-884, V-A61 Ethylene Bis[3,3-di(3-tert-butyl-4-
Erythropoietin Concentrated Solution, Ethanolamine Oleate Injection, III-520 hydroxyphenyl)butyrate], V-A62
I-857 Ethanol-free Chloroform, V-A41 Ethylene Chloride, see 1,2-Dichloroethane
Erythropoietin for Injection, III-511 Ethanolic Acetic–ammonia Buffer Ethylene Glycol and Diethylene Glycol
Erythropoietin Injection, III-509 pH 3.7, see Buffer Solution pH 3.7 in Ethoxylated Substances, V-A275
Esculin, V-A61 Ethanolic Hydrochloric Acid, V-A71 Ethylene Glycol Monoethyl Ether, see
Esketamine Hydrochloride, I-861 Ethanolic Iron(III) Chloride Solution, 2-Ethoxyethanol
Esomeprazole Magnesium Trihydrate, V-A76 Ethylene Glycol Monomethyl Ether,
I-862 Ethanolic Phosphomolybdic Acid V-A62
Essential Oils, IV-44, V-A308 Solution, V-A101 Ethylene Glycol Monomethyl Ether, see
Essential Oils, Fatty Oils and Resinified Ethanolic Potassium Hydroxide, V-A106 2-Methoxyethanol
Essential Oils, V-A308 Ethanolic Potassium Hydroxide VS, Ethylene Glycol Monopalmitostearate,
Essential Oils, Foreign Esters, V-A308 V-A143 I-898
Essential Oils in Herbal Drugs, Ethanolic Sodium Hydroxide, V-A120 Ethylene Glycol Monostearate, see
Determination of, V-A319 Ethanolic Sodium Hydroxide VS, Ethylene Glycol Monopalmitostearate
Essential Oils, Odour and Taste, V-A308 V-A144 Ethylene Glycol, see Ethane-1,2-diol
Essential Oils, Residue on Evaporation, Ethanolic Sulfuric Acid, V-A126 Ethylene Oxide, V-A62
V-A308 Ethanols, Dilute, I-884 Ethylene Oxide and Dioxan, Residual,
Essential Oils, Solubility in Alcohol, Ethanol, see Ethanol, Absolute V-A281
V-A309 Ethanol-soluble Extractive, Ethylene Oxide Solution, V-A62
Essential Oils, Water, V-A309 Determination of, V-A319 Ethylene Oxide Solution R1, V-A63
Ester Value, V-A304 Ether, I-885, V-A61 Ethylene Oxide Solution R2, V-A63
Esters, Reactions of, V-A257 Ether, Anaesthetic, I-886 Ethylene Oxide Solution R3, V-A63
Estimated Potency, I-14, II-14, III-14, Ether, Peroxide-free, V-A62 Ethylene Oxide Solution R4, V-A63
IV-14, V-14, V-A635 Ethical Considerations, Unlicensed Ethylene Oxide Solution R5, V-A63
17a-Estradiol, V-A61 Medicines, V-A752 Ethylene Oxide Stock Solution, V-A63
Estradiol and Norethisterone Acetate Ethinylestradiol, I-886 Ethylene Oxide Stock Solution R1,
Tablets, III-515 Ethinylestradiol Tablets, III-520 V-A63
V-A794 Index
Ethylenediamine, I-899, V-A63 Excipients, Use of, I-11, II-11, III-11, Farmed Salmon Oil, II-786
Ethylenediaminetetra-acetic Acid, V-A63 IV-11, V-11 Fast Blue B Salt, V-A64
(Ethylenedinitrilo)tetra-acetic Acid, see Excipients, I-37, II-37, III-37, IV-37, see Fast Red B Salt, V-A64
Ethylenediaminetetra-acetic Acid also Substances for Pharmaceutical Use Fast-atom bombardment (FAB), V-A177
2-Ethylhexane-1,3-diol, V-A63 Expert Advisory Groups, I-xii, V-A647 Fast-ion bombardment ionisation (liquid
2-Ethylhexanoic Acid, V-A63 Expression of content, I-24, II-24, secondary-ion mass spectrometry
2-Ethylhexanoic Acid, Determination of, III-24, IV-24, V-24 LSIMS), V-A177
V-A282 Expression of Standards, I-5, II-5, III-5, Fat, Hard, I-916
1,1-Ethylidenebis(tryptophan), V-A63 IV-5, V-5 Fatty Acids in Oils Rich in Omega-3-
N-Ethylmaleimide, V-A63 Exsiccated Calcium Sulfate, see Dried acids, Composition of, V-A313
2-Ethyl-2-methylsuccinic Acid, V-A63 Calcium Sulfate Fatty Oils and Resinified Essential Oils
Ethylmorphine Hydrochloride, I-899 Extemporaneous Preparation, Status of, in Essential Oils, V-A308
Ethylparaben, see Ethyl Hydroxybenzoate I-9, II-9, III-9, IV-9, V-9 Fatty Oils, Sterols in, V-A316
2-Ethylpyridine, V-A63 Extemporaneous Preparations, V-A756 Fc function of immunoglobulin, Test for,
1-Ethylquinaldinium Iodide, V-A63 Extractable Volume of Parenteral V-A412
Ethylvinylbenzene-Divinylbenzene Preparations, V-A360 Felbinac, I-917, V-S56
Copolymer, V-A63 Extraction of Alkaloids, Complete, Felbinac Cutaneous Foam, III-529
Ethylvinylbenzene-Divinylbenzene V-A321 Felbinac Gel, III-530
Copolymer R1, V-A64 Extraction of Drugs, Continuous, Felodipine, I-918
Etidronate Disodium, I-901 V-A320 Felodipine Tablets, Prolonged-release,
Etidronate Sodium, V-S55 Extraction Resin, Strontium Selective, III-531
Etidronate Tablets, III-522 V-A124 Felypressin, I-919
Etilefrine Hydrochloride, I-901 Extractive, Determination of Ethanol- Fenbufen, I-921, V-S56, V-A65
Etodolac, I-903, V-S55 soluble, V-A319 Fenbufen Capsules, III-532
Etodolac Capsules, III-523 Extractive, Determination of Water- Fenbufen Tablets, III-533
Etodolac Tablets, III-524 soluble, V-A319 Fenchlorphos, V-A65
Etofenamate, I-905 Extracts, IV-46 Fenchone, V-A65
Etomidate, I-907 Extracts, Dry Residue of, V-A325 Fennel, Bitter, IV-176
Etoposide, I-908, V-S55 Extracts, Loss on Drying of, V-A325 Fennel, Sweet, IV-181
Etoposide Capsules, III-526 Extracts, Water for Preparation of, Fenofibrate, I-922
Etoposide Concentrate, Sterile, III-527 II-1175 Fenoprofen, V-S57
Etoposide Infusion, III-526 Extraneous Agents in Viral Vaccines, Fenoprofen Calcium, I-924, V-S57
Etoposide Intravenous Infusion, see V-A475 Fenoprofen Tablets, III-534
Etoposide Infusion Extraneous Agents in Viral Vaccines for Fenoterol Hydrobromide, I-924
Etynodiol Diacetate, I-911, V-S56 Human Use, V-A475 Fenoterol Pressurised Inhalation, I-xxx
Eucalyptus, V-A590 Extraneous Agents in Viral Vaccines, Fentanyl, I-926
Eucalyptus Leaf, IV-174 Tests for, V-A637 Fentanyl Citrate, I-927
Eucalyptus Oil, IV-175 Eye, III-47 Fentanyl Injection, III-535
Eugenol, I-912, V-A64 Drops, III-47 Fentanyl Injection, Bupivacaine and,
Euglobulins, Bovine, V-A64 Ointments, III-47 III-219
Euglobulins, Human, V-A64 Eye Drops, V-A591 Fenticonazole Nitrate, I-929
European Goldenrod, IV-202 Codes for Single-dose Containers, Fenugreek, IV-182
European Pharmacopoeia, I-3, I-xxv, V-A591 Fenvalerate, V-A65
II-3, III-3, IV-3, V-3 Eye Drops, Alkaline, III-650 Feret’s diameter, V-A504
European Pharmacopoeia Commission, Eye Drops, Preservative-free, V-A754 Fermentation, Products of, I-930
Membership of the, V-A656 Eye Ointment Basis, III-1044 Ferric Ammonium Sulfate, see
European Pharmacopoeia Equivalent Eye Ointment, Simple, III-1044 Ammonium Iron(III) Sulfate
Texts, V-A13 Eye Preparations, III-45 Ferric Ammonium Sulfate Solution R1,
European Pharmacopoeia, General Eye Preparations of the BP, III-47 see Ammonium Iron(III) Sulfate Solution
Chapters of the, I-24, II-24, III-24, Eye Preparations of the BP, Additional R1
IV-24, V-24 Requirements for, III-47 Ferric Ammonium Sulfate Solution R2,
European Pharmacopoeia General see Ammonium Iron(III) Sulfate Solution
Methods, V-A13 R2
European Pharmacopoeia, General
Notices of the, I-20, II-20, III-20,
F Ferric Ammonium Sulfate Solution R5,
see Ammonium Iron(III) Sulfate Solution
F0 concept, application of, V-A529
IV-20, V-20 R5
FAB (Fast-atom bombardment), V-A177
European Pharmacopoeia, General Ferric Ammonium Sulfate Solution R6,
Factor IX Fraction, Assay of, V-A405
Statements of the, I-20, II-20, III-20, see Ammonium Iron(III) Sulfate Solution
Factor IX Fraction, Dried, IV-462
IV-20, V-20 R6
Factor VII Fraction, Dried, IV-458
European Pharmacopoeia, Other Ferric Ammonium Sulphate Solution R2,
Factor VIII Fraction, Assay of, V-A403
Provisions Applying to General see Ferric Ammonium Sulfate Solution
Factor VIII Fraction, Dried, IV-461
Chapters and Monographs of the, R2
Factor VIII (rDNA), Dried, IV-460
I-22, II-22, III-22, IV-22, V-22 Ferric Ammonium Sulphate Solution R5,
Factor Xa Solution, Bovine, V-A34
European Pharmacopoeia, see Ferric Ammonium Sulfate Solution
Factor Xa Solution R1, Bovine, V-A34
Supplementary Chapter IV, V-A656 R5
Factor XI Fraction, Dried, IV-463
European Viper Venom Antiserum, Ferric Ammonium Sulphate Solution R6,
Falling Ball Viscometer Method, V-A247
IV-497 see Ferric Ammonium Sulfate Solution
Famotidine, I-914
Evening Primrose Oil, Refined, see R6
Famotidine Tablets, III-527
Refined Evening Primrose Oil, Ferric Ammonium Sulphate, see Ferric
Farmed Cod-liver Oil, I-610
Ammonium Sulfate
Ferric Chloride, Anhydrous, see Iron(III) Fexofenadine Hydrochloride, I-937, Flucloxacillin Sodium, I-951, V-S59
Chloride, Anhydrous V-S57 Flucloxacillin Sodium for Injection,
Ferric Chloride Hexahydrate, I-932 Fexofenadine Tablets, III-540 III-545
Ferric Chloride Solution, Ethanolic, see Fibrin Blue, V-A65 Fluconazole, I-953
Iron(III) Chloride Solution, Ethanolic Fibrin Congo Red, see Congo Red Fibrin Flucytosine, I-954, V-S59
Ferric Chloride Solution R3, V-A65 Fibrin Sealant Kit, IV-467 Flucytosine Tablets, III-547
Ferric Chloride Solution, Radiolabelled Fibrinogen, V-A65 Fludarabine Phosphate, I-956
[59Fe], V-A65 Fibrinogen, Dried, IV-466 Fludeoxyglucose (18F) Injection, IV-655
Ferric Chloride Solution, Radiolabelled Fiducial Limits of Error, I-14, II-14, Fludrocortisone Acetate, I-959
[59Fe], Concentrated, V-A65 III-14, IV-14, V-14, V-A635 Fludrocortisone Tablets, III-548
Ferric Chloride Solution R1, see Iron(III) Field Desorption, V-A177 Flufenamic Acid, V-A65
Chloride Solution R1 Field Ionisation, Mass Spectrometry, Fluid thioglycollate medium, V-A458
Ferric Chloride Solution R2, see Iron(III) V-A177 Flumazenil, I-960, V-A65
Chloride Solution R2 Filgrastim Concentrated Solution, I-939 Flumazenil (N-[11C]methyl) Injection,
Ferric Chloride Solution, see Iron(III) Filling volume of vials, bottles and IV-658
Chloride Solution ampoules, Determination of, V-A531 Flumequine, I-961
Ferric Chloride, see Iron(III) Chloride Filters, Sieves and, V-A483 Flumetasone Pivalate, I-963
Hexahydrate Filtration - Sterilising, V-A527 Flumethasone Pivalate, see Flumetasone
Ferric Chloride-Sulfamic Acid Reagent, Finasteride, I-942 Pivalate
see Iron(III) Chloride-sulfamic Acid Finasteride Tablets, III-541 Flunarizine Dihydrochloride, I-964
Reagent Fine Particles, Aerodynamic Assessment Flunitrazepam, I-965, V-A65
Ferric Chloride-Sulphamic Acid Reagent, of, V-A361 Fluocinalone Acetonide Dihydrate,
see Ferric Chloride-Sulfamic Acid Fine Powder, Definition of, V-A483 V-S59
Reagent FIP, V-A608 Fluocinolone Acetonide, I-966
Ferric Nitrate, see Iron(III) Nitrate Fish Oil, Rich in Omega-3-Acids, I-943 Fluocinolone Acetonide Dihydrate, I-968
Ferric Sulfate Pentahydrate, see Iron(III) Fixed Oils, V-A309 Fluocinolone Cream, III-549
Sulfate Pentahydrate Fixed Oils by Thin-layer Fluocinolone Ointment, III-550
Ferric Sulfate, see Iron(III) Sulfate Chromatography, Identification of, Fluocinonide, I-969, V-S60
Ferric Sulphate, see Ferric Sulfate V-A309 Fluocinonide Cream, III-551
Ferricyanide Standard Solution (50 ppm Fixed Oils, Foreign Oils by Gas Fluocinonide Ointment, III-551
Fe(CN)6), V-A147 Chromatography, Test for, V-A311 Fluocortolone Cream, III-552
Ferrocyanide Standard Solution Fixing Solution, V-A65 Fluocortolone Hexanoate, I-970, V-S60
(100 ppm Fe(CN)6), V-A147 Fixing Solution for Isoelectric Focusing Fluocortolone Pivalate, I-971
Ferrocyphen, V-A65 in Polyacrylamide Gel, V-A65 Fluoranthene, V-A65
Ferrocyphen Solution, V-A65 Flavoxate Hydrochloride, I-945, V-S58 Fluorene, V-A65
Ferrocyphene, see Ferrocyphen Flavoxate Tablets, III-542 9-Fluorenone, V-A65
Ferroin Solution, V-A65 Flecainide Acetate, I-946, V-S58 Fluorenone Solution, V-A65
Ferroin, see Ferroin solution Flecainide Injection, III-543 (9-Fluorenyl)methyl Chloroformate,
Ferrous Ammonium Sulfate, see Flecainide Tablets, III-544 V-A66
Ammonium Iron(II) Sulfate Flexible Collodion, III-381 Fluoren-9-ylmethyl chloromethanoate,
Ferrous Ammonium Sulphate, see Ferrous Flocculation value (Lf) of diphtheria and see (9-Fluorenyl)methyl Chloroformate
Ammonium Sulfate tetanus toxins and toxoids (Ramon Fluorescamine, V-A66
Ferrous Fumarate, I-932 assay), V-A433 Fluorescein, I-973, V-A66
Ferrous Fumarate and Folic Acid Flocculation value (Lf) of diphtheria and Fluorescein Eye Drops, III-553
Tablets, III-537 tetanus toxins, Ramon assay, V-A433 Fluorescein Injection, III-554
Ferrous Fumarate Capsules, III-535 Flow Cytometry, V-A181 Fluorescein Sodium, I-974, V-S60,
Ferrous Fumarate Oral Suspension, Flowability, V-A489 V-A66
III-536 Flu(adj), see Inactivated Influenza Vaccine Fluorescein, Soluble, see Fluorescein
Ferrous Fumarate Tablets, III-537 (Surface Antigen) Sodium
Ferrous Gluconate, I-934 Flu(adj), see Influenza Vaccine (Surface Fluorescein-conjugated Rabies
Ferrous Gluconate Tablets, III-538 Antigen, Inactivated, Prepared in Cell Antiserum, V-A110
Ferrous Sulfate Heptahydrate, I-936 Cultures) Fluorescence Spectrophotometry,
Ferrous Sulfate Oral Solution, Paediatric, Flu(adj), see Influenza Vaccine (Whole V-A175
III-539 Virion, Inactivated, Prepared in Cell Fluoride (18F) Solution for
Ferrous Sulfate Solution R2, see Iron(II) Cultures) Radiolabelling, IV-659
Sulfate Solution R2 Flubendazole, I-948 Fluoride Standard Solution (1 ppm F),
Ferrous Sulfate Tablets, III-539 Flucloxacillin and Ampicillin Capsules, V-A147
Ferrous Sulfate Tablets, Prolonged- see Co-fluampicil Capsules Fluoride Standard Solution (10 ppm F),
release, III-539 Flucloxacillin and Ampicillin Oral V-A147
Ferrous Sulfate, see Iron(II) Sulfate Suspension, see Co-fluampicil Oral Fluorides, Limit Test for, V-A260
Ferrous Sulphate, Dried, I-935 Suspension Fluorimetry, V-A175
Ferrous Sulphate Heptahydrate, see Flucloxacillin Capsules, III-545 2-Fluoro-2-deoxy-D-glucose, V-A66
Ferrous Sulfate Heptahydrate Flucloxacillin Injection, III-545 2-Fluoro-2-deoxy-D-mannose, V-A66
Ferrous Sulphate Solution R2, see Ferrous Flucloxacillin Magnesium, V-S58 1-Fluoro-2,4-dinitrobenzene, V-A66
Sulfate Solution R2 Flucloxacillin Magnesium Octahydrate, Fluorodinitrobenzene, see 1-Fluoro-2,4-
Ferrous Sulphate Tablets, see Ferrous I-949 dinitrobenzene
Sulfate Tablets Flucloxacillin Magnesium, see Fluorodopa (18F) Injection, IV-660
Ferrous Sulphate, see Ferrous Sulfate Flucloxacillin Magnesium Octahydrate DL-6-Fluorodopa Hydrochloride, V-A66
Ferulic Acid, V-A65 Flucloxacillin Oral Solution, III-546 6-Fluorolevodopa Hydrochloride, V-A66
Feverfew, IV-183 Flucloxacillin Oral Suspension, III-547 Fluoromethalone, V-S61
V-A796 Index
Fluorometholone, I-976 Medicated, III-47 Freezing Point, Determination of,

Fluorometholone Eye Drops, III-555 Foeniculum Vulgare, V-A590 V-A239
1-Fluoro-2-nitro-4- Folic Acid, I-1001, V-A66 Fresh Bilberry, IV-98
trifluoromethylbenzene, V-A66 Folic Acid Injection, III-574 Fresh Bilberry Fruit Dry Extract,
Fluorouracil, I-977, V-S61 Folic Acid Tablets, III-575 Refined and Standardised, see Refined
Fluorouracil Cream, III-556 Folic Acid Tablets, Ferrous Fumarate and Standardised Fresh Bilberry Fruit
Fluorouracil Injection, III-557 and, III-537 Dry Extract,
Fluoxetine, V-S61 Foreign Esters in Essential Oils, V-A308 Fresh Bilberry Fruit, see Fresh Bilberry
Fluoxetine Capsules, III-557 Foreign Matter, V-A319 Freshly Prepared, Definition of, I-10,
Fluoxetine Hydrochloride, I-979, V-S62 Foreign Oils by Thin-layer II-10, III-10, IV-10, V-10
Fluoxetine Oral Solution, III-559 Chromatography, Test for, V-A309 Friability, V-A493
Flupentixol Decanoate, I-980, V-S62 Formaldehyde Solution, I-1003, V-A66 Friability of granules and spheroids,
Flupentixol Dihydrochloride, see Formaldehyde Solution (35 per cent), see V-A493
Flupentixol Hydrochloride Formaldehyde Solution Friability of Uncoated Tablets, V-A493
Flupentixol Hydrochloride, I-981 Formaldehyde Standard Solution (5 ppm Friars’ Balsam, IV-95
Flupentixol Injection, III-560 CH2O), V-A147 Fructose, I-1017, V-A66
Fluphenazine Decanoate, I-984 Formaldehyde, see Formaldehyde Solution Fructose Infusion, III-579
Fluphenazine Decanoate Injection, Formalin, see Formaldehyde Solution Fructose Intravenous Infusion, see
III-561 Formamide, V-A66 Fructose Infusion
Fluphenazine Dihydrochloride, see Formamide R1, V-A66 Fructose, see D-Fructose
Fluphenazine Hydrochloride Formamide, Treated, V-A66 Frusemide Injection, see Furosemide
Fluphenazine Enantate, I-985 Formic Acid, V-A66 Injection
Fluphenazine Hydrochloride, I-986 Formic Acid, Anhydrous, V-A66 Frusemide Tablets, see Furosemide Tablets
Fluphenazine Tablets, III-561 Formononetin, V-A66 Frusemide, see Furosemide
Flurazepam Capsules, III-562 Formoterol Fumarate Dihydrate, I-1004 Fuchsin, Basic, V-A66
Flurazepam Monohydrochloride, I-988, Formulated Preparations, I-37, III-37, Fuchsin Solution, Basic, V-A67
V-S62 IV-37 Fuchsin Solution, Decolorised, V-A67
Flurbiprofen, I-989, V-S63 General Monographs, I-37, III-37, Fuchsin Solution R1, Decolorised,
Flurbiprofen Eye Drops, III-563 IV-37 V-A67
Flurbiprofen Sodium, I-991, V-S63 Formulated Preparations, Consistency of, L-Fucose, V-A67
Flurbiprofen Suppositories, III-564 V-A357 Fucose, see L-Fucose
Flurbiprofen Tablets, III-564 Formulated Preparations, General Fucus, see Kelp
Flu, see Inactivated Influenza Vaccine Monographs for, I-3, I-5, II-3, II-5, Fulvestrant, I-1018
(Split Virion) III-3, III-5, IV-3, IV-5, V-3, V-5 Fumaric Acid, V-S65, V-A67
Flu, see Inactivated Influenza Vaccine Foscarnet Infusion, III-576 Fuming Nitric Acid, V-A93
(Surface Antigen) Foscarnet Intravenous Infusion, see Fumitory, IV-187
Flu, see Inactivated Influenza Vaccine Foscarnet Infusion, III-576 Furazolidone, I-1020, V-S65
(Whole Virion) Foscarnet Sodium, I-1006, V-S64 Furfuraldehyde, V-A67
Flu, see Influenza Vaccine (Surface Foscarnet Sodium Hexahydrate, see Furosemide, I-1020
Antigen, Inactivated, Prepared in Cell Foscarnet Sodium Furosemide Injection, III-579
Cultures) Fosfestrol Injection, III-577 Furosemide Tablets, III-580
Flu, see Influenza Vaccine (Surface Fosfestrol Sodium, I-1008, V-S64 Furosemide Tablets, Amiloride and, see
Antigen, Inactivated, Virosome) Fosfestrol Tablets, III-578 Co-amilofruse Tablets
Flu, see Influenza Vaccine (Whole Virion, Fosfomycin Calcium, I-1009 Fusidic Acid, I-1022, V-S65
Inactivated, Prepared in Cell Cultures) Fosfomycin Sodium, I-1010 Fusidic Acid Cream, III-581
Fluspirilene, I-992 Fosfomycin Trometamol, I-1011 Fusidic Acid Eye Drops, III-582
Flutamide, I-993 Fosinopril Sodium, I-1013 Fusidic Acid Oral Suspension, III-583
Fluticasone Cream, III-565 Fourstamen Stephania Root, see
Fluticasone Inhalation Powder, III-569 Stephania Tetrandra Root
Fluticasone Inhalation Powder, pre-
dispensed, III-570
Fractionated Coconut Oil, see Medium-
chain Triglycerides
G
Gabapentin, I-1025
Fluticasone Nasal Drops, III-566 Fractionated Palm Kernel Oil, II-487
Galactose, I-1027, V-A67
Fluticasone Nasal Spray, III-567 Fragmentometric double mass
Galactose, see D-Galactose
Fluticasone Ointment, III-568 spectrometry mode (multiple reaction
Galantamine Hydrobromide, I-1028
Fluticasone powder for Inhalation, monitoring (MRM)), V-A178
Gallic Acid, V-A67
metered-dose powder inhaler, see Fragmentometric mode (Selected-ion
Gallium (67Ga) Citrate Injection, IV-662
Fluticasone Inhalation Powder monitoring), V-A178
Gallium (68Ga) Chloride Solution,
Fluticasone Powder for Inhalation, pre- Framycetin Sulfate, I-1015
V-A67
metered units, see Fluticasone Inhalation Framycetin Sulphate, see Framycetin
Gallium (68Ga) Chloride Solution for
Powder, pre-dispensed Sulfate
Radiolabelling, IV-662
Fluticasone Pressurised Inhalation, Frangula Bark, IV-184
Gallium 68Ga Edotreotide Injection,
III-571 Frangula Bark Dry Extract,
IV-664
Fluticasone Propionate, I-994, V-S63 Standardised, IV-185
Ganciclovir, I-1030
Flutrimazole, I-996 Frankincense, Indian, IV-186
Garlic for Homoeopathic Preparations,
Fluvastatin Sodium, I-998 Free Formaldehyde, V-A447
IV-429
Fluvoxamine Maleate, I-999, V-S64 Free or Moving Boundary
Garlic Powder, IV-189
Fluvoxamine Tablets, III-572 Electrophoresis, V-A201
Gas Adsorption, Specific Surface Area
Flux-calcined Diatomaceous Filter-aid, Freeze-dried Cholera Vaccine, IV-510
by, V-A497
Washed, V-A50 Freeze-dried Typhoid Vaccine, IV-614
Gas Chromatography, V-A194
Foams, III-47
Gas Chromatography, Apparatus, Provisions Applying to, I-22, II-22, Glass Containers, Hydrolytic resistance
V-A194 III-22, IV-22, V-22 of the inner surfaces of, (surface test),
Gas Chromatography, Detectors, General Chapters of the European V-A531
V-A195 Pharmacopoeia, I-24, II-24, III-24, Glass Containers, Spectral transmission
Gas Chromatography, Injectors, V-A194 IV-24, V-24 for coloured, V-A534
Gas Chromatography, Mobile phases, General Methods of the European Glass Containers, surface treatment,
V-A195 Pharmacopoeia, V-A13 determination of, V-A533
Gas Chromatography, Static Head-space, General Monograph for Unlicensed Glass Containers, Type I, V-A530
V-A195 Medicines, III-77 Glass Containers, Type II, V-A530
Gas Chromatography, Stationary phases, General monographs, I-21, II-21, III-21, Glass Containers, Type III, V-A530
V-A194 IV-21, V-21 Glass grains test, V-A532
Gas chromatography/mass spectrometry, General Monographs for Formulated Glassware, Requirements for, I-6, II-6,
V-A176 Preparations, I-3, I-5, II-3, II-5, III-3, III-6, IV-6, V-6
Gas Detector Tubes, V-A299 III-5, IV-3, IV-5, V-3, V-5 Glauber’s Salt, see Sodium Sulfate
Gas sterilisation, V-A527, V-A528 General Notices, I-1, I-xxii, II-1, III-1, Glibenclamide, I-1041
Gas-gangrene Antitoxin (Novyi), IV-498 IV-1, V-1 Glibenclamide Tablets, III-591
Gas-gangrene Antitoxin (Oedematiens), General Notices of the European Gliclazide, I-1043, V-S66
see Gas-gangrene Antitoxin (Novyi) Pharmacopoeia, I-20, II-20, III-20, Gliclazide Tablets, III-592
Gas-gangrene Antitoxin (Perfringens), IV-20, V-20 Glimepiride, I-1044, V-S66
IV-499 General Notices, Part III, I-xxii Glimepiride Tablets, III-593
Gas-gangrene Antitoxin (Septicum), General Principle, V-A201 Glipizide, I-1046, V-S67
IV-500 General Reagents, V-A19 Glipizide Tablets, III-595
Gas/Ser, see Mixed Gas-gangrene Antitoxin General Statements of the European Gliquidone, I-1049, V-S67
Gastric Juice, Artificial, V-A67 Pharmacopoeia, I-20, II-20, III-20, Gliquidone Tablets, III-596
Gastro-resistant Aspirin Tablets, III-151 IV-20, V-20 Glossary, III-39
Gastro-resistant Bisacodyl Tablets, Gentamicin and Hydrocortisone Acetate Glucagon for Injection, Human, III-596
III-197 Ear Drops, III-590 Glucagon, Human, I-1050
Gastro-resistant Diclofenac Tablets, Gentamicin Cream, III-585 Glucosamine Hydrochloride, I-1051,
III-434 Gentamicin Ear Drops, III-586 V-A68
Gastro-resistant Erythromycin Capsules, Gentamicin Eye Drops, III-587 Glucosamine Sulfate Sodium Chloride,
III-501 Gentamicin Injection, III-588 I-1052
Gastro-resistant Erythromycin Tablets, Gentamicin Ointment, III-589 Glucose, I-1054, V-A68
III-502 Gentamicin Sulfate, I-1036 Glucose, Anhydrous, I-1055
Gastro-resistant Lansoprazole Capsules, Gentian, IV-189 Glucose Infusion, III-597
III-713 Gentian Infusion, Compound, IV-191 Glucose Infusion, Potassium Chloride
Gastro-resistant Lansoprazole Tablets, Gentian Infusion, Concentrated and, see Potassium Chloride and Glucose
III-715 Compound, IV-191 Infusion
Gastro-resistant Mesalazine Tablets, Gentian Mixture, Acid, IV-191 Glucose Infusion, Potassium Chloride,
III-782 Gentian Mixture, Alkaline, IV-192 Sodium Chloride and, see Potassium
Gastro-resistant Naproxen Tablets, Gentian Oral Solution, Acid, IV-191 Chloride, Sodium Chloride and Glucose
III-849 Gentian Oral Solution, Alkaline, IV-192 Infusion
Gastro-resistant Omeprazole Capsules, Gentian Root, see Gentian Glucose Infusion, Sodium Chloride and,
III-883 Gentian Tincture, IV-191 see Sodium Chloride and Glucose Infusion
Gastro-resistant Omeprazole Tablets, Geraniol, V-A67 Glucose Injection, Bupivacaine and,
III-887 Geranyl Acetate, V-A67 III-216
Gastro-resistant Pancreatin Tablets, Germanium Standard Solution (100 ppm Glucose Intravenous Infusion, Potassium
III-912 Ge), V-A147 Chloride and, see Potassium Chloride
Gastro-resistant Peppermint Oil Gestodene, I-1038 and Glucose Infusion
Capsules, IV-314 Ginger, IV-192 Glucose Intravenous Infusion, Potassium
Gastro-resistant Prednisolone Tablets, Ginger Essence, IV-193 Chloride, Sodium Chloride and, see
III-982 Ginger Tincture, Strong, IV-193 Potassium Chloride, Sodium Chloride and
Gastro-resistant Sodium Valproate Ginger Tincture, Weak, IV-193 Glucose Infusion
Tablets, III-1066 Ginkgo Dry Extract, Refined and Glucose Intravenous Infusion, Sodium
Gastro-resistant Sulfasalazine Tablets, Quantified, see Refined and Quantified Chloride and, see Sodium Chloride and
III-1076 Ginkgo Dry Extract, Glucose Infusion
GC Concentrical Column, V-A67 Ginkgo Leaf, IV-193 Glucose Intravenous Infusion, see Glucose
Gee’s Linctus, IV-360 Ginseng, IV-198 Infusion
Gelatin, I-1032, V-A67 Ginseng Dry Extract, IV-199 Glucose Irrigation Solution, III-598
Gelatin, Hydrolysed, V-A67 Ginseng, Siberian, see Eleutherococcus Glucose, Liquid, I-1056
Gels, III-72 Ginsenoside Rb1, V-A67 D-Glucose Monohydrate, V-A68
Gemcitabine Hydrochloride, I-1033 Ginsenoside Re, V-A67 Glucose Monohydrate, see Glucose
Gemfibrozil, I-1035, V-S66 Ginsenoside Rf, V-A67 Glucose, Sodium Chloride and Sodium
Gemfibrozil Capsules, III-584 Ginsenoside Rg1, V-A67 Citrate Oral Solution, Compound,
Gemfibrozil Tablets, III-585 Ginsenoside Rg2, V-A68 III-598
Gene Transfer Medicinal Products for Gitoxin, V-A68 Glucose, Spray-dried Liquid, I-1057
Human Use, V-A732 Glacial Acetic Acid, I-56, V-A20 Glucose Standard Solution, V-A147
General Chapters, V-A13 Glass Containers, Arsenic Test, V-A534 Glucose, see D-Glucose
General Chapters and Monographs of Glass Containers for Pharmaceutical D-Glucuronic Acid, V-A68
the European Pharmacopoeia, Other Use, V-A530 Glutamic Acid, I-1058, V-A68
V-A798 Index
Glutamyl endopeptidase for peptide Gonadorelin Acetate, I-1078 Haloperidol Oral Solution, III-620
mapping, V-A68 Gonadotrophin, Chorionic, I-532, V-A69 Haloperidol Oral Solution, Strong,
L-g-Glutamyl-L-cysteine, V-A68 Gonadotrophin, Serum, V-A69 III-621
Glutaraldehyde, V-A68 Goserelin, I-1079 Haloperidol Tablets, III-621
Glutaraldehyde Solution, III-599 Goserelin Implants, III-605 Halothane, I-1098
Glutaraldehyde Solution, Strong, I-1059 Graduated Glassware, Requirements for, Hamamelis Leaf, IV-205
Glutaric Acid, V-A68 I-6, II-6, III-6, IV-6, V-6 Hard Fat, I-916
Glutathione, I-1059 Gramicidin, I-1082 Hard Paraffin, II-501
L-Glutathione, Oxidised, V-A68 Granisetron Hydrochloride, I-1083 Harmonisation, Pharmacopoeial, V-A674
Glycan Analysis of Glycoproteins, Granules, III-48, see also name of Harmonised dissolution limits, V-A629
V-A225 substance; Coated; Effervescent; Gastro- Harpagophytum, see Devil’s Claw
Glycerin, see Glycerol resistant; Modified-release Harpagoside, V-A69
Glycerin Suppositories, III-599 Graphic Formula, Status of, I-4, II-4, Hartmann’s Solution for Injection,
Glycerol, I-1061, V-A68 III-4, IV-4, V-4 III-1059
Glycerol (85%), V-A68 Graphitised Carbon for Hausner Ratio, V-A501
Glycerol (85 per cent), I-1063 Chromatography, V-A38 Hawthorn Berries, IV-206
Glycerol (85 per cent) R1, V-A68 Greater Burnet Root, IV-114 Hawthorn Leaf and Flower, IV-208
Glycerol 1-decanoate, V-A68 Greater Celandine, IV-132 Hawthorn Leaf and Flower Dry Extract,
Glycerol Dibehenate, I-1064 Griseofulvin, I-1085, V-S68 IV-209
Glycerol Distearate, I-1065 Griseofulvin Tablets, III-609 Hawthorn Leaf and Flower Liquid
Glycerol Eye Drops, III-599 Guaiacol, I-1086, V-A69 Extract, Quantified, see Quantified
Glycerol Formal, I-1067 Guaiacum Resin, V-A69 Hawthorn Leaf and Flower Liquid
Glycerol Injection, Phenol and, III-948 Guaiazulene, V-A69 Extract
Glycerol Monocaprylate, I-1067 Guaifenesin, I-1087 Heavy Bismuth Subnitrate, I-295
Glycerol Monocaprylocaprate, I-1068 Guaiphenesin, V-A69 Heavy Kaolin, II-46
Glycerol Monolinoleate, I-1069 Guanethidine Monosulfate, I-1089 Heavy Magnesium Carbonate, II-162
Glycerol Mono-oleate, I-1070 Guanethidine Monosulphate, see Heavy Magnesium Carbonate and
Glycerol Monostearate 40-55, I-1071 Guanethidine Monosulfate Calcium Carbonate Tablets,
Glycerol 1-octanoate, V-A68 Guanethidine Tablets, III-610 Chewable, III-232
Glycerol R1, V-A68 Guanidine Hydrochloride, V-A69 Heavy Magnesium Oxide, II-171, V-A81
Glycerol Suppositories, III-599 Guanine, V-A69 Heavy Metal-free Nitric Acid, V-A93
Glycerol Triacetate, see Triacetin Guar, I-1090 Heavy Metal-free Sulfuric Acid, V-A126
Glyceryl Monostearate, Self-emulsifying, Guar Galactomannan, I-1090 Heavy Metals in Herbal Drugs and Fatty
I-1072 Guidance, Unlicensed Medicines, Oils, Limit Test for, V-A264
Glyceryl Trinitrate Ointment, III-600 V-A752 Heavy Metals, Limit Test for, V-A261
Glyceryl Trinitrate Solution, I-1073 Guidelines for Using the Test for Hedera Helix for Homoeopathic
Glyceryl Trinitrate Sublingual Spray, Sterility, V-A746 Preparations, IV-430
III-601 Guinea-pigs, I-15, II-15, III-15, IV-15, Hederacoside C, V-A69
Glyceryl Trinitrate Sublingual Tablets, V-15 Hederagenin, V-A69
see Glyceryl Trinitrate Tablets a-Hederin, V-A69
Glyceryl Trinitrate Tablets, III-602 Helium, I-1100, V-A69
Glyceryl Trinitrate Transdermal Patches,
III-603
H Helium for Chromatography, V-A69
Helium for Chromatography, see Helium
Haematopoietic Stem Cells, Human,
Glycidol, V-A68 HepA/HepB, see Hepatitis A (Inactivated)
IV-468
Glycine, I-1075, V-S67, V-A68 and Hepatitis B (rDNA) Vaccine
Haemodiafiltration Solutions,
Glycine Buffer pH 2.9, V-A153 Heparin, V-A69
Haemofiltration and, III-615
Glycine Buffer pH 11.3, V-A153 Heparin, Assay of, V-A409
Haemodialysis Solutions, III-610
Glycine Buffer Solution, V-A153 Heparin Calcium, I-1101
Haemodialysis Solutions, Water for
Glycine Irrigation Solution, III-604 Heparin in coagulation factors, Assay of,
Diluting Concentrated, III-613
Glycollic Acid, V-A68 V-A408
Haemofiltration and Haemodiafiltration
Glycopyrronium Bromide, I-1076 Heparin Injection, III-622
Solutions, III-615
Glycopyrronium Bromide Oral Solution, Heparin Sodium, I-1103
Haemoglobin, V-A69
III-604 Heparins, Low-molecular-mass, see Low-
Haemoglobin Solution, V-A69
Glycyrrhetic Acid, see Glycyrrhetinic Acid molecular-weight Heparins
Haemolytic effects in buffered systems,
Glycyrrhetinic Acid, V-A68, V-A69 Heparins, Low-molecular-weight, I-1105
V-A538
Glyoxal Bis(2-hydroxyanil), V-A69 HepA, see Hepatitis A Vaccine
Haemophilus Type b and Meningococcal
Glyoxal Sodium Bisulfite, V-A69 (Inactivated, Virosome)
Group C Conjugate Vaccine, IV-544
Glyoxal Sodium Bisulphite, see Glyoxal HepA, see Inactivated Hepatitis A Vaccine
Haemophilus Type b Conjugate Vaccine,
Sodium Bisulphite Hepatitis A Immunoglobulin, IV-475
IV-541
Glyoxal Solution, V-A69 Hepatitis A (Inactivated, Adsorbed) and
Halibut-liver Oil, I-1091
Glyoxal Standard Solution (2 ppm Typhoid Polysaccharide Vaccine,
Halibut-liver Oil Capsules, III-617
C2H2O2), V-A147 IV-550
Halofantrine Hydrochloride, I-1093
Glyoxal Standard Solution (20 ppm Hepatitis A (Inactivated) and Hepatitis B
Haloperidol, I-1094, V-S68
C2H2O2), V-A147 (rDNA) Vaccine, IV-551
Haloperidol Capsules, III-619
Glyoxalhydroxyanil, see Glyoxal Hepatitis A (Inactivated) and Hepatitis B
Haloperidol Decanoate, I-1096
Bis(2-hydroxyanil) (rDNA) Vaccine (Adsorbed), see
Haloperidol Injection, III-619
Goldenrod, IV-201 Hepatitis A (Inactivated) and Hepatitis
Haloperidol Oral Drops, Strong, III-621
Goldenrod, European, IV-202 B (rDNA) Vaccine
Haloperidol Oral Drops, see Haloperidol
Goldenseal Rhizome, see Goldenseal Root Hepatitis A vaccine, Assay of, V-A429
Oral Solution,
Goldenseal Root, IV-204 Hepatitis A Vaccine, Inactivated, IV-545
Hepatitis A Vaccine (Inactivated, Hexachlorophene Dusting Powder, Homoeopathic Use, Approved Synonyms
Adsorbed), see Inactivated Hepatitis A III-623 for, V-A590
Vaccine Hexachlorophene Dusting Powder, Zinc Honey, I-1119
Hepatitis A Vaccine (Inactivated, and, III-623 Honey Bee for Homoeopathic
Virosome), IV-547 Hexacosane, V-A70 Preparations, IV-431
Hepatitis B Immunoglobulin, IV-475 Hexadecylamidylsilyl Silica Gel for Honokiol, V-A71
Hepatitis B Immunoglobulin for Chromatography, V-A113 Hop Strobile, IV-210
Intravenous Use, IV-476 Hexadecylamidylsilyl Silica Gel for Horsetail, IV-213
Hepatitis B Vaccine (rDNA), IV-552 Chromatography, End-capped, HPV, see Human Papillomavirus Vaccine
Hepatitis B vaccine (rDNA), Assay of, V-A113 rDNA
V-A429 Hexadimethrine Bromide, V-A70 Human Albumin, V-A22
HepA/Typhoidsee Hepatitis A 2,2,2,6,6,6-Hexa-(1,1-dimethylethyl)- Human Albumin Coated Silica Gel for
(Inactivated, Adsorbed) and Typhoid 4,4,4-[2,4,6-trimethyl-1,3,5- Chromatography, V-A114
Polysacchatide Vaccine, IV-550 benzenetriyltrismethylene]-triphenol, Human Albumin Injection, Iodinated
HepB, see Hepatitis B Vaccine (rDNA) V-A70 (125I), see Iodinated (125I) Albumin
Heptachlor, V-A69 1,1,1,3,3,3-Hexafluoropropan-2-ol, Injection
Heptachlor Epoxide, V-A69 V-A70 Human Albumin Solution, V-A22
Heptafluorobutyric Acid, V-A69 Hexamethyldisilazane, V-A70 Human Albumin Solution R1, V-A22
Heptafluorobutyric Anhydride, V-A70 Hexamethylenetetramine, V-A70 Human Albumin Solution, see Albumin
Heptafluoro-N-methyl-N- Hexamethylenetetramine solution, Solution
(trimethylsilyl)butanamide, V-A70 V-A231 Human Albumin, see Albumin Solution
Heptaminol Hydrochloride, I-1108 Hexamidine Diisetionate, see Hexamidine Human anti-D immunoglobulin, Assay
Heptane, V-A70 Isetionate of, V-A415
2-Heptylamine, V-A70 Hexamidine Isetionate, I-1110 Human Anti-D Immunoglobulin for
Herbal and Complementary Medicines, Hexamine, V-A70 Intravenous Administration, see Anti-D
Crude Drugs; Traditional, Status of, n-Hexane, V-A70 Immunoglobulin for Intravenous Use
I-17, II-17, III-17, IV-17, V-17 Hexane, Purified, V-A70 Human Anti-D Immunoglobulin, see
Herbal Drug Preparations, IV-44 Hexetidine, I-1111 Anti-D (Rh0) Immunoglobulin
Herbal Drugs, IV-43 Hexosamines in Polysaccharide Vaccines, Human antithrombin III, Assay of,
Herbal Drugs, Aristolochic Acids I and V-A450 V-A410
II in, Test for, V-A325, V-A327 Hexylamine, V-A70 Human Antithrombin III Concentrate,
Herbal Drugs, Aristolochic Acids, Test Hexylresorcinol, I-1112 see Antithrombin III Concentrate
for, V-A325 Hexylsilyl Silica Gel for Human coagulation factor II, Assay of,
Herbal drugs, Definition, I-25, II-25, Chromatography, V-A113 V-A402
III-25, IV-25, V-25 Hib/MenC, see Haemophilus Type b and Human Coagulation Factor IX, see Dried
Herbal Drugs, Determination of Meningococcal Group C Conjugate Factor IX Fraction
Aflatoxin B1 in, V-A327 Vaccine Human coagulation factor VII, Assay of,
Herbal Drugs, Determination of Hib, see Haemophilus Type b Conjugate V-A402
Mycotoxins in, V-A327 Vaccine Human Coagulation Factor VIII
Herbal Drugs, Determination of Highly Purified Water, II-1170 (rDNA), see Dried Factor VIII (rDNA)
Ochratoxin A in, V-A329 Histamine Dihydrochloride, I-1113, Human Coagulation Factor VIII, see
Herbal Drugs for Homoeopathic V-A70 Dried Factor VIII Fraction
Preparations, IV-404 Histamine Phosphate, V-A70 Human Coagulation Factor VII, see Dried
Herbal Drugs for Homoeopathic Use, see Histamine Solution, V-A70 Factor VII Fraction
Herbal Drugs for Homoeopathic Histamine, Test for, V-A396 Human coagulation factor X, Assay of,
Preparations Histidine, I-1114 V-A405
Herbal Drugs, Microscopic Examination Histidine Hydrochloride Monohydrate, Human coagulation factor XI, Assay of,
of, V-A331 I-1115 V-A405
Herbal Drugs, Processed, see Processed Histidine Monohydrochloride, V-A70 Human Coagulation Factor XI, see Dried
Herbal Drugs HIV, V-A608 Factor XI Fraction
Herbal drugs- sampling and sample Holmium Oxide, V-A70 Human Euglobulins, V-A64
preparation, V-A330 Holmium Perchlorate Solution, V-A70 Human Fibrinogen, see Dried Fibrinogen
Herbal Medicinal Products for Oral Use, Homatropine, V-S69 Human Glucagon, I-1050
Microbiological Examination of, Homatropine Eye Drops, III-623 Human Glucagon for Injection, III-596
V-A480 Homatropine Hydrobromide, I-1116 Human Haematopoietic Progenitor
Herbal Medicinal Products for Oral Use, Homatropine Methylbromide, I-1118 Cells, Colony-forming Cell Assay for,
Microbiological Quality of, V-A481 DL-Homocysteine, V-A71 V-A443
Herbal Medicines, Traditional, I-xxii, L-Homocysteine Thiolactone Human Haematopoietic Stem Cells,
V-A763 Hydrochloride, V-A71 IV-468
Herbal Reference Materials, see Reference Homoeopathic Medicines, Status of, Human Hepatitis A Immunoglobulin, see
Materials I-18, II-18, III-18, IV-18, V-18 Hepatitis A Immunoglobulin
Herbal Teas, IV-48 Homoeopathic Pillules, Impregnated, Human Hepatitis B Immunoglobulin for
Herbal Teas, Instant, IV-49 IV-416 Intravenous Administration, see
Herpes Zoster Vaccine, see Shingles Homoeopathic Preparations, IV-403 Hepatitis B Immunoglobulin for
(Herpes Zoster) Vaccine (Live) Homoeopathic Preparations, Materials Intravenous Use
Hesperidin, V-A70 for use in the Manufacture of, V-A764 Human Hepatitis B Immunoglobulin, see
Hexachlorobenzene, V-A70 Homoeopathic Preparations, Pillules for, Hepatitis B Immunoglobulin
d-Hexachlorocyclohexane, V-A70 IV-416 Human immunoglobulin, anti-D
Hexachlorophene, I-1109, V-S68 Homoeopathic Stocks and Potentisation, antibodies, for intravenous
Methods of Preparation of, IV-405 administration, Test for, V-A417
V-A800 Index
Human Insulin, I-1185 Hydrated Iron (III) Phosphate for Hydrocortisone Acetate Injection,
Human Measles Immunoglobulin, see Homoeopathic Preparations, Hydrated III-629
Measles Immunoglobulin Iron (II) and, IV-436 Hydrocortisone Acetate Ointment,
Human Normal Immunoglobulin for Hydrated Iron(II) and Iron(III) Phosphate III-630
Intravenous Administration, see Normal for Homoeopathic Preparations, Hydrocortisone Acetate Oral Suspension,
Immunoglobulin for Intravenous Use IV-436 III-631
Human Normal Immunoglobulin, see Hydrated Iron(III) Phosphate for Hydrocortisone and Clioquinol Cream,
Normal Immunoglobulin Homoeopathic Preparations, IV-435 III-631
Human Papillomavirus Vaccine (rDNA), Hydrated Manganese Glycerophosphate, Hydrocortisone and Clioquinol
IV-575 II-187 Ointment, III-632
Human Plasma for Fractionation, see Hydrated Silica, Colloidal, II-804 Hydrocortisone and Neomycin Cream,
Plasma for Fractionation Hydrated Sodium Glycerophosphate, III-633
Human Plasma (Pooled and Treated for II-844 Hydrocortisone and Neomycin Ear
Virus Inactivation), see Plasma (Pooled Hydrated Sodium Perborate, see Sodium Drops, III-635
and Treated for Virus Inactivation) Perborate Hydrocortisone and Neomycin Eye
Human plasmin inhibitor, Assay of, Hydrazine, V-A71 Drops, III-635
V-A408 Hydrazine Hydrate, V-A71 Hydrocortisone Cream, III-627
Human Plasminogen, V-A103 Hydrazine Sulfate, V-A71 Hydrocortisone Cream, Miconazole and,
Human protein C activator, V-A410, Hydrazine sulfate solution, V-A231 III-814
V-A411 Hydrazine Sulphate, see Hydrazine Sulfate Hydrocortisone Hydrogen Succinate,
Human protein C, Assay of, V-A410 Hydrindantin, V-A71 I-1133
Human protein C-deficient plasma, Hydriodic Acid, V-A71 Hydrocortisone Ointment, III-628
V-A411 Hydrobromic Acid, 30 per cent, V-A71 Hydrocortisone Ointment, Miconazole
Human protein S, Assay of, V-A411 Hydrobromic Acid, 47 per cent, V-A71 and, III-816
Human protein S-deficient plasma, Hydrobromic Acid, Dilute, V-A71 Hydrocortisone Oromucosal Tablets,
V-A411 Hydrobromic Acid R1, Dilute, V-A71 III-628
Human a-1-proteinase Inhibitor, IV-477 Hydrocarbons (Type L), Low-vapour- Hydrocortisone Sodium Phosphate,
Human a-1-proteinase inhibitor, Assay pressure, V-A71 I-1134, V-S70
of, V-A419 Hydrochloric Acid, I-1123, V-A71 Hydrocortisone Sodium Phosphate
Human Prothrombin Complex, see Dried Hydrochloric Acid, Brominated, V-A71 Injection, III-637
Prothrombin Complex Hydrochloric Acid, Dilute, I-1123, Hydrocortisone Sodium Phosphate Oral
Human Rabies Immunoglobulin, see V-A71 Solution, III-638
Rabies Immunoglobulin Hydrochloric Acid, Dilute, Heavy Metal- Hydrocortisone Sodium Succinate,
Human Rubella Immunoglobulin, see free, V-A71 V-S71
Rubella Immunoglobulin Hydrochloric Acid, Ethanolic, V-A71 Hydrocortisone Sodium Succinate for
Human Tetanus Immunoglobulin, see Hydrochloric Acid, Heavy Metal-free, Injection, III-639
Tetanus Immunoglobulin V-A71 Hydrocortisone Sodium Succinate
Human Varicella Immunoglobulin for Hydrochloric Acid, Lead-free, V-A71 Injection, III-639
Intravenous Administration, see Hydrochloric Acid, Methanolic, V-A72 Hydroflumethiazide, I-1135, V-S71
Varicella Immunoglobulin for Intravenous Hydrochloric Acid R1, V-A72 Hydroflumethiazide Tablets, III-640
Use Hydrochloric Acid R1, Dilute, V-A72 Hydrofluoric Acid, V-A72
Human Varicella Immunoglobulin, see Hydrochloric Acid R2, Dilute, V-A72 Hydrogen, V-A72
Varicella Immunoglobulin Hydrochloric Acid, Stannated, V-A72 Hydrogen for Chromatography, V-A72
Human von Willebrand factor, Assay of, Hydrochloric Acid VS, V-A141 Hydrogen Peroxide Mouthwash, III-640
V-A406 Hydrochloric Methanol, V-A84 Hydrogen Peroxide Solution, I-1136
Human von Willebrand Factor, see von Hydrochlorothiazide, I-1124, V-S70 Hydrogen Peroxide Solution (3 per
Willebrand Factor Hydrochlorothiazide Oral Solution, cent), I-1136
Hyaluronate Solution, V-A71 Amiloride and, see Co-amilozide Oral Hydrogen Peroxide Solution (6 per
Hyaluronidase, I-1120 Solution cent), I-1136
Hyaluronidase Diluent, V-A71 Hydrochlorothiazide Tablets, III-626 Hydrogen Peroxide Solution (10 vol),
Hyaluronidase for Injection, III-624 Hydrochlorothiazide Tablets, Amiloride V-A72
Hyaluronidase Injection, III-624 and, see Co-amilozide Tablets Hydrogen Peroxide Solution (20 vol),
Hydralazine, V-S69 Hydrochlorothiazide Tablets, V-A72
Hydralazine Hydrochloride, I-1121, Triamterene and, III-388 Hydrogen Peroxide Solution (30 per
V-S69 Hydrocodone Hydrogen Tartrate cent), I-1137
Hydralazine Hydrochloride for Injection, Hydrate, I-1126 Hydrogen Peroxide Solution (100 vol),
III-624 Hydrocortisone, I-1127, V-A72 V-A72
Hydralazine Injection, III-624 Hydrocortisone Acetate, I-1130, V-S70, Hydrogen Peroxide Solution (200 vol),
Hydralazine Tablets, III-625 V-A72 V-A72
Hydrastine Hydrochloride, V-A71 Hydrocortisone Acetate and Neomycin Hydrogen Peroxide Solution, Dilute,
Hydrastis Canadensis for Homoeopathic Ear Drops, III-635 V-A72
Preparations, IV-431 Hydrocortisone Acetate and Neomycin Hydrogen Peroxide Solution, Dilute, see
Hydrated Aluminium Hydroxide for Eye Drops, III-635 Hydrogen Peroxide Solution (3 per cent)
Adsorption, I-115 Hydrocortisone Acetate and Neomycin Hydrogen Peroxide Solution, Strong,
Hydrated Aluminium Oxide, see Dried Eye Ointment, III-636 V-A72
Aluminium Hydroxide Hydrocortisone Acetate Cream, III-629 Hydrogen Peroxide Standard Solution
Hydrated Aluminium Phosphate, see Hydrocortisone Acetate Cream, (10 ppm H2O2), V-A147
Dried Aluminium Phosphate Miconazole and, III-817 Hydrogen Sulfide, V-A72
Hydrated Dihydralazine Sulfate, I-736 Hydrocortisone Acetate Ear Drops, Hydrogen Sulfide R1, V-A72
Gentamicin and, III-590 Hydrogen Sulfide Solution, V-A72
Hydrogen Sulphide R1, see Hydrogen Hydroxylamine Hydrochloride, V-A73 ID50, Definition of, I-30, II-30, III-30,
Sulfide R1 Hydroxylamine Hydrochloride Solution IV-30, V-30
Hydrogen Sulphide Solution, see R2, V-A73 ID50, V-A608
Hydrogen Sulfide Solution Hydroxylamine Solution, Alcoholic, Identification, I-12, II-12, III-12, IV-12,
Hydrogen Sulphide, see Hydrogen Sulfide V-A73 V-12
Hydrogenated Arachis Oil, I-188 Hydroxylamine Solution, Alkaline, Identification of Fixed Oils by Thin-layer
Hydrogenated Castor Oil, I-419 V-A73 Chromatography, V-A309
Hydrogenated Cottonseed Oil, I-641 Hydroxylamine Solution R1, Alkaline, Identification of Phenothiazines by Thin-
Hydrogenated Peanut Oil, see V-A73 Layer Chromatography, Test for,
Hydrogenated Arachis Oil Hydroxylated Polymethacylate Gel, V-A193
Hydrogenated Polyoxyl Castor Oil, I-421 V-A104 Identification of Steroids, V-A194
Hydrogenated Soya Oil, II-892 Hydroxymethylfurfural, V-A73 Idoxuridine, I-1167
Hydrogenated Soya-bean Oil, see Hydroxynaphthol Blue Sodium Salt, Idoxuridine Eye Drops, III-657
Hydrogenated Soya Oil V-A73 Ifosfamide, I-1168, V-S73
Hydrogenated Vegetable Oil, II-1145 4-(4-Hydroxyphenyl)butan-2-one, V-A73 Ifosfamide for Injection, III-658
Hydrogenated Vegetable Oils, Nickel in, Hydroxypropyl Starch, II-908 Ifosfamide Injection, III-658
V-A286 Hydroxypropylbetadex, I-1149 IMI, V-A608
Hydrogenated Wool Fat, II-1182 2-Hydroxypropylbetadex for IMI - International Mycological Institute,
Hydrolysed Gelatin, V-A67 Chromatography, V-A73 address of, I-31, II-31, III-31, IV-31,
Hydrolysed Starch, V-A123 Hydroxypropylcellulose, I-1152 V-31
Hydrolytic resistance - determination by Hydroxypropyl-b-cyclodextrin, V-A73 Imidazole, V-A73
flame atomic absorption spectrometry 8-Hydroxyquinoline, V-A73 Imidazole Buffer Solution pH 7.3,
(FAAS), V-A534 12-Hydroxystearic Acid, V-A73 V-A153
Hydrolytic resistance, Determination of, 5-Hydroxyuracil, V-A73 Imidazole Buffer Solution pH 6.5,
V-A531 Hydroxyurea Capsules, see V-A153
Hydrolytic resistance of glass grains, Hydroxycarbamide Capsules Imidazole, Recrystallised, V-A73
V-A532 Hydroxyzine Hydrochloride, I-1153 Imidazole Solution, V-A73
Hydrolytic stability of glass, V-A530 Hydroxyzine Oral Solution, III-644 Imidazole–Mercury Reagent, V-A73
Hydromorphone Hydrochloride, I-1138 Hydroxyzine Tablets, III-645 Iminodibenzyl, V-A74
Hydrophilic Silica Gel for Hygroscopicity, V-A716 Imipenem Monohydrate, I-1170
Chromatography, V-A114 Hymecromone, I-1154 Imipramine Hydrochloride, I-1171
Hydrophobic Colloidal Anhydrous Silica, Hyoscine, I-1155 Imipramine Tablets, III-659
II-805 Hyoscine Butylbromide, I-1156, V-S72 Immunoassays, V-A632
Hydroquinone, V-A72 Hyoscine Butylbromide Injection, III-648 Immunochemical Methods, V-A388
Hydroquinone Solution, V-A72 Hyoscine Butylbromide Tablets, III-649 Immunoelectrophoretic methods,
Hydrotalcite, I-1139 Hyoscine Eye Drops, III-646 V-A389
Hydrotalcite Tablets, III-641 Hyoscine Hydrobromide, I-1158, V-A73 Immunoglobulin, Test for Fc function
Hydrous Benzoyl Peroxide, I-259 Hyoscine Injection, III-647 of, V-A412
Hydrous Ointment, III-641 Hyoscine Tablets, III-647 Immunological Products, V-A420
Hydrous Wool Fat, II-1183 Hyoscyamine Sulfate, I-1159, V-A73 Immunoprecipitation methods, V-A389
Hydroxocobalamin Acetate, I-1140 Hyoscyamine Sulphate, see Hyoscyamine Immunosera, IV-489
Hydroxocobalamin Chloride, I-1141 Sulfate Immunosera (Antisera) and Vaccines,
Hydroxocobalamin Injection, III-641 Hyoscyamus for Homoeopathic Phenol in, V-A447
Hydroxocobalamin Sulfate, I-1142 Preparations, IV-432 Immunosera for Human Use, Animal, see
Hydroxocobalamin Sulphate, see Hypericin, V-A73 Immunosera
Hydroxoncolbalamin Sulfate Hypericum for Homoeopathic Imperatorin, V-A74
4-Hydroxybenzaldehyde, V-A72 Preparations, IV-434 Impinger, glass, Aerodynamic
2-Hydroxybenzimidazole, V-A72 Hypericum, see St. John’s Wort Assessment of Fine Particles – Fine
4-Hydroxybenzohydrazide, V-A72 Hyperoside, V-A73 Particle Dose and Particle Size
4-Hydroxybenzoic Acid, V-A72 Hypophosphorous Reagent, V-A73 Distribution, V-A361
4-Hydroxybiphenyl, V-A72 Hypoxanthine, V-A73 Impinger, Multi-stage Liquid Impinger,
Hydroxycarbamide, I-1143, V-S71 Hypromellose, I-1161 Aerodynamic Assessment of Fine
Hydroxycarbamide Capsules, III-642 Hypromellose Eye Drops, III-650 Particles – Fine Particle Dose and
Hydroxychloroquine, V-S72 Hypromellose Phthalate, I-1163 Particle Size Distribution, V-A363
Hydroxychloroquine Sulfate, I-1144 Implementation, Dates of, V-A657
Hydroxychloroquine Tablets, III-643 Implementation of pharmacopoeial
4-Hydroxycoumarin, V-A72
6-Hydroxydopa, V-A72
I methods, I-21, II-21, III-21, IV-21,
V-21
Ibuprofen, I-1164, V-S72
Hydroxyethyl Salicylate, I-1146 Impregnated Homoeopathic Pillules,
Ibuprofen Capsules, Prolonged-release,
Hydroxyethyl Starches, II-904 IV-416
III-650
Hydroxyethylcellulose, I-1147 Impurities, Expression of Limits for,
Ibuprofen Cream, III-651
Hydroxyethylmethylcellulose, I-1148 V-A618
Ibuprofen Gel, III-653
2-[4-(2-Hydroxyethyl)piperazin-1- Impurities in Substances for
Ibuprofen Oral Suspension, III-654
yl]ethanesulfonic Acid, V-A72 Pharmaceutical Use, Control of,
Ibuprofen Tablets, III-655
2-[4-(2-Hydroxyethyl)piperazin-1- V-A713
Ibuprofen Tablets, Prolonged-release,
yl]ethanesulphonic Acid, see 2-[4- Impurities, Limitation of Potential, I-4,
III-656
(2-Hydroxyethyl)piperazin-1- II-4, III-4, IV-4, V-4
Iceland Moss, IV-214
yl]ethanesulfonic Acid Impurities, Statements of, V-A619
Ichthammol, I-1166
4-Hydroxyisophthalic Acid, V-A73 Impurity Limits, Status of, I-13, II-13,
Ichthammol Cream, Zinc and, III-1179
Hydroxyl Value, V-A304 III-13, IV-13, V-13
V-A802 Index
Impurity Statements, Status of, I-4, II-4, Infusions, III-66 International Reference Preparation,
III-4, IV-4, V-4 Infusions, Extractable Volume Test, I-14, II-14, III-14, IV-14, V-14
IMS, II-248 V-A361 International System Of Units, I-31,
IMS, see Industrial Methylated Spirit Inhalation, Preparations for, III-50 II-31, III-31, IV-31, V-31
Inactivated Hepatitis A Vaccine, IV-545 Inhalations, III-55 International Unit, Definition of, I-14,
Inactivated Influenza Vaccine (Split Pressurised, III-55 II-14, III-14, IV-14, V-14
Virion), IV-558 Inhaled Products, V-A638 Intranasal Solutions, III-60
Inactivated Influenza Vaccine (Surface Injectable Insulin Preparations, III-665 Intranasal Suspensions, III-60
Antigen), IV-559 Injection volume, Liquid Intrinsic Dissolution, V-A354
Inactivated Influenza Vaccine (Whole Chromatography, V-A200 Invert Syrup, III-1085
Virion), IV-554 Injections, III-66 Iobenguane (123I) Injection, IV-669
Inactivated Poliomyelitis Vaccine, IV-588 Concentrated Solutions for, III-66 Iobenguane (131I) Injection for
2-Indanamine hydrochloride, V-A74 Injectors, Liquid Chromatography, Diagnostic Use, IV-670
Indapamide, I-1173 V-A199 Iobenguane (131I) Injection for
Indapamide Tablets, III-660 INN, V-A639 Therapeutic Use, IV-671
Indian Frankincense, IV-186 Inosine, V-A74 Iobenguane Sulfate for
Indian Squill, IV-359 Inositol, myo-, I-1178 Radiopharmaceutical Preparations,
Indicators, V-A760 Inositol Nicotinate, I-1179, V-S74 IV-643
Indicators, Use of Chemical, I-7, II-7, Inositol Nicotinate Tablets, III-664 Iobenguane Sulphate for
III-7, IV-7, V-7 Instant Herbal Teas, IV-49 Radiopharmaceutical Preparations, see
Indigo Carmine, V-A74 Instrumental Determination of Iobenguane Sulfate for
Indigo Carmine Solution, V-A74 Opalescence, V-A232 Radiopharmaceutical Preparations
Indigo Carmine Solution R1, V-A74 Insulin Aspart, I-1180 Iodic Acid, V-A74
Indinavir Sulfate, I-1174 Insulin Aspart Injection, III-668 Iodide Standard Solution (10 ppm I),
Indinavir Sulphate, see Indinavir Sulfate Insulin, Biphasic Isophane, III-669 V-A147
Indium (111In) Chloride Solution, Insulin, Bovine, I-1182 Iodide Standard Solution (20 ppm I),
IV-666 Insulin, Human, I-1185 V-A147
Indium (111In) Oxine Solution, IV-667 Insulin Injection, III-667 Iodide-free Starch Solution, V-A124
Indium (111In) Pentetate Injection, Insulin Injection, Biphasic, III-669 Iodides, Reactions of, V-A257
IV-668 Insulin Injection, Isophane, III-670 Iodinated (125I) Albumin Injection,
Indometacin, I-1177, V-S73, V-A74 Insulin Injection, Protamine Zinc, IV-648
Indometacin Capsules, III-662 III-671 Iodinated (125I) Human Albumin
Indometacin Suppositories, III-663 Insulin Injection, Soluble, see Insulin Injection, see Iodinated (125I) Albumin
Indoramin, V-S73 Injection Injection
Indoramin Hydrochloride, I-1177 Insulin Lispro, I-1187 Iodinated (131I) Norcholesterol Injection,
Indoramin Tablets, III-663 Insulin Lispro Injection, III-670 see Iodomethylnorcholesterol (131I)
Inductively Coupled Plasma-atomic Insulin, Porcine, I-1190 Injection
Emission Spectrometry, V-A171 Insulin Preparations, Injectable, III-665 Iodinated Potassium Iodide Solution,
Inductively Coupled Plasma-mass Insulin Preparations, see Injectable Insulin V-A106
Spectrometry, V-A178 Preparations Iodinated Povidone, II-641
Industrial Denatured Alcohol (Ketone- Insulin Zinc Injectable Suspension Iodinated Zinc Chloride Solution,
free), see Industrial Methylated Spirit (Amorphous), see Insulin Zinc V-A138
(Ketone-free) Suspension (Amorphous) Iodine, I-1201, V-A74
Industrial Denatured Alcohol, see Insulin Zinc Injectable Suspension Iodine-123 and Ruthenium-106 Spiking
Industrial Methylated Spirit (Crystalline), see Insulin Zinc Suspension Solution, V-A74
Industrial Methylated Spirit, II-248 (Crystalline) Iodine Bromide, V-A74
Industrial Methylated Spirit (95%), Insulin Zinc Injectable Suspension, see Iodine Bromide Solution, V-A74
V-A74 Insulin Zinc Suspension Iodine Chloride, V-A74
Industrial Methylated Spirit (Ketone- Insulin Zinc Suspension, III-672 Iodine Chloride Solution, V-A74
free), II-248 Insulin Zinc Suspension (Amorphous), Iodine Monochloride Reagent, Strong,
Industrial Methylated Spirits, II-248 III-672 V-A74
Influenza Vaccine (Split Virion), Insulin Zinc Suspension (Crystalline), Iodine Monochloride Solution, V-A74
Inactivated, IV-558 III-673 Iodine Oral Solution, Aqueous, III-675
Influenza Vaccine (Surface Antigen), Insulin Zinc Suspension, Mixed, see Iodine, Oxygen-flask Combustion
Inactivated, IV-559 Insulin Zinc Suspension Method for, V-A268
Influenza Vaccine (Surface Antigen, Interchangeable methods, I-22, II-22, Iodine Pentoxide, Recrystallised, V-A74
Inactivated, Prepared in Cell III-22, IV-22, V-22 Iodine Solution, Alcoholic, III-675,
Cultures), IV-561 Interferon Alfa-2a Injection, III-673 V-A74
Influenza Vaccine (Surface Antigen, Interferon Alfa-2 Concentrated Solution, Iodine Solution, Chloroformic, V-A75
Inactivated, Virosome), IV-564 I-1192 Iodine Solution R1, V-A75
Influenza Vaccine (Whole Virion), Interferon Beta-1a Concentrated Iodine Solution R2, V-A75
Inactivated, IV-554 Solution, I-1195 Iodine Solution R3, V-A75
Influenza Vaccine (Whole Virion, Interferon Gamma-1b Concentrated Iodine Solution R4, V-A75
Inactivated, Prepared in Cell Solution, I-1198 Iodine Trichloride, V-A75
Cultures), IV-555 Interferons, Assay of, V-A439 Iodine Value, V-A305
Infrared Reference Spectra, I-xxiv Intermediate Precision, V-A654 Iodine VS, V-A141
Infrared Reference Spectra, Preparation International Collaboration, I-xxvii Iodipamide, V-S74
of, V-S2 International Nonproprietary Names, Iodised Oil Fluid Injection, III-676
Infrared Spectrophotometry, V-A159 V-A639 Iodixanol, I-1202
Infusions, III-50, III-66 Iodoacetic Acid, V-A75
2-Iodobenzoic Acid, V-A75 Iron for Homoeopathic Preparations, Isoconazole Pessaries, III-688
3-Iodobenzylammonium Chloride, IV-434 Isoconazole Vaginal Tablets, III-688
V-A75 Iron for Homoeopathic Use, see Iron for Isodrin, V-A76
Iodoethane, V-A75 Homoeopathic Preparations Isoelectric Focusing, Anolyte for, V-A29
2-Iodohippuric Acid, V-A75 Iron, Limit Test for, V-A264 Isoelectric Focusing in Polyacrylamide
Iodomethane, V-A75 Iron Salicylate Solution, V-A76 Gel, Fixing Solution for, V-A65
Iodomethylnorcholesterol (131I) Iron Standard Solution (8 ppm Fe), Isoelectric Focusing in Polyacrylamide
Injection, IV-672 V-A147 Gels, V-A213
Iodoplatinate Reagent, V-A75 Iron Standard Solution (0.1% Fe), Isoelectric Focusing pH 3 to 5,
Iodoplatinate Reagent R1, V-A75 V-A147 Catholyte for, V-A39
2-Iodopropane, V-A75 Iron Standard Solution (1 ppm Fe), Isoflurane, I-1225
Iodosulphurous Reagent, see Iodosulfurous V-A147 IsohexaneSee 2-Methylpentane, V-A88
Reagent Iron Standard Solution (2 ppm Fe), Isoleucine, I-1227, V-A76
5-Iodouracil, V-A75 V-A147 Isomalt, I-1228, V-A76
Iofendylate Injection, III-676 Iron Standard Solution (10 ppm Fe), Isomaltitol, V-A76
Iohexol, I-1205 V-A147 Isomenthol, V-A76
Ion-cyclotron resonance analysers, Iron Standard Solution (20 ppm Fe), (þ)-Isomenthone, V-A77
V-A178 V-A147 Isometheptene, V-S75
Ion-exchange Resin, Strongly Acidic, Iron Standard Solution (250 ppm Fe), Isometheptene Mucate, I-1230
V-A75 V-A147 Isomethyleugenol, V-A77
Ion-exclusion Resin for Chromatography, Iron Sucrose Injection, III-687 Isoniazid, I-1231, V-S76, V-A77
V-A75 Iron(II) and Hydrated Iron(III) Phosphate Isoniazid Injection, III-689
Ionic Concentration, Potentiometric for Homoeopathic Preparations, Isoniazid Oral Solution, III-689
Determination of, Using Ion-selective Hydrated, IV-436 Isoniazid Solution, V-A77
Electrodes, V-A269 Iron(II) Sulfate, V-A76 Isoniazid Tablets, III-690
Ionising radiation sterilisation, V-A527, Iron(II) Sulfate Solution R2, V-A76 Isonicotinamide, V-A77
V-A528 Iron(II) Sulfate VS, V-A141 Isopentyl Benzoate, V-A77
Ion-trap analyser, V-A178 Iron(II) Sulfate-Citrate Solution, V-A76 Isophane Insulin, Biphasic, III-669
Iopamidol, I-1209, V-S74 Iron(II) Sulphate Solution R2, see Iron(II) Isophane Insulin Injection, III-670
Iopamidol Injection, III-677 Sulfate Solution R2 Isophane Insulin (NPH), see Isophane
Iopamidol Oral Solution, III-678 Iron(II) Sulphate VS, see Iron(II) Sulfate Insulin Injection
Iopanoic Acid, I-1211, V-S75 VS Isophane Insulin, see Isophane Insulin
Iopanoic Acid Tablets, III-679 Iron(II) Sulphate-Citrate Solution, see Injection
Iopromide, I-1212 Iron(II) Sulfate-Citrate Solution Isoprenaline Concentrate, Sterile, III-691
Iotrolan, I-1215 Iron(II) Sulphate, see Iron(II) Sulfate Isoprenaline Hydrochloride, I-1232
Ioxaglic Acid, I-1218 Iron(III) Chloride, Anhydrous, V-A75 Isoprenaline Injection, III-691
IP, V-A608 Iron(III) Chloride Hexahydrate, V-A75 Isoprenaline Sulfate, I-1233
I.P. - Collection Nationale de Culture de Iron(III) Chloride Solution, V-A76 Isoprenaline Sulphate, see Isoprenaline
Microorganismes (C.N.C.M.) Institut Iron(III) Chloride Solution, Ethanolic, Sulfate
Pasteur, address of, I-31, II-31, V-A76 Isopropyl Alcohol, I-1234
III-31, IV-31, V-31 Iron(III) Chloride Solution R1, V-A76 Isopropyl Iodide, V-A77
Ipecacuanha, IV-215 Iron(III) Chloride Solution R2, V-A76 Isopropyl Methanesulfonate, V-A77
Ipecacuanha Emetic Mixture, Paediatric, Iron(III) Chloride-Sulfamic Acid Reagent, Isopropyl Methanesulfonate in
IV-219 V-A76 Methanesulfonic Acid, see Methyl,
Ipecacuanha Emetic, Paediatric, IV-219 Iron(III) Chloride-Sulphamic Acid Ethyl and Isopropyl Methanesulfonate in
Ipecacuanha Liquid Extract, IV-217 Reagent, see Iron(III) Chloride-Sulfamic Methanesulfonic Acid
Ipecacuanha Liquid Extract, Acid Reagent Isopropyl Myristate, I-1235, V-A77
Standardised, IV-217 Iron(III) Nitrate, V-A76 Isopropyl Palmitate, I-1236
Ipecacuanha Oral Solution, Paediatric, Iron(III) Nitrate Solution, V-A76 Isopropylamine, V-A77
IV-219 Iron(III) Phosphate for Homoeopathic 4-Isopropylphenol, V-A77
Ipecacuanha, Prepared, IV-216 Preparations, Hydrated, IV-435 Isopulegol, V-A77
Ipecacuanha Root, see Ipecacuanha Iron(III) Phosphate for Homoeopathic Isoquercitroside, V-A77
Ipecacuanha Tincture, Standardised, Preparations, Hydrated Iron(II) and, Isosilibinin, V-A77
IV-218 Hydrated, IV-436 Isosorbide Dinitrate, V-S76
Ipratropium Bromide, I-1220 Iron(III) Sulfate, V-A76 Isosorbide Dinitrate, Diluted, I-1236
Ipratropium Inhalation Powder, hard Iron(III) Sulfate Pentahydrate, V-A76 Isosorbide Dinitrate Injection, III-692
capsule, III-681 Iron(III) Sulphate Pentahydrate, see Isosorbide Dinitrate Sublingual Tablets,
Ipratropium Nebuliser Solution, III-680 Iron(III) Sulfate Pentahydrate III-694
Ipratropium Powder for Inhalation, see Iron(III) Sulphate, see Iron(III) Sulfate Isosorbide Dinitrate Tablets, III-693
Ipratropium Inhalation powder, hard IR, see Infrared Spectrophotometry Isosorbide Mononitrate Capsules,
capsule Isatin, V-A76 Prolonged-release, III-695
Ipratropium Pressurised Inhalation, Isatin Reagent, V-A76 Isosorbide Mononitrate, Diluted, I-1238
III-683 Isatis Root, IV-219 Isosorbide Mononitrate Tablets, III-696
IPV, see Inactivated Poliomyelitis Vaccine ISO, V-A608 Isosorbide Mononitrate Tablets,
Irbesartan, I-1221, V-S75 Isoamyl Alcohol, V-A76 Prolonged-release, III-698
Irbesartan Tablets, III-684 Isoamyl Benzoate, V-A76 Isotopically Pure Deuterium Oxide,
Iron, V-A75 Isoandrosterone, V-A76 V-A50
Iron and Iron Salts, Reactions of, Isobutyl Acetate, V-A76 Isotretinoin, I-1240
V-A257 Isoconazole, I-1223 Isotretinoin Capsules, III-699
Iron Dextran Injection, III-685 Isoconazole Nitrate, I-1224 Isotretinoin Gel, III-700
V-A804 Index
Isoxsuprine Hydrochloride, I-1242 Kieselguhr, V-A77 Laser Light Diffraction, Particle Size
Ispaghula Husk, IV-221 Kieselguhr G, V-A77 Analysis by, V-A504
Ispaghula Husk Effervescent Granules, Kilogram, Definition of, I-32, II-32, Lassar’s Paste, III-1179
IV-221 III-32, IV-32, V-32 Lath, V-A504
Ispaghula Husk Granules, IV-221 Knotgrass, IV-228 Lauric Acid, V-A78
Ispaghula Husk Oral Powder, IV-222 Krameria, see Rhatany Root Lauromacrogol 400, II-78
Ispaghula Seed, IV-222 Krypton (81mKr) Inhalation Gas, IV-673 Lauroyl Macrogolglycerides, II-81
Isradipine, I-1244, V-S76 Kudzuvine Root, IV-230 Lauryl Alcohol, see Dodecan-1-ol
Isradipine Tablets, III-701 Lavandulol, V-A78
Italic Type, Significance of, I-8, II-8, Lavandulyl Acetate, V-A79
III-8, IV-8, V-8
Itraconazole, I-1245
L Lavender Flower, IV-232
Lavender Oil, IV-233
Lþ/10 dose, Definition of, I-30, II-30,
IU, V-A608 Lavender Oil, Spike, IV-235
III-30, IV-30, V-30
IU, Definition of, I-14, II-14, III-14, LCR, see Nucleic acid amplification, ligase
Labelled Potency, V-A635
IV-14, V-14 chain reaction (LCR)
Labelling of Radiopharmaceuticals,
IUPAC, V-A608 LD50, Definition of, I-30, II-30, III-30,
IV-629
Ivermectin, I-1247 IV-30, V-30
Labelling of Unlicensed Medicinal
Ivy Leaf, IV-223 LD50, V-A608
Products, V-A753
Lþ dose, Definition of, I-30, II-30,
Labelling, Requirements for, I-16, II-16,
III-30, IV-30, V-30
III-16, IV-16, V-16
J Labetalol, V-S77
Lead Acetate, V-A79
Lead Acetate Cotton, V-A79
Java Tea, IV-224 Labetalol Hydrochloride, II-57
Lead Acetate Paper, V-A79
Javanese Turmeric, IV-382 Labetalol Injection, III-706
Lead Acetate Solution, V-A79
Josamycin, II-39 Labetalol Tablets, III-706
Lead and Lead Compounds, Reactions
Josamycin Propionate, II-42 Lacidipine, II-59, V-S77
of, V-A257
Juniper, IV-226 Lacidipine Tablets, III-707
Lead Dioxide, V-A79
Juniper Oil, IV-226 Lactates, Reactions of, V-A257
Lead in Sugars, Limit Test for, V-A264
Justified and Authorised, Definition of, Lactic Acid, II-61, V-A78
Lead Liposoluble Standard Solution
I-5, II-5, III-5, IV-5, V-5 Lactic Acid Pessaries, III-708
(1000 ppm Pb), V-A147
Lactic Reagent, V-A78
Lead Nitrate, V-A79
Lactitol Monohydrate, II-62
Lead Nitrate Solution, V-A79
K Lactobionic Acid, II-64, V-A78
Lactose, II-65, V-A78
Lead Nitrate VS, V-A142
Kali Muriaticum, V-A590 Lead Standard Solution (0.1% Pb),
Lactose, Anhydrous, II-66
Kanamycin Acid Sulfate, II-44 V-A147
a-Lactose Monohydrate, V-A78
Kanamycin Acid Sulphate, see Lead Standard Solution (0.1% Pb) R1,
Lactose Monohydrate, see Lactose
Kanamycin Acid Sulfate V-A147
Lactulose, II-68
Kanamycin Monosulfate, see Kanamycin Lead Standard Solution (0.1 ppm Pb),
Lactulose, Liquid, see Lactulose Solution
Sulfate V-A148
Lactulose Oral Powder, III-708
Kanamycin Sulfate, II-45 Lead Standard Solution (0.5 ppm Pb),
Lactulose Solution, II-70
Kanamycin Sulphate, see Kanamycin V-A148
LAL Test, see Test for Bacterial Endotoxins
Sulfate Lead Standard Solution (0.25 ppm Pb),
Lamellar, V-A504
Kaolin and Morphine Mixture, III-702 V-A148
Lamivudine, II-73, V-S78
Kaolin and Morphine Oral Suspension, Lead Standard Solution (1 ppm Pb),
Lamivudine Tablets, III-710
see Kaolin and Morphine Mixture V-A148
Lamivudine Tablets, Zidovudine and, see
Kaolin, Heavy, II-46 Lead Standard Solution (2 ppm Pb),
Zidovudine and Lamivudine Tablets
Kaolin, Light, II-47, V-A77 V-A148
Lamotrigine, II-75
Kaolin, Light (Natural), II-47 Lead Standard Solution (10 ppm Pb),
Lamotrigine Tablets, III-711
Kaolin Mixture, III-702 V-A148
Lamotrigine Tablets, Dispersible, III-712
Kaolin Oral Suspension, III-702 Lead Standard Solution (10 ppm Pb)
Lanatoside C, V-A78
Kaolin Poultice, III-703 R1, V-A148
Lanolin, Anhydrous, see Wool Fat
Karaya Gum, see Sterculia Lead Standard Solution (10 ppm Pb)
Lanolin, see Hydrous Wool Fat
Karl Fischer Reagent VS, V-A142 R2, V-A148
Lansoprazole, II-77
mkat, V-A608 Lead Standard Solution (20 ppm Pb),
Lansoprazole Capsules, Gastro-resistant,
Kelp, IV-227 V-A148
III-713
Kelvin, Definition of, I-32, II-32, III-32, Lead Standard Solution (100 ppm Pb),
Lansoprazole Capsules, see Gastro-
IV-32, V-32 V-A148
resistant Lansoprazole Capsules
Kerosene, Deodorised, V-A77 Lead Subacetate Solution, V-A79
Lansoprazole Tablets, Gastro-resistant,
Ketamine Hydrochloride, II-48 Lead-free Ammonia, V-A25
III-715
Ketamine Injection, III-703 Lead-free Hydrochloric Acid, V-A71
Lansoprazole Tablets, see Gastro-resistant
Ketobemidone Hydrochloride, II-49 Lead-free Nitric Acid, V-A93
Lansoprazole Tablets
11-Keto-b-boswellic acid, V-A77 Lead-free Potassium Cyanide Solution,
Lanthanum Chloride Heptahydrate,
Ketoconazole, II-50 V-A105
V-A78
Ketoprofen, II-52, V-S77 Lead(II) Acetate, V-A79
Lanthanum Chloride Solution, V-A78
Ketoprofen Capsules, III-704 Lead(II) Acetate, see Lead Acetate
Lanthanum Nitrate, V-A78
Ketoprofen Gel, III-705 Lead(II) Nitrate, V-A79
Lanthanum Nitrate Solution, V-A78
Ketorolac Trometamol, II-54 Lead(IV) Oxide, V-A79
Lanthanum Trioxide, V-A78
Ketotifen Fumarate, II-55 Lead(IV) Oxide, see Lead Dioxide
Largehead Atractylodes Rhizome, IV-81
Ketotifen Hydrogen Fumarate, see Leflunomide, II-82
Ketotifen Fumarate
Legal Requirements, Unlicensed Light Magnesia, II-172 Lipophilic Suppositories, Softening Time
Medicines, V-A752 Light Magnesium Carbonate, II-163 Determination, V-A495
Leiocarposide, V-A79 Light Magnesium Oxide, II-172 Liquefied Phenol, II-546, V-A99
Lemon Balm, IV-236 Light obscuration particle count test, Liquid Chromatography, V-A199
Lemon Balm Dry Extract, IV-237 V-A379 Liquid Chromatography, Detectors,
Lemon Oil, IV-239, V-A79 Light Petroleum, V-A99 V-A200
Lemon Oil, Terpeneless, IV-240 Light Petroleum R1, V-A99 Liquid Chromatography, Injection
Lemon Peel, Dried, IV-238 Light Petroleum R2, V-A99 volume, V-A200
Lemon Spirit, IV-241 Light Petroleum R3, V-A99 Liquid Chromatography, Injectors,
Lemon Syrup, IV-241 Light petroleum R4, V-A99 V-A199
Lemon Verbena Leaf, IV-241 Light, Protected from, Definition of, Liquid Chromatography, Mobile phases,
Letrozole, II-83 I-12, II-12, III-12, IV-12, V-12 V-A199
Leucine, II-84, V-A79 Light, Protection from, V-A193 Liquid Chromatography, Pumping
Leuprorelin, II-86 Light, Subdued, Definition of, I-12, systems, V-A199
Leuprorelin for Injection, III-716 II-12, III-12, IV-12, V-12 Liquid Chromatography, Resolution
Leuprorelin Injection, III-716 Lignin, Reactions of, V-A257 factor, V-A200
Levamisole Hydrochloride, II-88 Lignocaine and Chlorhexidine Gel, see Liquid Chromatography, Run time,
Levetiracetam, II-89 Lidocaine and Chlorhexidine Gel V-A200
Levobunolol Eye Drops, III-717 Lignocaine Gel, see Lidocaine Gel Liquid Chromatography, Secondary
Levobunolol Hydrochloride, II-91, Lignocaine Hydrochloride, see Lidocaine peaks, V-A200
V-S78 Hydrochloride Liquid Chromatography, Stationary
Levocabastine Hydrochloride, II-92 Lignocaine Injection, see Lidocaine phases, V-A199
Levocarnitine, II-94 Injection Liquid chromatography/mass
Levodopa, II-95, V-S78, V-A79 Lignocaine Ointment, see Lidocaine spectrometry, V-A176
Levodopa and Carbidopa Tablets, Ointment Liquid Glucose, I-1056
III-357 Lignocaine Solution, Sterile, see Lidocaine Liquid Glucose, Spray-dried, I-1057
Levodopa Capsules, III-718 Solution, Sterile Liquid Lactulose, see Lactulose Solution
Levodopa Capsules, Benserazide Lignocaine, see Lidocaine Liquid Maltitol, II-184
Hydrochloride and, see Co-beneldopa Lime, Chlorinated, I-508 Liquid Paraffin, II-502, V-A97
Capsules Lime Flower, IV-243 Liquid Paraffin and Magnesium
Levodopa Tablets, III-719 Lime Water, III-237 Hydroxide Oral Emulsion, III-931
Levodropropizine, II-97 Limit of Detection, V-A655 Liquid Paraffin Oral Emulsion, III-930
Levomenol, V-A79 Limit of Quantitation, V-A655 Liquid Preparations for Oral Use, III-56
Levomenthol, II-98 Limit Tests, V-A259 Liquid Scintillation Cocktail, V-A80
Levomenthol Cream, III-720, V-A756 Limitation of Impurities, Expression of, Liquid Scintillation Cocktail R1, V-A80
Levomepromazine, V-S79 V-A618 Liquid Sorbitol (Crystallising), II-889
Levomepromazine Hydrochloride, II-99 Limits, Application of, I-13, II-13, Liquid Sorbitol (Non-crystallising),
Levomepromazine Injection, III-720 III-13, IV-13, V-13 II-890
Levomepromazine Maleate, II-100 Limits of content, Definition, I-25, Liquid Sorbitol, Partially Dehydrated,
Levomepromazine Tablets, III-721 II-25, III-25, IV-25, V-25 II-888
Levomethadone Hydrochloride, II-101 Limits of Error, Fiducial, V-A635 Liquids for Cutaneous Application,
Levonorgestrel, II-103 Limonene, V-A79 III-42
Levonorgestrel and Ethinylestradiol Linalol, V-A79 Liquids for Cutaneous Application of the
Tablets, III-723 Linalool, V-A79 BP, III-43
Levonorgestrel Tablets, III-722 Linalool, see Linalol Liquorice, IV-244
Levothyroxine Oral Solution, III-724 Linalyl Acetate, V-A79 Liquorice Dry Extract for Flavouring
Levothyroxine Sodium, II-106 Lincomycin Capsules, III-731 Purposes, IV-246
Levothyroxine Tablets, III-725 Lincomycin Hydrochloride, II-111, Liquorice Ethanolic Liquid Extract,
Lf dose, Definition of, I-30, II-30, V-S80 Standardised, IV-247
III-30, IV-30, V-30 Lincomycin Injection, III-731 Liquorice Liquid Extract, IV-248
Lidocaine, II-108 Linctus, Paediatric Simple, III-1044 Liquorice Root for use in TCM, IV-248
Lidocaine (1), V-S79 Linctus, Simple, III-1044 Liquorice Root, see Liquorice
Lidocaine (2), V-S79 Linctuses, III-58 Lisinopril Dihydrate, II-116
Lidocaine and Adrenaline Injection, Lindane, V-A79 Lisinopril Oral Solution, III-733
III-729 Linearity, V-A654 Lisinopril Tablets, III-734
Lidocaine and Chlorhexidine Gel, Liniments, III-43 Lithium, V-A80
III-730 Linoleic Acid, V-A79 Lithium and Sodium
Lidocaine and Epinephrine Injection, see Linolenic Acid, V-A80 Molybdotungstophosphate Solution,
Lidocaine and Adrenaline Injection Linolenyl Alcohol, V-A80 see Phosphomolybdotugstic Reagent
Lidocaine Cutaneous Solution, Sterile, Linoleoyl Macrogolglycerides, II-113 Lithium Carbonate, II-117, V-A80
III-728 Linoleyl Alcohol, V-A80 Lithium Carbonate Tablets, III-736
Lidocaine Gel, III-726 Linseed, IV-244 Lithium Carbonate Tablets, Prolonged-
Lidocaine Hydrochloride, II-109 Linseed Oil, Virgin, II-114 release, III-736
Lidocaine Injection, III-727 Linsidomine Hydrochloride, V-A80 Lithium Carbonicum, V-A590
Lidocaine Ointment, III-727 Liothyronine Sodium, II-114 Lithium Chloride, V-A80
Lidocaine Solution, Sterile, III-728 Liothyronine Tablets, III-732 Lithium Citrate, II-118
Light Kaolin, II-47, V-A77 Lipase Solvent, V-A80 Lithium Citrate Oral Solution, III-736
Light Kaolin (Natural), II-47 Lipophilic solid dosage forms, Lithium Hydroxide, V-A80
Light Liquid Paraffin, II-501 Dissolution test for, V-A349 Lithium Metaborate, Anhydrous, V-A80
Light Liquid Paraffin Eye Drops, III-930 Lithium Methoxide VS, V-A142
V-A806 Index
Lithium Standard Solution (100 ppm LSIMS (liquid secondary-ion mass Macrogol 400, see Polyethylene Glycol 400
Li), V-A148 spectrometry, fast-ion bombardment Macrogol 1000, see Polyethylene Glycol
Lithium Sulfate, V-A80 ionisation), V-A177 1000
Lithium Sulphate, see Lithium Sulfate Lumiflavine, V-A81 Macrogol 1500, see Polyethylene Glycol
Lithium trifluoromethanesulfonate, Luteolin-7-glucoside, V-A81 1500
V-A80 Lymecycline, II-140 Macrogol Stearate, II-157
Lithium trifluoromethanesulphonate, see Lymecycline Capsules, III-746 Macrogol Stearyl Ether, II-158
Lithium Trifluoromethanesulfonate Lynestrenol, II-142 Macrogolglycerides, Caprylcaproyl, I-390
Litmus, V-A80 Lysate sensitivity, Confirmation of the Macrogolglycerol Hydroxystearate, see
Litmus Paper, V-A80 labelled. Test for bacterial endotoxins, Hydrogenated Polyoxyl Castor Oil
Litmus Paper, Blue, V-A80 V-A391 Macrogolglycerol Ricinoleate, see Polyoxyl
Litmus Paper, Red, V-A80 Lysine Acetate, II-143 Castor Oil
Litmus Solution, V-A80 Lysine Hydrochloride, II-145 Macrogols, II-146
L-Leucine, see Leucine Macroscopical characteristics of Crude
Lo/10 dose, Definition of, I-30, II-30, Drugs, I-17, II-17, III-17, IV-17,
III-30, IV-30, V-30
Lobeline Hydrochloride, II-119
M V-17
Magaldrate, II-159
0.01M Ammonium and Cerium Nitrate,
Lofepramine Hydrochloride, II-120 Magaldrate Oral Suspension, III-748
see Ammonium Cerium(IV) Nitrate VS
Lofepramine Hydrochloride (Form A), Magnesia, Light, II-172
0.1M Ammonium and Cerium Sulfate,
V-S80 Magnesium, V-A81
see Ammonium Cerium(IV) Sulfate VS
Lofepramine Hydrochloride (Form B), Magnesium Acetate, V-A81
0.0167M Bromide-bromate, see Bromine
V-S80 Magnesium Acetate Tetrahydrate, II-160
VS
Lofepramine Tablets, III-736 Magnesium and Alkaline-earth Metals,
0.25M Citrate Buffer Solution pH 3.0,
Loganin, V-A80 Limit Test for, V-A264
V-A152
Lomustine, II-121, V-S81 Magnesium and Magnesium Salts,
M, Definition of, I-7, II-7, III-7, IV-7,
Lomustine Capsules, III-737 Reactions of, V-A257
V-7
Long Pepper, IV-251 Magnesium Aspartate, II-161
0.1M Ferric Ammonium Sulfate, see
Longifolene, V-A80 Magnesium Aspartate Dihydrate, see
Ammonium Iron(III) Sulfate VS
Loosestrife, IV-252 Magnesium Aspartate
0.1M Ferrous Ammonium Sulfate, see
Loperamide Capsules, III-738 Magnesium Carbonate, Heavy, II-162
Ammonium Iron(II) Sulfate VS
Loperamide Hydrochloride, II-123 Magnesium Carbonate Heavy and
0.1M Lanthanum Nitrate VS, V-A142
Loperamide Oxide Monohydrate, II-125 Calcium Carbonate Tablets,
0.2M Phosphate Buffer Solution pH 7.5,
Lopinavir, II-126 Chewable, III-232
see Phosphate buffer pH 7.5, 0.2M
Loprazolam Mesilate, II-130, V-S81 Magnesium Carbonate, Light, II-163
Loprazolam Tablets, III-739 Magnesium Carbonate Mixture,
see Phosphate Buffer pH 7.0, 0.1M
Loratadine, II-131, V-S81 Aromatic, III-748
Mixed
Loratadine Tablets, III-740 Magnesium Carbonate Oral Suspension,
Lorazepam, II-133, V-S82 Aromatic, III-748
V-A154
Lorazepam Injection, III-741 Magnesium Chloride, V-A81
0.05M Tris-hydrochloride Buffer Solution
Lorazepam Tablets, III-742 Magnesium Chloride Hexahydrate,
pH 7.5, see Tris-chloride Buffer pH 7.5
Lormetazepam, II-134, V-S82 II-164
R1
Lormetazepam Tablets, III-743 Magnesium Chloride 4.5-Hydrate, see
1M Tris-hydrochloride Buffer Solution
Losartan, V-S82 Partially Hydrated Magnesium Chloride
pH 8.0, V-A156
Losartan Potassium, II-135 Magnesium Chloride Injection, III-749
Macrogol 20,000 2-Nitrophthalate, see
Losartan Potassium Tablets, III-744 Magnesium Chloride, Partially Hydrated,
Polyethylene Glycol 20,000
Loss on Drying, Definition of II-165
2-Nitroterephthalate
Temperature Range, I-12, II-12, Magnesium Chloride VS, V-A142
Macrogol 200 R1, see Polyethylene Glycol
III-12, IV-12, V-12 Magnesium Citrate, Anhydrous, II-166
200 R1
Loss on Drying, Determination of, Magnesium Citrate Dodecahydrate,
Macrogol 6 Glycerol Caprylocaprate,
V-A296 II-166
II-150
Loss on Drying of Extracts, V-A325 Magnesium Citrate Nonahydrate, II-167
Macrogol 15 Hydroxystearate, II-152
Lotions, III-43 Magnesium Gluconate, II-168
Macrogol 20 Glycerol Monostearate,
Lotions, Powders for, III-43 Magnesium Glycerophosphate, II-169
II-151
Lovage Root, IV-253 Magnesium Glycerophosphate Oral
Macrogol 23 Lauryl Ether, V-A81
Lovastatin, II-138 Solution, III-749
Macrogol 30 Dipolyhydroxystearate,
Low-molecular-mass Heparins, see Low- Magnesium Glycerophosphate Tablets,
II-149
molecular-weight Heparins Chewable, III-750
Macrogol 40 Sorbitol Heptaoleate,
Low-molecular-weight Heparins, I-1105 Magnesium Hydroxide, II-169
II-157
Low-Oxygen Nitrogen, II-389 Magnesium Hydroxide and Aluminium
Macrogol Cetostearyl Ether, II-148
Low-substituted Carmellose Sodium, Hydroxide Tablets, III-383
Macrogol Glycerol Cocoates, II-150
I-413 Magnesium Hydroxide Mixture, III-750
Macrogol Lauryl Ether, II-153
Low-vapour-pressure Hydrocarbons Magnesium Hydroxide Oral Emulsion,
Macrogol Oleate, II-154
(Type L), V-A71, V-A81 Liquid Paraffin and, III-931
Macrogol Oleyl Ether, II-154
Lp/10 dose, Definition of, I-30, II-30, Magnesium Hydroxide Oral Suspension,
Macrogol Poly(vinyl alcohol) Grafted
III-30, IV-30, V-30 III-750
Copolymer, II-155
lr/100 dose, Definition of, I-30, II-30, Magnesium Hydroxide Oral Suspension,
Macrogol 20,000, see Polyethylene Glycol
III-30, IV-30, V-30 Aluminium Hydroxide and, III-382
20,000
L-Serine, see Serine Magnesium Lactate Dihydrate, II-170
Macrogol 200, see Polyethylene Glycol 200
Magnesium, Limit Test for, V-A264
Macrogol 300, see Polyethylene Glycol 300
Magnesium Muriaticum, V-A590
Magnesium Nitrate, V-A81 Maize Starch, Pregelatinised, see Materials Based on Plasticised Poly(Vinyl
Magnesium Nitrate Solution, V-A81 Pregelatinised Starch Chloride) for Containers for Human
Magnesium Nitrate Solution R1, V-A81 Malachite Green, V-A81 Blood and Blood Components,
Magnesium Oxide, V-A81 Malachite Green Solution, V-A81 V-A545
Magnesium Oxide, Heavy, II-171, Malathion, II-180, V-A81 Materials Based on Plasticised Poly(Vinyl
V-A81 Malathion Lotion, III-754 Chloride) for Tubing Used in Sets for
Magnesium Oxide, Light, II-172 Malathion Shampoo, III-754 the Transfusion of Blood and Blood
Magnesium Oxide R1, V-A81 MALDI (Matrix-assisted laser desorption Components, V-A548
Magnesium Peroxide, II-172 ionisation), V-A177 Materials for Containers for Human
Magnesium Pidolate, II-173 Maleate Buffer Solution pH 7.0, V-A153 Blood and Blood Components,
Magnesium Silicate for Pesicide Residue Maleic Acid, II-181, V-A81 V-A545
Analysis, V-A81 Maleic Anhydride, V-A81 Materials for use in the Manufacture of
Magnesium Standard Solution (0.1% Maleic Anhydride Solution, V-A82 Homoeopathic Preparations, V-A764
Mg), V-A148 Malic Acid, II-182, V-A82 Materials Used for the Manufacture of
Magnesium Standard Solution (10 ppm Mallow Flower, IV-257 Containers, V-A545
Mg), V-A148 Mallow Leaf, IV-258 Materials Used in Chromatographic
Magnesium Standard Solution (10 ppm Maltitol, II-183, V-A82 Tests, V-A712
Mg) R1, V-A148 Maltitol, Liquid, II-184 Matricaria Flowers, IV-263
Magnesium Standard Solution (100 ppm Maltodextrin, II-185 Matricaria Flower, see Matricaria Flowers
Mg), V-A148 Maltotriose, V-A82 Matricaria Liquid Extract, IV-267
Magnesium Standard Solution Mandarin Oil, IV-259 Matricaria Oil, IV-264
(1000 ppm Mg), V-A148 Mandelic Acid, V-A82 Matrix-assisted laser desorption
Magnesium Stearate, II-175 Manganese Gluconate, II-186 ionisation (MALDI), V-A177
Magnesium Sulfate, V-A81 Manganese Glycerophosphate, Hydrated, Meadowsweet, IV-268
Magnesium Sulfate, Dried, II-178 II-187 Measles Immunoglobulin, IV-476
Magnesium Sulfate Heptahydrate, II-177 Manganese Standard Solution (100 ppm Measles, Mumps and Rubella Vaccine,
Magnesium Sulfate Injection, III-751 Mn), V-A148 Live, IV-567
Magnesium Sulfate Mixture, III-751 Manganese Standard Solution Measles, Mumps, Rubella and Varicella
Magnesium Sulfate Oral Suspension, (1000 ppm Mn), V-A148 Vaccine (Live), IV-569
III-751 Manganese Sulfate, II-188 Measles Vaccine, Live, IV-566
Magnesium Sulfate Paste, III-752 Manganese Sulfate Monohydrate, II-188 Measles, see Measles Vaccine, Live
Magnesium Sulfate VS, V-A142 Manganese Sulfate, see Manganese(II) Measurement of Consistency by
Magnesium Sulfuricum, V-A590 Sulfate Penetrometry, V-A490
Magnesium Sulphate Heptahydrate, see Manganese Sulphate Monohydrate, see Measures, Expression of Weights and,
Magnesium Sulfate Heptahydrate Manganese Sulfate Monohydrate I-6, II-6, III-6, IV-6, V-6
Magnesium Sulphate Injection, see Manganese Sulphate, see Manganese Mebendazole, II-193, V-A82
Magnesium Sulfate Injection Sulfate Mebeverine, V-S83
Magnesium Sulphate Mixture, see Manganese(II) Sulfate, V-A82 Mebeverine Hydrochloride, II-194,
Magnesium Sulfate Mixture Manganese(II) Sulphate, see V-S83
Magnesium Sulphate Paste, see Manganese(ii) Sulfate Mebeverine Tablets, III-756
Magnesium Sulfate Paste Mannitol, II-189, V-A82 Meclozine Hydrochloride, II-195, V-A82
Magnesium Sulphate VS, see Magnesium Mannitol Infusion, III-755 Medicago Sativa for Homoeopathic
Sulfate VS Mannitol Intravenous Infusion, see Preparations, IV-437
Magnesium Sulphate, see Magnesium Mannitol Infusion Medical Air, I-80
Sulfate Mannitol, see D-Mannitol Medical Air, MRI Compatible, I-80
Magnesium Trisilicate, II-178 D-Mannose, V-A82 Medicated Chewing Gum, Drug Release
Magnesium Trisilicate Mixture, III-752 Mannose, see D-Mannose from, V-A350
Magnesium Trisilicate Mixture, Manufacture of Unlicensed Medicines, Medicated Chewing Gums, III-49
Compound, III-752 V-A753 Medicated Foams, III-47
Magnesium Trisilicate Oral Powder, Maprotiline Hydrochloride, II-191 Medicated Tampons, III-76
Compound, III-753 Marrubiin, V-A82 Medicinal Air, see Medical Air
Magnesium Trisilicate Oral Suspension, Marshmallow Leaf, IV-261 Medicinal Products for Human Use,
III-752 Marshmallow Root, IV-262 Gene Transfer, V-A732
Magnesium Trisilicate Tablets, Martin’s diameter, V-A504 Medicines, Unlicensed, V-A752
Chewable Aluminium Hydroxide and, Mass Spectrometry, V-A176 Medium-chain Triglycerides, II-1098
III-753 Mass Spectrometry, Inductively Coupled Medronic Acid for Radiopharmaceutical
Magnesium Trisilicate Tablets, Plasma-, V-A178 Preparations, IV-643
Chewable Compound, III-753 Mastic, IV-262 Medroxyprogesterone Acetate, II-197,
Magneson, V-A81 Materials Based on Non-plasticised V-S83
Magneson Reagent, V-A81 Poly(Vinyl Chloride) Containers for Medroxyprogesterone Injection, III-756
Magneson Solution, V-A81 Non-injectable, Aqueous Solutions, Medroxyprogesterone Tablets, III-758
Magnetic and electrostatic analysers, V-A550 Mefenamic Acid, II-199, V-S84
V-A177 Materials Based on Non-plasticised Mefenamic Acid Capsules, III-759
Magnolia Officinalis Bark, IV-254 Poly(Vinyl Chloride) for Dry Dosage Mefenamic Acid Tablets, III-760
Magnolia Officinalis Flower, IV-256 Forms for Oral Administration, Mefloquine Hydrochloride, II-200
Magnolol, V-A81 V-A552 Megestrol Acetate, II-202, V-S84
Maize Oil, V-A81 Materials Based on Plasticised Poly(Vinyl Megestrol Tablets, III-760
Maize Oil, Refined, II-179 Chloride) for Containers for Aqueous Meglumine, II-204
Maize Starch, II-911 Solutions for Intravenous Infusion, Meglumine Amidotrizoate Injection,
V-A554 III-761
V-A808 Index
Meglumine Iodipamide Injection, III-762 Mercaptopurine Oral Suspension, Mesityl Oxide, V-A83
Melaleuca Oil, see Tea Tree Oil III-772 Mesna, II-224
Melamine, V-A82 Mercaptopurine Tablets, III-773 Mesterolone, II-226
Melatonin, II-205, V-S84 Mercaptopurine, see 6-Mercaptopurine Mestranol, II-227
Melatonin Capsules, III-762 Mercuric Acetate Solution, see Metacresol, II-228
Melilot, IV-269 Mercury(II) Acetate Solution Metal Catalyst or Metal Reagent
Melissa Leaf Dry Extract, see Lemon Mercuric Acetate, see Mercury(II) Acetate Residues, V-A747
Balm Dry Extract Mercuric Bromide Paper, see Mercury(II) Metamizole Sodium Monohydrate, see
Melissa Leaf, see Lemon Balm Bromide Paper Dipyrone
Meloxicam, II-206, V-S85 Mercuric Bromide, see Mercury(II) Metanil Yellow, V-A83
Meloxicam Tablets, III-764 Bromide Metanil Yellow Solution, V-A83
Melphalan, II-208, V-S85 Mercuric Chloride, II-219 Metaphosphoric Acid, V-A83
Melphalan for Injection, III-766 Mercuric Chloride Solution, see Metaraminol Injection, III-787
Melphalan Injection, III-765 Mercury(II) Chloride Solution Metaraminol Tartrate, II-229
Melphalan Tablets, III-767 Mercuric Chloride, see Mercury(II) Metered-dose Preparations for
Melting Point, V-A235, V-A237, Chloride Inhalation, Pressurised, III-55
V-A238 Mercuric Iodide, see Mercury(II) Iodide Metformin Hydrochloride, II-230, V-S87
Determination by Capillary Method, Mercuric Nitrate, see Mercury(II) Nitrate Metformin Oral Solution, III-787
V-A235 Mercuric Oxide, see Mercury(II) Oxide, Metformin Tablets, III-788
Determination by Instantaneous Yellow Methacrylate Copolymer, Basic
method, V-A237 Mercuric Sulfate Solution, see Mercury(II) Butylated, II-231
Determination by Instrumental Sulfate Solution Methacrylate Copolymer (Type A),
method, V-A238 Mercuric Sulphate Solution, see Mercuric Ammonio, I-155
Melting Point Determination by Open Sulfate Solution Methacrylate Copolymer (Type B),
Capillary method, V-A237 Mercuric Thiocyanate Solution, see Ammonio, I-156
Melting Point, Determination of, Mercury(II) Thiocyanate Solution Methacrylic Acid, V-A84
V-A235 Mercuric Thiocyanate, see Mercury(II) Methacrylic Acid - Ethyl Acrylate
Membership of the European Thiocyanate Copolymer (1:1), II-232
Pharmacopoeia Commission, V-A656 Mercurius Corrosivus, V-A590 Methacrylic Acid - Ethyl Acrylate
MenAC, see Meningococcal Polysaccharide Mercurius Sublimatus Corrosivus, Copolymer (1:1) Dispersion
Vaccine V-A590 30 per cent, II-234
Menadiol Phosphate Injection, III-768 Mercury, V-A83 Methadone, V-S88
Menadiol Phosphate Tablets, III-769 Mercury and Mercury Compounds, Methadone Hydrochloride, II-237
Menadiol Sodium Phosphate, II-210, Reactions of, V-A257 Methadone Hydrochloride Oral
V-S85 Mercury, Nitric Acid Solution of, V-A83 Concentrate, III-790
Menadione, II-211, V-S86, V-A82 Mercury Standard Solution (5 ppm Hg), Methadone Injection, III-789
MenC(conj), see Meningococcal Group C V-A148 Methadone Linctus, III-789
Conjugate Vaccine Mercury Standard Solution Methadone Oral Solution (1 mg per
Meningococcal Group C Conjugate (10 ppm Hg), V-A148 mL), III-789
Vaccine, IV-570 Mercury Standard Solution Methadone Oral Solution, see Methadone
Meningococcal Polysaccharide Vaccine, (100 ppm Hg), V-A148 Linctus
IV-572 Mercury Standard Solution Methadone Tablets, III-791
Menotrophin, II-212 (1000 ppm Hg), V-A148 Methane, V-A84
Menotrophin for Injection, III-769 Mercury(II) Acetate, V-A83 Methane R1, V-A84
Menotrophin Injection, III-769 Mercury(II) Acetate Solution, V-A83 Methanesulfonic Acid, V-A84
Men, see Meningococcal Polysaccharide Mercury(II) Bromide, V-A83 Methanesulfonic Acid, Methanesulfonyl
Vaccine Mercury(II) Bromide Paper, V-A83 Chloride in, V-A289
Menthofuran, V-A82 Mercury(II) Chloride, V-A83 Methanesulfonic Acid, Methanolic,
Menthol, V-A82 Mercury(II) Chloride Solution, V-A83 V-A84
Menthol and Benzoin Inhalation, IV-270 Mercury(II) Iodide, V-A83 Methanesulfonic Acid, Methyl, Ethyl and
Menthol and Benzoin Inhalation Vapour, Mercury(II) Nitrate, V-A83 Isopropyl Methanesulfonate in,
IV-270 Mercury(II) Nitrate VS, V-A142 V-A287
Menthol in Aqueous Cream, see Mercury(II) Oxide, Yellow, V-A83 Methanesulfonyl chloride, V-A84
Levomenthol Cream Mercury(II) Sulfate Solution, V-A83 Methanesulfonyl Chloride in
Menthol, Racemic, see Racementhol Mercury(II) Sulphate Solution, see Methanesulfonic Acid, V-A289
Menthone, V-A82 Mercury(II) Sulfate Solution Methanesulphonic Acid, Methanolic, see
Menthyl Acetate, V-A82 Mercury(II) Thiocyanate, V-A83 Methanesulfonic Acid, Methanolic
Mepivacaine Hydrochloride, II-213 Mercury(II) Thiocyanate Solution, V-A83 Methanesulphonic Acid, see
Meprobamate, II-215 Meropenem Trihydrate, II-219 Methanesulfonic Acid
Meptazinol Hydrochloride, II-215, Mesalazine, II-221, V-S87 Methanesulphonyl chloride, V-A84
V-S86 Mesalazine Enema, III-774 Methanol, II-238, V-S88, V-A84
Meptazinol Injection, III-770 Mesalazine Foam Enema, III-776 Methanol, Acidifed, V-A84
Meptazinol Tablets, III-771 Mesalazine Granules, Prolonged-release, Methanol, Aldehyde-free, V-A84
Mepyramine Maleate, II-217, V-S86 III-778 Methanol and Propan-2-ol,
Mepyramine Tablets, III-771 Mesalazine Rectal Suspension, III-774 Determination of, V-A273
Mercaptoacetic Acid, V-A82 Mesalazine Suppositories, III-780 Methanol, Anhydrous, V-A84
2-Mercaptobenzimidazole, V-A82 Mesalazine Tablets, Gastro-resistant, Methanol, Deuterated, V-A49
2-Mercaptoethanol, V-A83 III-782 Methanol, Hydrochloric, V-A84
Mercaptopurine, II-218, V-S87, V-A83 Mesalazine Tablets, Prolonged-release, Methanol R1, V-A84
III-784 Methanol R2, V-A84
Methanolic Ammonia, V-A25 Methyl Behenate, see Methyl Docosanoate Methyl Salicylate Ointment, Strong,
Methanolic Hydrochloric Acid, V-A72 Methyl Benzenesulfonate, V-A85 III-794
Methanolic Methanesulfonic Acid, Methyl Benzenesulphonate, see Methyl Methyl Stearate, V-A89
V-A84 Benzenesulfonate Methyl Thymol Blue, V-A89
Methanolic Potassium Hydroxide, Methyl Benzoate, V-A85 Methyl Tricosanoate, V-A89
V-A106 Methyl Caprate, see Methyl Decanoate Methyl Tridecanoate, V-A89
Methanolic Sodium Hydroxide, V-A120 Methyl Caproate, V-A86 Methyl 3,4,5-Trimethoxybenzoate,
Methanolic Sodium Hydroxide Solution, Methyl Caprylate, V-A86 V-A89
V-A120 Methyl Cinnamate, V-A86 Methylal, V-A85
Methanolic Sodium Hydroxide Solution Methyl Decanoate, V-A86 4-Methylaminophenol sulfate, V-A85
R1, V-A120 Methyl Docosanoate, V-A86 Methylaminophenol-Sulfite Reagent,
Methanolic Sulfuric Acid, V-A126 Methyl Eicosenoate, V-A86 V-A85
Methanolic Methyl Erucate, V-A86 Methylaminophenol-Sulphite Reagent,
Tris(hydroxymethyl)methylamine Methyl, Ethyl and Isopropyl see Methylaminophenol-Sulfite Reagent
Solution, V-A135 Methanesulfonate in Active Methylamphetamine Hydrochloride,
Methenamine, II-239 Substances, V-A288 V-A85
Methimazole, V-A84 Methyl, Ethyl and Isopropyl Methylated Spirit, Industrial, II-248
Methionine, II-240, V-A84 Methanesulfonate in Methanesulfonic Methylated Spirit (Ketone-free),
DL-Methionine, II-241 Acid, V-A287 Industrial, II-248
11
L-Methionine ([ C]Methyl) Injection, Methyl Ethyl Ketone, see Butan-2-one Methylated Spirits, Industrial, II-248
IV-673 Methyl Green, V-A86 3-Methylbenzothiazolin-2-one hydrazone
Methods and conditions of sterilisation, Methyl Green-Iodomercurate Paper, hydrochloride, V-A85
V-A526 V-A86 Methylbenzothiazolone hydrazone
Methods of Analysis, Monograph Methyl Hydroxybenzoate, II-245, V-A87 hydrochloride, V-A85
Development, V-A651 Methyl Iodide, V-A87 (R)-(þ)-a-Methylbenzyl IsoCyanate,
Methods of Preparation of Methyl Isobutyl Ketone, V-A87 V-A85
Homoeopathic Stocks and Methyl Isobutyl Ketone R1, V-A87 (15R)-15-Methylprostaglandin F2a,
Potentisation, IV-405 Methyl Isobutyl Ketone R3, V-A87 V-A88
Methods of Preparation of Sterile Methyl Isobutyl Ketone R1, see 2-Methylbutane, V-A85
Products - Methods of Sterilisation, 4-Methylpentan-2-one R1 2-Methylbut-2-ene, V-A86
V-A526 Methyl Isobutyl Ketone R3, see 9-[(3-Methylbut-2-enyl)oxy]-7H-
Methods of Sterilisation for Parenteral 4-Methylpentan-2-one R3 furo[3,2-g][1]benzopyran-7-one, see
Preparations, III-66 Methyl Isobutyl Ketone, see Imperatorin
Methods of Sterilisation (Methods of 4-Methylpentan-2-one Methylcellulose, II-248
Preparation of Sterile Products), Methyl Laurate, V-A87 Methylcellulose 450, V-A86
V-A526 Methyl Lignocerate, V-A87 Methylcellulose Granules, III-794
Methotrexate, II-242 Methyl Linoleate, V-A87 Methylcellulose Tablets, III-795
Methotrexate Injection, III-791 Methyl g-linolenate, V-A87 Methyldopa, II-250, V-S89
Methotrexate Tablets, III-792 Methyl Margarate, V-A87 Methyldopa, racemic, V-A86
Methotrimeprazine Hydrochloride, see Methyl Methacrylate, V-A87 Methyldopa Tablets, III-795
Levomepromazine Hydrochloride Methyl Methanesulfonate, V-A87 Methyldopate Hydrochloride, II-252,
Methotrimeprazine Injection, see Methyl Methanesulfonate in V-S90
Levomepromazine Injection Methanesulfonic Acid, see Methyl, Methyldopate Injection, III-796
Methotrimeprazine Maleate, see Ethyl and Isopropyl Methanesulfonate in Methylene blue, V-A86
Levomepromazine Maleate Methanesulfonic Acid Methylene Blue Injection, see
Methotrimeprazine Tablets, see Methyl Myristate, V-A87 Methylthioninium Injection
Levomepromazine Tablets Methyl Nervonate, V-A87 Methylene chloride, V-A86
Methoxamine Hydrochloride, II-244, Methyl Nicotinate, II-246, V-S89 Methylene chloride, acidified, V-A86
V-S89 Methyl N-methylanthranilate, V-A87 Methylene Chloride, Acidified, see
Methoxamine Injection, III-793 Methyl Oleate, V-A87 Dichloromethane, Acidified
Methoxyazobenzene, V-A84 Methyl Orange, V-A87 Methylene Chloride, see Dichloromethane
Methoxychlor, V-A84 Methyl Orange Mixed Solution, V-A88 Methylenebisacrylamide, V-A86
trans-2-Methoxycinnamaldehyde, V-A84 Methyl Orange Solution, V-A88 4,4 0 -Methylenebis-N,N-dimethylaniline,
2-Methoxyethanol, V-A84 Methyl Orange-Xylene Cyanol FF V-A86
7-Methoxy-8-isopentenylcoumarin, see Solution, V-A88 4,4 0 -Methylenebis-N,N-dimethylaniline
Osthole Methyl Palmitate, V-A88 Reagent, V-A86
3-Methoxy-L-tyrosine, V-A85 Methyl Palmitoleate, V-A88 Methylergometrine Maleate, II-252
7-Methoxy-8-(3-methylbut-2-enyl)-2H-1- Methyl Parahydroxybenzoate, V-A88 Methyleugenol, V-A86
benzopyran-2-one, see Osthole Methyl Parahydroxybenzoate, see Methyl N-Methylglucamine, V-A86
1-(6-Methoxynaphthalen-2-yl)ethanone, Hydroxybenzoate Methylhydroxyethylcellulose, see
V-A84 Methyl Pelargonate, V-A88 Hydroxyethylmethylcellulose
6-Methoxy-2-naphthoic acid, V-A85 Methyl Red, V-A88 2-Methylimidazole, V-A87
Methoxyphenylacetic Acid, V-A85 Methyl Red Mixed Solution, V-A89 1-Methylimidazole R1, V-A87
Methoxyphenylacetic Reagent, V-A85 Methyl Red Solution, V-A89 N-Methyl-m-toluidine, V-A89
Methyl Acetate, V-A85 Methyl Salicylate, II-247, V-A89 2-Methyl-1,4-naphthoquinone, V-A87
Methyl 4-acetylbenzoate, V-A85 Methyl Salicylate Cutaneous Emulsion, 2-Methyl-5-nitroimidazole, V-A87
Methyl 4-acetylbenzoate Reagent, V-A85 III-794 2-Methyl-2-nitropropane-1,3-diol, V-A87
Methyl 4-aminobenzoate, V-A85 Methyl Salicylate Liniment, III-794 Methylparaben, see Methyl
Methyl Anthranilate, V-A85 Methyl Salicylate Ointment, III-794 Hydroxybenzoate
Methyl Arachidate, V-A85 2-Methylpentane, V-A88
V-A810 Index
4-Methylpentan-2-ol, V-A88 Metronidazole Suppositories, III-809 Micro-Organisms, Validation of

4-Methylpentan-2-one, V-A88 Metronidazole Tablets, III-810 Alternative Qualitative Tests for the
4-Methylpentan-2-one R1, V-A88 Metyrapone, II-283 Presence or Absence of, V-A722
4-Methylpentan-2-one R3, V-A88 Metyrapone (1), V-S93 Micro-Organisms, Validation of
Methylpentoses in Polysaccharide Metyrapone (2), V-S93 Alternative Quantitative Tests for the
Vaccines, V-A450 Metyrapone Capsules, III-810 Presence or Absence of, V-A723
4-Methylphenazone, V-A88 Mexenone, II-283, V-S93 Microscopic Examination of Herbal
Methylphenidate Hydrochloride, II-254 Mexenone Cream, III-811 Drugs, V-A331
Methylphenobarbital, II-255, V-S90 Mexiletine Capsules, III-811 Microscopic particle count test, V-A380
Methylphenobarbital Tablets, III-796 Mexiletine Hydrochloride, II-284, V-S94 Microscopy, optical, V-A503
Methylphenyloxazolybenzene, V-A88 Mexiletine Injection, III-812 MID, V-A608
1-Methyl-4-phenyl-1,2,3,6- Mianserin Hydrochloride, II-285, V-S94 Midazolam, II-291, V-S94
tetrahydropyridine, V-A88 Mianserin Tablets, III-812 Midazolam Injection, III-819
Methylpiperazine, V-A88 Mice, I-15, II-15, III-15, IV-15, V-15 Midazolam Oral Solution, III-819
Methylpiperazine, see N-Methylpiperazine Miconazole, II-287 Midazolam Oromucosal Solution,
4-(4-Methylpiperidin-1-yl)pyridine, Miconazole and Hydrocortisone Acetate III-820
V-A88 Cream, III-817 Mie theory, V-A504
Methylprednisolone, II-257, V-S90 Miconazole and Hydrocortisone Cream, Milk Thistle Dry Extract, Refined and
Methylprednisolone Acetate, II-259, III-814 Standardised, IV-272
V-S91 Miconazole and Hydrocortisone Milk-thistle Fruit, IV-271
Methylprednisolone Acetate Injection, Ointment, III-816 MIM, Multiple-ion monitoring, V-A178
III-798 Miconazole Cream, III-813 Minimising the Risk of Transmitting
Methylprednisolone Hydrogen Succinate, Miconazole Nitrate, II-289 Animal Spongiform Encephalopathy
II-261 Miconazole Oromucosal Gel, III-814 Agents Via Human and Veterinary
Methylprednisolone Tablets, III-797 Micro Determination of Water, see Medicinal Products, V-A592
2-Methylpropanol, V-A88 Determination of Water, Method III Minocycline Capsules, Prolonged-release,
2-Methylpropanol, see 2-Methylpropan Microbial Contamination, V-A636 III-821
-1-ol Microbial Contamination, Minocycline Hydrochloride, V-A89
Methylpyrrolidone, II-263 Supplementary Information, V-A636 Minocycline Hydrochloride Dihydrate,
N-Methylpyrrolidone, see Microbial Quality of Pharmaceutical II-294
Methylpyrrolidone Preparations, V-A637 Minocycline Hydrochloride, see
Methylrosanilinium Chloride, II-264 Microbiological Assay of Antibiotics, Minocycline Hydrochloride Dihydrate
Methylsilyl Silica Gel for V-A382, V-A634 Minocycline Tablets, III-822
Chromatography, V-A114 Microbiological Control of Cellular Minoxidil, II-295, V-S95
Methyltestosterone, II-266 Products, V-A479 Minoxidil Scalp Application, III-824
5-Methylthiazol-2-ylamine, V-A89 Microbiological Enumeration Tests, Minoxidil Scalp Cutaneous Solution,
Methylthioninium Chloride, II-267 Microbiological Examination of Non- III-824
Methylthioninium Injection, III-799 Sterile Products, V-A466 Mint Oil, Dementholised, IV-273
Methylthymol Blue, V-A89 Microbiological Examination of Herbal Mint Oil, Partly Dementholised, see
Methylthymol Blue Mixture, V-A89 Medicinal Products for Oral Use, Dementholised Mint Oil
N-Methyltrimethylsilyl- V-A480 Mirtazapine, II-297, V-S95
trifluoroacetamide, V-A89 Microbiological Examination of Non- Mirtazapine Oral Solution, III-825
Methysergide Maleate, II-269, V-S91 Sterile Products, V-A461 Mirtazapine Tablets, III-825
Methysergide Tablets, III-799 Microbiological Quality, Alternative Mirtazapine Tablets, Orodispersible,
Metipranolol, II-269, V-S91 Methods for Control of, V-A716 III-827
Metipranolol Eye Drops, III-800 Microbiological Quality of Herbal Misoprostol, II-298
Metixene Hydrochloride, II-270 Medicinal Products for Oral Use, Mitobronitol, II-300, V-S95
Metoclopramide, II-271 V-A481 Mitobronitol Tablets, III-828
Metoclopramide Hydrochloride, II-273 Microbiological Quality of Non-sterile Mitomycin, II-300
Metoclopramide Injection, III-801 Pharmaceutical Preparations and Mitoxantrone Concentrate, Sterile,
Metoclopramide Oral Solution, III-802 Substances for Pharmaceutical Use, III-829
Metoclopramide Tablets, III-803 V-A478 Mitoxantrone Hydrochloride, II-302
Metolazone, II-274 Microcrystalline Cellulose, I-468 Mitoxantrone Infusion, III-829
Metoprolol, V-S92 Microcrystalline Cellulose and Mitoxantrone Intravenous Infusion,
Metoprolol Injection, III-804 Carmellose Sodium, I-472 III-829
Metoprolol Succinate, II-275 Microcrystalline Cellulose, see Cellulose Mitozantrone Hydrochloride, see
Metoprolol Tartrate, II-277 for chromatography R1 Mitoxantrone Hydrochloride
Metoprolol Tartrate Tablets, III-805 Microfine Powder, Definition of, V-A483 Mitozantrone Intravenous Infusion, see
Metoprolol Tartrate Tablets, Prolonged- Microkatal, Definition of, I-32, II-32, Mitoxantrone Intravenous Infusion
release, III-806 III-32, IV-32, V-32, V-A632 Mixed Gas-gangrene Antitoxin, IV-500
Metre, Definition of, I-32, II-32, III-32, Micro-organisms, Cell component Mixed Phosphate Buffer pH 6.8, 0.2M,
IV-32, V-32 analysis methods for the detection of, V-A153
Metrifonate, II-279 V-A720 Mixed Phosphate Buffer pH 5.4, V-A153
Metronidazole, II-280, V-S92 Micro-organisms, Direct Measurement Mixed Phosphate Buffer pH 4.0, V-A153
Metronidazole Benzoate, II-281, V-S92 methods for the detection of, V-A719 Mixed Phosphate Buffer pH 6.8, V-A153
Metronidazole Gel, III-807 Micro-Organisms, Qualitative Tests for Mixed Phosphate Buffer pH 7.0, V-A153
Metronidazole Infusion, III-808 the Presence or Absence of, V-A717 Mixed Phosphate Buffer pH 10, V-A153
Metronidazole Intravenous Infusion, see Micro-Organisms, Quantitative Tests for Mixtures, III-58
Metronidazole Infusion Enumeration of, V-A717 MLD, V-A608
Metronidazole Oral Suspension, III-809
MMR, see Measles, Mumps and Rubella Morphine and Atropine Injection,
Vaccine, Live III-835 N
MMRVar, see Measles, Mumps, Rubella Morphine, Anhydrous, V-A89 Nabumetone, II-327, V-S97
and Varicella Vaccine (Live) Morphine Hydochloride, V-A89 Nabumetone Oral Suspension, III-841
Mobile phases, Liquid Chromatography, Morphine Hydrochloride, II-314 Nabumetone Tablets, III-842
V-A199 Morphine Oral Suspension, Kaolin and, Nadolol, II-328
Modafinil, II-303 see Kaolin and Morphine Mixture Nadroparin Calcium, II-330
Moderately Coarse Powder, Definition Morphine Sulfate, II-316 Naftidrofuryl, V-S97
of, V-A483 Morphine Sulfate Injection, III-835 Naftidrofuryl Capsules, III-843
Moderately Fine Powder, Definition of, Morphine Sulphate Injection, see Naftidrofuryl Hydrogen Oxalate, see
V-A483 Morphine Sulfate Injection Naftidrofuryl Oxalate
Modified b-Cyclodextrin for Chiral Morphine Sulphate, see Morphine Sulfate Naftidrofuryl Oxalate, II-332
Chromatography R1, V-A48 Morphine Suppositories, III-833 Nalidixic Acid, II-334, V-S98
Molar ellipticity, V-A247 Morphine Tablets, III-833 Nalidixic Acid Oral Suspension, III-843
Molarity, Definition of, I-7, II-7, III-7, Morphine Tablets, Prolonged-release, Nalidixic Acid Tablets, III-844
IV-7, V-7, V-A139 III-834 Nalorphine Hydrochloride, V-A90
Mole, Definition of, I-32, II-32, III-32, Morphine Tincture, Chloroform and, Naloxone Hydrochloride, II-335
IV-32, V-32 III-291 Naloxone Hydrochloride Dihydrate, see
Molecular Formula, Status of, I-4, II-4, Morpholine, V-A89 Naloxone Hydrochloride
III-4, IV-4, V-4 Morpholine for Chromatography, V-A90 Naloxone Injection, III-844
Molecular Mass Distribution in Mother Tinctures for Homoeopathic Naloxone Injection, Neonatal, III-845
Dextrans, V-A197 Preparations, IV-415 Naltrexone Hydrochloride, II-338
Molecular Sieve, V-A89 Motherwort, IV-275 Names of Medicinal Substances and
Molecular Sieve for Chromatography, Moxifloxacin Hydrochloride, II-318 Preparations, V-A639
V-A89 Moxisylyte Hydrochloride, II-319, V-S96 Names, Symbols and Atomic Weights of
Molecular Weight, Status of, I-4, II-4, Moxisylyte Tablets, III-836 Elements, V-A609
III-4, IV-4, V-4 Moxonidine, II-320 Nandrolone Decanoate, II-339, V-S98
Molgramostim Concentrated Solution, MRI, V-A608 Nandrolone Decanoate Injection, III-846
II-305 MRM (Multiple Reaction Monitoring), Nandrolone Phenylpropionate, II-341,
Molsidomine, II-308 Fragmentometric double mass V-S99
Molybdenum(VI) Oxide, V-A89 spectrometry mode, V-A178 Nandrolone Phenylpropionate Injection,
Molybdovanadic Reagent, V-A89 Mucic Acid, V-S96 III-846
Mometasone Aqueous Nasal Spray, Mullein Flower, IV-276 Naphazoline Hydrochloride, II-342
III-831 Multidose Container, V-A530 Naphazoline Nitrate, II-343
Mometasone Cream, III-830 Multiple-ion monitoring (MIM), V-A178 Naphthalene, V-A90
Mometasone Cutaneous Suspension, see Mumps Vaccine, Live, IV-574 Naphthalene-2,7-diol, V-A90
Mometasone Scalp Application Mumps, see Mumps Vaccine, Live Naphthalenediol Reagent Solution,
Mometasone Furoate, II-310 Mupirocin, II-321, V-S97 V-A90
Mometasone Ointment, III-832 Mupirocin Calcium, II-323 Naphthalenediol Solution, V-A90
Mometasone Scalp Application, III-830 Mupirocin Cream, III-837 Naphtharson, V-A90
Monoclonal Antibodies for Human Use, Mupirocin Nasal Ointment, III-839 Naphtharson Solution, V-A90
IV-487 Mupirocin Ointment, III-840 1-Naphthol, V-A90
Monocyte-Activation Test, V-A396 Murexide, V-A90 2-Naphthol Solution, V-A91
Monodocosahexaenoin, V-A89 Mustine Hydrochloride for Injection, see b-Naphthol Solution R1, V-A90
Monoethanolamine, see Ethanolamine Chlormethine Hydrochloride for Injection 1-Naphthol Solution, Strong, V-A91
Monofilament Sutures, Sterile Synthetic Mustine Hydrochloride, see Chlormethine a-Naphthol Solution, see 1-Naphthol
Absorbable, IV-724 Hydrochloride Solution
Monograph Development, V-A648, Mustine Injection, see Chlormethine Naphthol Yellow, V-A91
V-A649 Injection Naphthol Yellow S, V-A91
Mechanism, V-A648 Mycobacteria, V-A475 1-Naphtholbenzein, V-A91
Monograph Revisions, I-xxiii Mycobacteria, Test for, V-A637 1-Naphtholbenzein Solution, V-A91
Monograph Selection, Unlicensed Mycophenolate Mofetil, II-325 Naphtholbenzein Solution, see
Medicines, V-A754 Mycoplasmas, Test for, V-A637 1-Naphtholbenzein Solution
Monograph Titles, Changes in, V-A639 Mycoplasmas, Test for Absence of, Naphtholbenzein, see 1-Naphtholbenzein
Monograph Titles for Formulated V-A470 b-Naphthol, see 2-Naphthol
Preparations, V-A639 Mycotoxins in Herbal Drugs, 2-Naphthylacetic Acid, V-A91
Monographs, V-A579 Determination of, V-A327 1-Naphthylamine, V-A91
Abbreviated Titles of, V-A579 myo-Inositol, I-1178, V-A74 Naphthylamine, see 1-Naphthylamine
Monolithic Octadecylsilyl Silica Gel for Myosmine, V-A90 N-(1-Naphthyl)ethylenediamine
Chromatography, V-A114 b-Myrcene, V-A90 Dihydrochloride, V-A91
Montelukast Sodium, II-311 Myristic Acid, V-A90 Naphthylethylenediamine
Mordant Black 11, V-A89 Myristicine, V-A90 Dihydrochloride Solution, V-A91
Mordant Black 11 Solution, V-A89 Myristyl Alcohol, V-A90 Naphthylethylenediamine
Mordant Black 11 Triturate, V-A89 Myrrh, IV-277 Dihydrochloride, see N-
Mordant black 11 triturate R1, V-A89 Myrrh Tincture, IV-278 (1-Naphthyl)ethylenediamine
Mordant Black 11 Mixed Triturate, Myrtillin, V-A90 Dihydrochloride
V-A89 Naproxen, II-344, V-S99
Mordant Blue 3, V-A89 Naproxen Oral Suspension, III-847
Morison’s Paste, III-752 Naproxen Sodium, II-347
Morphine, V-S96 Naproxen Suppositories, III-847
V-A812 Index
Naproxen Tablets, III-848 Neomycin Tablets, III-852 Nicotinamide-adenine Dinucleotide,

Naproxen Tablets, Gastro-resistant, Neonatal Naloxone Injection, III-845 V-A92
III-849 Neostigmine Bromide, II-354 Nicotinamide-adenine Dinucleotide
Naringin, V-A91 Neostigmine Injection, III-853 Solution, V-A92
Narrow-leaved Coneflower Root, see Neostigmine Metilsulfate, II-355 Nicotine, II-366, V-S101
Echinacea Angustifolia Root Neostigmine Tablets, III-854 Nicotine Ditartrate Dihydrate, II-367
Nasal, III-60 Nephelometry, V-A231 Nicotine Inhalation Cartridges, III-857
Drops, III-60 Neroli Oil, IV-280 Nicotine Nasal Spray, III-858
Spray, III-60 trans-Nerolidol, V-A91 Nicotine Resinate, II-368
Nasal Preparations, III-58 Neryl Acetate, V-A91 Nicotine Resinate Medicated Chewing
Nasal Preparations of the BP, III-60 Nessler Cylinders, V-A259 Gum, III-862
Nateglinide, II-348 Netilmicin Sulfate, II-356 Nicotine Sublingual Tablets, III-859
Natrium Carbonicum, V-A590 Netilmicin Sulphate, see Netilmicin Sulfate Nicotine Transdermal Patches, III-861
Natrium Muriaticum, V-A590 Nettle, Common Stinging, for Nicotinic Acid, II-370, V-A92
Natrium Sulfuricum, V-A590 Homoeopathic Preparations, IV-439 Nicotinic Acid Tablets, III-864
Natural Camphor, I-385 Nettle Leaf, IV-281 Nicotinyl Alcohol Tablets, III-864
Natural Light Kaolin, II-47 Neurovirulence, V-A447 Nicotinyl Alcohol Tartrate, II-372
Natural Vitamin A Ester Concentrate, Neurovirulence of live virus vaccines, Nicoumalone Tablets, see Acenocoumarol
II-1161 Test for, V-A447 Tablets
NCIMB, V-A608 Neurovirulence of poliomyelitis vaccine Nicoumalone, see Acenocoumarol
NCIMB - National Collection of (oral), Test for, V-A448 Nifedipine, II-373, V-S101
Industrial and Marine Bacteria, Neutral Adrenaline Eye Drops/Neutral Nifedipine Capsules, III-864
address of, I-31, II-31, III-31, IV-31, Epinephrine Eye Drops, III-102 Nifedipine Capsules, Prolonged-release,
V-31 Neutral Aluminium Oxide, V-A23 III-865
NCPF, V-A608 Neutral glass, V-A530 Nifedipine Tablets, Prolonged-release,
NCPF - National Collection of Neutral Insulin Injection, see Insulin III-867
Pathogenic Fungi, address of, I-31, Injection Niflumic Acid, II-374
II-31, III-31, IV-31, V-31 Neutral Insulin, see Insulin Injection Nifuroxazide, II-376
NCTC, V-A608 Neutral Red, V-A91 Nikethamide, II-377, V-S101
NCTC - National Collection of Type Neutral Red Solution, V-A91 Nikethamide Injection, III-868
Cultures, address of, I-31, II-31, Nevirapine Hemihydrate, II-358 Nile Blue A, V-A92
III-31, IV-31, V-31 Nevirapine, see Anhydrous Nevirapine Nile Blue A Solution, V-A92
NCYC, V-A608 Niaouli Oil, Cineole Type, IV-278 Nilutamide, II-378
NCYC - National Collection of Yeast Nicergoline, II-360 Nimba Leaf, see Azadirachta Indica Leaf
Cultures, address of, I-31, II-31, Nickel Chloride Solution, Ammoniacal, Nimesulide, II-379
III-31, IV-31, V-31 V-A92 Nimodipine, II-381
N,N-Diethylaniline, V-A53 Nickel Chloride, see Nickel(II) Chloride Nimodipine Infusion, III-868
N,N-Diethyl-p-phenylenediamine Nickel in Hydrogenated Vegetable Oils, Nimodipine Intravenous Infusion, see
Sulphate, see N,N-Diethyl-p- V-A286 Nimodipine Infusion,
phenylenediamine Sulfate Nickel in Polyols, Limit Test for, Nimodipine Tablets, III-869
N,N-Dimethylaniline, V-A55 V-A265 Ninhydrin, V-A92
N,N-Dimethylformamide dimethylacetal, Nickel Liposoluble Standard Solution Ninhydrin and Stannous Chloride
V-A56 (1000 ppm Ni), V-A148 Reagent, V-A92
N,N-Dimethyloctylamine, V-A56 Nickel Nitrate Hexahydrate, V-A92 Ninhydrin and Stannous Chloride
N,N-Dimethylpiperazine, V-A56 Nickel Standard Solution (0.1 ppm Ni), Reagent R1, V-A92
N,N-Dimethyl-p-nitrosoaniline, V-A56 V-A148 Ninhydrin Reagent I, V-A92
N,N-Dimethyl-p-phenylenediamine Nickel Standard Solution (0.2 ppm Ni), Ninhydrin Solution, V-A92
Dihydrochloride, V-A56 V-A148 Ninhydrin Solution R1, V-A92
N,N-Dimethyltetradecylamine, V-A56 Nickel Standard Solution (5 ppm Ni), Ninhydrin Solution R2, V-A92
N,N-Diphenylbenzidine, V-A58 V-A148 Ninhydrin Solution R3, V-A92
Near-infrared spectrophotometry, Nickel Standard Solution (10 ppm Ni), Ninhydrin Solution R4, V-A92
V-A160 V-A148 NIR, see Near-infrared spectrophotometry
Neohesperidin, V-A91 Nickel Sulfate, see Nickel(II) Sulfate N-Isobutyldodecatetraenamide, V-A76
Neohesperidin-Dihydrochalcone, II-351 Nickel Sulphate, see Nickel Sulfate N-Isobutyldodecatetraenamide Solution,
Neomycin Cream, Hydrocortisone and, Nickel-Aluminium Alloy, V-A91 V-A76
III-633 Nickel-Aluminium Alloy (Halogen-free), Nitrate Standard Solution (2 ppm NO3),
Neomycin Ear Drops, Hydrocortisone V-A91 V-A148
Acetate and, III-635 Nickel(II) Chloride, V-A92 Nitrate Standard Solution (10 ppm
Neomycin Ear Drops, Hydrocortisone Nickel(II) Chloride Hexahydrate, V-A92 NO3), V-A148
and, III-635 Nickel(II) Sulfate, V-A92 Nitrate Standard Solution (100 ppm
Neomycin Ear Spray, Dexamethasone Nickel(II) Sulphate, see Nickel(II)Sulfate NO3), V-A148
and, III-418 Niclosamide, V-S100 Nitrate-free Water, V-A137
Neomycin Eye Drops, III-850 Niclosamide, Anhdrous, II-362 Nitrates, Reactions of, V-A257
Neomycin Eye Drops, Hydrocortisone Niclosamide Monohydrate, II-363 Nitrazepam, II-382, V-A92
Acetate and, III-635 Niclosamide Tablets, III-854 Nitrazepam Oral Suspension, III-871
Neomycin Eye Ointment, III-851 Niclosamide, see Anhydrous Niclosamide Nitrazepam Tablets, III-871
Neomycin Eye Ointment, Nicorandil, II-364, V-S100 Nitrendipine, II-383
Hydrocortisone Acetate and, III-636 Nicorandil Tablets, III-855 Nitric Acid, II-385, V-A92
Neomycin Sulfate, II-352 Nicotinamide, II-365, V-S100 Nitric Acid, Cadmium- and Lead-free,
Neomycin Sulphate, see Neomycin Sulfate Nicotinamide Tablets, III-857 V-A93
Nitric Acid, Dilute, V-A93 Nitrosodipropylamine Solution, V-A94 Normal Immunoglobulin Injection, see
Nitric acid, Dilute R1, V-A93 Nitrotetrazolium Blue, V-A94 Normal Immunoglobulin
Nitric acid, dilute R2, V-A93 Nitrous Oxide, II-390, V-A94 Noroxymorphone, V-A95
Nitric Acid, Fuming, V-A93 Nitrous Oxide in Gases, Determination Norpseudoephedrine Hydrochloride,
Nitric Acid, Heavy Metal-free, V-A93 of, V-A299 V-A95
Nitric Acid, Lead-free, V-A93 Nitro-vanado-molybdic Reagent, V-A94 Nortriptyline Capsules, III-879
Nitric Acid, Lead-free, Dilute, V-A93 Nizatidine, II-391, V-S102 Nortriptyline Hydrochloride, II-412
Nitric Acid, Lead-free R1, V-A93 Nizatidine Infusion, III-873 Nortriptyline Tablets, III-880
Nitric Acid Solution of Mercury, V-A83 Nizatidine Intravenous Infusion, see Noscapine, II-414
Nitric Acid VS, V-A142 Nizatidine Infusion, Noscapine Hydrochloride, II-415, V-A95
Nitric Oxide, II-385 Nizatidine Sterile Concentrate, III-873 Notices, I-ix, II-vii, III-vii, IV-vii, V-vii
Nitrile Silica Gel for Chromatography, N-Methylpyrrolidine, V-A88 Notices, General, I-1, II-1, III-1, IV-1,
V-A114 N-Methylpyrrolidone, V-A88 V-1
Nitrile Silica Gel for Chromatography NMR, see Nuclear Magnetic Resonance Notoginseng Root, IV-283
R1, V-A115 Spectrometry Nov/Ser, see Gas-gangrene Antitoxin
Nitrile Silica Gel for Chromatography N,N-Diethylethane-1,2-diamine, see (Novyi)
R2, V-A115 N,N-Diethylenediamine Nuclear Magnetic Resonance
Nitrilotriacetic Acid, V-A93 N,N-Diethylethylenediamine, V-A53 Spectrometry, V-A166
Nitrite Standard Solution (20 ppm N,N-Diethyl-p-phenylenediamine Nuclear Magnetic Resonance
NO2), V-A148 Sulfate, V-A53 Spectrometry NMR in the Solid State,
4-Nitroaniline, V-A93 N,N-Dimethylaniline, Determination of, V-A169
Nitroaniline Solution, Diazotised, V-A93 V-A282 Nuclear Magnetic Resonance
Nitroaniline, see 4-Nitroaniline N,N-Dimethyldodecylamine N-oxide, Spectrometry NMR of samples in
2-Nitrobenzaldehyde, V-A93 V-A55 solution, V-A168
Nitrobenzaldehyde Paper, V-A93 N,N-Dimethyl-L-phenylalanine, V-A56 Nuclear Magnetic Resonance
Nitrobenzaldehyde Solution, V-A93 N-Nitrosodiisopropanolamine, V-A94 Spectrometry Optimisation of
Nitrobenzaldehyde, see N,N,N,N-Tetramethyl-p- acquisition and processing parameters
2-Nitrobenzaldehyde phenylenediamine Dihydrochloride, for quantitative purposes, V-A167
Nitrobenzene, V-A93 V-A129 Nuclear Magnetic Resonance
4-Nitrobenzoic Acid, V-A93 Nomegestrol Acetate, II-394 Spectrometry Qualitative Analaysis,
Nitrobenzoyl Chloride, V-A94 Non-absorbable Sutures, Sterile, IV-726 V-A168
4-Nitrobenzyl Bromide, V-A94 Non-aqueous Titration, V-A267 Nuclear Magnetic Resonance
4-Nitrobenzyl Chloride, V-A94 Non-ionic Emulsifying Wax, see Spectrometry Quantitative Analysis,
Nitrobenzyl Chloride, see 4-Nitrobenzyl Cetomacrogol Emulsifying Wax V-A169
Chloride Nonivamide, V-A94 Nucleated Cell Count and Viability,
4-(4-Nitrobenzyl)pyridine, V-A94 Nonoxinol 9, II-395 V-A444
Nitrochromic Reagent, V-A94 Nonylamine, V-A95 Nucleic acid amplification, branched
Nitroethane, V-A94 Noradrenaline Acid Tartrate, II-395, deoxyribonucleic acid (bDNA),
2-Nitroethanol, V-A94 V-A95 V-A434
Nitrofural, see Nitrofurazone Noradrenaline Concentrate, Sterile, Nucleic acid amplification, isothermal
Nitrofurantoin, II-386, V-A94 III-875 ribonucleic acid (RNA) amplification,
Nitrofurantoin Oral Suspension, III-872 Noradrenaline Hydrochloride, II-397 V-A434
Nitrofurantoin Tablets, III-873 Noradrenaline Injection, III-874 Nucleic acid amplification, ligase chain
Nitrofurazone, II-387 Noradrenaline Tartrate, see Noradrenaline reaction (LCR), V-A434
(5-Nitro-2-furyl)methylene Diacetate, Acid Tartrate Nucleic acid amplification, polymerase
V-A94 Nordazepam, V-A95 chain reaction (PCR), V-A434
Nitrogen, II-388, V-A94 Norepinephrine Acid Tartrate, II-395 Nucleic acid amplification techniques,
Nitrogen, Determination of, V-A274 Norepinephrine Concentrate, Sterile, V-A434
Nitrogen Dioxide, V-A94 III-875 Nucleic Acids in Polysaccharide
Nitrogen for Chromatography, V-A94 Norepinephrine Hydrochloride, II-397 Vaccines, V-A449
Nitrogen Gas Mixture, V-A94 Norepinephrine Injection, III-874 Numeration of CD34/CD45þ Cells in
Nitrogen, Low-Oxygen, II-389 Norethisterone, II-399 Haematopoietic Products, V-A441
Nitrogen Monoxide, V-A94 Norethisterone Acetate, II-400 Nutmeg Oil, IV-284
Nitrogen Monoxide and Nitrogen Norethisterone Acetate Tablets, Estradiol Nystatin, II-416
Dioxide in Medicinal Gases, and, III-515 Nystatin Ointment, III-881
Determination of, V-A298 Norethisterone Tablets, III-876 Nystatin Oral Drops, III-881
Nitrogen, Oxygen-free, V-A94 Norethisterone Tablets, Estradiol and, Nystatin Oral Suspension, III-881
Nitrogen R1, V-A94 III-514 Nystatin Pastilles, III-881
Nitrogen-free Sulfuric Acid, V-A126 Norfloxacin, II-402 Nystatin Pessaries, III-882
Nitroglycerin Tablets, see Glyceryl Norfloxacin Eye Drops, III-877 Nystatin Tablets, III-882
Trinitrate Tablets Norfloxacin Tablets, III-877
Nitromethane, V-A94 Norflurane, II-404
Nitro-molybdovanadic Reagent, see Nitro-
vanado-molybdic Reagent
Norgestimate, II-410
Norgestrel, II-411
O
Oak Bark, IV-285
4-Nitrophenol, V-A94 Norgestrel Tablets, III-878
N,O-Bis(trimethylsilyl)acetamide, V-A33
4-Nitrophenylcarbamidesilyl Silica Gel DL-Norleucine, V-A95
Ochratoxin A in Herbal Drugs,
for Chromatography, V-A114 Normal Immunoglobulin, IV-469
Determination of, V-A329
3-Nitrosalicylic Acid, V-A94 Normal Immunoglobulin for Intravenous
Ochratoxin A Solution, V-A95
N-Nitrosodiethanolamine, V-A94 Use, IV-471
o-Coumaric Acid, V-A46
Nitrosodipropylamine, V-A94
V-A814 Index
Octadecan-1-ol, V-A95 Oleyl Alcohol, II-426, V-A96 Oracet Blue B Solution, V-A96
Octadecanoylaminopropylsilyl Silica Gel Olive Leaf, IV-285 Oracet Blue Solution, Dimethyl Yellow
for Chromatography, V-A114 Olive Leaf Dry Extract, IV-287 and, V-A56
Octadecyl [3-[3,5-bis(1,1-dimethylethyl)- Olive Oil, V-A96 Oral, III-58
4-hydroxyphenyl]-propionate], V-A95 Olive Oil Ear Drops, III-882 Emulsions, III-58
Octadecylsilyl Amorphous Organosilica Olive Oil, Refined, II-427 Oral Liquids, III-56
Polymer, V-A96 Olive Oil Substrate Emulsion, V-A96 Oral Liquids, Bioequivalence of, V-A755
Octadecylsilyl Amorphous Organosilica Olive Oil, Virgin, II-427 Oral Liquids of the BP, III-58
Polymer, End-capped Polar- Olive Oil, see Virgin Olive Oil Oral Liquids, Preservative-free, V-A754
embedded, V-A96 Olmesartan Medoxomil, II-429 Oral Liquids, Unlicensed, III-78
Octadecylsilyl Silica Gel for Olsalazine Sodium, II-430 Oral Powders, III-66
Chromatography, V-A114 Omega-3-Acid Ethyl Esters 60, II-433 Oral Rehydration Salts, III-891
Octadecylsilyl Silica Gel for Omega-3-Acid Ethyl Esters 90, II-435 Oral Suspensions, Unlicensed, III-78
Chromatography R1, V-A116 Omega-3-Acid Triglycerides, see Omega- Oral Use, Liquid Preparations for, III-56
Octadecylsilyl Silica Gel for 3-Marine Triglycerides Orange Oil, IV-295
Chromatography R2, V-A116 Omega-3-acids, Composition of Fatty Orange Oil, Sweet, IV-295
Octadecylsilyl Vinyl Polymer for Acids in Oils Rich in, V-A313 Orange Oil, Terpeneless, IV-297
Chromatography, V-A137 Omega-3-Acids, Fish Oil, Rich in, I-943 Orange Peel Infusion, IV-298
Octanal, V-A95 Omega-3-acids, Total Cholesterol in Oils Orange Peel Infusion, Concentrated,
n-Octane, V-A95 Rich in, V-A315 IV-298
Octanoic Acid, II-417, V-A95 Omega-3-Marine Triglycerides, II-437 Orange Spirit, Compound, IV-297
Octan-2-ol, V-A95 Omeprazole, II-439 Orange Syrup, IV-299
Octan-1-ol, see Octanol Omeprazole Capsules, Gastro-resistant, Orange Tincture, IV-299
3-Octanone, V-A95 III-883 Orcinol, V-A96
Octoxinol 10, II-418, V-A95 Omeprazole Magnesium, II-440 Orciprenaline Oral Solution, III-892
Octreotide Acetate, V-A95 Omeprazole Oral Suspension, III-885 Orciprenaline Sulfate, II-446
Octyl Gallate, II-419 Omeprazole Sodium, II-442 Orciprenaline Sulphate, see Orciprenaline
Octylamine, V-A95 Omeprazole Tablets, Gastro-resistant, Sulfate
Octylamine Phosphate Buffer pH 3.0, III-887 Orciprenaline Tablets, III-893
V-A153 4-O-Methyldopamine hydrochloride, Oregano, IV-299
Octyldodecanol, II-420 V-A86 Organ Preservation Solutions, III-894
Octylsilyl Silica Gel for Chromatography, 3-O-Methylestrone, V-A86 Organosilica Polymer, Amorphous,
V-A115 Omissions, I-xxiii Octadecylsilyl, V-A96
Octylsilyl Silica Gel for Chromatography Omissions, List of, I-xxx Organosilica Polymer, Amorphous,
R1, V-A116 Ondansetron, V-S102 Octadecylsilyl, End-capped, V-A96
Octylsilyl Silica Gel for Chromatography Ondansetron Hydrochloride, V-S102 Organosilica Polymer, Amorphous,
R2, V-A116 Ondansetron Hydrochloride Dihydrate, Polar-embedded Octadecylsilyl, End-
Octylsilyl Silica Gel for Chromatography II-444 capped, V-A96
R3, V-A116 Ondansetron Injection, III-888 Organosilica Polymer, Amorphous,
3-O-Desacyl-4’-Monophosphoryl Lipid Ondansetron Tablets, III-889 Propyl-2-phenylsilyl, End-capped,
A, I-676 Opacity, Standard Preparation of, V-A96
Odour, V-A258 V-A157 Organosilica Polymer for Mass
Odour and Taste of Essential Oils, Opalescence, Instrumental Spectrometry, Amorphous,
V-A308 Determination of, V-A232 Octadecylsilyl, End-capped, V-A96
Oestrogens, Conjugated, see Conjugated o,p-DDT, V-A49 Oriental Cashew for Homoeopathic
Estrogens Opiate Linctus for Infants, IV-360 Preparations, IV-421
Official, Definition of, I-3, II-3, III-3, Opiate Squill Linctus, IV-360 Orientvine Stem, IV-301
IV-3, V-3 Opiate Squill Linctus, Paediatric, IV-360 Orifice, Flow rate through, V-A501
Official Standards, I-4, II-4, III-4, IV-4, Opiate Squill Oral Solution, IV-360 Orodispersible Mirtazapine Tablets,
V-4 Opiate Squill Oral Solution, Paediatric, III-827
Official Titles, I-7, II-7, III-7, IV-7, V-7 IV-360 Oromucosal Preparations, III-60
Ofloxacin, II-421 Opium, IV-287 Orphenadrine Citrate, II-447
Oils Rich in Omega-3-acids, V-A313 Opium Dry Extract, Standardised, see Orphenadrine Hydrochloride, II-449
Oils Rich in Omega-3-acids, Standardised Opium Dry Extract, Orphenadrine Hydrochloride Tablets,
Composition of Fatty Acids in, Opium, Prepared, IV-289 III-894
V-A313 Opium, Raw, see Opium Orthophosphoric Acid, V-A96
Oils Rich in Omega-3-acids, Total Opium Tincture, IV-293 Orthophosphorous Acid, V-A96
Cholesterol in, V-A315 Opium Tincture, Camphorated, IV-293 Orthophosphorous Acid, see Phosphorous
Oily Cream, III-641 Opium Tincture, Concentrated Acid
Oily Phenol Injection, III-947 Camphorated, IV-293 Oscillating transducer density meter,
Ointment, Simple, III-1044 Opium Tincture, Standardised, see V-A242
Ointments, III-47, III-72 Standardised Opium Tincture, Oseltamivir Oral Solution, Paediatric,
Eye, III-47 Optical Microscopy, V-A503 III-895
Olanzapine, II-423 Optical Rotation, Determination of, Oseltamivir Phosphate, II-450
Old Tuberculin, IV-622 V-A241 Osmium Tetroxide, V-A96
Oleamide, V-A95 OPV, see Poliomyelitis Vaccine, Live Osmium Tetroxide Solution, V-A96
Oleanolic Acid, V-A95 (Oral) Osmolality, Determination of, V-A252
Oleic Acid, II-424, V-A95 Oracet Blue 2R, V-A96 Osthole, V-A96
Oleoyl Macrogolglycerides, II-425 Oracet Blue 2R Solution, V-A96 Ouabain, II-453
Oleuropein, V-A96 Oracet Blue B, V-A96 Oxacillin Sodium Monohydrate, II-454
Oxalic Acid, V-A96 Paediatric Codeine Oral Solution, see Pancreas Powder, V-A97
Oxalic Acid and Sulfuric Acid Solution, Paediatric Codeine Linctus Pancreas Powder, see Pancreatic Extract
V-A97 Paediatric Compound Tolu Linctus, Pancreatic Extract, II-489
Oxalic Acid and Sulphuric Acid IV-379 Pancreatin, II-492
Solution, see Oxalic Acid and Sulfuric Paediatric Compound Tolu Oral Pancreatin Granules, III-912
Acid Solution Solution, IV-379 Pancreatin Tablets, Gastro-resistant,
Oxaliplatin, II-456 Paediatric Co-trimoxazole Oral III-912
Oxazepam, II-459, V-S103, V-A97 Suspension, III-390 Pancreatin Tablets, see Gastro-resistant
Oxazepam Tablets, III-896 Paediatric Co-trimoxazole Tablets, Pancreatin Tablets
Oxcarbazepine, II-460 III-392 Pancuronium Bromide, II-494
Oxeladin Hydrogen Citrate, II-462 Paediatric Digoxin Injection, III-443 Pancuronium Injection, III-912
Oxetacaine, II-463, V-S103 Paediatric Digoxin Oral Solution, III-443 Panels of Experts, I-xii
Oxidising Substances, V-A308 Paediatric Docusate Oral Solution, Pansy, Wild, IV-302
Oxitropium Bromide, II-464 III-469 Pantoprazole Sodium Sesquihydrate,
Oxolinic Acid, II-466 Paediatric Ferrous Sulfate Oral Solution, II-495
Oxpentifylline, see Pentoxifylline III-539 Papain, V-A97
Oxprenolol, V-S103 Paediatric Ferrous Sulphate Oral Papaveretum, II-497
Oxprenolol Hydrochloride, II-467 Solution, see Paediatric Ferrous Sulfate Papaveretum Injection, III-913
Oxprenolol Tablets, III-897 Oral Solution Papaverine Hydrochloride, II-498,
2,2-Oxybis(N,N-dimethylethylamine, Paediatric Ipecacuanha Emetic, IV-219 V-S105, V-A97
V-A97 Paediatric Ipecacuanha Emetic Mixture, Papaverine Injection, III-914
Oxybuprocaine Eye Drops, III-897 IV-219 Paper Chromatography, V-A200
Oxybuprocaine Hydrochloride, II-468 Paediatric Ipecacuanha Emetic Oral Paper Chromatography, Ascending,
Oxybutynin, V-S104 Solution, IV-219 V-A200
Oxybutynin Hydrochloride, II-469 Paediatric Opiate Squill Linctus, IV-360 Paper Chromatography, Descending,
Oxybutynin Oral Solution, III-898 Paediatric Opiate Squill Oral Solution, V-A201
Oxybutynin Tablets, III-899 IV-360 Paper Chromatography Performance
Oxycodone, V-S104 Paediatric Oseltamivir Oral Solution, Test Solutions, V-A97
Oxycodone Capsules, III-902 III-895 Paper for Chromatography, V-A97
Oxycodone Hydrochloride, II-471 Paediatric Paracetamol Oral Solution, Paracetamol, II-499, V-S105, V-A97
Oxycodone Injection, III-903 III-915 Paracetamol, 4-Aminophenol-free,
Oxycodone Oral Solution, III-905 Paediatric Paracetamol Oral Suspension, V-A97
Oxycodone Tablets, Prolonged-release, III-917 Paracetamol and Caffeine Tablets,
III-906 Paediatric Phenobarbital Oral Solution, III-922
Oxygen, II-472, V-A97 III-946 Paracetamol and Caffeine Tablets,
Oxygen (15O), IV-675 Paediatric Simple Linctus, III-1044 Soluble, III-923
Oxygen (93 per cent), II-473 Paediatric Trimethoprim and Paracetamol and Dihydrocodeine
Oxygen in Medicinal Gases, Sulfamethoxazole Oral Suspension, Tablets, see Co-dydramol Tablets
Determination of, V-A298 III-390 Paracetamol Capsules, III-914
Oxygen, MRI Compatible, II-472 Paediatric Trimethoprim and Paracetamol Capsules, Codeine
Oxygen R1, V-A97 Sulfamethoxazole Tablets, III-392 Phosphate and, see Co-codamol Capsules
Oxygen-flask Combustion, V-A268 Paediatric Vitamins A, C and D Oral Paracetamol Capsules, Codeine
Oxygen-free Nitrogen, V-A94 Drops, III-1166 Phosphate, Caffeine and, see
Oxymetazoline Hydrochloride, II-474 Paeonol CRS, V-A157 Paracetamol, Codeine Phosphate and
Oxymetholone, II-476, V-S104 Paints, III-43 Caffeine Capsules
Oxymetholone Tablets, III-907 Pale Coneflower Root, see Echinacea Paracetamol, Codeine Phosphate and
Oxytetracycline Calcium, II-478 Pallida Root Caffeine Capsules, III-925
Oxytetracycline Capsules, III-907 Palladium, V-A97 Paracetamol, Codeine Phosphate and
Oxytetracycline Dihydrate, II-477 Palladium Chloride Solution, V-A97 Caffeine Tablets, III-927
Oxytetracycline Hydrochloride, II-480, Palladium Standard Solution (0.5 ppm Paracetamol Oral Solution, Paediatric,
V-A97 Pd), V-A148 III-915
Oxytetracycline Tablets, III-909 Palladium Standard Solution (20 ppm Paracetamol Oral Suspension, III-916
Oxytocin, II-482 Pd), V-A148 Paracetamol Oral Suspension, Paediatric,
Oxytocin Bulk Solution, see Oxytocin Palladium Standard Solution (500 ppm III-917
Concentrated Solution Pd), V-A148 Paracetamol Suppositories, III-918
Oxytocin Concentrated Solution, II-483 Palladium(II) Chloride, V-A97 Paracetamol Tablets, III-919
Oxytocin Injection, III-910 Palm Kernel Oil, Fractionated, II-487 Paracetamol Tablets, Codeine Phosphate
Oxytocin Injection, Ergometrine and, Palmatine Chloride, V-A97 and, Effervescent, see Effervescent Co-
III-498 Palmitic Acid, II-487, V-A97 codamol Tablets
Palmitoleic Acid, V-A97 Paracetamol Tablets, Codeine Phosphate
Palmityl Alcohol, V-A97 and, see Co-codamol Tablets
P Pamidronate Disodium for Infusion,
III-911
Paracetamol Tablets, Codeine
Phosphate, Caffeine and, see
Paclitaxel, II-484
Pamidronate Disodium for Intravenous Paracetamol, Codeine Phosphate and
Paediatric Alimemazine Oral Solution,
Infusion, III-911 Caffeine Tablets
III-113
Pamidronate Disodium Infusion, III-910 Paracetamol Tablets,
Paediatric Alimemazine Oral Solution,
Pamidronate Disodium Intravenous Dextropropoxyphene Hydrochloride
Strong, III-113
Infusion, III-910 and, see Co-proxamol Tablets
Paediatric Codeine Linctus, III-367
Pamidronate Disodium Pentahydrate, Paracetamol Tablets, Dihydrocodeine
II-488 and, see Co-dydramol Tablets
V-A816 Index
Paracetamol Tablets, Dispersible, III-920 Passion Flower Dry Extract, IV-304 Pentoxyverine Hydrogen Citrate, see
Paracetamol Tablets, Effervescent, Pastes, III-72 Pentoxyverine Citrate
III-920 Patches, Transdermal, Dissolution Test tert-Pentyl Alcohol, V-A98
Paracetamol Tablets, Soluble, III-921 for, V-A346 Pepper, IV-309
Paraffin, Hard, II-501 Patents, I-ix, II-vii, III-vii, IV-vii, V-vii Peppermint Emulsion, Concentrated,
Paraffin, Light Liquid, II-501 p-Coumaric Acid, V-A46 IV-313
Paraffin, Liquid, II-502, V-A97 p-Cresol, V-A47 Peppermint Essence, IV-313
Paraffin Ointment, III-930 PCR, see Nucleic acid amplification, Peppermint Leaf, IV-310
Paraffin Oral Emulsion, Liquid, III-930 polymerase chain reaction (PCR) Peppermint Leaf Dry Extract, IV-315
Paraffin, White Soft, II-503, V-A97 PD50, Definition of, I-30, II-30, III-30, Peppermint Oil, IV-312
Paraffin, Yellow Soft, II-504 IV-30, V-30 Peppermint Oil Capsules, Gastro-
Paraldehyde, II-505, V-A97 PD50, V-A608 resistant, IV-314
Paraldehyde Injection, III-931 p,p-DDD, V-A49 Peppermint Spirit, IV-313
Parametric Release, I-4, II-4, III-4, o,p-DDE, V-A49 Pepsin, II-529, V-A98
IV-4, V-4 p,p-DDT, V-A49 Pepsin Powder, V-A98
Pararosaniline Hydrochloride, V-A98 Pea Starch, II-912 Pepsin Powder, see Pepsin
Pararosaniline Solution, Decolorised, Peanut Oil, see Arachis Oil Peptide Identification by Nuclear
V-A98 Pefloxacin Mesilate, II-511 Magnetic Resonance Spectrometry,
Parenteral Preparations, III-63 Pefloxacin Mesilate Dihydrate, see V-A183
Parenteral Preparations, Extractable Pefloxacin Mesilate Peptide Mapping, V-A214
Volume of, V-A360 Pelargonium Root, IV-305 Peptide Mapping, Analysis and
Parenteral Preparations of the BP, III-66 Pemetrexed Disodium Heptahydrate, Identification of Peptides, V-A217
Parenteral Preparations, Water for Use in II-513 Peptide Mapping, Isolation and
Manufacture of, III-66 Penbutolol Sulfate, II-515 Purification, V-A215
Parnaparin Sodium, II-505 Penbutolol Sulphate, see Penbutolol Peptide Mapping, Selective Cleavage of
Paroxetine Hydrochloride, Anhydrous, Sulfate Peptide Bonds, V-A215
II-506 Penetrometry, Measurement of Perchloric Acid, V-A98
Paroxetine Hydrochloride Hemihydrate, Consistency by, V-A490 Perchloric Acid Solution, V-A98
II-508 Penicillamine, II-516 Perchloric Acid VS, V-A142
Paroxetine Hydrochloride, see Anhydrous Penicillamine Tablets, III-933 Perf/Ser, see Gas-gangerene Antitoxin
Paroxetine Hydrochloride Penicillinase Solution, V-A98 (Perfringens)
Paroxetine Tablets, III-931 Pentaerythrityl Tetrakis[3-(3,5-di-tert- Pergolide Mesilate, II-531
Parthenolide, V-A98 butyl-4-hydroxyphenyl)propionate, Perindopril Erbumine, II-532
Partially Dehydrated Liquid Sorbitol, V-A98 Perindopril Erbumine Tablets, III-938
II-888 Pentaerythrityl Tetranitrate, Diluted, Perindopril tert-Butylamine, see
Partially Hydrated Magnesium Chloride, II-518 Perindopril Erbumine
II-165 Pentafluoropropanoic Acid, V-A98 Periodic Acetic Acid Solution, V-A98
Particle characterisation by Microscopy, Pentafluoropropionic Anhydride, V-A98 Periodic Acid, V-A98
V-A503 Pentagastrin, II-520 Periodic Acid Reagent, V-A98
Particle count test, Light obscuration, Pentagastrin Injection, III-934 Periodic Acid Solution, V-A99
V-A379 Pentamidine Diisetionate, see Pentamidine Peritoneal Dialysis Solutions, III-940
Particle count test, Microscopic, V-A380 Isetionate Permethrin, V-A99
Particle density, V-A254 Pentamidine Injection, III-934 Peroxide Test Strips, V-A99
Particle shape, characterisation of, Pentamidine Isetionate, II-521, V-S105 Peroxide Value, V-A306
V-A504 Pentamidine Isetionate for Injection, Peroxide-free Ether, V-A62
Particle Size Analysis by Laser Light III-934 Peroxyacetic Acid Solution, V-A99
Diffraction, V-A504 n-Pentane, V-A98 Perphenazine, II-536, V-S107
Particle size, characterisation of, V-A503 1,2-Pentanediol, V-A98 Perphenazine Tablets, III-942
Particle size classification of powders, Pentane, see n-Pentane Pertussis vaccine (acellular), Assay of,
V-A483 Pentan-1-ol, V-A98 V-A430
Particle size distribution, estimation by Pentanol, see Pentan-1-ol Pertussis Vaccine (Acellular
analytical sieving, V-A485 3-Pentanone, V-A98 Component), Adsorbed, IV-581
Particle size, limit test by microscopy, Pentazocine, II-522 Pertussis Vaccine (Acellular, Co-
V-A503 Pentazocine Capsules, III-935 purified), Adsorbed, IV-582
Particle Size of Powders, V-A483– Pentazocine (Form B), V-S106 Pertussis Vaccine (Whole Cell,
V-A525 Pentazocine Hydrochloride, II-523 Adsorbed), IV-579
Particle-free Water, V-A137 Pentazocine Injection, III-936 Pertussis vaccine (Whole Cell), Assay of,
Particles, Sub-visible, Particulate Pentazocine Lactate, II-524, V-S106 V-A424
Contamination, V-A379 Pentazocine Suppositories, III-937 Peru Balsam, IV-315
Particles, Visible, Particulate Pentazocine Tablets, III-937 Perylene, V-A99
Contamination, V-A381 Pentetate Sodium Calcium for Pessaries, Suppositories and,
Particulate Contamination, V-A637 Radiopharmaceutical Preparations, Disintegration Test for, V-A335
Particulate Contamination, Limit Tests IV-645 Pesticide Residues, V-A322
for, V-A379 Pentetic Acid, V-A98 Pethidine, V-S107
Particulate Contamination, Visible Pentobarbital, II-524, V-S106 Pethidine Hydrochloride, II-537, V-S107
Particles, V-A381 Pentobarbital Sodium, II-525 Pethidine Injection, III-943
Partly Dementholised Mint Oil, see Pentobarbital Tablets, III-938 Pethidine Tablets, III-944
Dementholised Mint Oil Pentoxifylline, II-526 Petroleum, Light, V-A99
Passiflora, see Passion Flower Pentoxyverine Citrate, II-528 Petroleum, light R4, V-A99
Passion Flower, IV-303 Petroleum R1, Light, V-A99
Petroleum R2, Light, V-A99 2-Phenoxyaniline, V-A100 Pholcodine Oral Solution, see Pholcodine
Petroleum R3, Light, V-A99 Phenoxybenzamine Capsules, III-948 Linctus
Petroleum Spirit, V-A99 Phenoxybenzamine Hydrochloride, Phosalone, V-A101
Petroleum Spirit (boiling range, 408 to II-548, V-S108, V-A100 Phosphate Buffer, 0.025M Standard,
608), Aromatic-free, V-A99 Phenoxyethanol, II-549, V-A100 V-A153
PFU, I-30, II-30, III-30, IV-30, V-30 Phenoxyethanol, see 2-Phenoxyethanol Phosphate Buffer pH 7.5, 0.2M, V-A153
pH Indicator Strip, V-A99 Phenoxymethylpenicillin, II-550 Phosphate Buffer pH 6.8, 0.2M Mixed,
pH Values, Determination of, V-A248 Phenoxymethylpenicillin Oral Solution, V-A153
Pharmaceutical Preparations, III-37, III-948 Phosphate Buffer pH 2.5 R1, see Buffer
IV-37 Phenoxymethylpenicillin Potassium, Solution pH 2.5
Pharmaceutical Preparations, II-552 Phosphate Buffer pH 2.5, see Buffer
Microbiological Quality of, V-A637 Phenoxymethylpenicillin Tablets, III-949 Solution pH 2.5
Pharmaceutical Use, Substances for, Phentolamine Injection, III-950 Phosphate Buffer pH 3.0, V-A153
I-37, II-37, III-37, IV-37 Phentolamine Mesilate, II-554 Phosphate Buffer pH 3.5, V-A153
Pharmacopoeial Calculations, V-A757 Phenyl Benzoate, V-A100 Phosphate Buffer pH 5.4, Mixed,
Pharmacopoeial Harmonisation, V-A674 Phenyl Isothiocyanate, V-A100 V-A153
Pharmacopoeial Quantitative Analysis, Phenyl Silica Gel for Chromatography, Phosphate Buffer pH 4.0, V-A153
V-A757 V-A115 Phosphate Buffer pH 4.0, Mixed,
Pharmacopoeial Requirements, Basis of, Phenylacetic Acid, V-A100 V-A153
V-A615 Phenylalanine, II-555, V-A100 Phosphate Buffer pH 4.75, V-A153
a-Phellandrene, V-A99 o-Phenylbenzoic Acid, V-A100 Phosphate Buffer pH 4.9, V-A153
Phenacetin, V-A99 Phenylbutazone, II-556 Phosphate Buffer pH 6.8, Mixed,
Phenanthrene, V-A99 N-Phenylcarbazole, V-A100 V-A153
Phenanthroline Hydrochloride, V-A99 p-Phenylenediamine Dihydrochloride, Phosphate Buffer pH 7.0, Mixed,
Phenazone, II-538, V-A99 V-A100 V-A153
Phenelzine Sulfate, II-540 Phenylephrine, II-558 Phosphate Buffer pH 10, Mixed, V-A153
Phenelzine Sulphate, see Phenelzine Phenylephrine Eye Drops, III-951 Phosphate Buffer solution pH 7.0,
Sulfate Phenylephrine Hydrochloride, II-559 0.05m, V-A155
Phenelzine Tablets, III-944 Phenylephrine Injection, III-952 Phosphate Buffer Solution pH 7.5,
Phenindamine Tartrate, II-540 D-Phenylglycine, V-A100 0.33m, V-A155
Phenindione, II-541, V-S108 DL-Phenylglycine, V-A100 Phosphate Buffer Solution pH 7.0,
Phenindione Tablets, III-945 a-Phenylglycine, see DL-Phenylglycine 0.025M, V-A154, V-A155
Pheniramine Maleate, II-541 Phenylhexylsilyl Silica Gel for 0.067m Phosphate Buffer Solution
Phenobarbital, II-543, V-S108 Chromatography, V-A115 pH 7.0, V-A153
Phenobarbital Elixir, III-945 Phenylhydrazine, V-A100 Phosphate Buffer Solution pH 6.8 R1,
Phenobarbital Injection, III-946 Phenylhydrazine Hydrochloride, V-A101 see Phosphate Buffer pH 6.8, 0.2M
Phenobarbital Oral Solution, Paediatric, Phenylhydrazine Hydrochloride Solution, Mixed
III-946 V-A101 Phosphate Buffer Solution pH 6.0 R1,
Phenobarbital Oral Phenylhydrazine-Sulfuric Acid Solution, V-A154
SolutionseePhenobarbitalElixir, III-945 V-A101 Phosphate Buffer Solution pH 7.0 R2,
Phenobarbital Sodium, II-544 Phenylhydrazine-Sulphuric Acid V-A154
Phenobarbital Sodium Tablets, III-947 Solution, see Phenylhydrazine-Sulfuric Phosphate Buffer Solution pH 7.0 R3,
Phenobarbital Tablets, III-946 Acid Solution V-A154
Phenol, II-545, V-A99 Phenylmercuric Acetate, II-561 Phosphate Buffer Solution pH 7.0 R4,
Phenol and Glycerol Injection, III-948 Phenylmercuric Borate, II-561 V-A154
Phenol in Immunosera (Antisera) and Phenylmercuric Nitrate, II-562 Phosphate Buffer Solution pH 7.0 R5,
Vaccines, V-A447 1-Phenylpiperazine, V-A101 V-A154
Phenol Injection, Aqueous, III-947 Phenylpropanolamine Hydrochloride, Phosphate Buffer Solution pH 6.0, see
Phenol Injection, Oily, III-947 II-563 Citro-phosphate Buffer pH 6.0
Phenol, Liquefied, II-546, V-A99 Phenylsilyl Silica Gel for Phosphate Buffer Solution pH 6.8, see
Phenol Red, V-A99 Chromatography, V-A115 Citro-phosphate Buffer pH 6.8
Phenol Red Solution, V-A99 Phenylsilyl Silica Gel for Phosphate Buffer Solution pH 7.0, see
Phenol Red Solution R1, V-A99 Chromatography R1, V-A116 Citro-phosphate Buffer pH 7.0
Phenol Red Solution R2, V-A100 Phenytoin, II-564, V-S109 Phosphate Buffer Solution pH 7.2, see
Phenol Red Solution R3, V-A100 Phenytoin Capsules, III-952 Citro-phosphate Buffer pH 7.2
Phenoldisulfonic Acid Solution, V-A100 Phenytoin Injection, III-953 Phosphate Buffer Solution pH 3.5, see
Phenoldisulphonic Acid Solution, see Phenytoin Oral Suspension, III-954 Phosphate Buffer pH 3.5
Phenoldisulfonic Acid Solution Phenytoin Sodium, II-565 Phosphate Buffer Solution pH 3.2,
Phenolphthalein, II-546, V-A100 Phenytoin Tablets, III-954 V-A154, V-A155
Phenolphthalein Paper, V-A100 Phloroglucide, V-A101 Phosphate Buffer Solution pH 2.0,
Phenolphthalein solution, V-A100 Phloroglucinol, V-A101 V-A153
Phenolphthalein Solution R1, V-A100 Phloroglucinol, Anhydrous, II-567 Phosphate Buffer Solution pH 2.8,
Phenolphthalein-Thymol Blue Solution, Phloroglucinol Dihydrate, II-569 V-A154
V-A100 Phloroglucinol Solution, V-A101 Phosphate Buffer Solution pH 3.0,
Phenolsulfonphthalein, II-547 Pholcodine, II-571, V-S109 V-A154
Phenolsulphonphthalein, see Pholcodine Linctus, III-954 Phosphate Buffer Solution pH 3.5,
Phenolsulfonphthalein Pholcodine Linctus, Strong, III-955 V-A154
Phenothiazines, Related Substance in, Pholcodine Oral Solution, Strong, see Phosphate Buffer Solution pH 6.4,
V-A193 Pholcodine Linctus, Strong V-A154, V-A155
Phenoxyacetic Acid, V-A100
V-A818 Index
Phosphate Buffer Solution pH 5.4, Phthalic Anhydride, V-A102 Pivampicillin, II-601

0.067m, V-A154 Phthalic Anhydride Solution, V-A102 Pivmecillinam Hydrochloride, II-603
Phosphate Buffer Solution pH 6.5, Phthalylsulfathiazole, II-573 Pizotifen, V-S110
V-A154, V-A155 Phyllanthus Emblica Pericarp, IV-316 Pizotifen Malate, II-605, V-S111
Phosphate Buffer Solution pH 5.0, Phyllanthus Emblica Pericarp for use in Pizotifen Tablets, III-965
V-A154 THMP, see Phyllanthus Emblica Plantain, IV-319
Phosphate Buffer Solution pH 5.5, Pericarp Plasma, Citrated Rabbit, V-A102
V-A154 Physostigmine Salicylate, II-574 Plasma for Fractionation, IV-452
Phosphate Buffer Solution pH 5.6, Phytomenadione, II-575 Plasma, Platelet-poor, V-A102
V-A154 Phytomenadione Injection, III-956 Plasma (Pooled and Treated for Virus
Phosphate Buffer Solution pH 5.8, Phytomenadione Tablets, III-957 Inactivation), IV-453
V-A154 Phytosterol, II-577 Plasma, Substrate, V-A103
Phosphate Buffer Solution pH 6.0, Picein, V-A102 Plasma Substrate Deficient in Factor V,
V-A154 Picotamide Monohydrate, II-578 V-A103
Phosphate Buffer Solution pH 6.8, Picric Acid, V-A102 Plasma Substrate R1, V-A103
V-A154 Picric Acid Solution, V-A102 Plasma Substrate R2, V-A103
Phosphate Buffer Solution pH 7.0, Picric Acid Solution R1, V-A102 Plasma Substrate R3, V-A103
V-A154 Picrolonic Acid, V-A102 Plasmid Vectors for Human Use,
Phosphate Buffers, V-A153 Pillules for Homoeopathic Preparations, V-A733
Phosphate Oral Solution, III-956 IV-416 Plasmin, V-A408
Phosphate Standard Solution (5 ppm Pillules Impregnated, Homoeopathic, Plasmin chromogenic substrate, V-A408
PO4), V-A149 IV-416 Plasmin inhibitor, Assay of human,
Phosphate Standard Solution (100 ppm Pilocarpine Hydrochloride, II-579 V-A408
PO4), V-A148 Pilocarpine Hydrochloride Eye Drops, Plasminogen, Human, V-A103
Phosphate Standard Solution (200 ppm III-958 Plaster of Paris, see Dried Calcium Sulfate
PO4), V-A148 Pilocarpine Nitrate, II-580, V-S109 Plastic Additives, V-A573
Phosphate-albumin Buffered Saline Pilocarpine Nitrate Eye Drops, III-958 Plastic Containers and Closures, V-A535
pH 7.2, V-A155 Pimobendan, II-582 Plastic containers for aqueous solutions
Phosphate-albumin Buffered Saline Pimozide, II-583, V-S110 for parenteral infusion, V-A536
pH 7.2 R1, V-A155 Pimozide Tablets, III-959 Plate number, V-A186
Phosphate-buffered Saline pH 6.4, Pindolol, II-584, V-S110 Platelet Substitute, V-A103
V-A155 Pindolol Tablets, III-960 Platelet-poor Plasma, V-A102
Phosphate-buffered Saline pH 6.8, Pine Silvestris Oil, IV-318 Platinum Standard Solution (30 ppm
V-A155 a-Pinene, V-A102 Pt), V-A149
Phosphate-buffered Saline pH 7.4, Pinus Pinaster Type Turpentine Oil, Plutonium-242 Spiking Solution,
V-A155 IV-384 V-A103
Phosphate–Citrate Buffer Solution Pioglitazone Hydrochloride, II-586 Pneumococcal Polysaccharide Conjugate
pH 5.5, V-A155 Pipemidic Acid Trihydrate, II-587 Vaccine (Adsorbed), IV-586
Phosphates Enema, III-955 Piperacillin, II-588 Pneumococcal Polysaccharide Vaccine,
Phosphates, Limit Test for, V-A265 Piperacillin for Infusion, III-961 IV-584
Phosphates (Orthophosphates), Piperacillin for Intravenous Infusion, see Pneumo(conj), see Pneumococcal
Reactions of, V-A258 Piperacillin for Infusion Polysaccharide Conjugate Vaccine
Phospholipid, V-A101 Piperacillin Infusion, III-961 (Adsorbed)
Phosphomolybdic Acid, V-A101 Piperacillin Intravenous Infusion, see Pneumo, see Pneumococcal Polysaccharide
Phosphomolybdic Acid Solution, V-A101 Piperacillin Infusion Vaccine
Phosphomolybdic Acid Solution, Piperacillin Sodium, II-590 Podophyllin Paint, Compound, IV-321
Ethanolic, V-A101 Piperazine Adipate, II-592 Podophyllum Resin, IV-321
Phosphomolybdotungstic Reagent, Piperazine Citrate, II-593 Poldine Metilsulfate, II-605, V-S111
V-A101 Piperazine Citrate Elixir, III-962 Poldine Tablets, III-966
Phosphomolybdotungstic Reagent, Piperazine Citrate Oral Solution, III-962 Poliomyelitis Vaccine, Inactivated,
Dilute, V-A101 Piperazine Dipicrate Solution, V-A102 IV-588
Phosphoric Acid, II-572, V-A101 Piperazine Hydrate, II-594, V-A102 Poliomyelitis vaccine (inactivated), In
Phosphoric Acid, Dilute, II-573, V-A101 Piperazine Phosphate, II-595 vivo assay of, V-A432
Phosphoric Acid, Dilute R1, V-A101 Piperazine Phosphate Tablets, III-963 Poliomyelitis Vaccine, Live (Oral),
Phosphoric Vanillin Solution, V-A136 Piperazine Phosphate Tablets, Chewable, IV-591
Phosphorous Acid, V-A101 III-963 Poliomyelitis Vaccine (Oral), Test for
Phosphorus in Polysaccharide Vaccines, Piperidine, V-A102 neurovirulence of, V-A448
V-A449 Piperine, V-A102 Poliomyelitis Vaccine (Oral), see
Phosphorus Pentoxide, V-A101 Piperitone, V-A102 Poliomyelitis Vaccine, Live (Oral)
Phosphotungstic Acid Solution, V-A101 Piperonyl Butoxide CRS, V-A157 Poloxamer 124, V-A103
Phthalaldehyde, V-A101 Piracetam, II-596 Poloxamers, II-606
Phthalaldehyde Reagent, V-A101 Pirenzepine Dihydrochloride Poloxyethylene 20 Sorbitan
Phthalate Buffer pH 3.6, V-A155 Monohydrate, see Pirenzepine Monolaurate, see Polysorbate 20
Phthalate Buffer Solution pH 6.4, 0.5M, Hydrochloride Polyacrylamide Gel, Fixing Solution for
V-A155 Pirenzepine Hydrochloride, II-597 Isoelectric Focusing in, V-A65
Phthalate Buffer Solution pH 4.4, Piretanide, II-598 Polyacrylamide Gels, Isoelectric
V-A155 Pirimiphos-ethyl, V-A102 Focusing, V-A213
Phthalazine, V-A102 Piroxicam, II-599 Polyacrylamide Rod Gel Electrophoresis,
Phthalein Purple, V-A102 Piroxicam Capsules, III-963 V-A202
Phthalic Acid, V-A102 Piroxicam Gel, III-964
Polyacrylate Dispersion (30 per cent), Polymyxin and Bacitracin Eye Ointment, Potassium Borohydride, V-A105
II-608 III-966 Potassium Bromate, V-A105, V-A139
Poly[(cyanopropyl) Polymyxin and Bacitracin Ointment, Potassium Bromate VS, V-A143
methylphenylmethylsiloxane], V-A103 III-968 Potassium Bromide, II-620, V-A105
Poly[(cyanopropyl)(methyl)][(phenyl) Polymyxin B Sulfate, II-609 Potassium Carbonate, II-621, V-A105
(methyl)]siloxane, see Polymyxin B Sulphate, see Polymyxin B Potassium Carbonate Sesquihydrate,
Poly[(cyanopropyl) Sulfate V-A105
methylphenylmethylsiloxane] Polyolefines, V-A557 Potassium Chlorate, V-A105
Poly(cyanopropylphenyl)(14)(methyl) Polyoxyethylated Castor Oil, V-A104 Potassium Chloride, II-622, V-A105
(86)siloxane, V-A103 Polyoxyethylene 20 Sorbitan Mono- Potassium Chloride and Dextrose
Poly[(cyanopropyl)(phenyl)][dimethyl] oleate, see Polysorbate 80 Infusion, see Potassium Chloride and
siloxane, V-A103 Polyoxyethylene 20 Sorbitan Glucose Infusion
Poly(cyanopropyl)(7)(phenyl)(7)methyl) Monopalmitate, see Polysorbate 40 Potassium Chloride and Dextrose
(86)siloxane, V-A103 Polyoxyethylene 20 Sorbitan Intravenous Infusion, see Potassium
Poly(cyanopropyl)(phenylmethyl) Monostearate, see Polysorbate 60 Chloride and Glucose Infusion
siloxane, V-A103 Polyoxyethylene 23 Lauryl Ether, Potassium Chloride and Glucose
Poly(cyanopropyl)siloxane, V-A103 V-A104 Infusion, III-973
Poly(dimethyl)(85)(diphenyl) Polyoxyl Castor Oil, I-420 Potassium Chloride and Glucose
(15)siloxane, V-A104 Polyoxyl Castor Oil, Hydrogenated, Intravenouse Infusion, see Potassium
Poly(dimethyl)(75)(diphenyl)(25) I-421 Chloride and Glucose Infusion
siloxane, V-A104 Polypropylene for Containers and Potassium Chloride and Sodium
Poly(dimethyl)(diphenyl)(divinyl) Closures for Parenteral Preparations Chloride Infusion, III-973
siloxane, V-A104 and Ophthalmic Preparations, V-A566 Potassium Chloride and Sodium
Poly(dimethyl)(diphenyl)siloxane, Polysaccharide Vaccines, Composition Chloride Intravenous Infusion, see
V-A104 of, V-A449 Potassium Chloride and Sodium Chloride
Poly(dimethyl)(diphenyl)siloxane, base- Polysorbate 20, II-610, V-A104 Infusion
deactivated, V-A104 Polysorbate 40, II-611 Potassium Chloride Concentrate, Sterile,
Poly(dimethyl)siloxane, V-A104 Polysorbate 60, II-612 III-971
Poly(dimethylsiloxane), see Dimeticone Polysorbate 80, II-613, V-A104 Potassium Chloride, 0.1M, V-A105
Polyether Hydroxylated Gel for Polystyrene, V-S3, V-S4 Potassium Chloride Oral Solution,
Chromatography, V-A104 Polystyrene 900–1000, V-A104 III-972
Polyethylene, V-A561 Polythiazide, II-615, V-S111 Potassium Chloride, Sodium Chloride
Poly(ethylene - vinyl acetate) for Polythiazide Tablets, III-970 and Dextrose Infusion, see Potassium
Containers and Tubing for Total Poly(vinyl acetate), II-615 Chloride, Sodium Chloride and Glucose
Parenteral Nutrition Preparations, Poly(vinyl acetate) Dispersion Infusion
V-A569 30 per cent, II-617 Potassium Chloride, Sodium Chloride
Polyethylene Glycol 20,000 Poly(vinyl alcohol), II-618 and Dextrose Intravenous Infusion, see
2-Nitroterephthalate, V-A104 Poppy Petals, Red, IV-322 Potassium Chloride, Sodium Chloride and
Polyethylene Glycol 200 R1, V-A104 Porcine Insulin, I-1190 Glucose Infusion
Polyethylene Glycol 20,000, V-A104 Pore-size Distribution of Solids by Potassium Chloride, Sodium Chloride
Polyethylene Glycol 200, V-A104 Mercury Porosimetry, Porosity and, and Glucose Infusion, III-974
Polyethylene Glycol 300, V-A104 V-A513 Potassium Chloride, Sodium Chloride
Polyethylene Glycol 400, V-A104 Poria, IV-323 and Glucose Intravenous Infusion, see
Polyethylene Glycol 1000, V-A104 Porosity and Pore-size Distribution of Potassium Chloride, Sodium Chloride and
Polyethylene Glycol 1500, V-A104 Solids by Mercury Porosimetry, Glucose Infusion
Polyethylene Glycol Adipate, V-A104 V-A513 Potassium Chloride Tablets,
Polyethylene Glycol Succinate, V-A104 Potable Water, I-10, II-10, III-10, Effervescent, III-972
Polyethylene Terephthalate for IV-10, V-10 Potassium Chloride Tablets, Prolonged-
Containers for Preparations not for Potash Alum, see Alum release, III-972
Parenteral Use, V-A576 Potash, Caustic, see Potassium Hydroxide Potassium Chromate, V-A105
Polyethylene With Additives for Potash Solution, III-975 Potassium Chromate Solution, V-A105
Containers for Parenteral and Potassium Acetate, II-619, V-A104 Potassium Citrate, II-623, V-A105
Opthalmic Preparations, V-A562 Potassium Acid Phosphate Injection, Potassium Citrate Mixture, III-974
Polyethylene Without Additives for III-975 Potassium Citrate Oral Solution, III-974
Containers for Parenteral Preparations Potassium Acid Phosphate Oral Solution, Potassium Clavulanate, II-624
and for Ophthalmic Preparations, see Potassium Dihydrogen Phosphate Oral Potassium Clavulanate, Diluted, II-626
V-A561 Solution Potassium Clavulanate Injection,
Polyethyleneglycol, Polar-deactivated, Potassium and Potassium Salts, Amoxicillin and, see Co-amoxiclav
V-A104 Reactions of, V-A258 Injection
Polymethacrylate Gel, V-A104 Potassium Antimonate(V), V-A104 Potassium Clavulanate Intravenous
Polymethacrylate Gel, Hydroxylated, Potassium Antimonate(V) Solution, Infusion, Ticarcillin Sodium and, see
V-A104 V-A104 Ticarcillin and Clavulanic Acid Infusion
Poly[methyl(94)phenyl(5)vinyl(1)] Potassium Ascorbate Eye Drops, III-971 Potassium Clavulanate Oral Suspension,
siloxane, V-A104 Potassium Bicarbonate, II-620 Amoxicillin and, see Co-amoxiclav Oral
Poly[methyl(95)phenyl(5)]siloxane, Potassium Bicarbonate Solution, Suspension
V-A104 Saturated Methanolic, see Saturated Potassium Clavulanate Tablets,
Polymethylphenylsiloxane, V-A104 Methanolic Potassium Hydrogen Amoxicillin and, see Co-amoxiclav
Poly[methyl(trifluoropropylmethyl) Carbonate Solution Tablets
siloxane], V-A104 Potassium Bicarbonate, see Potassium
Polymorphism, V-A157 Hydrogen Carbonate
V-A820 Index
Potassium Clavulanate Tablets, Potassium Hydrogen Phthalate 0.05 M, Potassium Iodobismuthate Solution,
Dispersible Amoxicillin and, see V-A249 Acid, V-A106
Dispersible Co-amoxiclav Tablets Potassium Hydrogen Phthalate, 0.2M, Potassium Iodobismuthate Solution,
Potassium Clorazepate, see Dipotassium V-A106 Dilute, V-A106
Clorazepate Potassium Hydrogen Phthalate VS, Potassium Iodobismuthate Solution R1,
Potassium Cyanide, V-A105 V-A143 V-A106
Potassium Cyanide Solution, V-A105 Potassium Hydrogen Sulfate, V-A106 Potassium Iodobismuthate Solution R2,
Potassium Cyanide Solution, Lead-free, Potassium Hydrogen Sulphate, see V-A107
V-A105 Potassium Hydrogen Sulfate Potassium Iodobismuthate Solution R3,
Potassium Cyanide Solution PbT, Potassium Hydrogen Tartrate, II-630, V-A107
V-A105 V-A106 Potassium Iodobismuthate Solution R4,
Potassium Dichromate, V-A105, V-A139 Potassium Hydrogen Tartrate, saturated V-A107
Potassium Dichromate for at 25 8C, V-A249 Potassium Iodobismuthate Solution R5,
Homoeopathic Preparations, IV-438 Potassium Hydrogen Tartrate, see V-A107
Potassium Dichromate Solution, V-A105 Potassium Hydrogen (þ)-Tartrate Potassium Iodoplatinate Solution,
Potassium Dichromate Solution, Dilute, Potassium Hydroxide, II-630, V-A106 V-A107
V-A105 Potassium Hydroxide, Alcoholic, see Potassium, Limit Test for, V-A265
Potassium Dichromate Solution R1, Potassium Hydroxide VS, Ethanolic Potassium Mercuri-iodide Solution,
V-A105 Potassium Hydroxide, Ethanolic, V-A106 Alkaline, V-A107
Potassium Dichromate VS, V-A143 Potassium Hydroxide in Alcohol Potassium Metabisulfite, II-633
Potassium Dihydrogen Citrate, V-A105 (10% v/v), 0.5M, V-A106 Potassium Metabisulphite, see Potassium
Potassium Dihydrogen Ctrate 0.05 M, Potassium Hydroxide in Alcohol Metabisulfite
V-A249 (60% v/v), see Potassium Hydroxide in Potassium Nitrate, II-634, V-A107
Potassium Dihydrogen Orthophosphate, Ethanol (60%) VS Potassium Perchlorate, II-635
V-A105 Potassium Hydroxide in Ethanol (60%) Potassium Periodate, V-A107
Potassium Dihydrogen Phosphate, VS, V-A143 Potassium Permanganate, II-635,
II-628, V-A105 Potassium Hydroxide in Ethanol (90%) V-A107
Potassium Dihydrogen Phosphate VS, V-A143 Potassium Permanganate and Phosphoric
0.025 M þ Disodium Hydrogen Potassium Hydroxide, 2M Alcoholic, Acid Solution, V-A107
Phosphate 0.025 M, V-A249 V-A106 Potassium Permanganate Solution,
Potassium Dihydrogen Phosphate Potassium Hydroxide, Methanolic, V-A107
Concentrate, Sterile, III-975 V-A106 Potassium Permanganate Solution,
Potassium Dihydrogen Phosphate, 0.2M, Potassium Hydroxide Solution, III-975 Dilute, V-A107
V-A105 Potassium Hydroxide Solution, Potassium Permanganate VS, V-A143
Potassium Dihydrogen Phosphate Alcoholic, V-A106 Potassium Perrhenate, V-A107
0.0087 M þ Disodium Hydrogen Potassium Hydroxide Solution R1, Potassium Persulfate, V-A107
Phosphate 0.0303 M, V-A249 Alcoholic, V-A106 Potassium Persulphate, see Potassium
Potassium Dihydrogen Phosphate Oral Potassium Hydroxide VS, V-A143 Persulfate
Solution, III-975 Potassium Hydroxide VS, Ethanolic, Potassium Plumbite Solution, V-A107
Potassium Ferricyanide Solution, see V-A143 Potassium Pyroantimonate Solution, see
Potassium Hexacyanoferrate(III) Solution Potassium Hydroxyquinoline Sulfate, Potassium Antimonate(V) Solution
Potassium Ferricyanide, see Potassium II-631 Potassium Pyroantimonate, see Potassium
Hexacyanoferrate(III) Potassium Hydroxyquinoline Sulfate and Antimonate(V)
Potassium Ferriperiodate Solution, Benzoyl Peroxide Cream, III-976 Potassium Sodium (þ)-Tartrate, V-A107
V-A105 Potassium Hydroxyquinoline Sulphate Potassium Sodium Tartrate
Potassium Ferrocyanide Solution, see and Benzoyl Peroxide Cream, see Tetrahydrate, II-636
Potassium Hexacyanoferrate(II) Solution Potassium Hydroxyquinoline Sulfate and Potassium Sorbate, II-637, V-A107
Potassium Ferrocyanide, see Potassium Benzoyl Peroxide Cream Potassium Standard Solution
Hexacyanoferrate(II) Potassium Hydroxyquinoline Sulphate, (0.2 per cent K), V-A149
Potassium Fluoride, V-A105 see Potassium Hydroxyquinoline Sulfate Potassium Standard Solution (20 ppm
Potassium Hexacyanoferrate(II), V-A105 Potassium Iodate, II-632, V-A106, K), V-A149
Potassium Hexacyanoferrate(II) Solution, V-A139 Potassium Standard Solution (100 ppm
V-A106 Potassium Iodate Tablets, III-976 K), V-A149
Potassium Hexacyanoferrate(III), V-A105 Potassium Iodate VS, V-A143 Potassium Standard Solution (600 ppm
Potassium Hexacyanoferrate(III) Solution, Potassium Iodide, II-632, V-A106 K), V-A149
V-A106 Potassium Iodide and Starch Solution, Potassium Sulfate, II-637, V-A107
Potassium Hexacyanoferrate(III) Solution, V-A106 Potassium Sulphate, see Potassium Sulfate
Dilute, V-A106 Potassium Iodide Solution, V-A106 Potassium Tartrate, see Dipotassium (þ)-
Potassium Hyaluronate, V-A106 Potassium Iodide Solution, Dilute, Tartrate
Potassium Hyaluronate Stock Solution, V-A106 Potassium Tetraiodomercurate Solution,
V-A106 Potassium Iodide Solution, Iodinated, V-A107
Potassium Hydrogen Aspartate V-A106 Potassium Tetraiodomercurate Solution,
Hemihydrate, II-629 Potassium Iodide Solution, Iodinated Alkaline, V-A107
Potassium Hydrogen Carbonate, V-A106 R1, V-A106 Potassium Tetraoxalate 0.05 M, V-A249
Potassium Hydrogen Carbonate Potassium Iodide Solution, Saturated, Potassium Tetroxalate, V-A107
Solution, Saturated, V-A106 V-A106 Potassium Thiocyanate, V-A107
Potassium Hydrogen Carbonate, see Potassium Iodide VS, V-A143 Potassium Thiocyanate Solution,
Potassium Bicarbonate Potassium Iodobismuthate Solution, V-A107
Potassium Hydrogen Phthalate, V-A106, V-A106 Potato Starch, II-912
V-A139
Potency, Estimated, I-14, II-14, III-14, Prednisolone Enema, III-980 Procainamide, V-S113
IV-14, V-14, V-A635 Prednisolone Pivalate, II-655 Procainamide Hydrochloride, II-666
Potency, Labelled, V-A635 Prednisolone Sodium Phosphate, II-656 Procainamide Injection, III-989
Potency of Antibiotics, I-14, II-14, Prednisolone Sodium Phosphate Ear Procainamide Tablets, III-989
III-14, IV-14, V-14 Drops, III-985 Procaine Benzylpenicillin, II-667
Potency, Stated, I-14, II-14, III-14, Prednisolone Sodium Phosphate Eye Procaine Hydrochloride, II-668, V-A107
IV-14, V-14, V-A635 Drops, III-986 Procaine Penicillin, see Procaine
Potency, True, V-A635 Prednisolone Tablets, III-981 Benzylpenicillin
Potential Adulteration, I-25, II-25, Prednisolone Tablets, Gastro-resistant, Processed Herbal Drugs, IV-44
III-25, IV-25, V-25 III-982 Processed Liquorice Root for use in
Potentiometric Determination of Ionic Prednisone, II-658 TCM, IV-249
Concentration Using Ion-selective Preface, I-x Processed Salvia Miltiorrhiza Rhizome
Electrodes, V-A269 Prefilled Syringes, Extractable Volume and Root, IV-341
Potentiometric Titration, V-A267 test, V-A361 Processed White Peony Root, IV-307
Potentisation, Methods of Preparation of Pregelatinised Maize Starch, see Prochlorperazine (1), V-S114
Homoeopathic Stocks and, IV-405 Pregelatinised Starch Prochlorperazine (2), V-S114
Povidone, II-638, V-A107 Pregelatinised Starch, II-913 Prochlorperazine Buccal Tablets, III-991
Povidone, Iodinated, II-641 Prekallikrein activator, Test for, V-A407 Prochlorperazine Injection, III-990
Povidone-Iodine Eye Drops, III-977 Preparation of Homoeopathic Stocks and Prochlorperazine Maleate, II-669
Povidone-Iodine Mouthwash, III-977 Potentisation, Methods of, IV-405 Prochlorperazine Mesilate, II-670,
Povidone-Iodine Solution, III-978 Preparation of inoculum, V-A477 V-S114
Powder, Coarse, Definition of, V-A483 Preparation of Unlicensed Medicines, Prochlorperazine Oral Solution, III-990
Powder, Fine, Definition of, V-A483 V-A753 Prochlorperazine Tablets, III-992
Powder fineness, V-A483 Preparations, Extemporaneous, V-A756 Procyclidine, V-S115
Powder Flow, V-A500 Preparations for Inhalation, III-50 Procyclidine Hydrochloride, II-670,
Powder, Microfine, Definition of, Preparations for Inhalation, aerodynamic V-S115
V-A483 assessment of fine particles, V-A361 Procyclidine Injection, III-992
Powder, Moderately Coarse, Definition Preparations for Inhalation of the BP, Procyclidine Tablets, III-993
of, V-A483 III-55 Production and Testing of Vaccines,
Powder, Moderately Fine, Definition of, Preparations for Irrigation, III-55 V-A446
V-A483 Preparations for Nebulisation, V-A373 Production of Radiopharmaceuticals,
Powder, Superfine, Definition of, Characterisation, V-A373 IV-629
V-A483 Preparations, Rectal, III-68 Production statements, I-25, II-25,
Powder, Very Fine, Definition of, Preparations, Vaginal, III-79 III-25, IV-25, V-25
V-A483 Prepared Belladonna, IV-88 Production, Status of, I-9, II-9, III-9,
Powdered Cellulose, I-473 Prepared Belladonna Herb, see Prepared IV-9, V-9
Powdered Tragacanth, see Tragacanth Belladonna Products of Fermentation, I-930
Powdered Valerian, IV-385 Prepared Calamine, I-346 Products of Recombinant DNA
Powders, III-66, III-67 Prepared Chalk, I-489 Technology, II-731
Dusting, III-67 Prepared Ipecacuanha, IV-216 Products with Risk of Transmitting
for Cutaneous Application, III-67 Prepared Opium, IV-289 Agents of Animal Spongiform
Oral, III-66 Prepared Stramonium, IV-368 Encephalopathies, II-900
Powders for Lotions, III-43 Preservation Solutions, Organ, see Organ Progesterone, II-671, V-S115
Powders, Particle size classification of, Preservation Solutions Progesterone Injection, III-994
V-A483 Preservative-free Eye Drops, V-A754 Proguanil Hydrochloride, II-673, V-S116
Powders, Particle Size of, V-A483– Preservative-free Oral Liquids, V-A754 Proguanil Tablets, III-995
V-A525 Preservative-free Unlicensed Medicines, Projected area diameter, V-A504
Powders, Wettability of Porous Solids V-A754 Proline, II-674, V-A107
Including, V-A518 Pressurised Inhalations, III-55 Prolonged-release Alfuzosin Tablets,
Poxvirus Vectors for Human Use, Pressurised Pharmaceutical Preparations, III-110
V-A738 III-68 Prolonged-release Aminophylline
ppm, V-A608 Pre-washed Manganese(IV) Oxide, V-A82 Tablets, III-127
ppm, Definition of, I-6, II-6, III-6, IV-6, Prilocaine, II-659, V-S112 Prolonged-release Bezafibrate Tablets,
V-6 Prilocaine Hydrochloride, II-661 III-194
Pramipexole Dihydrochloride Prilocaine Injection, III-987 Prolonged-release Cefaclor Tablets,
Monohydrate, II-642 Primaquine Diphosphate, see Primaquine III-248
Pravastatin Sodium, II-643 Phosphate Prolonged-release Clarithromycin
Pravastatin Tablets, III-978 Primaquine Phosphate, II-662 Tablets, III-315
Prazepam, II-645 Primary Aromatic Amino-nitrogen, Prolonged-release Clomipramine Tablets,
Praziquantel, II-646 Determination of, V-A268 III-332
Prazosin, V-S112 Primary opalescent suspension (formazin Prolonged-release Diclofenac Capsules,
Prazosin Hydrochloride, II-648 suspension), V-A231 III-432
Prazosin Tablets, III-979 Primary solutions, V-A233 Prolonged-release Diclofenac Tablets,
Precipitation Indicators, V-A760 Primary Standards, V-A139 III-435
Precipitation Titrations, V-A759 Primidone, II-664, V-S113 Prolonged-release Diltiazem Tablets,
Precision, V-A654 Primidone Oral Suspension, III-987 III-446
Prednicarbate, II-649 Primidone Tablets, III-988 Prolonged-release Dipyridamole
Prednisolone, II-651, V-S112, V-A107 Primula Root, IV-323 Capsules, III-453
Prednisolone Acetate, II-653, V-A107 Probenecid, II-665, V-S113 Prolonged-release Felodipine Tablets,
Prednisolone Acetate Injection, III-984 Probenecid Tablets, III-988 III-531
V-A822 Index
Prolonged-release Ferrous Sulfate Promethazine, V-S116 Protamine Zinc Insulin, see Protamine
Tablets, III-539 Promethazine Hydrochloride, II-676 Zinc Insulin Injection
Prolonged-release Ferrous Sulphate Promethazine Hydrochloride Tablets, Protected from Light, Definition of,
Tablets, see Prolonged-release Ferrous III-998 I-12, I-28, II-12, II-28, III-12, III-28,
Sulfate Tablets Promethazine Injection, III-997 IV-12, IV-28, V-12, V-28, V-A193
Prolonged-release Ibuprofen Capsules, Promethazine Oral Solution, III-997 Protein in Blood Products,
III-650 Promethazine Teoclate, II-677 Determination of, V-A275
Prolonged-release Ibuprofen Tablets, Promethazine Teoclate Tablets, III-999 Protein in Polysaccharide Vaccines,
III-656 Propacetamol Hydrochloride, II-678 V-A449
Prolonged-release Indapamide Tablets, Propafenone Hydrochloride, II-680 Protein, Total, Determination of,
III-661 Propane-1,3-diol, V-A107 V-A283
Prolonged-release Isosorbide Propanol, II-681, V-A108 Prothrombin Complex, Dried, IV-465
Mononitrate Capsules, III-695 Propan-2-ol and Methanol, Protirelin, II-697
Prolonged-release Isosorbide Determination of, V-A273 Protopine Hydrochloride, V-A108
Mononitrate Tablets, III-698 Propanol R1, V-A107, V-A108 Protriptyline, V-S118
Prolonged-release Lithium Carbonate 2-Propanol R2, V-A108 Protriptyline Hydrochloride, II-699
Tablets, III-736 2-Propanol R1, see Propan-2-ol R1 Protriptyline Tablets, III-1005
Prolonged-release Mesalazine Granules, 2-Propanol, see Propan-2-ol Proxymetacaine, V-S118
III-778 Propantheline Bromide, II-683 Proxymetacaine Eye Drops, III-1005
Prolonged-release Mesalazine Tablets, Propantheline Tablets, III-999 Proxymetacaine Hydrochloride, II-699,
III-784 Propetamphos, V-A108 V-S119
Prolonged-release Metoprolol Tartrate Propidium Iodide, V-A108 Proxyphylline, II-700
Tablets, III-806 Propionaldehyde, V-A108 Prunus Spinosa Fruit for Homoeopathic
Prolonged-release Minocycline Capsules, Propionic Acid, V-A108 Preparations, IV-438
III-821 Propionic Anhydride, V-A108 Pseudoephedrine, V-S119
Prolonged-release Morphine Tablets, Propionic Anhydride Reagent, V-A108 Pseudoephedrine Hydrochloride, II-701
III-834 Propofol, II-684, V-S117 Pseudoephedrine Oral Solution, III-1006
Prolonged-release Nifedipine Capsules, Propofol Injection, III-1000 Pseudoephedrine Tablets, III-1007
III-865 Propranolol, V-S117 Psyllium Seed, IV-324
Prolonged-release Nifedipine Tablets, Propranolol Capsules, Prolonged-release, Pteroic Acid, V-A108
III-867 III-1001 Puerarin, V-A108
Prolonged-release Oxybutynin Tablets, Propranolol Hydrochloride, II-686, Pulegone, V-A108
III-901 V-A108 Pumice Powder, V-A108
Prolonged-release Oxycodone Tablets, Propranolol Injection, III-1002 Pumping systems, Liquid
III-906 Propranolol Tablets, III-1003 Chromatography, V-A199
Prolonged-release Potassium Chloride Propyl Acetate, V-A108 Purified Hexane, V-A70
Tablets, III-972 Propyl Gallate, II-687 Purified Talc, II-968
Prolonged-release Potassium Tablets, Propyl Hydroxybenzoate, II-688, V-A108 Purified Water, II-1168
Bumetanide and, see Bumetanide and Propyl Parahydroxybenzoate, V-A108 Purple Coneflower Herb, see Echinacea
Prolonged-release Potassium Tablets Propyl Parahydroxybenzoate, see Propyl Purpurea Herb
Prolonged-release Propranolol Capsules, Hydroxybenzoate Purple Coneflower Root, see Echinacea
III-1001 Propylene Glycol, II-690, V-S117, Purpurea Root
Prolonged-release Salbutamol Capsules, V-A108 Putrescine, V-A108
III-1026 Propylene Glycol Cutaneous Solution, Pycnometric Density of Solids, V-A496
Prolonged-release Salbutamol Tablets, see Propylene Glycol Solution Pygeum Africanum Bark, see Pygeum
III-1037 Propylene Glycol Dicaprylocaprate, Bark
Prolonged-release Tamsulosin Capsules, II-690 Pygeum Bark, IV-325
III-1088 Propylene Glycol Dilaurate, II-691 Pyrantel Embonate, II-702
Prolonged-release Tamsulosin Tablets, Propylene Glycol Monolaurate, II-692 Pyrazinamide, II-703
III-1089 Propylene Glycol Monopalmitostearate, Pyrazinamide (1), V-S119
Prolonged-release Theophylline Tablets, II-693 Pyrazinamide (2), V-S120
III-1104 Propylene Glycol Monostearate, see Pyrazinamide Oral Suspension, III-1008
Prolonged-release Tramadol Capsules, Propylene Glycol Monopalmitostearate Pyrazinamide Tablets, III-1009
III-1124 Propylene Glycol Solution, III-1003 Pyrazine-2-carbonitrile, V-A108
Prolonged-release Tramadol Tablets, Propylene Oxide, V-A108 Pyridin-2-amine, V-A108
III-1125 Propylparaben, see Propyl Pyridine, V-A108
Prolonged-release Venlafaxine Capsules, Hydroxybenzoate Pyridine, Anhydrous, V-A108
III-1154 Propylsilyl Silica Gel for Pyridine Bromide Solution, V-A108
Prolonged-release Venlafaxine Tablets, Chromatography, V-A115 Pyridine-3-carboxaldehyde, V-A109
III-1157 Propylthiouracil, II-694, V-S118 Pyridinium Hydrobromide Perbromide,
Prolonged-release Verapamil Capsules, Propylthiouracil Tablets, III-1004 V-A109
III-1158 Propyphenazone, II-695 Pyridostigmine Bromide, II-705
Prolonged-release Verapamil Tablets, Protamine Hydrochloride, I-xxx Pyridostigmine Tablets, III-1009
III-1161 Protamine Sulfate, II-696, V-A108 Pyridoxine Hydrochloride, II-706,
D-Prolyl-L-phenylalanyl-L-arginine Protamine Sulfate Injection, III-1005 V-S120
4-Nitroanilide Hydrochloride, V-A107 Protamine Sulphate Injection, see Pyridoxine Tablets, III-1010
Promazine, V-S116 Protamine Sulfate Injection 2-Pyridylamine, V-A109
Promazine Hydrochloride, II-675 Protamine Sulphate, see Protamine Sulfate Pyrid-2-ylamine, see 2-Pyridylamine
Promazine Injection, III-996 Protamine Zinc Insulin Injection, III-671 Pyridylazonaphthol, V-A109
Promazine Tablets, III-996 Pyridylazonaphthol Solution, V-A109
4-(2-Pyridylazo)resorcinol Monosodium Quinine Sulphate Tablets, see Quinine Reagents, Descriptions of, I-7, II-7,
Salt, V-A109 Sulfate Tablets III-7, IV-7, V-7
Pyrimethamine, II-707, V-S120 Quinine Sulphate, see Quinine Sulfate Reagents, General, V-A19
Pyrimethamine Tablets, III-1011 Quinoline, V-A110 Recently Prepared, Definition of, I-10,
Pyrocatechol, see Catechol Quinoline Solution, V-A110 II-10, III-10, IV-10, V-10
Pyrogallol, V-A109 Quinolin-8-ol, V-S121 Recombinant DNA Technology,
Pyrogallol Solution, Alkaline, V-A109 Products of, II-731
Pyrogens, Test for, V-A394 Recommendations on Dissolution
Pyroxylin, II-708
Pyrrolidine, V-A109
R Testing, V-A344
Recrystallised Imidazole, V-A73
Rabbit Erythrocyte Suspension, V-A110
Pyrrolidone, II-709, V-A109 Recrystallised Iodine Pentoxide, V-A74
Rabies Antiserum, Fluorescein-
Pyruvic Acid, V-A109 Rectal Preparations, III-68
conjugated, V-A110
Rectified Spirit, I-884
Rabies Immunoglobulin, IV-478
Red Cinchona Bark, see Cinchona Bark
Rabies Vaccine, IV-596
Q Rabies Vaccine for Human Use Prepared
Red Litmus Paper, V-A80
Red Poppy Petals, IV-322
Q values, V-A629 in Cell Cultures, see Rabies Vaccine
Red solution, V-A233
Quadrupoles, V-A178 Rab, see Rabies Vaccine
Redox Indicators, V-A760
Qualitative Reactions and Tests, V-A255 Racecadotril, II-721
Redox Titrations, V-A759
Qualitative Tests for the Presence or Racementhol, II-722
Reducing Mixture, V-A110
Absence of Micro-Organisms, V-A717 Racemic Camphor, I-387
Reference buffer solutions, Preparation
Quality systems, I-21, II-21, III-21, Racemic Ephedrine Hydrochloride, see
of, V-A249
IV-21, V-21 Racephedrine Hydrochloride
Reference Materials, V-A157
Quantified Hawthorn Leaf and Flower Racemic Menthol, see Racementhol
Reference Materials and Spectra, I-12,
Liquid Extract, IV-210 Racephedrine Hydrochloride, II-724
II-12, III-12, IV-12, V-12
Quantified St. John’s Wort Dry Extract, Raclopride ([11C]Methoxy) Injection,
Reference Materials, Chemical and
IV-362 IV-676
Biological, see Reference Materials
Quantitation Limit, V-A655 Raclopride Tartrate, V-A110
Reference Preparation, International,
Quantitative Analysis, Pharmacopoeial, Radian, Definition of, I-32, II-32,
I-14, II-14, III-14, IV-14, V-14
V-A757 III-32, IV-32, V-32
Reference spectra, I-12, II-12, III-12,
Quantitative Tests for Enumeration of Radioactivity, Specific, IV-629
IV-12, V-12
Micro-Organisms, V-A717 Radiochemical Purity, IV-629
Reference spectra, concordance of, I-12,
Quantities, I-22, II-22, III-22, IV-22, Radionuclides Mentioned in the
II-12, III-12, IV-12, V-12
V-22 European Pharmacopoeia, Table of
Reference Spectra, Preparation of
Quercetin Dihydrate, V-A109 Physical Characteristics of, IV-634
Infrared, V-S2
Quercitrin, V-A109 Radionuclidic Purity, IV-629
Reference Standards, V-A728
Quillaia, IV-325 Radiopharmaceutical Preparations,
Reference Substances and Reference
Quillaia Bark, IV-326 IV-629
Preparations, I-15, II-15, III-15,
Quillaia Bark, see Quillaia Radiopharmaceuticals, IV-629
IV-15, V-15
Quillaia Liquid Extract, IV-327 Labelling of, IV-629
Reference Substances (BP),
Quillaia Saponins, Purified, V-A109 Production of, IV-629
Supplementary Information, V-A653
Quillaia Tincture, IV-327 Sterility of, IV-629
Reference suspensions, V-A231
Quinaldine Red, V-A109 Storage of, IV-629
References to regulatory documents,
Quinaldine Red Solution, V-A109 Raft strength, see Appendix XVII F2
I-22, II-22, III-22, IV-22, V-22
Quinapril Hydrochloride, II-710 Raloxifene Hydrochloride, II-724
Refined Almond Oil, I-101
Quinhydrone, V-A109 Raman Spectrometry, V-A180
Refined and Quantified Ginkgo Dry
Quinidine, V-A109 Ramipril, II-726, V-S121
Extract, IV-195
Quinidine Bisulfate, II-713 Ramipril Capsules, III-1016
Refined and Standardised Capsicum
Quinidine Bisulphate, see Quinidine Ramipril Tablets, III-1017
Oleoresin, IV-119
Bisulfate (1R)-(–)-Ammonium
Refined and Standardised Fresh Bilberry
Quinidine Sulfate, II-714, V-A109 10-Camphorsulfonate, V-A26
Fruit Dry Extract, IV-98
Quinidine Sulfate Tablets, III-1011 (1R)-(–)-Ammonium
Refined and Standardised Milk Thistle
Quinidine Sulphate Tablets, see Quinidine 10-Camphorsulphonate, see (1R)-(–)-
Dry Extract, IV-272
Sulfate Tablets Ammonium 10-Camphorsulfonate
Refined Arachis Oil, see Arachis Oil
Quinidine Sulphate, see Quinidine Sulfate Range, V-A655
Refined Borage Oil, I-301
Quinine, V-A109 Ranitidine Hydrochloride, II-729,
Refined Borage (Starflower) Oil, see
Quinine Bisulfate, II-715 V-S121
Refined Borage Oil
Quinine Bisulfate Tablets, III-1012 Ranitidine Injection, III-1019
Refined Castor Oil, I-422
Quinine Bisulphate Tablets, see Quinine Ranitidine Oral Solution, III-1020
Refined Coconut Oil, see Coconut Oil
Bisulfate Tablets Ranitidine Tablets, III-1021
Refined Evening Primrose Oil, I-914
Quinine Bisulphate, see Quinine Bisulfate Rapeseed Oil, V-A110
Refined Maize Oil, II-179
Quinine Dihydrochloride, II-717 Rapeseed Oil, Refined, II-731
Refined Olive Oil, II-427
Quinine Dihydrochloride Infusion, Ratanhia, V-A590
Refined Rapeseed Oil, II-731
III-1013 Ratio Turbidimetry, V-A232
Refined Safflower Oil, II-777
Quinine Dihydrochloride Sterile Raw Opium, see Opium
Refined Sesame Oil, II-797
Concentrate, III-1014 Reaction of Solution and Colour of
Refined Soya Oil, II-893
Quinine Hydrochloride, II-718, V-A109 Certain Indicators, V-A248
Refined Soya-bean Oil, see Refined Soya
Quinine Sulfate, II-719, V-A110 Reagents, I-23, II-23, III-23, IV-23,
Oil
Quinine Sulfate Tablets, III-1015 V-23
Refined Starflower Oil, see Refined Borage
Oil
V-A824 Index
Refined Sugar, see Sucrose Rhus Toxicodendron for Homoeopathic Ruthenium-106, Iodine-123 and, Spiking
Refined Sunflower Oil, II-963 Preparations, see Toxicodendron Solution, V-A74
Refined Wheat-germ Oil, II-1177 Quercifolium for Homoeopathic Ruthenium Red, V-A110
Refractive Index, Determination of, Preparations Ruthenium Red Solution, V-A110
V-A241 Ribavirin, II-740, V-S122 Rutin, V-A110
Rehydration Salts, Oral, III-891 Ribavirin for Nebulisation, see Ribavirin Rutoside Trihydrate, II-773
Reichstein’s Substance S, V-A110 Powder for Nebuliser Solution
Related substances in phenothiazines, Ribavirin Nebuliser Solution, see
V-A193
Related Substances, Tests for, V-A617
Ribavirin Powder for Nebuliser Solution
Ribavirin Powder for Nebuliser Solution,
S
Sabinene, V-A111
Relative Atomic and Molecular Masses, III-1022
Saccharin, II-774, V-A111
I-25, II-25, III-25, IV-25, V-25 Riboflavin, II-742
Saccharin Sodium, II-776, V-A111
Relative Density, Determination of, Riboflavin Sodium Phosphate, II-744
Saccharin, Soluble, see Saccharin Sodium
V-A241, V-A242 Ribose, V-A110
Safflower Flower, IV-335
Relative retention, V-A188 Ribose in Polysaccharide Vaccines,
Safflower Oil, Refined, II-777
Relative viscometers, V-A246 V-A451
Saffron for Homoeopathic Preparations,
Release Assay, V-A636 Ribwort Plantain, see Plantain
IV-440
Repaglinide, II-733 Rice Starch, II-914
Saffron for Homoeopathic Use, see
Repeatability, V-A654 Ricinoleic Acid, V-A110
Saffron for Homoeopathic Preparations
Reproducibility, V-A655 Rifabutin, II-745
Safrole, V-A111
Requirements, Pharmacopoeial, I-xxvi Rifampicin, II-747, V-S122
Sage Leaf, IV-336
Reserpine, II-735, V-A110 Rifampicin Capsules, III-1023
Sage Leaf (Salvia officinalis), see Sage
Residual Ethylene Oxide and Dioxan, Rifampicin Oral Suspension, III-1024
Leaf
V-A281 Rifamycin Sodium, II-748
Sage Leaf, Three-lobed, IV-337
Residual Pertussis Toxin and Rifaximin, II-750
Sage Oil, IV-338
Irreversibility of Pertussis Toxoid, Rilmenidine Dihydrogen Phosphate,
Sage Oil, Clary, see Sage Oil
V-A434 II-752
Sage Tincture, IV-337
Residual Solvent Levels in Active Ringer-Lactate Solution for Injection,
SAL - Sterility Assurance Level, V-A526
Substances, Excipients and Medicinal III-1059
Sal Volatile Solution, see Aromatic
Products, Limiting of, V-A658 Risedronate Sodium 2.5-Hydrate, II-753
Ammonia Solution
Residual Solvents, V-A276, V-A619, Risperidone, II-754
Sal Volatile Spirit, see Aromatic Ammonia
V-A658 Ritodrine Hydrochloride, II-757, V-S122
Spirit
Residual Solvents, Impurities Guidelines Ritodrine Injection, III-1024
Salannin CRS, V-A157
for, V-A658 Ritodrine Tablets, III-1025
Salbutamol, II-778, V-S123
Residue on Evaporation of Essential Oils, Ritonavir, II-758
Salbutamol Capsules, Prolonged-release,
V-A308 Rivastigmine, II-761
III-1026
Resin for Reversed-phase Ion Rivastigmine Hydrogen Tartrate, II-763
Salbutamol Inhalation Powder, III-1031
Chromatography, V-A110 Rizatriptan Benzoate, II-765
Salbutamol Inhalation Powder,
Resistance to Crushing of Tablets, Robustness, V-A655
pre-dispensed, III-1032
V-A495 Rocuronium Bromide, II-766
Salbutamol Injection, III-1027
Resolution factor, Liquid Roman Chamomile Flower, see
Salbutamol Nebuliser Solution, III-1029
Chromatography, V-A200 Chamomile Flowers
Salbutamol Oral Solution, III-1030
Resorcinol, II-736, V-A110 Ropivacaine Hydrochloride
Salbutamol Powder for Inhalation,
Resorcinol Reagent, V-A110 Monohydrate, II-769
metered-dose powder inhalers, see
Restharrow Root, IV-327 Rose, Dog, IV-158
Salbutamol Inhalation Powder
Retardation factor, V-A186 Roselle, IV-331
Salbutamol Powder for Inhalation,
Retention factor, V-A185 Rosemary Leaf, IV-332
pre-metered units, see Salbutamol
Retention time, V-A184 Rosemary Oil, IV-334
Inhalation Powder, pre-dispensed
Retinol Concentrate (Oily Form), Rosmarinic Acid, V-A110
Salbutamol Pressurised Inhalation,
Synthetic, II-737 Rosmarinic acid CRS, V-A157
III-1034
Retinol Concentrate (Powder Form), Rotating cylinder method, Dissolution
Salbutamol Sulfate, II-780, V-S123
Synthetic, II-738 Test for Transdermal Patches, V-A348
Salbutamol Sulphate, see Salbutamol
Retinol Concentrate, Rotating viscometer method, V-A245
Sulfate
Solubilisate/Emulsion, Synthetic, Rotavirus (live, oral), see Rotavirus
Salbutamol Tablets, III-1035
II-739 Vaccine (Live, Oral)
Salbutamol Tablets, Prolonged-release,
Retinol Concentrate (Water-dispersible Rotavirus Vaccine (Live, Oral), IV-599
III-1037
Form, Synthetic, see Synthetic Retinol Roxithromycin, II-771
Salcatonin Injection, see Calcitonin
Concentrate Solubilisate/Emulsion (RS)-Methotrexate, V-A84
(Salmon) Injection
Retroviridae-derived Vectors for Human (1RS)-1-(6-Methoxynaphthalen-2-
Salcatonin, see Calcitonin (Salmon)
Use, V-A740 yl)ethanol, V-A84
Salicin, V-A111
L-Rhamnose, V-A110 Rubber Closures for Containers for
Salicylaldehyde, V-A111
Rhamnose, see L-Rhamnose Aqueous Parenteral Preparations,
Salicylaldehyde Azine, V-A111
Rhaponticin, V-A110 V-A540
Salicylates, Reactions of, V-A258
Rhatany Root, IV-328 Rubella Immunoglobulin, IV-479
Salicylic Acid, II-783, V-S123, V-A111
Rhatany Tincture, IV-329 Rubella Vaccine, Live, IV-602
Salicylic Acid Collodion, III-1038
Rheum Palmatum, V-A590 Rubella, see Rubella Vaccine, Live
Salicylic Acid Cream, III-1038
Rhodamine 6 G, V-A110 Run time, Liquid Chromatography,
Salicylic Acid Ointment, III-1038,
Rhodamine B, V-A110 V-A200
V-A756
Rhubarb, IV-329 Ruscogenins, V-A110
Rhubarb Tincture, Compound, IV-331
Salicylic Acid Ointment, Coal Tar and, Selenium Standard Solution (100 ppm Sieves and Filters, V-A483
III-1091 Se), V-A149 Sieving, determination of particle size by,
Salicylic Acid Ointment, Dithranol and, Selenium Sulfide, II-792 V-A485
III-463 Selenium Sulfide Application, III-1041 Signal-to-noise ratio, V-A188
Salicylic Acid Paste, Zinc and, III-1179 Selenium Sulfide Scalp Application, Silanised Diatomaceous Earth for GC
Saline pH 7.2, Phosphate-albumin III-1041 R1, V-A50
Buffered, V-A155 Selenium Sulphide Scalp Application, see Silanised Diatomaceous Support, V-A51
Saline pH 6.4, Phosphate-buffered, Selenium Sulfide Scalp Application Silanised Silica Gel H, V-A117
V-A155 Selenium Sulphide, see Selenium Sulfide Silanised Silica Gel HF254, V-A117
Saline pH 7.2 R1, Phosphate-albumin Self-emulsifying Glyceryl Monostearate, Sildenafil Citrate, II-802
Buffered, V-A155 I-1072 Silibinin, V-A112
Saline Solution, V-A111 Self-emulsifying Mono- and Diglycerides Silica, Colloidal Anhydrous, II-804
Salmeterol Xinafoate, II-784 of Food Fatty Acids, see Self- Silica, Colloidal Hydrated, II-804
Salmon Oil, Farmed, II-786 emulsifying Glyceryl Monostearate Silica, Dental-type, II-806
Salvia Miltiorrhiza Root and Rhizome, Self-emulsifying Monostearin, see Self- Silica Gel, V-A112
IV-340 emulsifying Glyceryl Monostearate Silica Gel p-Acceptor - p-Donor for
Salvianolic Acid B, V-A111 Selfheal Fruit-Spike, IV-347 Chiral Separations, V-A112
Salvianolic Acid B CRS, V-A157 Semicarbazide Acetate Solution, V-A112 Silica Gel AD for Chiral Separation,
Sand, V-A111 Semicarbazide Hydrochloride, V-A112 V-A112
Sanguisorba root, see Greater Burnet Root Semi-solid Preparations for Cutaneous Silica Gel AGP for Chiral
Santonin, V-A111 Application, III-70 Chromatography, V-A112
Saponification Value, Determination of, Semi-solids or Gels, Texture Analysis of, Silica Gel, Anhydrous, V-A112
V-A306 V-A492 Silica Gel BC for Chiral
Saquinavir Mesilate, II-788 Senega, V-A590 Chromatography, V-A112
Sarafloxacin Hydrochloride, V-A111 Senega Root, IV-349 Silica Gel F254, V-A116
Saturated Methanolic Potassium Senega, see Senega Root Silica Gel for Chiral Chromatography,
Hydrogen Carbonate, V-A106 Senna Fruit, Alexandrian, IV-349 Urea Type, V-A112
Saturated Potassium Iodide Solution, Senna Fruit, Tinnevelly, IV-350 Silica Gel for Chromatography, V-A112
V-A106 Senna Granules, Standardised, IV-352 Silica Gel for Chromatography, Alkyl-
Saturated Sodium Chloride Solution, Senna Leaf, IV-353 bonded for use with Highly Aqueous
V-A119 Senna Leaf Dry Extract, Standardised, Mobile Phases, V-A113
Saw Palmetto Fruit, IV-343 IV-354 Silica Gel for Chromatography, Alkyl-
(1S)-(þ)-10-Camphorsulfonic Acid, Senna Liquid Extract, IV-351 bonded for use with Highly Aqueous
V-A37 Senna Pods, Alexandrian, see Alexandrian Mobile Phases, End-capped, V-A113
(1S)-(þ)-10-Camphorsulphonic Acid, see Senna Fruit Silica Gel for chromatography,
(1S)-(þ)-10-Camphorsulfonic Acid Senna Pods, Tinnevelly, see Tinnevelly Amidohexadecylsilyl, V-A113
Schisandra Fruit, IV-345 Senna Fruit Silica Gel for Chromatography,
Schisandrin, V-A111 Senna Tablets, IV-352 Aminohexadecylsilyl, V-A113
Scintillation Cocktail, Liquid, V-A80 Sep/Ser, see Gas-gangerene Antitoxin Silica Gel for Chromatography,
Sclareol, V-A111 (Septicum) Aminopropylmethylsilyl, V-A113
Scopoletin, V-A112 Serine, II-793, V-A112 Silica Gel for Chromatography,
Scutellariae Baicalensis Root, IV-346 Sertaconazole Nitrate, II-794 Aminopropylsilyl, V-A113
(S)-3,5-Dichloro-2,6-dihydroxy-N- Sertraline Hydrochloride, II-795 Silica Gel for Chromatography, Amylose-
[(1-ethylpyrrolidin-2- Sertraline Hydrochloride (A), V-S124 derivative of, V-A113
yl)methyl]benzamide hydrobromide, Sertraline Hydrochloride (B), V-S124 Silica Gel for Chromatography,
V-A51 Sertraline Tablets, III-1041 Butylsilyl, V-A113
SDS-PAGE Running Buffer, V-A112 Serum Gonadotrophin, V-A69 Silica Gel for Chromatography,
SDS-PAGE Sample Buffer Sesame Oil, Refined, II-797 Butylsilyl, End-capped, V-A113
(Concentrated), V-A112 Sesame Oil, see Refined Sesame Oil Silica Gel for Chromatography, Crown-
SDS-PAGE Sample Buffer for Reducing Sets for the Transfusion of Blood and ether, V-A113
Conditions (Concentrated), V-A112 Blood Components, V-A541 Silica Gel for Chromatography,
Sealed Container, V-A530 Sevoflurane, II-799 Cyanosilyl, V-A113
Searle type viscometer, V-A245 Shear Cell Flow Methods, V-A502 Silica Gel for Chromatography, Di-
Second, Definition of, I-32, II-32, Shellac, II-801 isobutyloctadecylsilyl, V-A113
III-32, IV-32, V-32 Shingles (Herpes Zoster) Vaccine (Live), Silica gel for chromatography,
Secondary Band, Definition of, V-A193 IV-603 Diisopropylcyanopropylsilyl, V-A113
Secondary Peak, Definition of, V-A196 Shingles (live), see Shingles (Herpes Silica Gel for Chromatography,
Secondary peaks, Liquid Zoster) Vaccine Dimethyloctadecylsilyl, V-A113
Chromatography, V-A200 SI, V-A608 Silica Gel for Chromatography, Diol,
Secondary Spot, Definition of, V-A193 SI Units, I-31, II-31, III-31, IV-31, V-A113
Selegiline, V-S124 V-31 Silica Gel for Chromatography,
Selegiline Hydrochloride, II-790 SI Units, Use of, I-6, II-6, III-6, IV-6, Dodecylsilyl, End-capped, V-A113
Selegiline Oral Solution, III-1038 V-6 Silica Gel for Chromatography,
Selegiline Tablets, III-1040 Sialic acid in Polysaccharide Vaccines, Hexadecylamidylsilyl, V-A113
Selenious Acid, V-A112 V-A451 Silica Gel for Chromatography,
Selenium, V-A112 Sialic Acid, see N-Acetylneuraminic Acid Hexadecylamidylsilyl, End-capped,
Selenium Dioxide, V-A112 Siam Benzoin, IV-92 V-A113
Selenium Disulfide, see Selenium Sulfide Siam Benzoin Tincture, IV-92 Silica Gel for Chromatography,
Selenium Standard Solution (1 ppm Se), Siberian Ginseng, see Eleutherococcus Hexylsilyl, V-A113
V-A149 Sieve Test, see Particle Size of Powders
V-A826 Index
Silica Gel for Chromatography, Silica Gel for Chromatography R1, Silver Standard Solution (5 ppm Ag),
Hexylsilyl, End-capped, V-A114 Octadecylsilyl, End-capped, Base- V-A149
Silica Gel for Chromatography, Human deactivated, V-A116 SIM (Selected-ion monitoring), V-A178
Albumin, V-A114 Silica Gel for Chromatography R1, Simeticone, II-808
Silica Gel for Chromatography, Aminopropylsilyl, V-A113 Simeticone for Oral Use, II-810
Hydrophilic, V-A114 Silica Gel for Chromatography R1, Simeticone Suspension for Infants,
Silica Gel for Chromatography, Nitrile, V-A115 III-1043
Methylsilyl, V-A114 Silica Gel for Chromatography R1, Similar Biological Medicinal Products,
Silica Gel for Chromatography, Nitrile, Octadecylsilyl, V-A116 V-A765
V-A114 Silica Gel for Chromatography R1, Similar, definition of, I-5, II-5, III-5,
Silica Gel for Chromatography, Nitrile, Octylsilyl, V-A116 IV-5, V-5
End-capped, V-A114 Silica Gel for Chromatography R1, Simple Eye Ointment, III-1044
Silica Gel for Chromatography, Phenylsilyl, V-A116 Simple Linctus, III-1044
4-Nitrophenylcarbamidesilyl, V-A114 Silica Gel for Chromatography R2, Simple Linctus, Paediatric, III-1044
Silica Gel for Chromatography, Nitrile, V-A115 Simple Ointment, III-1044
Octadecanoylaminopropylsilyl, V-A114 Silica Gel for Chromatography R2, Simvastatin, II-810, V-S125
Silica gel for Chromatography, Octadecylsilyl, V-A116 Simvastatin Tablets, III-1044
Octadecylsilyl, V-A114 Silica Gel for Chromatography R2, Sinensetin, V-A118
Silica Gel for Chromatography, Octylsilyl, V-A116 Single-dose Container, V-A530
Octadecylsilyl, Base-deactivated, Silica Gel for Chromatography R3, Sinomenine, V-A118
V-A114 Octylsilyl, V-A116 Sitostanol, V-A118
Silica Gel for Chromatography, Silica Gel for Chromatography, Strong b-Sitosterol, V-A118
Octadecylsilyl, End-capped, V-A114 cation-exchange, V-A116 Size-exclusion Chromatography, V-A196
Silica Gel for Chromatography, Silica Gel for Chromatography, Strong- Size-exclusion Chromatography, Silica
Octadecylsilyl, End-capped, Base- anion-exchange, V-A116 Gel for, V-A116
deactivated, V-A114 Silica Gel for Chromatography, (S)-Lactic Acid, II-62
Silica Gel for Chromatography, Trimethylsilyl, V-A116 Slip Point, V-A237
Octadecylsilyl, Monolithic, V-A114 Silica Gel for Size-exclusion Smallpox Vaccine (Live), IV-604
Silica Gel for Chromatography, Chromatography, V-A116 (S)-(-)-a-Methylbenzyl Isocyanate,
Octadecylsilyl, with Embedded Polar Silica Gel G, V-A116 V-A85
Groups, End-capped, V-A114 Silica Gel GF254, V-A117 SMV(live), see Smallpox Vaccine (Live)
Silica Gel for Chromatography, Silica Gel H, V-A117 SN50, V-A608
Octadecylsilyl, with Polar Incorporated Silica Gel H, Silanised, V-A117 Soap, Soft, II-812
Groups, End-capped, V-A114 Silica Gel HF254, Silanised, V-A117 Soap Spirit, III-1046
Silica Gel for Chromatography, Silica Gel HF254, V-A117 Soda, Caustic, see Sodium Hydroxide
Octylsilyl, V-A115 Silica Gel OC for Chiral Separations, Soda Lime, II-813
Silica Gel for Chromatography, V-A117 Soda Mint Tablets, III-1048
Octylsilyl, Base-deactivated, V-A115 Silica Gel OD for Chiral Separations, Soda-lime-silica glass, V-A530
Silica Gel for Chromatography, V-A117 Sodium, V-A118
Octylsilyl, End-capped, V-A115 Silica Gel OJ for Chiral Separations, Sodium Acetate, V-A118
Silica Gel for Chromatography, V-A117 Sodium Acetate ([1-11C]) Injection,
Octylsilyl, End-capped, Base- Silica Gel Plate, TLC, V-A132 IV-678
deactivated, V-A115 Silica, Hydrophobic Colloidal Sodium Acetate, Anhydrous, V-A118
Silica Gel for Chromatography, Anhydrous, II-805 Sodium Acetate Buffer pH 7.0, V-A155
Octylsilyl, with Polar Incorporated Silicates, Reactions of, V-A258 Sodium Acetate Buffer Solution pH 4.0,
Groups, End-capped, V-A115 Silicone, V-A571 0.1 M, V-A155
Silica Gel for Chromatography, Silicone Elastomer for Closures and Sodium Acetate Buffer Solution pH 4.5,
Oxypropionitrilsilyl, V-A115 Tubing, V-A572 V-A155
Silica Gel for Chromatography, Silicotungstic Acid, V-A117 Sodium Acetate Solution pH 6.0,
Palmitamidopropylsilyl, End-capped, Silicristin, V-A117 Buffered, V-A155
V-A115 Silidianin, V-A117 Sodium Acetate Trihydrate, II-814
Silica Gel for Chromatography, Phenyl, Silver and Silver Compounds, Reactions Sodium Acid Citrate, II-814
V-A115 of, V-A258 Sodium Acid Phosphate, see Sodium
Silica Gel for Chromatography, Silver, Colloidal, for External Use, II-807 Dihydrogen Phosphate Dihydrate
Phenylethyl, End-capped, V-A115 Silver Diethyldithiocarbamate, V-A117 Sodium Alendronate, II-815
Silica Gel for Chromatography, Silver Manganese Paper, V-A118 Sodium Alendronate Tablets, see
Phenylhexylsilyl, V-A115 Silver Nitrate, II-808, V-A118 Alendronic Acid Tablets
Silica Gel for Chromatography, Silver Nitrate Cutaneous Solution, see Sodium Alginate, II-816
Phenylhexylsilyl, End-capped, V-A115 Silver Nitrate Solution Sodium Amidotrizoate, II-817, V-S125
Silica Gel for Chromatography, Silver Nitrate Reagent, V-A118 Sodium Aminosalicylate Dihydrate,
Phenylsilyl, V-A115 Silver Nitrate Solution, III-1043, V-A118 II-818
Silica Gel for Chromatography, Silver Nitrate Solution, Ammoniacal, Sodium and Sodium Salts, Reactions of,
Phenylsilyl, End-capped, V-A115 V-A118 V-A258
Silica Gel for Chromatography, Silver Nitrate Solution in Pyridine, Sodium Arsenite, V-A118
Propoxybenzene, End-capped, V-A115 V-A118 Sodium arsenite solution, V-A118
Silica Gel for Chromatography, Silver Nitrate Solution R1, V-A118 Sodium Arsenite VS, V-A144
Propylsilyl, V-A115 Silver Nitrate Solution R2, V-A118 Sodium Ascorbate, II-819
Silica Gel for Chromatography R1, Silver Nitrate Solution, Sterile, III-1043 Sodium Ascorbate Solution, V-A118
Octadecylsilyl, End-capped, V-A116 Silver Nitrate VS, V-A143 Sodium Aurothiomalate, II-821
Silver Oxide, V-A118
Sodium Aurothiomalate Injection, Chloride, see Potassium Chloride, Sodium Cromoglicate Powder for
III-1046 Sodium Chloride and Glucose Infusion Inhalation, see Sodium Cromoglicate
Sodium Azide, V-A118 Sodium Chloride and Dextrose Inhalation Powder, hard capsule
Sodium Benzoate, II-823 Intravenous Infusion, see Sodium Sodium Cyclamate, II-836
Sodium Bicarbonate, II-824 Chloride and Glucose Infusion Sodium Decanesulfonate, V-A119
Sodium Bicarbonate Ear Drops, III-1046 Sodium Chloride and Glucose Infusion, Sodium Decanesulphonate, see Sodium
Sodium Bicarbonate Eye Lotion, III-1052 Decanesulfonate
III-1047 Sodium Chloride and Glucose Infusion, Sodium Decyl Sulfate, V-A119
Sodium Bicarbonate Infusion, III-1047 Potassium Chloride, see Potassium Sodium Decyl Sulphate, see Sodium Decyl
Sodium Bicarbonate Intravenous Chloride, Sodium Chloride and Glucose Sulfate
Infusion, see Sodium Bicarbonate Infusion Sodium Deoxycholate, V-A119
Infusion Sodium Chloride and Glucose Sodium Deoxyribonucleate, V-A119
Sodium Bicarbonate Oral Solution, Intravenous Infusion, Potassium Sodium Diethyldithiocarbamate, V-A119
III-1047 Chloride, see Potassium Chloride, Sodium Diethyldithiocarbamate
Sodium Bicarbonate Powder for Oral Sodium Chloride and Glucose Infusion Solution, V-A119
Solution, III-1048 Sodium Chloride and Glucose Sodium Dihydrogen Orthophosphate,
Sodium Bicarbonate Solution, see Sodium Intravenous Infusion, see Sodium V-A119
Hydrogen Carbonate Solution Chloride and Glucose Infusion Sodium Dihydrogen Orthophosphate,
Sodium Bicarbonate Tablets, Sodium Chloride and Sodium Citrate Anhydrous, V-A119
Compound, III-1048 Oral Solution, Compound Glucose, Sodium Dihydrogen Orthophosphate
Sodium Bicarbonate, see Sodium III-598 Monohydrate, V-A119
Hydrogen Carbonate Sodium Chloride Eye Drops, III-1049 Sodium Dihydrogen Phosphate, V-A119
Sodium Bismuthate, V-A118 Sodium Chloride Eye Lotion, III-1049 Sodium Dihydrogen Phosphate,
Sodium Borate, see Borax Sodium Chloride Eye Ointment, anhydrous, II-838, V-A119
Sodium Bromide, II-824, V-A118 III-1049 Sodium Dihydrogen Phosphate
Sodium Butanesulfonate, V-A118 Sodium Chloride Infusion, III-1050 Dihydrate, II-838
Sodium Butanesulphonate, see Sodium Sodium Chloride Infusion, Potassium Sodium Dihydrogen Phosphate
Butanesulfonate Chloride and, see Potassium Chloride Monohydrate, II-839, V-A119
Sodium Butyl Hydroxybenzoate, II-825 and Sodium Chloride Infusion Sodium Dioctyl Sulfosuccinate, V-A119
Sodium Butylparaben, II-825 Sodium Chloride Intravenous Infusion, Sodium Dithionite, V-A120
Sodium Calcium Edetate, II-826, Potassium Chloride and, see Potassium Sodium Dodecyl Sulfate, V-A120
V-A119 Chloride and Sodium Chloride Infusion Sodium Dodecyl Sulfate Polyacrylamide
Sodium Calcium Edetate Concentrate, Sodium Chloride Intravenous Infusion, Gel Electrophoresis, V-A202
Sterile, III-1048 see Sodium Chloride Infusion Sodium Dodecyl Sulfate VS, V-A144
Sodium Calcium Edetate Infusion, Sodium Chloride Irrigation Solution, Sodium Dodecyl Sulfate, see Sodium
III-1048 III-1050 Lauryl Sulfate
Sodium Calcium Edetate Injection, see Sodium Chloride Mouthwash, Sodium Dodecyl Sulphate VS, see
Sodium Calcium Edetate Infusion Compound, III-1050 Sodium Dodecyl Sulfate VS
Sodium Calcium Edetate Intravenous Sodium Chloride Nebuliser Solution, Sodium Dodecyl Sulphate, see Sodium
Infusion, see Sodium Calcium Edetate III-1050 Dodecyl Sulfate
Infusion Sodium Chloride Oral Solution, III-1051 Sodium Edetate, V-A120
Sodium Caprylate, II-827 Sodium Chloride Solution, III-1051, Sodium Edetate, see Disodium Edetate
Sodium Carbonate, V-A119 V-A119 Sodium Etacrynate for Injection,
Sodium Carbonate 0.025 M þ Sodium Sodium Chloride Solution, Saturated, III-1054
Hydrogen Carbonate 0.025 M, V-A119 Sodium Etacrynate Injection, III-1054
V-A249 Sodium Chloride Tablets, Soluble, Sodium Ethyl Parahydroxybenzoate, see
Sodium Carbonate, Anhydrous, II-828, III-1052 Ethyl Hydroxybenzoate Sodium
V-A119, V-A139 Sodium Cholate, V-A119 Sodium Feredetate, II-840, V-S125
Sodium Carbonate Decahydrate, II-829 Sodium Chromate (51Cr) Sterile Sodium Feredetate Oral Solution,
Sodium Carbonate Monohydrate, II-830, Solution, IV-679 III-1055
V-A119 Sodium Citrate, II-833, V-A119 Sodium Fluoresceinate, V-A120
Sodium Carbonate Solution, V-A119 Sodium Citrate Buffer Solution pH 7.8 Sodium Fluoresceinate, see Fluorescein
Sodium Carbonate Solution, Dilute, (0.034M Sodium Citrate, 0.101M Sodium
V-A119 Sodium Chloride), V-A155 Sodium Fluoride, II-840, V-A120
Sodium Carbonate Solution R1, V-A119 Sodium Citrate Eye Drops, III-1052 Sodium Fluoride (18F) Injection, IV-680
Sodium Carbonate Solution R2, V-A119 Sodium Citrate Irrigation Solution, Sodium Fluoride Mouthwash, III-1056
Sodium Cetostearyl Sulfate, II-830, III-1053 Sodium Fluoride Oral Drops, III-1056
V-A119 Sodium Citrate Oral Solution, Sodium Fluoride Oral Solution, III-1056
Sodium Cetostearyl Sulphate, see Sodium Compound Glucose, Sodium Chloride Sodium Fluoride Tablets, III-1057
Cetostearyl Sulfate and, III-598 Sodium Formate, V-A120
Sodium Chloride, II-832, V-A119, Sodium Citrate Solution for Bladder Sodium Fusidate, II-841
V-A139 Irrigation, Sterile, III-1053 Sodium Fusidate Ointment, III-1057
Sodium Chloride and Dextrose Infusion, Sodium Clodronate Tetrahydrate, II-834 Sodium Glucuronate, V-A120
III-1052 Sodium Cobaltinitrite, V-A119 Sodium Glycerophosphate, Hydrated,
Sodium Chloride and Dextrose Infusion, Sodium Cobaltinitrite Solution, V-A119 II-844
Potassium Chloride, see Potassium Sodium Cromoglicate, II-835 Sodium Glycocholate, V-A120
Chloride, Sodium Chloride and Glucose Sodium Cromoglicate Eye Drops, Sodium Heptanesulfonate, V-A120
Infusion III-1053 Sodium Heptanesulfonate Monohydrate,
Sodium Chloride and Dextrose Sodium Cromoglicate Inhalation V-A120
Intravenous Infusion, Potassium Powder, hard capsule, III-1053
V-A828 Index
Sodium Heptanesulphonate Sodium Iodide (123I) Solution, see Sodium Octanesulphonate Monohydrate,
Monohydrate, see Sodium Sodium Iodide (123I) Injection see Sodium Octanesulfonate Monohydrate
Heptanesulfonate Monohydrate Sodium Iodide Injection, III-1059 Sodium Octanesulphonate, see Sodium
Sodium Heptanesulphonate, see Sodium Sodium Iodobismuthate Solution, Octanesulfonate
Heptanesulfonate V-A121 Sodium Octanoate, see Sodium Caprylate
Sodium Hexanesulfonate, V-A120 Sodium Iodohippurate (123I) Injection, Sodium Octyl Sulfate, V-A121
Sodium Hexanesulfonate Monohydrate IV-686 Sodium Octyl Sulphate, see Sodium Octyl
for Ion-pair Chromatography, V-A120 Sodium Iodohippurate (131I) Injection, Sulfate
Sodium Hexanesulphonate IV-687 Sodium Oxalate, V-A122
Monohydrate, see Sodium Sodium Iodohippurate Dihydrate for Sodium Pentanesulfonate, V-A122
Hexanesulfonate Monohydrate Radiopharmaceutical Preparations, Sodium Pentanesulfonate Monohydrate,
Sodium Hexanesulphonate, see Sodium IV-646 V-A122
Hexanesulfonate Sodium Lactate Infusion, III-1059 Sodium Pentanesulfonate Monohydrate
Sodium Hyaluronate, II-845 Sodium Lactate Injection, III-1059 R1, V-A122
Sodium Hydrogen Carbonate, V-A120 Sodium Lactate Injection, Compound, Sodium Pentanesulphonate Monohydrate
Sodium Hydrogen Carbonate Oral III-1059 R1, see Sodium Pentanesulfonate
Solution, see Sodium Bicarbonate Oral Sodium Lactate Intravenous Infusion, Monohydrate R1
Solution Compound, III-1059 Sodium Pentanesulphonate
Sodium Hydrogen Carbonate Solution, Sodium Lactate Intravenous Infusion, see Monohydrate, see Sodium
V-A120 Sodium Lactate Infusion Pentanesulfonate Monohydrate
Sodium Hydrogen Carbonate, see Sodium Sodium Lactate Solution, II-849 Sodium Pentanesulphonate, see Sodium
Bicarbonate Sodium Laurilsulfate, V-A121 Pentanesulfonate
Sodium Hydrogen Sulfate, V-A120 Sodium Laurilsulfate, see Sodium Dodecyl Sodium Perborate, II-857
Sodium Hydrogen Sulphate, see Sodium Sulfate Sodium Perborate, Hydrated, see Sodium
Hydrogen Sulfate Sodium Laurilsulfate, see Sodium Lauryl Perborate
Sodium Hydrogensulfite, V-A120 Sulfate Sodium Perchlorate, V-A122
Sodium Hydrogensulphite, see Sodium Sodium Lauryl Sulfate, II-851, V-A121 Sodium Periodate, V-A122
Hydrogensulfite Sodium Lauryl Sulfate, see Sodium Sodium Periodate Solution, V-A122
Sodium Hydroxide, II-848, V-A120 Dodecyl Sulfate Sodium Periodate VS, V-A144
2 M Sodium hydroxide, V-A120 Sodium Lauryl Sulphate, see Sodium Sodium Pertechnetate (99mTc) Injection
Sodium Hydroxide, Ethanolic, V-A120 Dodecyl Sulfate (Fission), IV-690
Sodium Hydroxide, Methanolic, V-A120 Sodium Lauryl Sulphate, see Sodium Sodium Pertechnetate (99mTc) Injection
Sodium Hydroxide Solution, V-A120 Lauryl Sulfate (Non-fission), IV-691
Sodium Hydroxide Solution, Carbonate- Sodium Laurylsulfonate for Sodium Phenylbutyrate, II-857
free, V-A120 Chromatography, V-A121 Sodium Phosphate (32P) Injection,
Sodium Hydroxide Solution, Dilute, Sodium Laurylsulphonate for IV-692
V-A120 Chromatography, see Sodium Sodium Phosphate Buffer Solution
Sodium Hydroxide Solution, Methanolic, Laurylsulfonate for Chromatography pH 8.0, 0.02M, V-A156
V-A120 Sodium Metabisulfite, II-852, V-A121 Sodium Phosphate Dihydrate, see
Sodium Hydroxide Solution R1, Sodium Metabisulphite, see Sodium Disodium Hydrogen Phosphate Dihydrate
Methanolic, V-A120 Metabisulfite Sodium Phosphates Enema, III-955
Sodium Hydroxide Solution, Strong, Sodium Methanesulfonate, V-A121 Sodium Phosphate, see Disodium
V-A120 Sodium Methoxide VS, V-A144 Hydrogen Phosphate Dodecahydrate
Sodium Hydroxide VS, V-A144 Sodium Methyl Hydroxybenzoate, II-853 Sodium Phosphite, V-A122
Sodium Hydroxide VS, Ethanolic, Sodium Methyl Parahydroxybenzoate, see Sodium Phosphite Pentahydrate, V-A122
V-A144 Sodium Methyl Hydroxybenzoate Sodium Picosulfate, II-859
Sodium 2-Hydroxybutyrate, V-A120 Sodium Methylparaben, see Sodium Sodium Picosulfate Elixir, III-1061
Sodium Hypobromite Solution, V-A121 Methyl Hydroxybenzoate Sodium Picosulfate Oral Powder, see
Sodium Hypochlorite Solution, V-A121 Sodium Molybdate, V-A121 Compound Sodium Picosulfate Powder for
Sodium Hypochlorite Solution (3% Cl), Sodium Molybdate Dihydrate, II-854 Oral Solution
V-A121 Sodium Molybdate (99Mo) Solution Sodium Picosulfate Oral Solution,
Sodium Hypochlorite Solution, Dilute, (Fission), IV-688 III-1061
III-1058, V-A121 Sodium 1,2-Naphthoquinone-4- Sodium Picosulfate Powder for Oral
Sodium Hypochlorite Solution, Strong, sulfonate, V-A121 Solution, Compound, III-1062
III-1058, V-A121 Sodium Nitrate, V-A121 Sodium Picrate Solution, Alkaline,
Sodium Hypochlorite Solution, Strong, Sodium Nitrite, II-855, V-A121 V-A122
see Sodium Hypochlorite Solution (3% Sodium Nitrite Solution, V-A121 Sodium Polystyrene Sulfonate, II-860,
Cl) Sodium Nitrite VS, V-A144 V-S126
Sodium Hypophosphite, V-A121 Sodium Nitroprusside, II-856, V-A121 Sodium Polystyrene Sulphonate, see
Sodium Iodide, II-848, V-A121 Sodium Nitroprusside for Injection, Sodium Polystyrene Sulfonate
Sodium Iodide (123I) Injection, IV-681 III-1060 Sodium Potassium Tartrate, V-A122
Sodium Iodide (123I) Solution for Sodium Nitroprusside Infusion, III-1060 Sodium Potassium Tartrate, see Potassium
Radiolabelling, IV-681 Sodium Nitroprusside Intravenous Sodium (þ)-Tartrate
Sodium Iodide (131I) Capsules for Infusion, see Sodium Nitroprusside Sodium Propionate, II-861
Diagnostic Use, IV-682 Infusion Sodium Propyl Hydroxybenzoate, II-862
Sodium Iodide (131I) Capsules for Sodium Nitroprusside-Carbonate Sodium Propyl Parahydroxybenzoate, see
Therapeutic Use, IV-683 Solution, V-A121 Sodium Propyl Hydroxybenzoate
Sodium Iodide (131I) Solution, IV-684 Sodium Octanesulfonate, V-A121 Sodium Propylparaben, see Sodium Propyl
Sodium Iodide (131I) Solution For Sodium Octanesulfonate Monohydrate, Hydroxybenzoate
Radiolabelling, IV-685 V-A121 Sodium Pyrophosphate, V-A122
Sodium Pyrosulfite, see Sodium Sodium Tetrahydroborate Reducing Soluble Sulfacetamide, see Sulfacetamide
Metabisulfite Solution, V-A123 Sodium
Sodium Rhodizonate, V-A122 Sodium Tetraphenylborate, V-A123 Solutions for Haemodialysis, see
Sodium Salicylate, II-864, V-A122 Sodium Tetraphenylborate Solution, Haemodialysis Solutions
Sodium Selenite Pentahydrate, II-864 V-A123 Solutions for Haemofiltration and for
Sodium (S)-Lactate, II-850 Sodium Tetraphenylborate VS, V-A144 Haemodiafiltration, see Haemofiltration
Sodium (S)-Lactate Solution, II-850 Sodium Thioglycollate, V-A123 and Haemodiafiltration Solutions
Sodium Standard Solution (50 ppm Na), Sodium Thiosulfate, II-875, V-A123 Solutions for Organ Preservation, see
V-A149 Sodium Thiosulfate, Anhydrous, V-A123 Organ Preservation Solutions
Sodium Standard Solution (200 ppm Sodium Thiosulfate Injection, III-1064 Solutions for Peritoneal Dialysis, see
Na), V-A149 Sodium Thiosulfate VS, V-A145 Peritoneal Dialysis Solutions
Sodium Standard Solution (1000 ppm Sodium Thiosulphate Injection, see Solvents, I-23, II-23, III-23, IV-23,
Na), V-A149 Sodium Thiosulfate Injection V-23
Sodium Starch Glycolate (Type A), Sodium Thiosulphate VS, see Sodium Solvents for Pharmacopoeial Tests, I-12,
II-865 Thiosulfate VS II-12, III-12, IV-12, V-12
Sodium Starch Glycolate (Type B), Sodium Thiosulphate, see Sodium Solvents, Residual, V-A276
II-866 Thiosulfate Somatostatin, II-877
Sodium Starch Glycolate (Type C), Sodium Tungstate, V-A123 Somatropin, II-878
II-867 Sodium Valproate, II-875 Somatropin Concentrated Solution,
Sodium Stearate, II-868 Sodium Valproate Oral Solution, II-880
Sodium Stearyl Fumarate, II-869 III-1064 Somatropin for Injection, III-1067
Sodium Stibogluconate, II-870 Sodium Valproate Tablets, III-1065 Somatropin Injection, III-1066
Sodium Stibogluconate Injection, Sodium Valproate Tablets, Gastro- Sophora Flower, IV-355
III-1063 resistant, III-1066 Sophora Flower-Bud, IV-356
Sodium Sulfate, II-872, V-A122 Soft Soap, II-812 Sorbic Acid, II-882, V-A123
Sodium Sulfate, Anhydrous, II-871, Softening Time Determination of, Sorbitan Laurate, II-883
V-A122 V-A495 Sorbitan Monolaurate, see Sorbitan
Sodium sulfate, anhydrous R1, V-A122 Solid Oral Dosage Forms, Dissolution Laurate
Sodium Sulfate Decahydrate, V-A122 Testing of, V-A624 Sorbitan Mono-oleate, see Sorbitan Oleate
Sodium Sulfate Decahydrate, see Sodium Solids, Determination of Total, V-A319– Sorbitan Monopalmitate, see Sorbitan
Sulfate V-A332 Palmitate
Sodium Sulfide, V-A122 Solids Including Powders, Wettability of Sorbitan Monostearate, see Sorbitan
Sodium Sulfide Solution, V-A122 Porous, V-A518 Stearate
Sodium Sulfide Solution R1, V-A122 Solids, Pycnometric Density of, V-A496 Sorbitan Oleate, II-884
Sodium Sulfite, V-A122 Solochrome Dark Blue, V-A123 Sorbitan Palmitate, II-884
Sodium Sulfite, Anhydrous, II-872, Solochrome Dark Blue Mixture, V-A123 Sorbitan Sesquioleate, II-885
V-A122 Solubility, I-26, II-26, III-26, IV-26, Sorbitan Stearate, II-885
Sodium Sulfite Heptahydrate, II-873 V-26, V-A716 Sorbitan Trioleate, II-886
Sodium Sulfite, see Sodium Sulfite Freely soluble, Definition of, I-26, Sorbitol, II-886, V-A123
Heptahydrate II-26, III-26, IV-26, V-26 Sorbitol (Crystallising), Liquid, II-889
Sodium Sulphate, Anhydrous, see Sodium Practically insoluble, Definition of, Sorbitol (Non-crystallising), Liquid,
Sulfate, Anhydrous I-26, II-26, III-26, IV-26, V-26 II-890
Sodium Sulphate, see Sodium Sulfate Slightly soluble, Definition of, I-26, Sorbitol, Partially Dehydrated Liquid,
Sodium Sulphide Solution R1, see II-26, III-26, IV-26, V-26 II-888
Sodium Sulfide Solution R1 Soluble, Definition of, I-26, II-26, Sorbitol Solution (70 per cent)
Sodium Sulphide Solution, see Sodium III-26, IV-26, V-26 (Crystallising), see Liquid Sorbitol
Sulfide Solution Sparingly soluble, Definition of, I-26, (Crystallising)
Sodium Sulphide, see Sodium Sulfide II-26, III-26, IV-26, V-26 Sorbitol Solution (70 per cent) (Non-
Sodium Sulphite, Anhydrous, see Sodium Very slightly soluble, Definition of, crystallising), see Liquid Sorbitol (Non-
Sulphite, Anhydrous I-26, II-26, III-26, IV-26, V-26 crystallising)
Sodium Sulphite Heptahydrate, see Very soluble, Definition of, I-26, Sotalol Hydrochloride, II-891
Sodium Sulfite Heptahydrate II-26, III-26, IV-26, V-26 Sotalol Injection, III-1069
Sodium Sulphite, see Sodium Sulfite Solubility, Definition of Terms Used, Sotalol Tablets, III-1070
Sodium (þ)-Tartrate, V-A122 I-11, II-11, III-11, IV-11, V-11 Soya Oil, Hydrogenated, II-892
Sodium Tartrate, see Sodium (þ)-Tartrate Solubility in Alcohol of Essential Oils, Soya Oil, Refined, II-893
Sodium Taurodeoxycholate, V-A122 V-A309 Soya-bean casin digest medium, V-A458
Sodium Tetraborate, V-A122 Solubility, Status of, I-11, II-11, III-11, Spanish Sage Oil, IV-339
Sodium Tetraborate, see Borax IV-11, V-11 Spearmint Oil, IV-358
Sodium Tetrachloroaurate Dihydrate for Soluble Fluorescein, see Fluorescein Special, V-A752
Homoeopathic Preparations, IV-441 Sodium Specific Optical Rotation, Determination
Sodium Tetradecyl Sulfate Concentrate, Soluble Insulin Injection, see Insulin of, V-A241
II-874 Injection Specific Radioactivity, IV-629
Sodium Tetradecyl Sulfate Injection, Soluble Insulin, see Insulin Injection Specific Surface Area by Air
III-1063 Soluble Paracetamol and Caffeine Permeability, V-A487
Sodium Tetradecyl Sulphate Tablets, III-923 Specific Surface Area by Gas Adsorption,
Concentrate, see Sodium Tetradecyl Soluble Paracetamol Tablets, III-921 V-A497
Sulfate Concentrate Soluble Saccharin, see Saccharin Sodium Specific surface area determination,
Sodium Tetradecyl Sulphate Injection, Soluble Sodium Chloride Tablets, Brunauer, Emmett and Teller (BET)
see Sodium Tetradecyl Sulfate Injection III-1052 theory and, V-A497
Sodium Tetrahydroborate, V-A122 Soluble Starch, V-A123 Specificity, V-A653
V-A830 Index
Specified Micro-organisms, Tests for, Stabiliser-free Di-isopropyl Ether, V-A54 Starch, Hydrolysed, V-A123
V-A637 Stabiliser-free Tetrahydrofuran, V-A128 Starch Iodate Paper, V-A123
Spectinomycin Dihydrochloride Stability of Unlicensed Medicines, Starch Iodide Paper, V-A123
Pentahydrate, II-893 Storage and, V-A755 Starch, Maize, II-911
Spectral transmission for coloured glass Standard Dichlorophenolindophenol Starch Mucilage, V-A123
containers, V-A534 Solution, V-A52 Starch, Potato, II-912
Spectrometry, Mass, V-A176 Standard 2,6-Dichlorophenolindophenol Starch, Pregelatinised, II-913
Spectrometry, Nuclear Magnetic Solution, Double-strength, V-A52 Starch, Pregelatinised Hydroxypropyl,
Resonance, V-A166 Standard, International, I-14, II-14, II-910
Spectrometry, Raman, V-A180 III-14, IV-14, V-14 Starch, Soluble, V-A123
Spectrometry, X-Ray Fluorescence, Standard of opalescence, V-A231 Starch Solution, V-A124
V-A175 Standard Phosphate Buffer, 0.025M, Starch Solution, Iodide-free, V-A124
Spectrophotometry, Absorption, V-A153 Starch Solution R1, V-A124
Ultraviolet and Visible, V-A165 Standard Preparations for Biological Starch Solution R2, V-A124
Spectrophotometry, Atomic, Emission Assays, V-A632 Starch Substrate, V-A124
and Absorption, V-A170 Standard Solution for the Micro Starch, Tapioca, II-914
Spectrophotometry, Derivative, V-A166 Determination of Water, V-A123 Starch, Wheat, II-915
SPF, I-30, II-30, III-30, IV-30, V-30 Standard Solutions for Atomic Starflower Oil, Refined, see Refined
SPF, Chicken Flocks Free from Spectometry, Elementary, V-A147 Borage Oil
Specified Pathogens for the Production Standard Terms, V-A639 Stated Potency, I-14, II-14, III-14,
and Quality Control of Vaccines, Standardised Aloes Dry Extract, IV-55 IV-14, V-14, V-A635
V-A452 Standardised Belladonna Leaf Dry Static Head-space Gas Chromatography,
Spherulite, V-A504 Extract, IV-89 V-A195
Spike Lavender Oil, IV-235 Standardised Belladonna Leaf Tincture, Stationary phases, Liquid
Spindle viscometers, V-A246 see Belladonna Tincture Chromatography, V-A199
Spirapril Hydrochloride Monohydrate, Standardised Capsicum Tincture, IV-121 Stavudine, II-915
II-895 Standardised Cascara Dry Extract, Steam sterilisation, V-A528
Spirit, Industrial Methylated, II-248 IV-128 Steam sterilisation (Heating in an
Spirit (Ketone-free), Industrial Standardised Cinchona Liquid Extract, autoclave), V-A526
Methylated, II-248 IV-138 Stearic Acid, II-917, V-A124
Spirit, Rectified, I-884 Standardised Frangula Bark Dry Extract, Stearic Anhydride, V-A124
Spirits, III-72 IV-185 Stearoyl Macrogolglycerides, II-918
Spirits, Industrial Methylated, II-248 Standardised Ipecacuanha Liquid Stearyl Alcohol, II-919, V-A124
Spirits of the BP, III-72 Extract, IV-217 Stem Cells, Human Haematopoietic,
Spironolactone, II-897, V-S126 Standardised Ipecacuanha Tincture, IV-468
Spironolactone Oral Suspension, IV-218 Stephania Tetrandra Root, IV-364
III-1070 Standardised Milk Thistle Dry Extract, Sterculia, IV-365
Spironolactone Tablets, III-1071 Refined and, IV-272 Sterculia Granules, IV-365
Spongiform Encephalopathies, Animal, Standardised Opium Dry Extract, IV-290 Sterculia Gum, see Sterculia
Products with Risk of Transmitting Standardised Opium Tincture, IV-291 Sterile Catgut, IV-721
Agents of, II-900 Standardised Senna Granules, IV-352 Sterile Cetrimide Cutaneous Solution,
Spongiform Encephalopathy Agents Via Standardised Senna Leaf Dry Extract, III-279
Human and Veterinary Medicinal IV-354 Sterile Cetrimide Solution, III-279
Products, Minimising the Risk of Standards, Official, I-4, II-4, III-4, IV-4, Sterile Clonazepam Concentrate, III-333
Transmitting Animal, V-A592 V-4 Sterile Concentrate, Nizatidine, III-873
Spray-dried Acacia, I-42 Standards, Primary, V-A139 Sterile Concentrate, Quinine
Spray-dried Liquid Glucose, I-1057 Standards, Reference, V-A728 Dihydrochloride, III-1014
Sprays, III-60 Stannated Hydrochloric Acid, V-A72 Sterile Containers of Plasticised
Nasal, III-60 Stannous Chloride, V-A123 Poly(Vinyl Chloride) for Human
Squalane, II-900, V-A123 Stannous Chloride Dihydrate, II-902 Blood Containing Anticoagulant
Squill, IV-359 Stannous Chloride Solution, V-A123 Solution, V-A539
Squill, Indian, IV-359 Stannous Chloride Solution AsT, see Sterile Co-trimoxazole Concentrate,
Squill Linctus, Compound, IV-360 Tin(II) Chloride Solution AsT III-389
Squill Linctus, Opiate, IV-360 Stannous Chloride Solution R1, V-A123 Sterile Dobutamine Concentrate, III-465
Squill Linctus, Paediatric Opiate, IV-360 Stannous Chloride Solution R2, V-A123 Sterile Dopamine Concentrate, III-471
Squill Liquid Extract, IV-359 Stannous Chloride Solution R1, see Sterile Ephedrine Concentrate, III-493
Squill Oral Solution, Opiate, IV-360 Tin(II) Chloride Solution R1 Sterile Etoposide Concentrate, III-527
Squill Oral Solution, Paediatric Opiate, Stannous Chloride Solution R2, see Sterile Isoprenaline Concentrate, III-691
IV-360 Tin(II) Chloride Solution R2 Sterile Lidocaine Cutaneous Solution,
Squill Oxymel, IV-360 Stannous Chloride Solution, see Tin(II) III-728
SSI, V-A608 Chloride Solution Sterile Lidocaine Solution, III-728
S.S.I. - Statens Serum Institut, address Stannous Chloride, see Tin(II) Chloride Sterile Lignocaine Solution, see Sterile
of, I-31, II-31, III-31, IV-31, V-31 Stanolone, V-A123 Lidocaine Solution
St. John’s Wort, IV-361 Stanozolol, II-902, V-S126 Sterile Mitoxantrone Concentrate,
St. John’s Wort Quantified Dry Extract, Staphylococcus aureus Strain V8 Protease III-829
see Quantified St. John’s Wort Dry Type XVII-B, V-A123 Sterile Non-absorbable Ligatures, see
Extract Star Anise, IV-66 Sterile Non-absorbable Sutures
St Marks Solution, see Compound Glucose, Star Anise Oil, IV-67 Sterile Non-absorbable Sutures, IV-726
Sodium Chloride and Sodium Citrate Starch, V-A123 Sterile Noradrenaline Concentrate,
Oral Solution Starch, Cassava, II-914 III-875
Sterile Norepinephrine Concentrate, Streptomycin Injection, III-1073 Sub-visible Particles, Particulate

III-875 Streptomycin Sulfate, II-922, V-A124 Contamination, V-A379
Sterile Plastic Containers for Human Streptomycin Sulfate for Injection, Succinate Buffer Solution pH 4.6,
Blood and Blood Components, III-1074 V-A156
V-A537 Streptomycin Sulphate for Injection, see Succinic Acid, V-A124
Sterile Potassium Chloride Concentrate, Streptomycin Sulfate for Injection Sucralfate, II-923
III-971 Streptomycin Sulphate, see Streptomycin Sucralose, II-925
Sterile Potassium Dihydrogen Phosphate Sulfate Sucrose, II-927, V-A124
Concentrate, III-975 Strong Sucrose Monopalmitate, II-928
Sterile Products, Methods of Preparation Aminohydroxynaphthalenesulfonic Sucrose Stearate, II-929
of, V-A526 Acid Solution, V-A24 Sudan Red, V-A124
Sterile Silver Nitrate Solution, III-1043 Strong Ammonia Solution, I-154 Sudan Red G, V-A124
Sterile Single-use Plastic Syringes, Strong Ammonium Acetate Solution, Sudan Red Solution, V-A125
V-A543 III-135 Sudan Yellow, V-A125
Sterile Sodium Calcium Edetate Strong Cation Exchange Resin (Calcium Sudan Yellow Solution, V-A125
Concentrate, III-1048 Form), V-A39 Sufentanil, II-931
Sterile Sodium Citrate Solution for Strong cation-exchange Silica Gel for Sufentanil Citrate, II-932
Bladder Irrigation, III-1053 Chromatography, V-A116 Sugar, Compressible, II-934, V-S32
Sterile Sutures, see name of suture Strong Cetrimide Solution, I-485 Sugar, Refined, see Sucrose
Sterile Synthetic Absorbable Braided Strong Coal Tar Solution, III-1091 Sugar Spheres, II-935
Sutures, IV-723 Strong Ginger Tincture, IV-193 Suggested Methods, Status of, I-14,
Sterile Synthetic Absorbable Strong Glutaraldehyde Solution, I-1059 II-14, III-14, IV-14, V-14
Monofilament Sutures, IV-724 Strong Haloperidol Oral Drops, III-621 Sulbactam Sodium, II-935
Sterile Trisodium Edetate Concentrate, Strong Haloperidol Oral Solution, Sulfacetamide Sodium, II-937
III-1146 III-621 Sulfacetamide, Soluble, see Sulfacetamide
Sterilisation, Biological indicators of, Strong Iodine Monochloride Reagent, Sodium
V-A528 V-A74 Sulfadiazine, II-938, V-S127
Sterilisation, Dry heat, V-A527, V-A528 Strong Methyl Salicylate Ointment, Sulfadiazine Injection, III-1074
Sterilisation, Gas, V-A527, V-A528 III-794 Sulfadoxine, II-940
Sterilisation, Ionising radiation, V-A527, Strong 1-Naphthol Solution, V-A91 Sulfafurazole, II-941
V-A528 Strong Paediatric Alimemazine Oral Sulfaguanidine, II-942
Sterilisation, Methods and conditions of, Solution, III-113 Sulfamethizole, II-943
V-A526 Strong Pholcodine Linctus, III-955 Sulfamethoxazole, II-944, V-S127
Sterilisation, Methods of, I-10, II-10, Strong Pholcodine Oral Solution, see Sulfamethoxazole and Trimethoprim
III-10, IV-10, V-10, V-A526 Strong Pholcodine Linctus Preparations, see Co-trimoxazole
Sterilisation of Parenteral Preparations, Strong Sodium Hydroxide Solution, Preparations
Methods of, III-66 V-A120 Sulfamethoxazole Oral Suspension,
Sterilisation, steam, V-A528 Strong Sodium Hypochlorite Solution, Trimethoprim and, see Co-trimoxazole
Sterilisation, steam (Heating in an III-1058, V-A121 Oral Suspension
autoclave), V-A526 Strong-anion-exchange Silica Gel for Sulfamethoxazole Tablets, Dispersible
Sterilisation (steam) of aqueous Chromatography, V-A116 Trimethoprim and, III-392
preparations, Application of the F0 Strongly Acidic Ion-exchange Resin, Sulfamethoxazole Tablets, Trimethoprim
concept to, V-A529 V-A75, V-A124 and, see Co-trimoxazole Tablets
Sterilisation, Terminal, V-A526 Strongly Basic Anion Exchange Resin, Sulfamic Acid, V-A125
Sterilising Filtration, V-A527 V-A28 Sulfan Blue, V-A125
Sterility Assurance Level (SAL), V-A526 Strongly Basic Anion Exchange Resin Sulfanilamide, V-A125
Sterility of Radiopharmaceuticals, IV-629 Chromatography, V-A28 Sulfanilic Acid, V-A125, V-A139
Sterility of the product to be examined, Strontium (89Sr) Chloride Injection, Sulfanilic Acid Solution, V-A125
test for, V-A459 IV-693 Sulfanilic Acid Solution, Diazotised,
Steroids, Identification of, V-A194 Strontium Carbonate, V-A124 V-A125
Steroids, Tetrazolium Assay of, V-A275 Strontium Chloride, V-A124 Sulfanilic Acid Solution R1, V-A125
Sterols in Fatty Oils, V-A316 Strontium Chloride Hexahydrate, Sulfasalazine, II-945, V-S127
Sticks, III-72 V-A124 Sulfasalazine Tablets, III-1075
Stigmasterol, V-A124 Strontium Selective Extraction Resin, Sulfasalazine Tablets, Gastro-resistant,
Stinging Nettle, Common, for V-A124 III-1076
Homoeopathic Preparations, IV-439 Strontium Standard Solution Sulfate Buffer Solution pH 2.0, V-A156
Stomata, V-A321 (1.0 per cent Sr), V-A149 Sulfate Standard Solution (10 ppm SO4),
Storage and Stability of Unlicensed Strontium-85 Spiking Solution, V-A124 V-A149
Medicines, V-A755 Strontium-85 Standard Solution, Sulfate Standard Solution (10 ppm SO4)
Storage of Radiopharmaceuticals, IV-629 V-A124 R1, V-A149
Storage Statements, Status of, I-15, Styrene, V-A124 Sulfate Standard Solution (100 ppm
II-15, III-15, IV-15, V-15 Styrene-divinylbenzene Copolymer, SO4), V-A149
Stramonium Leaf, IV-366 V-A124 Sulfated Ash, Determination of, V-A293,
Stramonium, Prepared, IV-368 Subdued Light, Definition of, I-12, V-A294, V-A295, V-A296, V-A297,
Streptokinase Bulk Solution, see II-12, III-12, IV-12, V-12, V-A193 V-A298, V-A299, V-A300, V-A301,
Streptokinase Concentrated Solution Subsidiary Titles, Status of, I-7, II-7, V-A302, V-A303
Streptokinase Concentrated Solution, III-7, IV-7, V-7 Sulfates, Limit Test for, V-A266
II-920 Substances for Pharmaceutical Use, I-37, Sulfates, Reactions of, V-A258
Streptokinase for Injection, III-1072 II-37 Sulfathiazole, II-947, V-A125
Streptokinase Injection, III-1072 Sulfinpyrazone, II-948
V-A832 Index
Sulfinpyrazone Tablets, III-1078 Sulphur Dioxide R1, see Sulfur Dioxide Suxamethonium Chloride Injection,
Sulfite Standard Solution (1.5 ppm R1 III-1085
SO2), V-A149 Sulphur Dioxide Solution, see Sulfur Suxibuzone, II-964
Sulfite Standard Solution (80 ppm SO2), Dioxide Solution Sweet Fennel, IV-181
V-A149 Sulphur Dioxide, see Sulfur Dioxide Sweet Orange Oil, IV-295
Sulfomolybdic Reagent R2, V-A125 Sulphur for External Use, see Sulfur for Swelling Index, V-A319
Sulfomolybdic Reagent R3, V-A125 External Use Swertiamarin, V-A126
Sulfosalicylic Acid, V-A125 Sulphuric Acid, Alcoholic Solution of, see Symbols, Atomic Weights of Elements,
Sulfur Dioxide, V-A125 Sulfuric Acid, Alcoholic Solution of Names and, V-A609
Sulfur Dioxide, Determination of, Sulphuric Acid, Dilute, see Sulfuric Acid, Symmetry factor, V-A187
V-A293 Dilute Symphytum Officinale Root, Ethanol
Sulfur Dioxide R1, V-A125 Sulphuric Acid, Ethanolic, see Sulfuric Decoction for Homoeopathic
Sulfur Dioxide Solution, V-A125 Acid, Ethanolic Preparations, IV-443
Sulfur for External Use, II-951 Sulphuric Acid, Heavy Metal-free, see Symphytum Officinale Root for
Sulfur for Homoeopathic Preparations, Sulfuric Acid, Heavy Metal-free Homoeopathic Preparations, IV-442
IV-441 Sulphuric Acid, 2.5M Alcoholic, see Synonyms, Approved, V-A579
Sulfur-free Toluene, V-A132 Sulfuric Acid, 2.5m Alcoholic Synthetic Absorbable Braided Sutures,
Sulfuric Acid, II-952, V-A125 Sulphuric Acid, 0.25M Alcoholic, see Sterile, IV-723
Sulfuric Acid, Alcoholic Solution of, Sulfuric Acid, 0.25m Alcoholic Synthetic Absorbable Monofilament
V-A126 Sulphuric Acid, Methanolic, see Sulfuric Sutures, Sterile, IV-724
Sulfuric Acid, Dilute, II-952, V-A126 Acid, Methanolic Synthetic Air, I-82
Sulfuric Acid, Ethanolic, V-A126 Sulphuric Acid, Nitrogen-free, see Synthetic Air, MRI Compatible, I-82
Sulfuric Acid, Heavy Metal-free, V-A126 Sulfuric Acid, Nitrogen-free Synthetic Medicinal Air, see Synthetic Air
Sulfuric Acid, 2.5M Alcoholic, V-A126 Sulphuric Acid VS, see Sulfuric Acid VS Synthetic Peptides, Determination of
Sulfuric Acid, Methanolic, V-A126 Sulphuric Acid–Formaldehyde Reagent, Acetic Acid in, V-A286
Sulfuric Acid, Nitrogen-free, V-A126 see Sulfuric Acid–Formaldehyde Reagent Synthetic Retinol Concentrate (Oily
Sulfuric acid, nitrogen-free R1, V-A126 Sulphuric Acid, see Sulfuric Acid Form), II-737
Sulfuric Acid VS, V-A145 Sulphur, see Sulfur Synthetic Retinol Concentrate (Powder
Sulfuric Acid–Formaldehyde Reagent, Sulpiride, II-953, V-S128 Form), II-738
V-A126 Sulpiride Tablets, III-1079 Synthetic Retinol Concentrate,
Sulindac, II-950, V-S128 Sultamicillin, II-954 Solubilisate/Emulsion, II-739
Sulindac Tablets, III-1078 Sultamicillin Tosilate Dihydrate, II-957 Synthetic Retinol Concentrate (Water-
Sulphamic Acid, see Sulfamic Acid Sumatra Benzoin, IV-93 dispersible Form, see Synthetic Retinol
Sulphan Blue, see Sulfan Blue Sumatra Benzoin Tincture, IV-94 Concentrate Solubilisate/Emulsion
Sulphanilamide, see Sulfanilamide Sumatriptan, II-959, V-S128 Synthetic Vitamin A Concentrate (Oily
Sulphanilic Acid Solution, Diazotised, see Sumatriptan Injection, III-1080 Form), see Synthetic Retinol Concentrate
Sulfanilic Acid Solution, Diazotised Sumatriptan Nasal Spray, III-1082 (Oily Form)
Sulphanilic Acid Solution R1, see Sumatriptan Succinate, II-961, V-S129 Synthetic Vitamin A Concentrate
Sulfanilic Acid Solution R1 Sumatriptan Tablets, III-1083 (Powder Form), see Synthetic Retinol
Sulphanilic Acid Solution, see Sulfanilic Sunflower Oil, V-A126 Concentrate (Powder Form)
Acid Solution Sunflower Oil, Refined, II-963 Synthetic Vitamin A Concentrate,
Sulphanilic Acid, see Sulfanilic Acid Supercritical Fluid Chromatography, (Solubilisate/Emulsion), see Synthetic
Sulphate Buffer Solution pH 2.0, see V-A212 Retinol Concentrate, Solubilisate/
Sulfate Buffer Solution pH 2.0 Supercritical Fluid Chromatography, Emulsion
Sulphate Standard Solution (10 ppm Detectors, V-A212 Syringes, Sterile Single-use, Plastic,
SO4) R1, see Sulfate Standard Solution Supercritical Fluid Chromatography, V-A543
(10 ppm SO4) R1 Injectors, V-A212 Syrup, III-1085
Sulphate Standard Solution (10 ppm Supercritical Fluid Chromatography, System Suitability, V-A198
SO4), see Sulfate Standard Solution Mobile phases, V-A212 System Suitability, Chromatographic
(10 ppm SO4) Supercritical Fluid Chromatography, Tests, V-A619
Sulphate Standard Solution (100 ppm Pumping system, V-A212 System suitability requirements for
SO4), see Sulfate Standard Solution Supercritical Fluid Chromatography, monographs of the British
(100 ppm SO4) Stationary phases, V-A212 Pharmacopoeia, V-A191
Sulphated Ash, Determination of, see Superfine Powder, Definition of, V-A483 System Suitability Testing, V-A655
Sulfated Ash, Determination of Supplementary Chapters, Contents of
Sulphathiazole, see Sulfathiazole the, V-A613
Sulphite Standard Solution (1.5 ppm
SO2), see Sulfite Standard Solution
Suppositories, V-A495
Softening Time Determination,
T
Table of Physical Characteristics of
(1.5 ppm SO2) V-A495
Radionuclides Mentioned in the
Sulphite Standard Solution (80 ppm Suppositories and Pessaries,
European Pharmacopoeia, IV-634
SO2), see Sulfite Standard Solution Disintegration Test for, V-A335
Tablets, III-73, III-75
(80 ppm SO2) Surface Test, V-A531
Chocolate Basis for, III-75
Sulphomolybdic Reagent R3, see Surgical Spirit, III-1084
Content of active ingredient, III-75
Sulfomolybdic Reagent R3 Sutures, IV-721
Tablets and Capsules, Disintegration
Sulphomolybdic Reagent, see Sutures, Sterile Non-absorbable, IV-726
Test for, V-A333
Sulfomolybdic Reagent R2 Sutures, Sterile Synthetic Absorbable
Tablets, Disintegration Test for,
Sulphosalicylic Acid, see Sulfosalicylic Acid Braided, IV-723
V-A333–V-A378
Sulphur Dioxide, Determination of, see Sutures, Sterile Synthetic Absorbable
Tablets, Dissolution Test for, V-A336
Sulfur Dioxide, Determination of Monofilament, IV-724
Tablets, Friability of Uncoated, V-A493
Suxamethonium Chloride, II-963
Tablets of the BP, III-75 Technetium (99mTc) Mertiatide Test for Bacterial Endotoxins, V-A390
Tablets, Resistance to Crushing of, Injection, IV-706 Test for efficacy of antimicrobial
V-A495 Technetium (99mTc) Microspheres preservation, V-A477
Tadalafil, II-965 Injection, IV-707 Test for neurovirulence of live virus
Tagatose, V-A126 Technetium (99mTc) Pentetate Injection, vaccines, V-A447
Talc, V-A126 IV-708 Test for neurovirulence of poliomyelitis
Talc Dusting Powder, III-1087 Technetium (99mTc) Sestamibi Injection, vaccine (oral), V-A448
Talc, Purified, II-968 IV-709 Test for Sterility, V-A458
Talc, see Purified Talc Technetium (99mTc) Succimer Injection, Test for sterility of the product to be
Tamoxifen, V-S129 IV-710 examined, V-A459
Tamoxifen Citrate, II-970 Technetium (99mTc) Tin Pyrophosphate Test methods for cell cultures, V-A455
Tamoxifen Tablets, III-1087 Injection, IV-711 Testing of Vaccines, Production and,
Tamper-evident Container, Definition of, Technetium (99mTc) Colloidal Rhenium V-A446
I-16, II-16, III-16, IV-16, V-16 Sulphide Injection, see Technetium Testosterone, II-991, V-S130, V-A127
Tamper-proof Container, V-A530 (99mTc) Colloidal Rhenium Sulfide Testosterone Decanoate, II-993, V-S130
Tamper-proof Container, Definition of, Injection Testosterone Enantate, II-994
I-16, II-16, III-16, IV-16, V-16 Technetium (99mTc) Human Albumin Testosterone Enantate Injection,
Tampons, III-76 Injection, see Technetium (99mTc) III-1098
Medicated, III-76 Albumin Injection Testosterone Implants, III-1100
Tamsulosin Capsules, Prolonged-release, Technical Changes to Monographs, Testosterone Isocaproate, II-996, V-S130
III-1088 I-xxx Testosterone Propionate, II-998,
Tamsulosin Hydrochloride, II-972 Tecnazene, V-A127 V-S131, V-A127
Tamsulosin Tablets, Prolonged-release, Teicoplanin, II-975 Testosterone Propionate Injection,
III-1089 Telmisartan, II-977 III-1100
Tannic Acid, II-974, V-A126 Temazepam, II-979 Tests and Assays, I-12, II-12, III-12,
Tannic Acid Reagent, V-A127 Temazepam Oral Solution, III-1091 IV-12, V-12
Tannins in Herbal Drugs, Determination Temazepam Tablets, III-1092 Tetanus Antitoxin, IV-501
of, V-A324 Temperature, I-24, II-24, III-24, IV-24, Tetanus Antitoxin for Human Use, see
Tanshinone IIA CRS, V-A157 V-24 Tetanus Antitoxin
Tapioca Starch, II-914 Temperature, Expression of, I-6, II-6, Tetanus Immunoglobulin, IV-479
Tapped Density of Powders, Bulk III-6, IV-6, V-6 Tetanus Vaccine, (Adsorbed), IV-609
Density and, V-A516 Tenoxicam, II-981 Tetanus vaccine (adsorbed), Assay of,
Tar, II-974 Tenoxicam for Injection, III-1093 V-A424
Tar, Coal, II-974 Tenoxicam Injection, III-1093 Tetrabutylammonium Bromide, V-A127
Tartaric Acid, II-975, V-A127 Tenoxicam Tablets, III-1094 Tetrabutylammonium Buffer Solution
Tartrates, Reactions of, V-A258 Terazosin Hydrochloride Dihydrate, pH 7.0, V-A156
Taurodeoxycholic Acid Sodium Salt, II-982 Tetrabutylammonium Dihydrogen
V-A127 Terbinafine Hydrochloride, II-985 Orthophosphate, V-A127
Taxifolin, V-A127 Terbutaline Sulfate, II-986 Tetrabutylammonium Dihydrogen
Td/IPV, see Diphtheria, Tetanus and Terbutaline Sulphate, see Terbutaline Phosphate, see Tetrabutylammonium
Poliomyelitis (Inactivated) Vaccine Sulfate Dihydrogen Orthophosphate
(Adsorbed, Reduced Antigen(s) Content) Terbutaline Tablets, III-1096 Tetrabutylammonium Hydrogen Sulfate,
Tea Tree Oil, IV-369 Terconazole, II-988 V-A127
Tears, Artificial, III-650 Terfenadine, II-989, V-S129 Tetrabutylammonium Hydrogen Sulfate
Technetium, IV-696, IV-697 Terfenadine Oral Suspension, III-1097 R1, V-A128
Technetium (99mTc) Albumin Injection, Terfenadine Tablets, III-1097 Tetrabutylammonium Hydrogen
IV-694 Terminal sterilisation, V-A526 Sulphate R1, see Tetrabutylammonium
Technetium (99mTc) Bicisate Injection, Terminalia Arjuna Stem Bark, IV-370 Hydrogen Sulfate R1
IV-695 Terminalia Belerica Fruit, IV-371 Tetrabutylammonium Hydrogen
Technetium (99mTc) Colloidal Rhenium Terminalia Chebula Fruit, IV-372 Sulphate, see Tetrabutylammonium
Sulfide Injection, IV-696 Terminology used in Monographs on Hydrogen Sulfate
Technetium (99mTc) Colloidal Sulfur Biological Products, V-A446 Tetrabutylammonium Hydroxide,
Injection, IV-697 Terms, Definition of, I-5, II-5, III-5, V-A128
Technetium (99mTc) Colloidal Sulphur IV-5, V-5 Tetrabutylammonium Hydroxide in
Injection, see Technetium (99mTc) Terpeneless Lemon Oil, IV-240 2-Propanol, V-A145
Colloidal Sulfur Injection Terpeneless Orange Oil, IV-297 Tetrabutylammonium Hydroxide in
Technetium (99mTc) Colloidal Tin g-Terpinene, V-A127 Propan-2-ol VS, V-A145
Injection, IV-698 Terpinen-4-ol, V-A127 Tetrabutylammonium Hydroxide, 0.4M,
Technetium (99mTc) Etifenin Injection, Terpineol, II-991, V-A127 V-A128
IV-699 Terpinolene, V-A127 Tetrabutylammonium Hydroxide
Technetium (99mTc) Exametazime tert-Butyl Methyl Ether R1, see 1,1- Solution, V-A128
Injection, IV-700 Dimethylethyl Methyl Ether R1 Tetrabutylammonium Hydroxide
Technetium (99mTc) Gluconate tert-Butyl Methyl Ether, see 1,1- Solution (104 g/L), V-A128
Injection, IV-701 Dimethylethyl Methyl Ether Tetrabutylammonium Hydroxide
Technetium (99mTc) Macrosalb tert-Butylamine, see 1,1- Solution (400 g/L), V-A128
Injection, IV-702 Dimethylethylamine Tetrabutylammonium Hydroxide VS,
Technetium (99mTc) Mebrofenin tert-Butylhydroperoxide, V-A36 V-A145
Injection, IV-703 Test for Anti-D antibodies in human Tetrabutylammonium Iodide, V-A128
Technetium (99mTc) Medronate immunoglobulin for intravenous Tetrabutylammonium Iodide VS,
Injection, IV-704 administration, V-A417 V-A145
V-A834 Index
Tetracaine Eye Drops, III-1100 Tetrazolium Assay of Steroids, V-A275 Thin-layer Chromatography, Sample
Tetracaine Hydrochloride, II-999 Tetrazolium Blue, V-A129 application, V-A192
Tetrachloroethane, V-A128 Tetrazolium Blue Solution, Alkaline, Thin-layer Chromatography, Vertical
Tetrachlorvinphos, V-A128 V-A129 development, V-A192
Tetracosactide, II-1000 Tetrazolium Bromide, V-A129 Thin-layer Chromatography, Visual
Tetracosactide Injection, III-1101 Tetrazolium salt, V-A129 Evaluation, V-A192
Tetracosactide Zinc Injection, III-1102 Tetryzoline Hydrochloride, II-1006 Thin-layer Chromatography,
Tetracos-15-enoic acid methyl ester, Tet, see Adsorbed Tetanus Vaccine Visualisation reagents, V-A191
V-A128 Tet/Ser, see Tetanus Antitoxin Thioacetamide, V-A130
Tetracycline, II-1002, V-A128 Texture Analysis of Semi-solids or Gels, Thioacetamide Reagent, V-A130
Tetracycline Capsules, III-1103 V-A492 Thioacetamide Solution, V-A130
Tetracycline Hydrochloride, II-1003, Thallium Standard Solution (10 ppm Thiobarbituric Acid, V-A130
V-A128 Tl), V-A149 Thiobarbituric Acid–citrate Buffer,
Tetracycline Tablets, III-1104 Thallium(I) Nitrate, V-A129 V-A156
n-Tetradecane, V-A128 Thallium(I) Sulfate, V-A129 Thioctic Acid, II-1016
Tetradecylammonium Bromide, V-A128 Thallium(I) Sulphate, see Thallium(I) Thiodiethylene Glycol, see Thiodiglycol
Tetraethylammonium Hydrogen Sulfate, Sulfate Thiodiglycol, V-A130
V-A128 Thallous (201Tl) Chloride Injection, Thioglycollic Acid, see Mercaptoacetic
Tetraethylammonium Hydrogen IV-712 Acid
Sulphate, see Tetraethylammonium Thallous Sulfate, see Thallium(I) Sulfate Thiomalic acid, V-A130
Hydrogen Sulfate Thallous Sulphate, see hallous Sulfate Thiomersal, II-1018, V-A130
Tetraethylammonium Hydroxide Thebaine, V-A129 Thiopental, V-S131
Solution, V-A128 Theobroma Oil, II-1007 Thiopental Injection, III-1106
Tetraethylene Pentamine, V-A128 Theobromine, II-1007, V-A130 Thiopental Sodium, II-1019
Tetraheptylammonium Bromide, V-A128 Theophylline, II-1008, V-S131, V-A130 Thiopental Sodium and Sodium
Tetrahexylammonium Hydrogen Sulfate, Theophylline Hydrate, II-1009 Carbonate, see Thiopental Sodium
V-A128 Theophylline Monohydrate, see Thiopental Sodium for Injection,
Tetrahydrofuran, V-A128 Theophylline Hydrate III-1107
Tetrahydrofuran for Chromatography, Theophylline Tablets, Prolonged-release, Thioridazine, II-1020
V-A128 III-1104 Thioridazine (1), V-S132
Tetrahydrofuran, Stabiliser-free, V-A128 Theophylline-ethylenediamine, Thioridazine (2), V-S132
a-Tetralone, V-A129 Anhydrous, see Aminophylline Thioridazine Hydrochloride, II-1022
Tetramethylammonium Chloride, Theophylline-ethylenediamine Hydrate, Thiotepa, II-1023, V-S132
V-A129 see Aminophylline Hydrate Thiotepa for Injection, III-1108
Tetramethylammonium Hydrogen Thermal Analysis, Determination of, Thiotepa Injection, III-1108
Sulfate, V-A129 V-A250 Thiourea, V-A130
Tetramethylammonium Hydroxide Thermogravimetry, V-A250 THM, V-A608
Pentahydrate, V-A129 Thermomicroscopy, V-A251 THMP, V-A608
Tetramethylammonium Hydroxide Thermospray, Ionisation, Mass Thomson Kudzuvine Root, IV-231
Solution, V-A129 Spectrometry, V-A177 Three-lobed Sage Leaf, IV-337
Tetramethylammonium Hydroxide Thiamazole, II-1011, V-A130 Threonine, II-1024, V-A130
Solution, Dilute, V-A129 Thiamine Hydrochloride, II-1012 Threonine, see L-Threonine
Tetramethylammonium Hydroxide, see Thiamine Injection, III-1105 Thrombin, V-A130
Tetramethylammonium Hydroxide Thiamine Nitrate, II-1014 Thrombin, Bovine, V-A130
Pentahydrate Thiamine Tablets, III-1106 Thrombin, Human, see Thrombin
Tetramethylbenzidine, V-A129 Thiamphenicol, II-1015 Thrombin Solution, V-A130
1,1,3,3-Tetramethylbutylamine, V-A129 2-(2-Thienyl)acetic Acid, V-A130 Thrombin Solution, Human R1, V-A130
Tetramethyldiaminodiphenylmethane Thimerosal, see Thiomersal Thrombin Solution, Human, see
Reagent, see 4,4-Methylenebis-N,N- Thin-layer Chromatography, V-A191 Thrombin Solution
dimethylaniline Reagent Thin-layer Chromatography, Additional Thromboplastin, V-A130
Tetramethyldiaminodiphenylmethane, see points for the British Pharmacopoeia, Thromboplastin Reagent, V-A130
4,4-Methylenebis-N,N-dimethylaniline V-A193 Thujone, V-A130
Tetramethylethylenediamine, V-A129 Thin-layer Chromatography, Thyme, IV-373
Tetramethylsilane, V-A129 Chromatographic tank, V-A191 Thyme Oil, Thymol Type, IV-375
Tetrandrine, V-A129 Thin-layer Chromatography, Thyme Oil, see Thyme Oil, Thymol Type
1,2,3,4-Tetra-O-acetyl-b-D- Documentation, V-A191 Thyme, Wild, IV-376
glucopyranose, V-A127 Thin-layer Chromatography, Thymidine, V-A130
1,3,4,6-Tetra-O-acetyl-b-D- Fluorescence detection device, V-A191 Thymine, V-A130
mannopyranose, V-A127 Thin-layer Chromatography, Horizontal Thymol, II-1025, V-A130
Tetra-O-Acetyl-Mannose Triflate for development, V-A192 Thymol Blue, V-A131
Radiopharmaceutical Preparations, Thin-layer Chromatography, Thymol Blue Solution, V-A131
IV-647 Micropipettes, microsyringes, Thymolphthalein, V-A131
1,2,3,4-Tetraphenylcyclopenta-1,3-diene, calibrated disposable capillaries, Thymolphthalein Solution, V-A131
V-A129 V-A191 Thymoxamine Hydrochloride, see
1,2,3,4-Tetraphenylcyclopenta-1,3- Thin-layer Chromatography, Plates, Moxisylyte Hydrochloride
dienone, V-A129 V-A191 Thymoxamine Tablets, see Moxisylyte
Tetraphenylethylene, V-A129 Thin-layer Chromatography, Tablets
Tetrapropylammonium Chloride, Preconditioning of the plates, V-A191 Thyroxine Oral Solution, see
V-A129 Thin-layer Chromatography, Levothyroxine Oral Solution
Tetrazepam, II-1005 Quantitative Measurement, V-A192
Thyroxine Sodium, see Levothyroxine Tiotropium Bromide Monohydrate, Tolbutamide, II-1060, V-S134
Sodium II-1043 Tolbutamide Tablets, III-1123
Thyroxine Tablets, see Levothyroxine Titan Yellow, V-A131 Tolfenamic Acid, II-1061
Tablets Titan Yellow Paper, V-A131 o-Tolidine, V-A132
Tiabendazole, II-1026 Titan Yellow Solution, V-A131 o-Tolidine Solution, V-A132
Tiabendazole Chewable Tablets, Titanium, V-A131 Tolnaftate, II-1063
III-1109 Titanium Dioxide, II-1046, V-A131 Tolu Balsam, IV-377
Tiabendazole Tablets, see Tiabendazole Titanium Ointment, III-1119 Tolu Linctus, Paediatric Compound,
Chewable Tablets Titanium Standard Solution (100 ppm IV-379
Tianeptine Sodium, II-1027 Ti), V-A149 Tolu Oral Solution, Paediatric
Tiapride Hydrochloride, II-1028 Titanium Trichloride Solution, see Compound, IV-379
Tiaprofenic Acid, II-1029 Titanium(III) Chloride Solution Tolu Syrup, IV-379
Tibolone, II-1031 Titanium Trichloride, see Titanium(III) Toluene, V-A132
Tibolone Tablets, III-1109 Chloride Toluene, Sulfur-free, V-A132
Ticarcillin, V-S133 Titanium Trichloride–Sulfuric Acid Toluene, Sulphur-free, see Toluene,
Ticarcillin and Clavulanic Acid for Reagent, see Titanium(III) Chloride– Sulfur-free
Infusion, III-1111 Sulfuric Acid Reagent Toluene-o-sulfonamide, V-A133
Ticarcillin and Clavulanic Acid for Titanium Trichloride–Sulphuric Acid Toluene-o-sulphonamide, see Toluene-o-
Intravenous Infusion, see Ticarcillin and Reagent, see Titanium Trichloride– sulfonamide
Clavulanic Acid for Infusion Sulfuric Acid Reagent Toluene-p-sulfonamide, V-A133
Ticarcillin and Clavulanic Acid Infusion, Titanium(III) Chloride, V-A131 Toluene-p-sulfonic Acid, V-A133
III-1111 Titanium(III) Chloride Solution, V-A131 Toluene-p-sulphonamide, see Toluene-p-
Ticarcillin and Clavulanic Acid Titanium(III) Chloride VS, V-A145 sulfonamide
Intravenous Infusion, see Ticarcillin and Titanium(III) Chloride–Sulfuric Acid Toluene-p-sulphonic Acid, see Toluene-p-
Clavulanic Acid for Infusion Reagent, V-A131 sulfonic Acid
Ticarcillin Sodium, II-1032 Titanium(III) Chloride–Sulphuric Acid o-Toluenesulfonamide, see Toluene-o-
Ticarcillin Sodium and Potassium Reagent, see Titanium(III) Chloride– sulfonamide
Clavulanate Intravenous Infusion, see Sulfuric Acid Reagent p-Toluenesulfonamide, see Toluene-p-
Ticarcillin and Clavulanic Acid Infusion Titles of Monographs, Changes to, sulfonamide
Tic/enceph, see Tick-borne Encephalitis I-xxxiii Toluenesulfonic Acid, see Toluene-p-
Vaccine, Inactivated Titles, Official, I-7, II-7, III-7, IV-7, V-7 sulfonic Acid
Tick-borne Encephalitis Vaccine, Titration, Non-aqueous, V-A267 Toluenesulfonylurea, V-A133
Inactivated, IV-610 Titrations, Complexometric, V-A268 o-Toluenesulphonamide, see o-
Ticlopidine Hydrochloride, II-1034 Titrimetric Analysis, V-A759 Toluenesulphonamide
Tilidine Hydrochloride Hemihydrate, TLC Aluminium Oxide G Plate, V-A131 p-Toluenesulphonamide, see p-
II-1036 TLC Octadecylsilyl Silica Gel F254 Plate, Toluenesulfonamide
Time-of-flight analysers, V-A178 V-A132 Toluenesulphonamide, see
Timolol, V-S133 TLC Octadecylsilyl Silica Gel Plate, Toluenesulfonamide
Timolol Eye Drops, III-1114 V-A132 Toluenesulphonic Acid, see
Timolol Eye Drops, Dorzolamide and, TLC Performance Test Solution, Toluenesulfonic Acid
III-474 V-A132 Tolu-flavour Solution, IV-378
Timolol Maleate, II-1037 TLC Silica Gel F254 Plate, V-A132 o-Toluic Acid, V-A133
Timolol Tablets, III-1114 TLC Silica Gel F254 Silanised Plate, o-Toluidine, V-A133
Tin, V-A131 V-A132 Toluidine Blue, V-A133
Tin Liposoluble Standard Solution TLC Silica Gel G Plate, V-A132 o-Toluidine Hydrochloride, V-A133
(1000 ppm Sn), V-A149 TLC Silica Gel GF254 Plate, V-A132 Topical Powders, III-67
Tin Standard Solution (0.1 ppm Sn), TLC Silica Gel Plate, V-A132 Topical Powders of the BP, III-67
V-A149 TLC Silica Gel Plate for Aminopolyether Topical Preparations, III-70
Tin Standard Solution (5 ppm Sn), Test, V-A132 Topical Semi-solid Preparations, III-70
V-A149 TLC Silica Gel Plate for Chiral Topical Semi-solid Preparations of the
Tinctures of the BP, IV-48 Separations, Octadecylsilyl, V-A132 BP, III-72
Tinidazole, II-1039 TLC Silica Gel Silanised Plate, V-A132 Torasemide, Anhydrous, II-1064
Tin(II) Chloride, V-A131 Tobramycin, II-1047 Tormentil, IV-379
Tin(II) Chloride Solution, V-A131 Tobramycin Injection, III-1120 Tormentil Tincture, IV-380
Tin(II) Chloride Solution AsT, V-A131 a-Tocopherol, V-A132 Tosylarginine Methyl Ester
Tin(II) Chloride Solution R1, V-A131 Tocopherol, all-rac-Alpha, II-1049 Hydrochloride, V-A133
Tin(II) Chloride Solution R2, V-A131 Tocopherol, RRR-Alpha, II-1050 Tosylarginine Methyl Ester
Tinnevelly Senna Fruit, IV-350 a-Tocopheryl Acetate, V-A132 Hydrochloride Solution, V-A133
Tinnevelly Senna Pods, see Tinnevelly Tocopheryl Acetate, all-rac-Alpha, Tosylchloramide Sodium, II-1066
Senna Fruit II-1051 Tosyl-lysyl-chloromethane
Tinzaparin Sodium, II-1041 Tocopheryl Acetate Concentrate Hydrochloride, V-A133
Tinzaparin Sodium Injection, III-1115 (Powder Form), Alpha, II-1054 Tosylphenylalanylchloromethane,
Tioconazole, II-1041, V-S133 Tocopheryl Acetate, RRR-Alpha-, V-A133
Tioconazole Cream, III-1117 II-1053 Total Ash, V-A322
Tioconazole Cutaneous Solution, Tocopheryl Hydrogen Succinate, Alpha, Total Cholesterol in Oils Rich in Omega-
III-1118 II-1055 3-acids, V-A315
Tioconazole Nail Solution, III-1118 Tocopheryl Hydrogen Succinate, RRR- Total Ionic Strength Adjustment Buffer,
Tioguanine, II-1042, V-S134 Alpha, II-1057 V-A156
Tioguanine Tablets, III-1118 Tolazamide, II-1059, V-S134 Total Ionic Strength Adjustment Buffer
Tolazamide Tablets, III-1122 R1, V-A156
V-A836 Index
Total Organic Carbon in Water for Triamcinolone Acetonide Nasal Spray, Trimethadione, II-1105
Pharmaceutical Use, Determination of, III-1138 Trimethoprim, II-1106, V-S138
V-A253 Triamcinolone Cream, III-1135 Trimethoprim and Sulfamethoxazole
Total Protein, Determination of, V-A283 Triamcinolone Dental Paste, III-1136 Oral Suspension, see Co-trimoxazole
Total Solids, Determination of, V-A319– Triamcinolone Hexacetonide, II-1083, Oral Suspension
V-A332 V-S137 Trimethoprim and Sulfamethoxazole
Total Viable Aerobic Count, V-A637 Triamcinolone Hexacetonide Injection, Preparations, see Co-trimoxazole
Toxaphene, V-A133 III-1139 Preparations
Toxicodendron Quercifolium for Triamcinolone Ointment, III-1135 Trimethoprim and Sulfamethoxazole
Homoeopathic Preparations, IV-443 Triamcinolone Oromucosal Paste, Tablets, Dispersible, see Co-trimoxazole
Trachyspermum Ammi, IV-380 III-1136 tablets, Dispersible
Traditional Herbal and Complementary Triamcinolone Tablets, III-1137 Trimethoprim and Sulfamethoxazole
Medicines, Crude Drugs; Status of, Triamterene, II-1085 Tablets, see Co-trimoxazole Tablets
I-17, II-17, III-17, IV-17, V-17 Triamterene and Hydrochlorothiazide Trimethoprim Oral Suspension, III-1143
Traditional Herbal Medicines, I-xxii, Tablets, III-388 Trimethoprim Tablets, III-1144
V-A763 Triamterene Capsules, III-1139 Trimethylchlorosilane, V-A134
Traditional Herbal Medicines, Tribasic Calcium Phosphate, see Calcium 2,2,4-Trimethylpentane, V-A134
Supplementary Chapter VII, V-A763 Phosphate Trimethylpentane for chromatography,
Tragacanth, IV-381, V-A133 Tribenoside, II-1086 V-A135
Tramadol Capsules, III-1123 Tribromophenol, V-A133 Trimethylpentane R1, V-A135
Tramadol Capsules, Prolonged-release, Tributyl Acetylcitrate, II-1087 Trimethylpentane, see 2,2,4-
III-1124 Tributyl Citrate, V-A133 Trimethylpentane
Tramadol Hydrochloride, II-1066, Tributyl Orthophosphate, V-A133 Trimethylsilyl Silica Gel for
V-S135 Tributyl Phosphate, II-1089, V-A133 Chromatography, V-A116
Tramadol Tablets, Prolonged-release, Trichlorethylene, see Trichloroethylene N-Trimethylsilylimidazole, V-A135
III-1125 Trichloroacetic Acid, II-1090, V-A134 3-Trimethylsilyl-1-propanesulfonic Acid,
Tramazoline Hydrochloride Trichloroacetic Acid Cutaneous Sodium Salt, V-A135
Monohydrate, II-1068 Solution, see Trichloroacetic Acid Trimethylsulfonium Hydroxide, V-A135
Trandolapril, II-1069, V-S135 Solution Trimethylsulphonium Hydroxide, see
Trandolapril Capsules, III-1126 Trichloroacetic Acid Solution, III-1140, Trimethylsulfonium Hydroxide
Tranexamic Acid, II-1071, V-S135 V-A134 Trimipramine Maleate, II-1108, V-S138
Tranexamic Acid Injection, III-1128 1,1,1-Trichloroethane, V-A134 Trimipramine Tablets, III-1145
Tranexamic Acid Mouthwash, III-1129 Trichloroethylene, V-A134 Tri-n-butyl Phosphate, see Tributyl
Tranexamic Acid Tablets, III-1129 Trichlorotrifluoroethane, V-A134 Phosphate
trans-Cinnamic Acid, V-A44 Tricine, V-A134 Trinitrin Tablets, see Glyceryl Trinitrate
trans-Cinnamic Aldehyde, V-A44 Triclofos Oral Solution, III-1140 Tablets
Transdermal Patches, III-76 Triclofos Sodium, II-1091, V-S137 2,4,6-Trinitrobenzene Sulfonic Acid,
Transdermal Patches, Dissolution Test Tricosane, V-A134 V-A135
for, V-A346 Tridocosahexaenoin, V-A134 2,4,6-Trinitrobenzenesulphonic Acid, see
Transmitting Agents of Animal Triethanolamine, II-1091, V-A134 2,4,6-Trinitrobenzenesulfonic Acid
Spongiform Encephalopathies, Triethyl Citrate, II-1094 Triolein, V-A135
Products with Risk of, II-900 Triethyl Phosphonoformate, V-A134 Triphenylamine, V-A135
Transmitting Animal Spongiform Triethylamine, V-A134 Triphenylethylene, V-A135
Encephalopathy Agents Via Human Triethylamine Hydrogen Carbonate Triphenylmethanol, V-A135
and Veterinary Medicinal Products, Solution, V-A134 2,3,5-Triphenyltetrazolium Chloride,
Minimising the Risk of, V-A592 Triethylamine R2, V-A134 V-A135
Transparency, V-A649, V-A651 Triethylenediamine, V-A134 Triphenyltetrazolium Chloride Solution,
Transparency of Monographs, V-A619 Triflumuron, V-A134 V-A135
Tranylcypromine Sulfate, II-1072, Trifluoperazine, V-S137 Tripotassium Phosphate Trihydrate,
V-S136 Trifluoperazine Hydrochloride, II-1095 V-A135
Tranylcypromine Tablets, III-1130 Trifluoperazine Tablets, III-1141 Triprolidine Hydrochloride, II-1110,
Trapidil, II-1073 Trifluoroacetic Acid, V-A134 V-S139
Trazodone Capsules, III-1131 Trifluoroacetic Anhydride, V-A134 Triprolidine Tablets, III-1145
Trazodone Hydrochloride, II-1074, 3-Trifluoromethylaniline, V-A134 Tris-acetate Buffer Solution pH 8.5,
V-S136 4-Trifluoromethylphenol, V-A134 V-A156
Trazodone Tablets, III-1132 Trifluorothymidine Eye Drops, see Tris-albumin buffer solution, V-A419
Treated Ethyl Acetate, V-A62 Trifluridine Eye Drops Tris-chloride Buffer pH 7.4, V-A156
Treated Formamide, V-A66 Trifluorothymidine, see Trifluridine Tris-chloride Buffer pH 7.5, V-A156
Trehalose Dihydrate, II-1076 Trifluridine, II-1095, V-S138 Tris-chloride Buffer pH 7.5 R1, V-A156
Tretinoin, II-1078 Trifluridine Eye Drops, III-1141 Tris-chloride Buffer pH 8.1, V-A156
Tretinoin Cutaneous Solution, see Triflusal, II-1097 Tris-chloride Buffer pH 8.6, V-A156
Tretinoin Solution Triglycerides, Medium-chain, II-1098 Triscyanoethoxypropane, V-A135
Tretinoin Gel, III-1134 Triglycerol Diisostearate, II-1100 1,3,5-Tris(3,5-di-(1,1-dimethylethyl)-4-
Tretinoin Solution, III-1134 Trigonelline Hydrochloride, V-A134 hydroxybenzyl)-1H,3H,5H-1,3,5-
Triacetin, II-1080, V-A133 Trihexyphenidyl Hydrochloride, II-1101 triazine-2,4,6-trione, V-A135
Triamcinolone, II-1080, V-A133 Trihexyphenidyl Tablets, III-1142 Tris-(2,4-di-(1,1-dimethylethyl)phenyl)
Triamcinolone Acetonide, II-1081, Trimebutine Maleate, II-1102 Phosphite, V-A135
V-S136, V-A133 Trimetazidine Dihydrochloride, see Tris-EDTA BSA Buffer Solution
Triamcinolone Acetonide Injection, Trimetazidine Hydrochloride pH 8.4, V-A156
III-1137 Trimetazidine Hydrochloride, II-1103 Tris-EDTA Buffer pH 8.4, V-A156
Tris-glycine Buffer Solution pH 8.3, Tris-sodium Acetate-sodium Chloride Ultraviolet ray lamps for analytical
V-A156 Buffer Solution pH 8.0, V-A157 purposes, V-A193
Tris-hydrochloride Buffer Solution Tritiated (3H) Water Injection, IV-713 Umbelliferone, V-A136
pH 6.8, 1M, V-A156 Trolamine, see Triethanolamine Uncoated Tablets, Friability of, V-A493
Tris-hydrochloride Buffer Solution Trometamol, II-1110 Undecanoic Acid, V-A136
pH 7.5, 0.05M, V-A156 Tropic Acid, V-A135 Undecenoic Acid, II-1125
Tris-hydrochloride Buffer Solution Tropicamide, II-1111, V-S139 Undecylenic Acid, see Undecenoic Acid
pH 8.0, V-A156 Tropicamide Eye Drops, III-1146 Uniformity of Content, V-A357
Tris-hydrochloride Buffer Solution Tropine, V-A135 Uniformity of Dosage Units, V-A358
pH 8.3, V-A156 Tropisetron Hydrochloride, II-1113 Uniformity of Weight (Mass), V-A357
Tris-hydrochloride Buffer Solution Trospium Chloride, II-1115 Uniformity of Weight (Mass), Capsules,
pH 8.8, 1.5M, V-A156 Troxerutin, II-1116, V-A135 V-A357
Tris-hydrochloride Buffer Solution True density, V-A254 Uniformity of (Weight) Mass of
pH 9.0, 0.05M, V-A156 True Potency, V-A635 Delivered Doses from Multidose
Tris(hydroxymethyl)aminoethane Trypsin, II-1117, V-A136 Containers, V-A357
Solution R1, V-A135 Trypsin for Peptide Mapping, V-A136 Uniformity of Weight (Mass), Powders
Tris(hydroxymethyl)aminomethane Tryptophan, II-1119, V-A136 for Parenteral Use, V-A357
Buffer Solution pH 7.5, see Tris- TSE, see Products with risk of transmitting Units, International System Of, I-31,
chloride Buffer pH 7.5 Agents of Animal Spongiform II-31, III-31, IV-31, V-31
Tris(hydroxymethyl)aminomethane Encephalopathies Units of Activity of Biological
Buffer Solution pH 8.1, see Tris- Tuberculin for Human Use, Old, see Old Preparations, V-A632
chloride Buffer pH 8.1 Tuberculin Units of Biological Activity, Definition
Tris(hydroxymethyl)aminomethane Tuberculin, Old, IV-622 of, I-14, II-14, III-14, IV-14, V-14
Buffer Solution pH 8.1, V-A157 Tuberculin P.P.D., see Tuberculin Purified Unlicensed Medicines, I-xxiii, V-A752
Tris(hydroxymethyl)aminomethane Protein Derivative Unlicensed Medicines, Ethical
Buffer Solution pH 7.4, V-A157 Tuberculin Purified Protein Derivative, Considerations, V-A752
Tris(hydroxymethyl)aminomethane IV-623 Unlicensed Medicines, General
Buffer Solution pH 7.5, V-A157 Tuberculin Purified Protein Derivative monograph for, III-77
Tris(hydroxymethyl)aminomethane for Human Use, see Tuberculin Purified Unlicensed Medicines, Guidance,
EDTA Buffer Solution pH 8.4, see Protein Derivative V-A752
Tris-EDTA Buffer pH 8.4 Tubes for Comparative Tests, I-12, Unlicensed Medicines, Labelling of,
Tris(hydroxymethyl)aminomethane II-12, III-12, IV-12, V-12, V-A259 III-77, V-A753
sodium chloride buffer solution Tubing Used in Sets for the Transfusion Unlicensed Medicines, Legal
pH 7.4, see Tris-chloride Buffer pH 7.4 of Blood and Blood Components, Requirements, V-A752
Tris(hydroxymethyl)aminomethane Materials Based on Plasticised Unlicensed Medicines, Monograph
Sodium Chloride Buffer Solution Poly(Vinyl Chloride) for, V-A548 Selection, V-A754
pH 7.4 R1, V-A157 Turbidimetry, V-A232 Unlicensed Medicines, Preservative-free,
Tris(hydroxymethyl)aminomethane Turbidity standard, V-A231 V-A754
Sodium Chloride Buffer solution Turmeric, Javenese, IV-382 Unlicensed Medicines, Standards for
pH 7.4, see tris-chloride buffer pH 7.4 Turmeric Rhizome, IV-383 Preparation and Manufacture, V-A753
Tris(hydroxymethylaminomethane) Turpentine Oil, IV-384 Unlicensed Medicines, Status of, I-18,
Solution, see Turpentine Oil, Pinus Pinaster Type, II-18, III-18, IV-18, V-18
Tris(hydroxymethyl)methylamine IV-384 Unsaponifiable Matter, V-A307
Solution Typhoid (live, oral), see Typhoid (Strain Uracil, V-A136
Tris(hydroxymethyl)aminomethane- Ty 21a) Vaccine, Live (Oral) Urea, II-1125, V-A136
EDTA Buffer Solution pH 8.4, Typhoid Polysaccharide Vaccine, IV-612 Urea Cream, III-1147
V-A157 Typhoid (Strain Ty 21a) Vaccine, Live Urease-active Meal, V-A136
Tris(hydroxymethylaminomethane), see (Oral), IV-615 Uridine, V-A136
Tris(hydroxymethyl)methylamine Typhoid Vaccine, IV-614 Urofollitropin, II-1126
Tris(hydroxymethyl)methylamine, Typhoid Vaccine, Freeze-dried, IV-614 Urofollitropin for Injection, III-1148
V-A135 Typhoid, see Typhoid Polysaccharide Urofollitropin Injection, III-1147
Tris(hydroxymethyl)methylamine Vaccine Urokinase, II-1128
Solution, V-A135 Typhoid, see Typhoid Vaccine Uronic acids in Polysaccharide Vaccines,
Tris(hydroxymethyl)methylamine Typhoid, see Typhoid Vaccine, Freeze-dried V-A451
Solution, Methanolic, V-A135 Tyramine, V-A136 Ursodeoxycholic Acid, II-1129, V-S139
Tris(hydroxymethyl)nitromethane, Tyrosine, II-1121, V-A136 Ursodeoxycholic Acid Capsules, III-1148
V-A135 Tyrosine, see L-Tyrosine Ursodeoxycholic Acid Tablets, III-1149
Trisodium Citrate, see Sodium Citrate Tyrothricin, II-1122 Ursolic Acid, V-A136
Trisodium Edetate Infusion, III-1146 Urtica Urens Herb for Homoeopathic
Trisodium Edetate Intravenous Infusion, Preparations, IV-446
see Trisodium Edetate Infusion
Trisodium Orthophosphate, V-A135
U Urushiol I, V-A136
Urushiol II, V-A136
Ubidecarenone, II-1123
Trisodium Phosphate Dodecahydrate, see
Ultraviolet and Visible Absorption
Trisodium Orthophosphate
Spectrophotometry, V-A165
Tris-sodium Acetate Buffer Solution
pH 7.4, V-A157
Ultraviolet and Visible Absorption V
Spectrophotometry, Derivative Vaccine Strain, Choice of, I-9, II-9,
Tris-sodium Acetate Buffer Solution
Spectrophotometry, V-A166 III-9, IV-9, V-9
pH 8.0, V-A157
Ultraviolet Light, Definition of, V-A193 Vaccines, IV-502
Tris-sodium Acetate-sodium Chloride
Buffer Solution pH 7.4, V-A157
V-A838 Index
Vaccines, Adsorbed, Aluminium in, Vegetable Oil, Hydrogenated, II-1145 Searle type, V-A245
V-A446 Venlafaxine Capsules, Prolonged-release, Spindle, V-A246
Vaccines, Adsorbed, Calcium in, V-A447 III-1154 U-tube, V-A243
Vaccines and Immunosera (Antisera), Venlafaxine Hydrochloride, II-1145, Viscose Wadding, Absorbent, IV-720
Phenol in, V-A447 V-S140 Viscosity, V-A243, V-A244, V-A245,
Vaccines for Human Use, Cell Venlafaxine Tablets, III-1156 V-A247
Substrates for the Production of, Venlafaxine Tablets, Prolonged-release, Capillary viscometer method, V-A244
V-A454 III-1157 Coefficient, V-A243
Vaccines for Human Use, see Vaccines Verapamil, V-S140 Determination of, V-A243
Vaccines, Production and Testing of, Verapamil Capsules, Prolonged-release, Dynamic, V-A243
V-A446 III-1158 Falling ball viscometer method,
Vaginal Preparations, III-79 Verapamil Hydrochloride, II-1147 V-A247
Valaciclovir Hydrochloride, Anhydrous, Verapamil Injection, III-1159 Kinematic, V-A243
II-1131 Verapamil Tablets, III-1160 Rotating viscometer method, V-A245
Valencene, V-A136 Verapamil Tablets, Prolonged-release, Visible Absorption Spectrophotometry,
Valerenic Acid, V-A136 III-1161 Ultraviolet and, V-A165
Valerian, IV-385 Veratric Acid, V-A136 Visible Particles, Particulate
Valerian Dry Aqueous Extract, IV-388 Veratrole, V-A136 Contamination, V-A381
Valerian Dry Hydroalcoholic Extract, Verbena Herb, IV-391 Vitamin A, II-1159
IV-389 Verbenone, V-A136 Vitamin A Concentrate (Oily Form),
Valerian Root, Cut, see Cut Valerian Very Fine Powder, Definition of, V-A483 Synthetic, see Synthetic Retinol
Valerian Root, see Valerian Vigabatrin, II-1149, V-S141 Concentrate (Oily Form)
Valerian Tincture, IV-390 Vigabatrin Oral Powder, III-1162 Vitamin A Concentrate (Powder Form),
Valeriana, V-A590 Vigabatrin Tablets, III-1162 Synthetic, see Synthetic Retinol
Valeric Acid, V-A136 Vinblastine Injection, III-1163 Concentrate (Powder Form)
Validation of Alternative Qualitative Vinblastine Sulfate, II-1151 Vitamin A Concentrate,
Tests for the Presence or Absence of Vinblastine Sulfate for Injection, (Solubilisate/Emulsion), Synthetic, see
Micro-Organisms, V-A722 III-1163 Synthetic Retinol Concentrate,
Validation of Alternative Quantitative Vinblastine Sulphate, see Vinblastine Solubilisate/Emulsion
Tests for the Presence or Absence of Sulfate Vitamin A Ester Concentrate, Natural,
Micro-Organisms, V-A723 Vincristine Injection, III-1164 II-1161
Validation of Analytical Procedures, Vincristine Sulfate, II-1152 Vitamin B6, see Pyridoxine Hydrochloride
V-A653 Vincristine Sulfate for Injection, III-1164 Vitamins A, C and D Oral Drops,
Validation of pharmacopoeial methods, Vincristine Sulphate, see Vincristine Paediatric, III-1166
I-21, II-21, III-21, IV-21, V-21 Sulfate Vitamins B and C Injection, III-1169
Valine, II-1135, V-A136 Vindesine Injection, III-1165 Vitexin, V-A137
Valproic Acid, II-1136, V-S140 Vindesine Sulfate, II-1154 Volatile Oil in Drugs, see Essential Oils in
Valsartan, II-1137 Vindesine Sulfate for Injection, III-1165 Herbal Drugs, Determination of
Vanadium Standard Solution (1 g/L V), Vindesine Sulphate, see Vindesine Sulfate Voltametric Titrations, V-A268
V-A149 Vinorelbine Tartrate, II-1155 Volumetric Reagents, V-A139
Vancomycin Capsules, III-1151 Vinpocetine, II-1158 Volumetric Solutions, V-A139
Vancomycin Hydrochloride, II-1139 Vinyl Acetate, V-A136 Volumetric Solutions, Preparation and
Vancomycin Hydrochloride for Infusion, Vinyl Chloride, V-A136 Standardisation, V-A139
III-1152 Vinyl Polymer for Chromatography, von Willebrand Factor, IV-482
Vancomycin Hydrochloride for Injection, Octadecyl, V-A137 von Willebrand factor, human, Assay of,
see Vancomycin Hydrochloride for Vinyl Polymer for Chromatography, V-A406
Infusion Octadecylsilyl, V-A137 Voriconazole, II-1163
Vancomycin Hydrochloride for 2-Vinylpyridine, V-A137 VS, V-A608
Intravenous Infusion, see Vancomycin 1-Vinylpyrrolidin-2-one, V-A137
Hydrochloride for Infusion Vinylpyrrolidone Copolymer for
Vancomycin Hydrochloride for Oral
Solution, III-1153
Chromatography, Divinylbenzene and,
V-A60
W
Wadding, Viscose, Absorbent, IV-720
Vancomycin Infusion, III-1152 Viper Venom Antiserum, European,
Warfarin, V-S141
Vancomycin Injection, see Vancomycin IV-497
Warfarin Oral Suspension, III-1170
Infusion Viral Safety, V-A592
Warfarin Sodium, II-1165
Vancomycin Intravenous Infusion, see Viral Vaccines, Extraneous Agents in,
Warfarin Sodium Clathrate, II-1166
Vancomycin Infusion V-A475
Warfarin Tablets, III-1171
Vancomycin Oral Solution, III-1153 Virgin Almond Oil, I-101
Washed Flux-calcined Diatomaceous
Vanillin, II-1141, V-A136 Virgin Castor Oil, I-423
Filter-aid, V-A50
Vanillin Reagent, V-A136 Virgin Linseed Oil, II-114
Water, V-A137
Vanillin Solution, Phosphoric, V-A136 Virgin Olive Oil, II-427
Water (15O) Injection, IV-714
Varicella Immunoglobulin, IV-481 Virgin Wheat-germ Oil, II-1176
Water, Ammonia-free, V-A137
Varicella Immunoglobulin for Viscometer, V-A243, V-A245, V-A246,
Water, Ammonium-free, see Water,
Intravenous Use, IV-482 V-A247
Ammonia-free
Varicella Vaccine, (Live), IV-616 Absolute, V-A245
Water Bath, Definition of, I-7, II-7,
Var(live), see Varicella Vaccine (Live) Concentric cylinder, V-A245
III-7, IV-7, V-7
Vectors for Human Use, Poxvirus, Cone-plate, V-A246
Water, Carbon Dioxide-free, V-A137
V-A738 Couette type, V-A245
Water, Determination of, V-A294
Vecuronium Bromide, II-1141 Falling ball, V-A247
Vegetable Fatty Oils, II-1143 Relative, V-A246
Water, Determination of, Micro, see Willow Bark, IV-393 Zidovudine Capsules, III-1173
Determination of Water, Method III Willow Bark Dry Extract, IV-394 Zidovudine Tablets, III-1174
Water, Distilled, V-A137 Withaferin A CRS, V-A157 Zinc, V-A138, V-A139
Water, Distilled, Deionised, V-A137 Withania Somnifera Root, IV-395 Zinc Acetate, II-1193, V-A138
Water for Chromatography, V-A137 Withania Somnifera Root for use in Zinc Acetate Cutaneous Solution,
Water for Diluting Concentrated THMP, see Withania Somnifera Root Erythromycin and, see Erythromycin
Haemodialysis Solutions, III-613 Withanolide A CRS, V-A157 and Zinc Acetate Lotion
Water for Formulated Preparations, Withanolide B CRS, V-A157 Zinc Acetate Dihydrate, see Zinc Acetate
Quality of, I-10, II-10, III-10, IV-10, Wool Alcohols, II-1177 Zinc Acetate Lotion, Erythromycin and,
V-10 Wool Alcohols Ointment, III-1172 III-507
Water for Injections, II-1172, V-A137 Wool Fat, II-1178 Zinc Acetate Solution, V-A138
Water for Preparation of Extracts, Wool Fat, Hydrogenated, II-1182 Zinc Acexamate, II-1194
II-1175 Wool Fat, Hydrous, II-1183 Zinc, Activated, V-A138
Water for Use in Manufacturing Wool Wax Alcohols, see Wool Alcohols Zinc and Castor Oil Cream, III-1179
Parenteral Preparations, III-66 Working Parties, I-xii Zinc and Castor Oil Ointment, III-1179
Water, Highly Purified, II-1170 Wormwood, IV-397 Zinc and Coal Tar Paste, III-1179
Water in Essential Oils, V-A309 wP, see Pertussis Vaccine (Whole Cell, Zinc and Hexachlorophene Dusting
Water in Medicinal Gases, Adsorbed) Powder, III-623
Determination of, V-A298 Zinc and Ichthammol Cream, III-1179
Water, Nitrate-free, V-A137 Zinc and Salicylic Acid Paste, III-1179
Water, Particle-free, V-A137
Water, Potable, I-10, II-10, III-10,
X Zinc and Zinc Salts, Reactions of,
V-A258
Xanthan Gum, II-1184
IV-10, V-10 Zinc Chloride, II-1196, V-A138
Xanthines, Reactions of, V-A258
Water, Purified, II-1168 Zinc Chloride Solution, Iodinated,
Xanthydrol, V-A137
Water R1, V-A137 V-A138
Xanthydrol R1, V-A137
Water, Standard Solution for the Micro Zinc Chloride VS, V-A145
Xanthydrol Reagent, V-A137
Determination of, V-A149 Zinc Chloride–Formic Acid Solution,
Xanthydrol Solution, V-A137
Water-bath, I-23, II-23, III-23, IV-23, V-A138
Xenon (133Xe) Injection, IV-714
V-23 Zinc Cream, III-1177
X-Ray Fluorescence Spectrometry,
Water-Solid Interactions, V-A300 Zinc Gluconate, II-1196
V-A175
Determination of Sorption- Zinc Iodide, V-A138
X-ray Powder Diffraction (XRPD),
Desorption Isotherms and of Water Zinc Iodide and Starch Solution,
Characterisation of Crystalline and
Activity, V-A300 V-A138
Partially Crystalline Solids by, V-A508
Water-soluble Extractive, Determination Zinc Ointment, III-1177
XRPD, Characterisation of Crystalline
of, V-A319 Zinc Ointment, Coal Tar and, III-1091
and Partially Crystalline Solids by
Weak Cationic Resin, V-A39 Zinc Oxide, II-1197, V-A138
X-ray Powder Diffraction, V-A508
Weak Copper Sulfate Solution, V-A46 Zinc Paste, Compound, III-1177
m-Xylene, V-A137, V-A138
Weak Ginger Tincture, IV-193 Zinc Powder, V-A138
Xylene Cyanol FF, V-A138
Websites, I-xxvi Zinc Shot, V-A138
Xylenol Orange, V-A138
Weight per millilitre, Determination of, Zinc Standard Solution (5 mg/mL Zn),
Xylenol Orange Solution, V-A138
V-A241 V-A149
Xylenol Orange Triturate, V-A138
Weights and Measures, Expression of, Zinc Standard Solution (5 ppm Zn),
Xylitol, II-1186
I-6, II-6, III-6, IV-6, V-6 V-A150
Xylometazoline, V-S141
Weights, Atomic, I-6, II-6, III-6, IV-6, Zinc Standard Solution (10 ppm Zn),
Xylometazoline Hydrochloride, II-1188
V-6 V-A149
Xylometazoline Nasal Drops, III-1172
Well-closed Container, V-A530 Zinc Standard solution (25 ppm Zn),
Xylose, II-1189, V-A138
Wettability of Porous Solids including V-A149
Powders, V-A518 Zinc Standard Solution (100 ppm Zn),
Wheat Starch, II-915 V-A149
Wheat-germ Oil, Refined, II-1177 Y Zinc Stearate, II-1198
Wheat-germ Oil, Virgin, II-1176 Yarrow, IV-398 Zinc Sulfate, V-A138
White Beeswax, I-239 Yel(live), see Yellow Fever Vaccine, Live Zinc Sulfate Capsules, III-1178
White Cutaneous Emulsion, III-732 Yellow Beeswax, I-239 Zinc Sulfate Eye Drops, III-1178
White Embrocation, III-732 Yellow Fever Vaccine, Live, IV-617 Zinc Sulfate Heptahydrate, II-1199
White Horehound, IV-212 Yellow Mercury(II) Oxide, V-A83 Zinc Sulfate Hexahydrate, II-1199
White Liniment, III-732 Yellow Petroleum Jelly, see Yellow Soft Zinc Sulfate Injection, III-1178
White Peony Root, IV-306 Paraffin Zinc Sulfate Lotion, III-1178
White Peony Root for use in THM, see Yellow Soft Paraffin, II-504 Zinc Sulfate Monohydrate, II-1200
White Peony Root Yellow solution, V-A233 Zinc Sulfate Tablets, III-1178
White Petroleum Jelly, see White Soft Yohimbine Hydrochloride, II-1190 Zinc Sulfate VS, V-A145
Paraffin Zinc Sulphate Capsules, see Zinc Sulfate
White Soft Paraffin, II-503, V-A97 Capsules
White’s Tar Paste, III-1179
Whitfield’s Ointment, see Compound
Z Zinc Sulphate Eye Drops, see Zinc Sulfate
Eye Drops
(3Z)-3-Butylidene-1,3,4,5-
Benzoic Acid Ointment Zinc Sulphate Injection, see Zinc Sulfate
tetrahydroisobenzofuran-1-one, see
WHO ISA, V-A632 Injection
(Z)-Ligustilide
Wild Pansy, IV-302 Zinc Sulphate Lotion, see Zinc Sulfate
Zidovudine, II-1191, V-S142
Wild Pansy (Flowering Aerial Parts), see Lotion
Zidovudine and Lamivudine Tablets,
Wild Pansy Zinc Sulphate Tablets, see Zinc Sulfate
III-1175
Wild Thyme, IV-376 Tablets
V-A840 Index
Zinc Sulphate VS,ee Zinc Sulfate VS,

V-A145
Zinc Sulphate, see Zinc Sulfate
Zinc Undecenoate, II-1200
Zinc Undecylenate, see Zinc Undecenoate
Zincum Sulfuricum, V-A590
Ziprasidone Hydrochloride
Monohydrate, II-1201
Zirconium Standard Solution (1 g/L Zr),
V-A150
Zirconyl Chloride, V-A138
Zirconyl Nitrate, V-A138
Zirconyl Nitrate Solution, V-A138
(Z)-Ligustilide, V-A79
Z-Ligustilide CRS, V-A157
Zolpidem Tartrate, II-1203
Zone Electrophoresis Using a Supporting
Medium, V-A201
Zopiclone, II-1204, V-S142
Zopiclone Tablets, III-1180
Zuclopenthixol Acetate, II-1206, V-S142
Zuclopenthixol Acetate Injection,
III-1181
Zuclopenthixol Decanoate, II-1207
Zuclopenthixol Decanoate Injection,
III-1183
Zuclopenthixol Hydrochloride, II-1209,
V-S143
Zuclopenthixol Tablets, III-1183

BP 2014 Index

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

BP 2014 Index

Hochgeladen von

Copyright:

Verfügbare Formate

page numbers in bold type relate to monograph titles Index V-A767

Pages – Vol I: i – xxxiv, (Preliminaries and Introduction)

Acetate Buffer Solution pH 4.6, see N-Acetyl-L-cysteine, V-A20

Adamantane, V-A21 Diphtheria, Tetanus, Pertussis (Acellular Alcoholic Dimethylaminobenzaldehyde

Aminomethylalizarindiacetic Acid Ammonia, Concentrated, V-A25 Ammonium Citrate, V-A26

Bisbenzimide, V-A33 Blood and Blood Components, Materials Bromazepam, I-309

2,6-Dichlorophenolindophenol Sodium Diethylene Glycol in Ethoxylated 5,7-Di-iodo-8-hydroxyquinoline, V-A54

Fluorometholone, I-976 Medicated, III-47 Freezing Point, Determination of,

4-Methylpentan-2-ol, V-A88 Metronidazole Suppositories, III-809 Micro-Organisms, Validation of

Naproxen Tablets, III-848 Neomycin Tablets, III-852 Nicotinamide-adenine Dinucleotide,

Phosphate Buffer Solution pH 5.4, Phthalic Anhydride, V-A102 Pivampicillin, II-601

Sterile Norepinephrine Concentrate, Streptomycin Injection, III-1073 Sub-visible Particles, Particulate

Zinc Sulphate VS,ee Zinc Sulfate VS,

Das könnte Ihnen auch gefallen